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Low Back Pain (LBP) is a condition that most people experience at least once in their 
lifetime and for which many will seek physiotherapeutic intervention. Recently published 
and internationally recognised clinical guidelines for the management of LBP recommend 
the use of spinal manual and manipulative therapy techniques alongside exercise, advice, 
education  and pharmaceutical therapies, particularly in the early stages. Other areas of 
development in the last decade include classification systems, clinical prediction rules 
(CPR‘s), patient-reported outcome measures (PROMS‘s) and minimum clinically important 
difference (MCID) thresholds. Additionally, sympathetic nervous system (SNS) measures 
of treatment responses are now recognised as providing quantifiable indicators of 
peripheral, spinal and central effects of manual therapy interventions although research in 
the lumbar spine is very limited with none providing data on a patient population.  
The aims of the study were; to determine the reliability and stability of the Biopac System 
in recording skin conductance (SC) activity levels and calculate the smallest real difference 
(SRD) statistic; to generate data on the magnitude of SC response to two commonly 
utilised treatments for LBP; and to observe the changes in a clinical population receiving 
guideline-endorsed physiotherapy treatment for the management of acute and sub-acute 
LBP. Furthermore, clinical data analysis sought to identify correlations of SC measures to 
PROM‘s and evaluate the feasibility of using SC responses as a predictive tool for 
therapeutic outcome. 
The ability of the Biopac System to reliably record SNS activity was established by using 
SC measurements with 12 participants on two occasions, one-week apart. Data was 
recorded within a natural, non-laboratory setting. Results established that SC 
measurements could be reliably recorded between data sessions with a measurement 
variability of; ICC=0.99 (p<0.005) with an SRD value of 0.315 μmho‘s (4.633%). In 
conclusion, any SC change above the SRD could be regarded as an SNS change that is 
independent of any measurement error or variability thus representing a real change 
ascribable to the intervention under investigation.  
The pre-clinical investigation compared the magnitude of SC response (SCR) of two, 
independently administered, specific MT techniques, applied, after randomisation, to the 
Lumbar 4/5 segment of 50 asymptomatic healthy volunteers. Treatments included; a 
rotatory lumbar manipulation technique or a repeated McKenzie extension in lying 
exercise. Findings revealed that both techniques produced statistically significant 
changes in SNS activity in the lower limbs (> SRD) with manipulative technique SCR‘s 
(76%) that were twice the size of the McKenzie repeated extension in lying exercise (EIL) 
technique (35.7%)( p=0.0005). Only the manipulation technique had a lasting effect that 
was carried into the final rest period (p=0.012) but the SNS response was not a side-
specific phenomenon (p= 0.76).  
The final clinical study recruited 60 acute and sub-acute LBP patients (symptoms of up to 
12 weeks duration) who received guideline-recommended physiotherapy treatment within 
xvi 
 
a hospital-based musculoskeletal out-patient physiotherapy department. SCRs were 
recorded throughout all treatment episodes with standardised, validated PROM‘s used 
for comparison of status at inception, mid-point and at discharge. Functional impairment 
was determined using the Oswestry Disability Index (ODI) and the Roland Morris 
Disability Questionnaire (RMDQ) with pain intensity evaluated with the Narrative Pain 
Rating Score (NPRS).  
A preliminary comparison, between the asymptomatic population and a random selection 
from the patient population, revealed that patients had treatment SCR‘s that were 
significantly greater (three-fold) than those of the asymptomatic groups (manipulation, 
p=0.003; EIL exercises p=0.001).  
Analysis of the patient data indicated that pre-treatment/baseline SC activity levels in the 
inception data capture point were lower than at discharge (18 µMho‘s; p<0.0005) but, 
conversely, that treatment SC levels were initially high, but diminished in magnitude by 
discharge (230 to 172 µMho‘s; p<0.0005) representing a SCR reduction of 125%. 
Correlational analyses of change scores of maximum SCR‘s to PROM‘s, from inception 
to discharge suggested weak positive correlations of SCR treatment responses to 
functional disability score improvements (rho 0.278) and pain intensity reductions 
(rho=0.229) that were significant for function (p=0.033) but not significant for pain 
(p=0.080). The final analyses indicated that there were trends in the magnitude of 
response to specific elements of treatment with manipulation having the largest SCR 
(266%). Further evaluative analysis of SC readings as a predictor, at inception, of 
functional outcome, at discharge indicated that a critical/cut-off value of 195% may 
indicate those patients least and most likely to respond positively to MT treatment. 
Preliminary logistic regression analysis indicated that the 195% SCR value was excellent 
at identifying poor responders but less successful at identifying good responders, 
functionally, to treatment. Nonetheless, SCR was a better predictor of outcome than 
duration of symptoms and patient age. Characteristically, patients achieving the 195% 
value were most likely to have higher functional disability and pain intensity scores at 
inception but by discharge had required fewer treatments, had greater overall functional 
improvement and lower pain intensities than those not achieving this threshold. 
In conclusion, SC activity levels and  SCR‘s may be a reliable, stable, alternative and 
objective measure of LBP patients‘ SNS status and changes that occur as a result of 
symptom abatement throughout a course of physiotherapy treatment. SC readings may 
(indirectly) reflect the state of dorsal horn (DH) sensitisation and of the central nervous 
system (CNS) processing system and its facilitatory capacity to activate the descending 
pain inhibitory system (DPIS). Further research, in patient populations (including chronic 
LBP patients), is recommended to verify these findings and validate the 195% SCR cut-
off point. Definitive RCT‘s are indicated to further the understanding of guideline-
endorsed physiotherapy treatment (a complex intervention –MRC, 2000) and to 
determine whether the SNS activity measurements can be used to help classify, predict, 




1.1 The global impact of low back pain (LBP) and its management 
Low back pain (LBP) is a costly and disabling disorder with a great impact on individual 
patients, society and health care providers (Waddell, 1996) and a ―burden in Western 
Countries‖ (Pransky et al., 2011). Low back pain is one of the main causes of absence 
from work in the UK and in 2004/5 an estimated 4.5 million working days were lost 
through musculoskeletal disorders that mainly affected the back (Health and Safety 
Executive, 2005) and is one of the single most referred conditions to physiotherapy 
departments. The economic impact of LBP was estimated, in the UK (1998), to possibly 
exceed £10 billion (Maniadakis and Gray, 2000).  
1.2. Physiotherapeutic management of low back pain 
A number of studies have endorsed the use of physiotherapy in the management of 
LBP with some providing focussed advocacy for exercise therapies (Richardson and 
Jull, 1995; Hides, Jull and Richardson, 2001; Hayden et al., 2005; Cairns, Foster and 
Wright, 2006; CSP, 2006 pt 1; Mayer, Mooney and Dagenais, 2008;  NICE, 2009) and 
others supporting the use of manual therapies (Clinical Standards Advisory Group 1994; 
Royal College of General Practitioners, 1997 & 1999; UK BEAM trial Team 2004; and 
the Chartered Society of Physiotherapy Guidelines Pt 2, 2006). Most Systematic 
Reviews of LBP management (CSP, 2006; Ernst and Canter, 2006; Murphy, van 
Teijlingen and Gobbi, 2006; Brontfort et al., 2008; Haldeman and Dagenais, 2008; 
Dagenais et al., 2010) have emphasised the need for primary research that investigates 
effective treatment options for LBP which is also an important consideration for the 
patient, the treating clinician and for health care policy makers. Furthermore, there has 
been a call to look at treatment effects beyond asymptomatic healthy norms and a drive 
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to integrate the theory of the findings from these healthy populations into the clinical 
environment with patients receiving complex therapeutic LBP interventions. Whilst the 
development of patient-reported outcome measures (PROM‘s) have provided some 
insight into clinically observed patient experiences of therapy (Khorsan et al., 2008), 
these have traditionally been criticised, by the scientific community, as being ―soft‖, 
subjective measures thereby setting the challenge for the development of objective, 
―gold-standard‖ measures of change in patient populations (Lawrence et al., 2008 and 
Goertz et al., 2012). Despite this, there remains a paucity of research evidence that 
supports, empirically, what patients and clinicians experience regarding the symptoms 
of LBP and the benefits of therapy.  
1.3. Low back pain classification 
Attempts have been made, within the last two decades, to classify LBP in order to assist 
clinicians and researchers with decision making processes and issues of heterogeneity 
of patient populations. The most commonly utilised and publicised classification system 
in (physiotherapy) LBP literature is the binary differentiation method of ―specific LBP‖ or 
―non specific LBP‖ (NSLBP) with further delineation into acute (up to 6 weeks symptom 
duration), sub-acute (4-12 weeks duration) and chronic (greater than 12 weeks) LBP. 
This ―system‖ forms the basis of the decision making process often called ―diagnostic 
triage‖ whereby symptoms are ultimately determined to be specific (with a known patho-
anatomical causative factor e.g. malignancy, infection, disc prolapse, fracture, 
ankylosing spondylitis or other systemic inflammatory disorders) or non-specific (defined 
as tension, soreness and/or stiffness in the lower back region for which it is not possible 
to identify a specific cause – NICE, 2009). In 1987, Spitzer et al., introduced the Quebec 
Task Force activity-related classification system which recognises the multi-
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dimensionality of LBP and provides a system by which published research populations 
can be compared. 
1.4. Measuring the effectiveness of treatment strategies 
Despite both clinical research and anecdotal evidence supporting patient-reported 
benefits of physiotherapy treatment (van Tulder, Koes and Boulter, 1997; Foster et al., 
1999; Sparkes, 2005), the biological/ neurophysiological mechanisms underlying the 
effects of treatment modalities, particularly within patient populations, remain unknown. 
Although this does not negate the clinical effects of physiotherapy, it hinders 
acceptance by the wider scientific and health care communities and impedes the 
development of rational strategies for improving the delivery and the accuracy of 
provision of therapeutic strategies and has implications for effective resource 
management. It is recognised (Pengel et al., 2003) that most patients‘ symptoms 
improve within the first month from inception although it is also recognised that up to 
84% have continued pain and recurrent episodes requiring further intervention, usually 
in the form of manual and exercise therapies, which has become a key feature of the 
CSP (2006 pts 1 and 2) and NICE Guidelines (2009) for the management of LBP. In the 
Clinical Standards Advisory Group (1994) guidelines, manipulation was recommended 
where symptoms lasted for ―more than a few days‖ and for patients who needed 
additional help with pain relief or who were failing to return to normal activities.  A 
number of studies (Hadler, Curtis and Gillings, 1987; Goodsell, Lee and Latimer, 2000; 
UK BEAM, 2004; Konstantinou et al., 2007) have demonstrated clear patient-reported 
benefits from manual and manipulative techniques with an ever-increasing body of 
clinical evidence now supporting the use of spinal manual and manipulative therapies in 
the treatment of LBP (Dagenais et al., 2010). Despite this, debate remains within the 
literature regarding the magnitude of response, the mechanism of effect and the clinical 
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significance of observed treatment effects (Potter et al., 2005). Nonetheless, the 
outcomes reported in studies to date are indirect, proxy measures of patient-reported 
(subjective) benefits and are worthy of further substantiation with empirical, 
neurophysiological data comparisons although this has yet to be conducted (with the 
Biopac System for skin conductance (SC) data acquisition and management) on a 
patient population receiving guideline-endorsed physiotherapy treatment. 
1.5. Manual Therapy (MT) and the quantification of treatment responses  
The recent publication of Guidelines for the management of LBP recommend the use of 
manual therapy (MT) (particularly manipulative techniques), advice to stay active and 
return to work, self-management strategies, use of non-steroidal anti-inflammatory 
medications (NSAID‘s) and analgesics, exercise and acupuncture in the acute and sub-
acute stages of the condition (up to 12 weeks symptom duration), (CSP, 2006; van 
Tulder et al., 2006; Savigny et al., 2009; Chou et al., 2009 and NICE, 2009). These 
Guidelines are supported by a number of studies that demonstrated clear patient-
reported MT benefits (Goodsell et al., 2000; Konstantinou et al., 2007; Bialosky et al., 
2009b). However, there continues to be debate, within the literature, regarding the 
magnitude and the clinical significance of observed treatment effects (Potter et al., 2005; 
Theodore, 2010) and, indeed, the existence of ―acute‖ LBP within the population where 
Hesbaek et al., (2003) argue that LBP was, in fact, a chronic, recurrent condition 
presenting with periodic attacks and temporary remissions, an opinion that was 
supported by Loeser and Melzack (1999, p.1609) in their concluding statement that;  
“It is not the duration of pain that distinguishes acute from chronic pain but, more 
importantly, the inability of the body to restore its physiological functions to 
normal homeostatic levels.”   
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The dilemma facing the clinician, in determining the therapeutic, and indeed the 
physiological effects of MT interventions in the lumbar spine, within a patient population 
has been the difficulty in accurately, quantitatively and non-invasively measuring the 
proposed effects, in an objective and quantifiable way, a complicated therapeutic 
interaction incorporating multiple (guideline endorsed) treatment strategies. Indeed, MT 
is a common treatment option for pain (Nahin et al., 2009) and has been shown to be 
effective for some individuals with musculoskeletal LBP (Childs et al., 2004). However 
despite its recognised clinical effectiveness, the mechanisms by which MT results in 
reductions in pain intensity and functional disability remain largely unknown. A number 
of researchers have considered the potential role of MT on pain processing (Vernon, 
2000; Pickar, 2002 and Bialosky et al., 2009) with a recent systematic review and meta-
analysis (Coronardo et al., 2012) demonstrating a link between SMT and immediate 
increases in mechanical pressure pain thresholds (PPT). Furthermore, several 
researchers have explored the neurophysiological basis of specific MT techniques in the 
cervical spine (Sterling et al., 2001; Moulson and Watson, 2006) and upper limbs 
(Vicenzino et al., 2001 and Paungmali et al., 2003), utilising the SNS as a measure of 
neurophysiological response, namely, skin conductance (SC) in the periphery. 
However, there is only a limited research base studying SNS (SC) changes occurring in 
the lumbar spine and lower limbs (Perry and Green, 2008, Moutzouri, Perry and Billis, 
2012; Tsirakis and Perry 2010; Perry et al., 2011; Rao and Perry, 2011) and none of 
which were conducted in a patient population receiving guideline-recommended 
treatment within a pragmatic yet controlled hospital environment. Specific sudomotor 
SNS changes have been reported with lumbar MT treatments on normal healthy 
populations with Perry and Green (2008) reporting statistically significant SNS changes 
in the order of 13.5% (p=0.005) on the side of treatment in their treatment group that  
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received unilateral grade III postero-anterior mobilizations (at a rate of 2Hz) and Perry et 
al. (2011) indicating that manipulative techniques have a greater magnitude of skin 
conductance response (SCR) than McKenzie repeated extensions in lying exercises 
(76.3% and 35.7% respectively). Perry and Green (2008) were the first to demonstrate 
a significant side specific effect compared to the untreated side, to placebo and control 
conditions (p=0.002) with Perry et al. (2011) being the first to quantify the magnitude of 
effect of two commonly utilized physiotherapeutic interventions. Moutzouri, Perry and 
Billis (2012) and Rao and Perry (2011) explored the effects of a centrally applied 
mobilisation with movement (MWM sustained natural apophyseal glide - SNAG) 
performed on the L4 motion segment during lumbar flexion and extension, revealing a 
percentage increase in SNS activity in  lower limbs in the order of 11% and 21% 
respectively. This response was double that of the placebo conditions and statistically 
significant compared to the control group (p=0.05 and p=0.01 respectively) with Rao 
and Perry (2011) revealing that 10 repetitions resulted in a significantly greater SCR 
than the 6 repetitions performed in the study by Moutzouri, Perry and Billis (2012). 
Tsirakis and Perry (2010) also investigated the effects of a unilaterally applied modified 
Spinal Mobilization with Leg Movement (SMWLM) technique described by Mulligan 
(2004: p.77) on SNS changes in the lower limbs. These authors revealed that the 
SMWLM technique resulted in a statistically significant increase in a percentage change 
in SNS activity in the order of 30.6% (p= 0.049) within the treatment side. Again, 
participants were healthy asymptomatic volunteers and not patients with symptomatic 
LBP. Furthermore, treatments were conducted, in isolation to any other therapeutic 
intervention, within a controlled, non-clinical environment thereby questioning the 
external validity of these findings to ―normal‖ clinical practice. 
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Neurophysiological (SNS) effects following MT have revealed, in humans, that MT 
produces an immediate hypoalgesic (Wright and Vicenzino, 1995; Vicenzino et al. 1995 
and 2001; Paungmali et al. 2003; Solly, 2004; Zusman, 2004; Bialosky et al. 2008 and 
2009b) and sympathoexcitatory effect (Paungmali et al., 2003; Perry and Green, 2008; 
Perry et al. 2011; Moutzouri, Perry and Billis, 2012) that are specific to mechanical 
(Vicenzino et al., 1995 and 1996; Sterling et al. 2001) and thermal nocioception 
(Bialosky et al. 2008 and 2009b). These findings have led to the concept that MT exerts 
its initial effects by activating specific pathways from the peri-acqueductal gray (PAG) 
region of the brain (Reynolds 1969; Morgan, 1991 in Potter, McCarney and Oldhand, 
2005; Lanotte et al. 2005; Bialosky et al., 2009a) and also by the spinal cord and central 
pain modulatory circuits and inhibition of the dorsal horn (Price et al. 2002). These 
mechanisms can be influenced differently by different types of manual techniques 
including oscillatory (Chiu and Wright, 1996; Perry and Green, 2008; Jowsey and Perry 
2010) and non-oscillatory techniques (Paungmali et al. 2003; Moulson and Watson, 
2006; Moutzouri, Perry and Billis, 2012; Tsirakis and Perry, 2010; Perry et al., 2011; 
Rao and Perry, 2011). These results reinforce the concept that the administration of 
spinal MT can result in recordable SNS responses.  
1.6. The structure of the thesis 
The aims of this programme of studies fell into 3 distinct areas (chapters 3, 4 and 5) and 
were developed to add to the body of knowledge required to further understand the 
mechanisms of action of guideline-endorsed physiotherapy treatment (advice, MT and 
exercise) on LBP patient outcomes. The working hypotheses included:  
1) That the Biopac data acquisition system is a reliable and stable method of 
recording SC activity levels in a non-laboratory environment (chapter 3); 
8 
 
2) That the magnitude of observable SNS responses differ according to the nature 
of the MT stimulus provided (chapter 4 and 5);  
 
3) That differences can be observed in SC activity levels and responses within- and 
between-populations (healthy normals and symptomatic LBP patients) according 
to the underlying state of the neurophysiological system (i.e. pain intensity, 
functional disability levels) (chapters 4 and  5);  
 
4) That relationships may exist between changes in SCR (to treatment) and  
patient-reported outcome measures (PROM‘s) of pain intensity and functional 
disability; 
 
5) That SC measures might posses an ability (at inception) to predict a positive 
functional outcome at discharge (chapter 5). 
 
Thus, Volume I of this thesis includes the literature review (chapter 2) summarising the 
current understanding of the epidemiology, prognosis and current guidelines for the 
comprehensive management of LBP. This is followed by a review of the literature 
regarding clinical prediction rules and of the outcome measures selected for the clinical 
study (Oswestry Disability Index; Roland Morris Disability Questionnaire and the 
Narrative Pain Rating Scale). The main focus of the literature review includes the 
current understanding of (and the professional knowledge-gaps in) the 
neurophysiological processes occurring following the onset of LBP and the proposed 
mechanism of action of selected (guideline-endorsed) manual therapy treatments. 
Chapter 3 presents the reliability study of the Biopac equipment in measuring SNS (SC) 
measurement variability within a non-laboratory setting. This is followed by a study 
investigating the magnitude of effect of two commonly used and currently unexplored 
treatments, McKenzie repeated extension in lying (EIL) exercise and the rotator lumbar 
manipulation techniques, on asymptomatic healthy volunteers (chapter 4). Chapter 5  
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presents the final (main) clinical study involving patients, with the final chapter (6 in 
volume II) drawing the findings of chapters 3, 4 and 5 together, identifying key 
limitations and proposing future avenues of research whilst recognising the place for 
this research within a developing, conceptional model of the effects of physiotherapy in 
the management of LBP.    
Volume II of this thesis comprises of the clinical discussion of chapter 5 and the final 
discussion of the thesis findings, the limitations of the study and future research 
recommendations. The conclusions to the study (chapter 7), the reference list (chapter 
8) and the Appendices can also be found in volume II.
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2. Literature Review 
 
This section introduces the reader to the current understanding of the epidemiology 
and prognosis of LBP. It details the existing classification systems currently utilized 
within clinical environments and the validity and reliability of patient-reported 
outcome measures (PROM‘s) used in the hospital setting for the final clinical study. 
Current practice guidelines for the management of LBP are reviewed and the 
development and validity of clinical prediction rules for patients with LBP. The current 
concepts underpinning the measurement of neurophysiological responses and the 
interpretation of these measures is then explored followed by a review of the 
research examining the phenomenon of pain perception and pain processing 
mechanisms. Finally, a review of the current literature underpinning the concepts 
behind the neurophysiological mechanisms of action of spinal manual therapies are 
presented. 
2.1 The Epidemiology and Prognosis of Low Back Pain 
Low Back Pain (LBP) has been well documented to be an extremely common health 
problem both in the United Kingdom (UK) and internationally (Andersson, 1998; 
Lidgren 2003; Rapoport et al. 2004 and Dionne, Dunn and Croft, 2006). In the UK, 
Maniadakis and Gray (2000) estimated that LBP accounted for over £10 billion in 
direct and indirect expenditure. Epidemiological studies of LBP have challenges 
similar to clinical studies regarding the heterogeneity of the populations of studies 
available for comparison and pooling of data.  
Prevalence data and reports on LBP have been collated and reported for numerous 
decades. Current reports of the prevalence of LBP within the adult general 
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population of the United Kingdom (UK) have reported the point prevalence to be 
18% (Harkess et al., 2005), one-month prevalence 39% (Croft et al., 1995) and one-
year prevalence 36.1% (Demyttenaere et al., 2007) although there is a lack of clarity 
regarding the chosen definition of LBP used. This obstacle provided the impetus for 
Dionne et al. (2008) to utilise a Delphi process to reach an international agreement 
for a definition for LBP 
„Pain between the inferior margin of the 12th rib and the inferior gluteal 
folds that is bad enough to limit usual activities or change the daily 
routine for more than 1 day. This pain can be with or without pain 
going down the leg. This pain does not include pain from feverish 
illness or menstruation.‟   
Harkess et al. (2005) also identified that the prevalence of LBP had increased more 
than two-fold between 1950 and 1995 in the northwest region of England from 6.3% 
to 16.3% in males and from 8.6% to 17.3% in females (age standardized rates). 
In the paper by Hoy et al., (2010) a comprehensive summary of the epidemiology 
literature on LBP was provided. The authors estimated the 1 year incidence of the 
first-ever episode of LBP ranged from 6.3% (Biering-Sorensen, 1982) to 15.4% 
(Croft et al., 1999), while estimates of the 1 year incidence of any episode (i.e. first-
ever or recurrent) ranged from 1.5% (Al-Awadhi et al., 2005) to 36% (Croft et al., 
1999). Within the context of health care and clinic-based studies, episode remission 
at 1 year ranges from 54% (Schiottz-Christensen et al., 1999), to 90% (Van den 
Hoogen et al., 1997) although there is a lack of clarity, within the literature, between 
the incidences of symptom recurrence within this time period. While these findings 
would seem positive, the natural history of LBP has long been observed to be 
extremely variable, lasting for a few days to more than a year (Roland, 1983). 
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Indeed, Hestbaek, Leboeuf-Yde and Manniche (2003) argued that as many as 50% 
of people with activity-limiting LBP within a general population (i.e. not those 
receiving workers compensation) will go on to have recurrent episodes within the first 
year (60% by 2 years and 70% by 5 years) and they highlighted the view of Dunn, 
Jordan and Croft (2006) that LBP is a chronic, recurrent condition and therefore the 
categorisation of LBP into acute (up to 6 weeks duration), sub-acute (6-12 weeks 
duration) and chronic (from 3 month onward duration) is obsolete. Cassidy et al. 
(2005) found that the rate of recurrence increased with age and Hoy et al. (2010) 
concluded that true remission is rare, a fact supported by Hush et al. (2009) in their 
focus group study that revealed that symptom attenuation, functional ability and 
quality of life are all factors considered by patients under the construct of ―recovery‖ 
however, these elements are also recognised to be poorly quantified by currently 
utilised PROM‘s and fail to adequately capture the true experiences of patients with 
LBP (Hush et al., 2010). 
Regarding the duration of symptoms, Von Korff et al. (1993) found that at the 1 year 
follow-up period the median number of LBP pain days in patients who‘s LBP lasted 
less than 3 months was 15.5 days and for patients whose pain lasted between 3 to 6 
months the median duration was 128.5 days. Van de Hoogen et al. (1998) found the 
median episode of pain from inception to remission to be 42 days with Henschke et 
al., (2009) reporting duration of symptoms to be 58 days (53 to 63 days) with only 
71.8% of his population being pain free by 1 year and 72.5% having restoration of 
function. In contrast, Hancock et al. (2009) found the median number of days to 
recovery to range between 6-22 days however, their population were acute LBP 
patients and the sub-group reported (17.9% of the total sample population) only 
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represented the predicted ‗quick recoverers‘ so their results should be interpreted 
with caution. 
Studies that attempt to attribute causative factors to the occurrence of LBP have 
suggested anatomical structures such as bones, discs, joints, ligaments, muscles, 
neural structure, viscera and blood vessels (Deyo et al., 2001). In reality, only 5-15% 
cases can be attributed to a specific cause such as an osteoporotic fracture, 
neoplasm or infection (Hollingworth et al., 2002 and Woolf and Pfleger, 2003). The 
remaining 85% to 95% are generally classified as ‗non-specific LBP‘ as there is no 
identifiable, specific cause for their symptoms. Epidemiological studies have 
attempted to infer causation by the examination of factors that may have 
relationships or predispose populations to the condition (Beaglehole, Bonita and 
Kjellstrom, 1993), however, due to the methodological and clinical heterogeneity in 
studies investigating causation, Hoy et al., (2010) concluded that it was not possible 
at this point in time to relate causation to causality but a number of risk factors that 
could influence the onset and course of LBP were identified. Age was found to be a 
common risk factor with the incidence of getting LBP being highest in the third 
decade (Kopec, Sayre and Esdaile, 2004; Straker et al., 2011) with prevalence 
increasing to the age of 65 years (Lawrence et al., (1998). Kopec, Sayre and Esdaile 
(2004) found no gender differences in prevalence of LBP, however the systematic 
review of Hoy et al. (2010) revealed a mean and median prevalence of LBP that was 
higher in women. Dionne et al., (2001) discovered that low educational status was 
associated with an increase in prevalence of LBP and this study also revealed that 
this association is a strong predictor of episode duration and poor outcome, a finding 
that contradicts those of Croft and Rigby (1994) who revealed an inverse relationship 
between social status and LBP occurrence.  Body weight was found to be a weak 
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risk factor by Leboeuf-Yde (2000) although Battie et al. (1995) found that heredity 
played a major role in lumbar disc degeneration. However, the study by Nachemson 
(1999) demonstrated that there was no correlation between evidence of radiographic 
disc disease and symptom reproduction.  
Within the last decade there has been a deluge of studies exploring the psychosocial 
factors associated with LBP including stress, anxiety, depression and adverse pain 
behaviours and that psychosocial factors are significantly associated with the 
transition of LBP from acute to chronic status (Pincus et al., 2002) with job 
dissatisfaction being particularly noted (van Tulder, Koes and Bombardier, 2002).  
In conclusion, epidemiological studies measuring the prevalence of LBP have 
demonstrated a two-fold increase in the last 50 years (Harkess et al., 2005) 
however, the frequency of LBP in the last decade has shown little change 
(Rossignol, Rozenberg and Leclerc, 2009). The course of LBP in the general 
population is not considered to be transient or self-limiting, it is now considered to be 
a chronic condition that presents with periodic attacks and temporary remission 
(Hesbaek et al., 2003). Although causative factors for NSLBP have yet to be 
identified, a number of epidemiological risk factors have been suggested and include 
age, gender, educational status, heredity and psychosocial factors including job 
dissatisfaction (Hoy et al., 2010). Prognostically, limited methodological quality of 
primary and review literature means that there remains uncertainty about the 
reliability of conclusions that can be drawn (Hayden et al. 2009) however baseline 
factors consistently reported to be associated with poor outcomes for acute and sub-
acute LBP include; higher levels of functional disability, higher intensities of pain, the 
presence of leg pain, duration of symptoms, older age, poor general health, 
increased psychosocial stress, demanding work relations and compensation issues 
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(Hayden et al., 2009) and supported by the review of Chou and Shekelle (2010). 
Indeed, Henschke et al., (2009) reported that acute LBP patients that present with 
these prognostic factors had unfavourable outcomes including slower recovery and 
restoration of function with a third of the sample reporting continued symptoms at the 
1 year review. Kent and Keating (2008) suggested that the validity of prognostic 
factors are enhanced when associated with valid and reliable PROM‘s (i.e. Oswestry 
Disability Index, Numeric Pain Rating Scale, etc) and studies in the last couple of 
decades have increasingly been utilising these to quantify their treatment effects and 
make associations to predictive and prognostic factors.     
2.2. Classification Systems, Guidelines and Clinical Prediction Rules 
 
2.2.1. Classification Systems 
The development of classification systems in the field of LBP have been of interest to 
clinicians and researchers for the last 50 years and are considered by many to hold 
a particularly important role in the advancement of practice through the stratification 
of pathological, pathomechanical and psychosocial findings into categories that 
subsequently – through a process of further abstraction and subsequent analysis – 
allow for the formulation of generalisations that ultimately are designed to benefit 
patient care and reduce costs.  Indeed, the ―creation of order from chaos‖ 
(Chapman, 2009) by the application of systematic analysis and knowledge synthesis 
together with the implementation of structural concepts is one of the eminent 
achievements that have come to define human civilization and, indeed the research 
process.  
For a classification system to be clinically useful, O‘Sullivan, in 2005, argued that it 
should be based on identification of the underlying mechanism/s that drive the 
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disorder, in order to provide guidance for targeted interventions which, in turn, should 
predict the outcome of the condition. Therefore, a review of the current situation 
regarding classification systems is presented followed by consideration of developed 
guidelines for the management of LBP and the role of clinical prediction tools in 
assessing treatment outcomes. 
The most commonly utilised and publicised classification system in (physiotherapy) 
LBP literature is the binary differentiation method of ―specific LBP‖ or ―non specific 
LBP‖ (NSLBP) that forms the basis of decision making process often called 
―diagnostic triage‖ whereby the patients symptoms are determined to be specific 
(with a known patho-anatomical causative factor e.g. malignancy, infection, fracture, 
ankylosing spondylitis or other systemic inflammatory disorders) or non-specific 
(defined as tension, soreness and/or stiffness in the lower back region for which it 
isn‘t possible to identify a specific cause – NICE, 2009).  
Beyond this binary system, criteria to classify LBP can be defined as belonging to 
specific theoretical constructs/categories (e.g. diagnosis of disc prolapse with 
radiculopathy) or dimensions (i.e. patho-anatomical) of the domain being classified 
(Deyo et al., 1994) and a number of categorical constructs and emergent dimensions 
and domains have been developed in the last 30 years (Table 1). In 1987 the 
Quebec Task Force on Spinal Disorders (Spitzer, Leblanc and Dupuis, 1987) 
developed an activity-related classification system (QTFC) for the differentiation of 
spinal disorders that was validated for clinical and research stratification (Atlas et al., 
1996). This classification system is reproduced in Table 2. Despite its validation for 
use, and its apparent ease of application (by clearly identifying the stage of the 
disorder – acute, sub-acute or chronic -, the patho-anatomical diagnosis +/- red 
flags, signs and symptoms and work status) it is often regarded as lacking the 
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specificity required for use with NSLBP where most patients who require non-
surgical intervention fall, however, it is multidimensional in nature and is capable of 
facilitating comparative analyses for use within systematic literature-based reviews. 
Since 1987, the QTFC system has largely been superceded by the biopsychosocial 




Dimension Category Approach Key Proponents Outcome Measure 
Uni-
dimensional 
Patho-anatomical Radiological diagnosis 
Facet joint & Disc degeneration, tears and prolapse 
Spondylolisthesis, formaminal & spinal stenosis 




CT & MRI scans 
Diagnostic injections 
Signs & Symptoms Area & nature of pain 
 
Impairments in segmental movement & function 
 
Symptom provocation tests 
Delitto et al., (1995) 
McGill (2004) 




VAS for pain/symptoms, 
Pain Drawings 
Function (e.g. walking 
distance), Range of motion 
Biofeedback 
Diagnostic blocks 
Prognosis Based on future outcome of patient Engel, von Korff & Katon 
(1996), Dionne et al. (1997) 




Patho-mechanical Levels of physical activity/inactivity 
 
Loading postures & repetitive movements 
 
Exposure to whole body vibration 
Ergonomic & environmental factors 
Newcomer & Sinaki (1996) 
Pope & Hansen (1992) 
Adams et al. (1999) 
Nachemson (1999) 
McGill (2004) 
Abenhaim et al. (2000) 
Anthropometry 
Work station & work 
posture assessment 
(OWAS) 
Neuro-physiological Peripheral, spinal cord and central pain mechanisms 
 
Complex biochemical & neuro-modulation changes at 
spinal cord and cortical levels 
Flor and Turk (1984) 
Moseley (2003) 
Wright & Zusman (2004) 
Wand & O‘Connell (2008) 
Vicenzino et al. (1998) 
Anaesthetic Injections 
Functional MRI 
Proxy measures of SNS 
function 
EEG & EMG 
Psychosocial Descending cortical Pain modulation 
Cortical and cognitive up-regulation and attention 
Linton (2000) 
Zusman (2002) 
Moseley et al. (2007) 
Fear-Avoidance 
questionnaire (FABQ) 
Health Anxiety and 




anatomical, signs & 
symptoms, psychosocial 
(biopsychosocial) 
Quebec Task Force Classification (QTFC) 
Based on stage of disorder (acute, sub-acute or 
chronic), patho-anatomical diagnosis (+/- ‗red‘ flags), 
signs & symptoms, ‗yellow‘ flags & work status 
Spitzer, Leblanc and 
Dupuis (1987) 





Motor control & 
movement impairment 
Chronic pain disorders, patho-anatomical diagnosis 
(tissue injury, pain, motor response), patho-mechanical 
impairment, neurophysiological changes 
(sympathetically maintained & centrally mediated 
pain), mal-adaptive coping strategies, fear & avoidance 
beliefs 
O‘Sullivan (2005) 
Childs et al. (2004) 
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Table 2: The Activity-Related Quebec Task Force Classification System for Spinal 
Disorders 
Classification Symptoms Duration of 
Symptoms 
Working Status at 
time of evaluation 
1 Pain without radiation  
 
a = < 7 days 
b = 7 days to 7 weeks 
c = > 7 weeks  
 
 
W = Working 
I   = Idle 
2 Pain + radiation to extremity 
(proximally) 
3 Pain + radiation to extremity 
(distally) 
4 Pain + radiation to extremity 
(neurologic signs) 
5 Presumptive spinal nerve 
compression on X-ray 
(instability or fracture) 
  
6 Spinal nerve root compression 
confirmed by myelography, CT 
or MRI scan 
7 Spinal stenosis 
8 Postsurgical status 1-6 months after 
intervention 
9 Postsurgical status 
9.1. Asymptomatic 
9.2. Symptomatic 
> 6 months after 
intervention 
10 Chronic pain syndrome  W = Working 
I   = Idle 11 Other diagnoses 
(Adapted from Spitzer, Leblanc and Dupuis, 1987) 
The classification of LBP has been proposed as a research (and clinical) priority (Ford 
et al., 2007) due to the possible confounding effects of sample heterogeneity on effect 
sizes for outcome studies investigating treatment efficacy however, considerable 
variability exists in the literature on the classification of LBP (Petersen, 1999; Riddle, 
1998; Ford et al., 2007). Published classification systems vary in their purpose and in 
their selection of dimensions, categories and criteria. Furthermore, Ford et al., (2007) 
identified that this variability is also inherent in the recommended methodology for 
developing and validating LBP classification systems (Fairbank and Pynsent, 1992; 
Deyo et al., 1994 and Bogduk, 1997). 
Current approaches or models used for the diagnosis and classification of LBP are 
largely uni-dimensional however, in thelast decade there has been greater acceptance 
of the multi-dimensionality of LBP (and in particular chronic LBP) and newer models are 
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now being introduced in classification systems to explicate the historical difficulties of 
identifying and recruiting homogeneous subgroups for research trials and avoid the 
problems of sample heterogeneity that have hampered research and limited 
assimilation of findings into evidence-based practice (Fritz and George, 2000).  
Previously displayed within the text of Table 1 (modified from O‘Sullivan, 2005) 
summarises the key approaches used to classify LBP patients‘. The limitations of all 
classification systems, and particularly the uni-dimensional categories, are that no 
single system has sufficient evidence to support clinical and research use (Ford et al., 
2007). The traditional medical (and physiotherapeutic) approach to diagnosis of LBP 
has been from a patho-anatomical perspective (Nachemson, 1999) with a 
systematically investigative process of hypothetico-deductive reasoning (and 
radiographic ―evidence‖) that leads the clinician to a potential source of the symptoms 
(e.g. joint degeneration, disc prolapse with or without associated nerve pain) and therein 
guides management. However, as Nachemson (1999) conceded, many ‗abnormal‘ 
(radiographic) findings are also commonly observed in pain-free populations and patho-
anatomical findings correlate poorly with levels of pain and disability therefore limiting 
the universal applicability of this system, particularly with chronic LBP.  
The signs and symptoms classification was originally advocated in the 1980‘s by 
McKenzie (1981 and 2000) and Maitland (1986). This classification system sought to 
detail the patients area, behaviour and nature of pain, to determine impairments in 
spinal movement and function, palpate changes in segmental mobility (hyper and hypo-
mobility), as well as recording pain responses to mechanical stress (provocation testing) 
and the effects of repetitive movement on pain behaviour (peripheralisation and 
centralisation). Evidence for the efficacy of this classification approach for the 
management of LBP remains limited (Maher, Latimer and Refshauge, 1999;Bogduk, 
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2004) although Elvey and O‘Sullivan (2004) contended that this may well be due to 
limitations in published research designs and a lack of appreciation of the 
biopsychosocial (multi-dimensional) nature of chronic sub-groups of LBP populations. 
Prognostic classification systems are based on the future outcomes of the patient 
(Engel, von Korff and Katon, 1996; Dionne et al., 1997) but have limited use for the 
selection of treatment of management options. Dankaerts et al., (2006) argued that a 
poor prognosis might occur simply because an appropriate treatment that might 
otherwise have addressed the cause has not been applied (e.g. the lack of availability of 
a qualified manipulative therapists or an acupuncturist).  
Patho-mechanical classification system (also known as the mechanical loading model – 
O‘Sullivan, 2005) is associated with mechanical factors that are reported to be 
associated with the initial development of LBP and are frequently reported to contribute 
to the recurrence and exacerbation of LBP. Factors within this dimension include; 
sustained and loaded postures and movements, exposure to whole body vibration, 
repetitive loading tasks as well as sudden and repeated spinal loading associated with 
sports or manual work (Adams et al., 1999; Nachemson, 1999; McGill, 2004). McGill 
(2004) also identified the additional influence of ergonomic and environmental factors 
(e.g. seating and work place design) as well as anthropometric considerations that 





































































Since the 1980‘s there has been a growing interest within the physiotherapy literature of 
the involvement of the nervous system in pain disorders with a growing body of 
knowledge that documents the complex biochemical and neuro-modulation changes 
that occur in the periphery, the autonomic nervous system as well as at spinal cord and 
cortical levels (Flor and Turk, 1984; Flor et al., 1997; Vicenzino et al., 1995 and 2001; 
Moseley, 2003; Wright and Zusman, 2004; Bialosky et al., 2008 and 2009). This has 
resulted in the ‗neuro-physiological‘ classification system that asserts that pain can be 
generated and maintained at a peripheral level, as well as centrally at both spinal cord 
and cortical levels. Central sensitisation of pain can occur secondary to sustained 
peripheral nociceptive input resulting in changes at spinal cord and cortical levels 
(Zusman, 2002; Wand and O‘Connell, 2008).  
Recent advancements in the understanding of the changes that can occur within the 
nervous system and associated cortical ‗adaptations‘ have resulted in the development 
of psychological, social and cognitive approaches to the management of LBP patients 
(Linton, 2000; Zusman, 2002; Woby et al., 2004). Mal-adaptive coping strategies 
(Linton, 2000), social and work factors can all reinforce psychological factors that can 
increase the central drive of pain and whilst the debate continues as to whether these 
factors are a predisposition or a result of a pain disorder there is evidence that cognitive 
behavioural interventions are effective in reducing disability within sub-groups of chronic 
LBP populations (Woby et al., 2004, Moseley, 2007, O‘Sullivan et al., 2012). 
Multi-dimensional classification systems of LBP have been advocated by a number of 
authors (Elvey and O‘Sullivan, 2004; McCarthy et al., 2004; O‘Sullivan, 2005; Dankaerts 
et al., 2006 and Ford et al., 2007). O‘Sullivan (2005) stated that the role of the treating 
clinician is to consider all dimensions of the disorder based on an interview, thorough 
physical examination combined with a review of any medical and radiological tests as 
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well as appropriately selected (reliable and valid) screening questionnaires in order to 
determine the dominance and relationship of factors with the purpose of guiding 
management and predicting prognosis (Elvey and O‘Sullivan, 2004).  
It would seem that the requirements of an appropriate classification system is that it 
should have a comprehensive set of dimensions that adequately describe the complex 
nature of LBP however, these rudiments are not currently being met within the literature 
and no single classification system has sufficient evidence to support clinical and 
research use (Petersen, 1999; Riddle, 1998; Nachemson, Gunnar and Andersson, 
1982; Ford et al., 2007). O‘Sullivan (2005) proposed a mechanism based classification 
system derived from a biopsychosocial perspective for use with chronic LBP patients 
(see figure 1 for details) that acknowledges the multi-dimensionality and diversity of 
presentation within this population. O‘Sullivan‘s (2005) model proposed three broad 
sub-groups of patients within his classification system;  
1) Adaptive movement and/or motor impairment disorders (with the presence of 
 an underlying pathological process e.g. disc prolapse, stenosis with 
associated radicular pain +/- neurological deficit, spondylolithesis) that are 
driven by patho-anatomical processes and responsive to specifically targeted 
management,  
 
2) Mal-adaptive movement impairment disorder where the dominant drive of the 
 pain is from the forebrain and is secondary to psychosocial factors it is 
therefore inconsistent and non-mechanical (results in disordered movement 
and motor control impairments),  
3) Mal-adaptive movement or motor impairment disorders with associated  faulty    
coping strategies result in abnormal tissue loading (associated with either 
excessive or reduced segmental spinal stability). 
 
 O‘Sullivans‘  (2005) classification system has received some positive reviews with a 
number of researchers providing nascent evidence of its reliability (Dankaerts et al., 
2006 and 2007; Fersum et al., 2009). 
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Whilst research into the classification of chronic LBP provides its own challenges, a 
number of researchers have argued that these classification systems lack construct 
validity within the acute and sub-acute patient populations (Paatelma, Karvonen and 
Heinonen, 2009). Paatelma, Karvonen and Heinonen (2009) conducted a pilot study to 
investigate the reliability of a treatment based classification (TBC) system (that 
classified patients in accordance with a patho-anatomical/patho-physiological/tissue 
origin classification system) on patients with LBP. Whilst they found the TBC system 
reliable within acute and sub-acute patients, they suggested that the complexity of 
chronic LBP patients (with higher levels of distress and disability) resulted in a lack of 
effectiveness in improving important outcomes. 
Wand and O‘Connell (2008) suggested that the disappointing results, of clinical 
research into sub-grouping of NSLBP, requires an alternative perspective regarding 
classification systems and management strategies. They contested that patients whose 
condition is considered chronic will exhibit different signs, symptoms and behaviours to 
those whose condition is sub-acute or acute, and that different mechanisms may be 
occurring in the acute and sub-acute populations because mal-adaptive individualisation 
of response to the underlying problem/condition (as seen in chronic LBP patients) has 
yet to materialize at a conscious or sub-conscious/cortical level. Furthermore, Wand 
and O‘Connell (2008) observed that the research into the sub-grouping of acute LBP 
patients allowed the successful prediction of outcomes to manipulation (Flynn et al., 
2002; Childs et al., 2004) and stability training (Hicks et al., 2005; Fritz, Whitman and 
Childs, 2005), a phenomenon that has yet to prove successful within a chronic LBP 
patient population. Wand and O‘Connell (2008) implied that with prolonged exposure to 
LBP, there may be a transition period (from acute to chronic – possibly within the ‗sub-
acute‘ period) whereby the patho-mechanical, patho-anatomical and signs/symptoms 
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clustering of an acute LBP presentation may be superseded by cortical reorganisation, 
motor control changes and dorsolateral prefrontal cortex degeneration. They speculated 
that the reason for the relative lack of success of sub-classification systems, treatment 
outcomes and clinical prediction rules in chronic LBP patients may reflect a therapeutic 
void in appropriate ‗brain-training‘ and normalisation of neurological processing.   
In summary, within the literature there remains controversy within the field of 
classification systems for LBP patients. Whilst some authors advocate their use within 
acute and sub-acute sub-groups of patients, there is greater diversity of opinion 
regarding their use within a chronic LBP patient population, indeed, a number of authors 
suggest that this group should be further divided into smaller factions and classified 
within a biopsychosocial or cortical-reorganisation model. One area of agreement is that 
classification systems have an important role in the advancement and the reporting of 
clinical practice and research, in the provision of guidance for targeted interventions and 
the prediction of therapeutic outcome. Within the final clinical study of this thesis, the 
QTFC system was utilised for comparative purposes (classification levels 1-4) and due 
to its ease of application within the clinical setting, its accepted multidimensionality and 





2.2.2. Clinical Guidelines 
Clinical guidelines have been defined as ―systematically developed statements to assist 
practitioners and patients decisions about appropriate health care for specific clinical 
circumstances‖ (Field and Lohr, 1990: 38). The main aim of clinical guidelines is to 
―improve the quality of care received by patients‖ (Woolf, 1999) and attempt to utilize an 
evidence-informed strategy, together with professional consensus, in order to inform 
clinical reasoning for assessment and treatment.  
Care for LBP is fragmented with patients seeking care from GP‘s, other primary and 
secondary care settings, pharmacists, independent allied healthcare practitioners or not 
at all. Differences in the training, education and scope of practice of these providers 
have lead to the heterogeneity observed in the management of LBP (Koes et al., 2001; 
Haldeman and Dagenais, 2008). In an ideal world, all providers involved in managing 
LBP should be guided by the methodologically best available scientific evidence in order 
to minimize the ineffectiveness, cost and potential harm of procedures. Clinical 
guidelines endeavour to locate, evaluate, synthesize and summarise the evidence thus 
making the practice of evidence-based practice accessible to all.  
Clinical guidelines have a number of advantages; they can identify which interventions 
are unsupported by clinical research and, therefore, may be dangerous, or at best, 
ineffective for the patient; they also are able to clarify those interventions that have a 
research base to support their effectiveness thereby ―reducing morbidity and mortality 
and improving quality of life‖ (Woolf, 1999). However, methods for developing guidelines 
are not yet standardized, which may impact the perceived validity of the 
recommendations. Koes et al., (2001), van Tulder et al., (2004) and Arnau et al., (2006) 
reported that although guideline recommendations were similar, discrepancies were 
28 
 
noted regarding the use of medication, spinal manipulation therapy (SMT), exercise and 
patient education. 
Woolf (1999) advised that guidelines may be harmful to both patients and health care 
professionals as research and evidence can often be lacking, misleading or 
misinterpreted and therefore, compromise the quality of care received. Indeed, Woolf 
(1999) warns that guidelines have the potential to take away a healthcare professionals 
ability to be an autonomous practitioner by providing limited recommendations for 
treatment and devalue the clinically reasoned decision making processes required for 
individually tailored treatment prescription. 
Internationally, a number of clinical practice guidelines related to the specific 
assessment and management of LBP have been published since the turn of the 
millennium and although the methods for conducting the process have varied, most 
have been considered to be of high methodological quality (despite some relying heavily 
on systematic reviews for quality assessments, with the potential of bias in the 
overstatement of objectivity of this process), have consisted of multidisciplinary 
professionals and had similar recommendations (Dagenais, Tricco and Haldeman, 
2010). Pillastrini et al.‘s (2011) international review of guidelines for LBP management 
recognised the high quality of both of the UK guideline publications (CSP 2006 and 
NICE, 2009) ranking them in the top three guidelines alongside the Canadian TOP 
program (TOP, 2009). Pillastrini et al., (2011) indicated that the average quality of the 
guidelines studied in their review had improved in the last 10 years and are increasingly 
aligned in their provision of therapeutic recommendations, however, their review was 
focused on chronic LBP and within primary care and may lack external validity to the 
management of acute and sub-acute LBP and to the secondary care environment.   
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Of the reviews considered within the current literature review, six guidelines discussed 
the management of acute LBP, six discussed Chronic LBP management and six 
considered LBP with substantial neurological involvement. At all stages, advice to stay 
active, education and SMT were recommended with different pharmaceutical 
recommendations at each stage.     
Currently, national (UK) guidelines recommend an initial triage to facilitate effective 
diagnosis and management of the patients‘ condition (NICE, 2009). This process allows 
the clinician to differentiate between spinal pathology (and ‗red flag‘ presentations), 
nerve root pain and specific or non-specific low back pain (NSLBP) in the ―early 
treatment and management of persistent or recurrent LBP‖. The NICE guidelines (2009) 
define ―persistent or recurrent NSLBP‖ as pain that has ―lasted for more than 6 weeks, 
but for less than 12 months‖. The principles of management within the NICE guidelines 
(2009) care pathway fall into 4 key areas; 1) diagnostic triage and review, 2) promotion 
of self management (advice and education on the nature of NSLBP, encourage normal 
activities, exercise and return to work), 3) prescription of appropriate drug treatment for 
pain management (first-line treatment is paracetamol, which if unsuccessful may include 
a progressive cascade to NSAID‘s or weak opioids, tricyclic antidepressants and finally 
strong opioids), 4) specific  treatments lasting up to 12 weeks (a structured exercise 
programme of up to 8 sessions, or up to 9 sessions of manual therapy including spinal 
manipulation, or up to 10 sessions of acupuncture needling). In the event of a poor 
outcome or unsatisfactory improvement then the pathway guides the clinician to 
consider a combined physical and psychological treatment programme (up to 8 weeks 
of 100 hours of cognitive behavioural therapy and exercise). In the event of the pain 
lasting more than 1 year then an orthopaedic surgical opinion may be sought. The NICE 
guidelines (2009) are the only ones that suggest specific parameters for some of the 
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recommended interventions for chronic LBP, although, the evidence upon which these 
were made is unclear. However, Dagenais, Tricco and Haldeman (2010) applauded this 
strategy and advised the adoption of parameter setting to facilitate the modification of 
the clinical approach and/or patient expectations when measurable outcomes fail to 
improve. A key issue with the current guidelines, which is becoming increasingly 
recognised, is the apparent delay in the publication of treatment guidelines (in particular 
the use of manipulation techniques) and their actualisation into current practice. 
Although it is recognised that the publication of the NICE guidelines (2009) is a recent 
event, it is well-known that manipulative treatment for the management of LBP among 
physiotherapists is limited with Foster et al., (1999) indicating that only a 3% of her 
therapists reported using manipulative techniques, with Jackson (2001) and Gracey et 
al., (2002) recording only a 5% usage. Clearly, these surveys were conducted over a 
decade ago and more up-to-date information might provide better insight into clinical 
practice, however, the lack of empirical evidence into its direct relationship to PROM‘s 
inhibits clinical decision-making. 
Despite the strong recommendation that clinicians evaluate the severity of symptoms 
and functional limitations of patients, it was apparent that none of the papers offered 
guidance on choices of specific outcome measures that might accomplish this purpose. 
Ostelo and de Vet (2005) outlined clinically important and validated instruments to 
assess pain (e.g. Visual Analogue Scale, or the Numeric Pain Rating Scale) and there 
are numerous other instruments available to measure physical function or disability 
specific to LBP (e.g. the Oswestry Disability Index and the Roland Morris Disability 
Questionnaire) some of which have been successfully translated and validated within 
other cultures and have the benefit of having the Minimum Clinically Important 
Difference (MCID) established for LBP which have been reported to correspond to 
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improvements (on the instruments scale) of between 25-50%. Despite this wealth of 
‗evidence‘, PROM‘s do not feature in the current guidelines and individual practitioners, 
practices and departments are left to decide on the outcome measures appropriate for 
their own patients. Whilst this may have some benefit in a world of diversity/ 
heterogeneity, it may be considered to be an impediment for ongoing clinical research. 
2.2.3. Clinical Prediction Rules 
Clinical prediction rules (CPR‘s) are research-based tools that quantify the contributions 
of relevant patient characteristics to provide statistical/numeric indices that assist 
clinicians in identifying the combinations of clinical examination findings that can predict 
a condition or outcome (Fritz et al., 2003; Fritz, 2009; Cook, 2008). 
Falk and Fahey (2009) summarise the key elements of CPR‘s as follows:  
―Clinical prediction rules quantify the contribution of symptoms, clinical signs, and 
available diagnostic tests, and stratify patients according to the probability of 
having a target disorder. The outcome of interest can be diverse and be anywhere 
along the diagnostic, prognostic, and therapeutic spectrum‖. 
 
CPR‘s have been used to describe the likelihood of the presence or absence of a 
condition (e.g. the presence of red flags in LBP patients), assist in determining patient 
prognosis (e.g.. Return to work, full recovery or development of chronic disability), and 
help the classification of patients for treatment either according to guidelines (e.g. acute, 
sub-acute or chronic NSLBP/urgent or routine) or according to treatment-based 
classification systems (e.g. McKenzie classification – McKenzie, 1981; or the 
movement-impairment classification system – O‘Sullivan, 2005).  
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Paatelma et al., (2009) examined Inter-tester reliability in classifying sub-acute low-
back-pain patients, comparing specialist and non-specialist examiners. They observed 
that; 
―Although a number of LBP classification systems have been proposed, what is 
still unclear is which clinical tests between assessing clinicians are sufficiently 
reliable to allow subgroup categorization. The reliability and validity of the overall 
classification systems has been tested and has been reported as moderate or 
good‖.  
 
As to the reliability of tests used for placing presentations of low-back pain, into 
separate groupings, the evidence is variable. Paatelma et al., (2009) summarised the 
current evidence base as follows;  
 1) Discogenic and sacroiliac joint pain = fair to good,  
 2) Segmental dysfunction/facet pain = poor,  
 3) Clinical lumbar instability = poor to good; and  
 4) Clinical central or lateral stenosis = no reliable clinical tests. 
 
CPR‘s are an attempt to move away from intuitive guessing about which patient has a 
particular diagnosis and which will respond to a specific intervention by replacing this 
with an evidence-informed ―list‖ of characteristics that, through an algorhythmic process, 
result in treatment selection or outcome prognosis. However, successful diagnosis and 
subsequent sub-grouping of patients by CPR‘s are subject to biases that affect their 
validity and application in clinical practice especially within complex situations (Fahey 
and Van der Lei, 2008; p. 213-236; Reilly and Evans, 2006). Flynn et al., (2002) utilised 
this heuristic reasoning approach by selecting only 5 criteria for a spinal manipulation 
CPR in NSLBP patients. Their 5 criteria included; duration of current episode (less than 
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16 days), extent of symptoms (not distal to the knee), Fear Avoidance Behaviour 
questionnaire (FABQ) score (of less than 19 points), segmental mobility testing 
(identifying 1 or more hypo-mobile lumbar segments) and hip range of motion (a loss of 
more than 35° of internal rotation in one or both hips). Flynn et al., (2002) predicted that 
patients who had at least 4 out of the 5 CPR‘s could successfully be predicted to 
achieve at least 50% improvement in disability (as measured by the Oswestry Disability 
Index) within 1 week with a maximum of 2 manipulative interventions with a positive 
likelihood ratio of 24.4. Interestingly, the FABQ has been criticised as lacking credibility 
within an acute population with symptoms of less than 16 days duration (Williams, 2006) 
and has reported ceiling effects (Kovac et al., 2006) and the minimum clinically 
important difference (MCID) level has yet to be identified, although it has been identified 
as possessing moderate correlates (rho=0.52) with the RMDQ (Williams, 2006). 
Childs et al., (2004) conducted a validation study of this CPR and achieved an odds 
ratio of 60.8 indicating that patients that are positive on the ‗rule‘ and received 
manipulation had a 92% chance of a successful outcome, with an associated number 
needed to treat for benefit at 4 weeks of 1.9. These (and other studies by the same 
authors) are the only published reports of CPR‘s for NSLBP that correspond to a level II 
clinical prediction rule as described by McGinn et al., (2002).  
Underwood et al., (2007) conducted a secondary data analysis of the UKBEAM (2004) 
dataset to discover if baseline characteristics of patients could predict response to 
treatment. They discovered that age, work status, ‗pain and disability‘, ‗quality of life‘ 
and ‗beliefs‘ at baseline could predict overall outcome however they could not predict 
response to treatment allocation leading Sweetman (2008) to contest that Underwood et 
al., (2007) may have had more success if they had selected physical examination 
characteristics for baseline levels. Burton et al., (2004) were able to predict outcomes in 
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chronic LBP patients receiving osteopathic manipulation. Similar to the findings of Von 
Korff et al., (1993) and Thomas et al., (1999), they discovered that patients with a 
history of back pain (at baseline and prior to treatment) in excess of 3 weeks were more 
likely to have recurrent pain at 1 and 4 year follow ups (55% compared to 14% with 
acute LBP). The same was true for patients presenting with leg pain, and high fear-
avoidance beliefs and the presence of depressive symptoms. Contrary to Sweetmans‘ 
comments, Burton et al., (2004) also revealed that ‗standard clinical examination data‘ 
were unhelpful in the prediction of recurrence or long-term disability.  
Hancock et al., (2009) focused on the predictive capacity of a CPR on acute LBP 
patients. The primary aim of the study was to develop a CPR to allow clinicians to 
identify the recovery rates of acute LBP patients. They revealed that 3 prognostic 
factors (baseline pain, duration of current episode and number of previous episodes) 
were able to differentiate between quick (baseline pain ≤ 7/10; duration ≤ 5 days; 
previous episodes ≤ 1) and slow recoverers. Patients fitting the ―quick‖ recovery CPR 
were 3.5 times more likely to be recovered at any point than patients without the CPR 
characteristics. A limitation of this study was the small number of patients that were 
finally analysed within the different strata of the CPR (42 out of the total population of 
239 = 17.5%) which might inherently bias any CPR identified.   
CPR studies have been frequently criticised within the physiotherapy literature for 
demonstrating poor methodological quality. Typical areas of concern include a lack of 
blinding of outcome assessors or treating therapists, a lack of homogeneity within 
sample populations, small sample sizes, an insufficient follow-up period and, a lack of 
an assessment of potential psychosocial prognostic factors (Beneciuk, Bishop and 
George, 2009). The lack of further validation of CPR‘s within similar and different LBP 
populations is also a major limitation in the use of CPR‘s for the variety of clinical 
35 
 
settings that therapists are employed. Kent and Keating (2008) conducted a systematic 
review investigating the prognostic factors for a predictive rule for poor outcome in 
patients with recent-onset NSLBP. Their findings were inconclusive due to poor, diverse 
and disparate methodological quality in the literature reviewed and they recommended 
strategies for future prognostic research in order to rectify this problem within future 
reviews.  More recently, the development (Hill et al., 2008 and Hay et al., 2008) and 
subsequent validation (Hill et al., 2010), in the primary care setting, of the STarTBack 
screening tool for the sub-grouping of people with LBP, has received acclaim. The tool 
provides a means of identifying prognostic factors indicating an increased risk of poor 
outcome thereby allowing subsequent treatment to be targeted towards factors that are 
modifiable (Jones et al., 2006; Koes and van Tulder 2006 and Hilfiker et al., 2007). Fritz, 
Beneciuk and George (2011) attempted to assess the use of the tool, within a number 
of American physical therapy clinics, as a means of describing patterns of change in 
clinical outcomes of a case series of 214 LBP patients. Outcome measures included the 
0-10 point narrative pain rating score (NPRS) and the Oswestry Disability Index (ODI) 
with low, medium and high risk categories identified using the STarTBack tool. Although 
the authors found conflicting results to those of Hill et al., (2008 and 2010) and Hay et 
al., (2008) regarding sub-group classification and outcome, Fritz, Beneciuk and George 
(2011) did agree that the STaRTBack Tool may, when combined with their own CRP, 
provide important prognostic information for physical therapists, however, they 
conceded that further research is required to ascertain its use in providing guidance for 
appropriate treatment selection particularly as the majority of patients tend to fall into 
the medium risk category. 
Fritz (2009) cautioned that while useful as part of decision making, CPR‘s should not 
replace clinical judgement – and should be seen as complementary to that process – 
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which needs to involve experience, clinical opinion, and intuition as well as research 
evidence. CPR‘s use quantitative methods to build upon the body of literature and 
expert opinion and can provide quick and inexpensive estimates of probability. Clinical 
prediction rules can be of great value to assist clinical decision making but should not 
be used indiscriminately (Fritz, 2009). Falk and Fahey (2009) advised that the 
development of valid clinical prediction rules should be a goal of physiotherapy 
research. Furthermore, specific areas in need of attention include deriving and 
validating CPR‘s to identify patients for treatments that are likely to result in substantially 
different outcomes in heterogeneous groups of patients (CSP, 2002). Within the field of 
physiotherapy and NSLBP, the majority of CPR-related research has focused on 
prediction of treatment response and, as Fritz (2009) argued, this is the best context in 
which to develop CPR‘s where the nature of the condition (NSLBP) is heterogeneous, 
with several viable yet discrete treatment approaches which result in complexities in the 
process of clinical decision making especially when the presumption that sub-groups 
within the population exist. Fritz (2009) claimed that CPR‘s within this context have the 
potential to improve the efficiency and effectiveness of clinical care, however, for true 
objectivity, in the absence of bias, the subjective nature of currently utilised PROM‘s 





2.3. Outcome Measures and measures of clinical and statistical benefits 
According to Copay et al., (2010) health-related quality of life measures are the 
primary assessment tools for spinal treatments because they have established validity 
and reliability (McDowell and Newell, 1996) however, outcome scores do not always 
translate into meaningful clinical changes or benefits in patients lives or ‗recovery‘ 
(Hush et al., 2010) and are not always transferrable from one population to another. 
Nevertheless, patient-reported outcome measures (PROM‘s) are widely used and 
accepted both clinically and academically as key tools for measurement of patient 
responses to treatment. 
The term minimal important clinical difference (MCID) was first described by Jaeschke 
et al., (1989) who argued that although statistically significant changes often occurred 
in instruments measuring change after intervention, in some cases the significant 
change reported lacked clinical significance. Thus, their operational definition of a 
MCID was forged;  
“…. The smallest difference in score in the domain of interest which 
patients perceive as beneficial and which would mandate, in the absence 
of troublesome side effects and excessive cost, a change in the patient's 
management.” 
  
Jaeschke et al.‘s, (1989) definition involved two constructs; 1) a minimal amount of 
patient reported change and 2) something significant enough to change patient 
management. At the heart of this measure is the patients‘ perception of what is 
meaningful change to them. 
Since Jaescheke et al.‘s, (1989) development of the MCID a number of measures 
have been identified that mimic MCID‘s, notably the MID (minimally important 
difference), MCD (minimal clinical difference), or the MCSD (minimal clinically 
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significant difference). Although similar sounding, these terms vary in meaning and 
typically involve change values beyond the variations of the instrument. At present, 
there is no standard as to how to calculate MCID‘s, and this has resulted in a lack of 
clarity concerning the true interpretation of clinical, patient change. This is confounded 
by the fact that PROM‘s are, essentially, subjective in nature and can vary according 
to the health and patho-anatomical presentation of the patient (e.g. LBP with and 
without radiating symptoms or neurological dysfunction, or age, socioeconomic status 
and duration of symptoms). Cook (2008) supported Norman, Stratford, and Regehr‘s 
(1997) argument, making a case for the development of CPR‘s by suggesting that 
whilst MCID‘s and PROM‘s are a valuable tool for assessing patients perceptions of 
the benefits of therapy, more objective measures should be nurtured to ―define a new 
line of inquiry… where attributes of patients that are related to the likelihood of 
responding positively are prognostically stratified into responsive and stable groups‖.  
Measurement of the effect of physiotherapy (and MT techniques) on the SNS (and in 
particular, SC changes, could provide an important, objective measure of ―effect‖ 
beyond the constraints of PROM‘s. However, meaningful representation of effect or 
―benefit‖ requires that, in the first instance, an assessment, statistically, of the reliability 
(and stability) of the measurement is performed. For this, a number of methods 
(calculations) can be utilised. Classically, the intraclass correlation coefficient (ICC), 
standard error of measurement (SEM) and the smallest real difference (SRD) are used 
to establish the variability, repeatability and the stability of a measure (discussed 
further in chapter 3) although these calculations only provide a statistical construct of 
significant effect rather than clinical measures of perceived improvement.   
The restoration of ‗normal‘ function and relief of pain and symptoms are key outcomes 
for physiotherapy and rehabilitation. Traditionally, subjective patient-reported outcome 
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measures (PROM‘s) have been utilised to assess function and monitor changes over 
time. The World Health Organisation‘s (WHO) International Classification of 
Functioning, Disability and Health [ICIDH-2] report defines ‗activity limitations‘ as 
 “difficulties an individual may have in executing activities” (ICIDH-2, 2000). 
Symptoms and impairments such as reduced range of movement and a restricted 
straight-leg raise are observable by therapists however, direct observation of activity 
levels and limitation is less practical and is better assessed by PROM‘s as these can 
more accurately gauge the impact of LBP and symptoms on functional daily activities. 
Validated, standardised patient-reported questionnaires are a convenient method of 
collecting and synthesising large amounts of information on activity limitations (Delitto, 
1994; Beattie and Maher, 1997) although until the study by Davidson and Keating 
(2002) few had been conducted specifically on physiotherapy patient populations. 
Nonetheless, since the late 1990‘s and the advent and incorporation of evidence-
based practice (Sackett et al., 1996), both primary and secondary care physiotherapy 
departments have incorporated validated PROM‘s as a means of documenting and 
auditing patients responses to treatment and have become everyday tools for 
monitoring patient treatment responses. Within the Hospital setting of the current 
clinical study (University Hospitals of Leicester NHS Trust – Leicester Royal Infirmary 
Site), both the Oswestry Disability Index (ODI) and the Roland Morris Disability 
Questionnaire (RMDQ) are utilized with LBP patients (at inception and discharge) 
alongside the verbal/narrative pain rating scale (NPRS) which is used within and 
between all patient treatments. The NPRS  is used to establish changes in symptoms 
(pain intensity) during and between treatment episodes and the ODI and RMDQ are 
used to assess functional limitation. Additionally, the ODI has been used to assess 
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outcomes to specific treatments in the CPR developed by Fritz et al. (2002) and Childs 
et al., (2004) with the establishment of a change score, at discharge, of 50% (or more) 
indicating a positive outcome. Consequently, these PROM‘s were the secondary 
outcome measures for the clinical study (skin conductance activity levels and 
responses being the primary OM‘s).  
Allocating a search strategy incorporating the key terms for ODI, RMDQ and NPRS, 
the following ‗hits‘ in the published literature (up to October 2011) were identified; the 
ODI (more than 735 titles); pain rating scales (VAS – in excess of 1075 titles; NPRS – 
in excess of 1025 titles) and the RMDQ (more than 335 titles). These three PROM‘s 
were the most widely used further supporting their selection within the clinical study, 
with documented evidence of reliability and validity. Since this literature search, Goertz 
et al., (2012) have published a systematic study specifically focusing on PROM‘s for 
HVLAT for LBP, namely VAS, NPRS, RMDQ and ODI. Goertz et al., (2012) concluded 
that heterogeneity and inconsistencies in reporting restricted their ability to report 
definitive findings, however they did concur with Hush et al., (2010) and Pransky et al., 
(2011) that assessment of the functional capacity of patients may be of greater clinical 
value than assessing reported pain levels, but that new measures of outcome are 
warranted for future clinical trials.  
2.3.1. The Oswestry Disability Index (ODI) 
The Oswestry Disability Index (ODI) is a condition/disease specific (LBP) patient 
reported outcome measure that was first developed in 1976 and originally published in 
1980 by Fairbank et al., and has been widely used within healthcare. Individual items 
on the index were selected based on the experience of the scale‘s developers and 
were pilot tested in a sample of 25 patients. The questionnaire requires only 5 minutes 
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to complete and 1 minute to score and consists of 10 items addressing different 
aspects of function. Each item is scored from 0 to 5, with higher values representing 
greater disability (giving a potential total score of 10 x 5 = 50). The total score is 
divided by the highest possible score (accounting for questions that are purposely 
omitted by the patient; e.g. ‗sex life‘) and multiplied by 100 to produce a percentage 
score (0-100%).  
Various versions and modifications have been made to the original ODI (Version 1.0) 
which was modified by Baker et al., (1989) who removed references to medication 
from the ‗pain‘ and ‗sleeping‘ items, thereby improving the relevance of these items to 
people not taking medication (ODI Version 2.0). Fairbank and Pynsent (2000) further 
modified the ‗travel‘ section to produce Version 2.1. Other modifications have occurred 
by various spine societies and Hudson-Cook et al., (1989) replaced ‗sex life‘ with a 
new item called ‗changing degree of pain‘ however, this version and other 
modifications have been highly criticised as they are considered to be conceptually 
different from the other items. 
Davidson (2007) conducted a Rasch analysis of three versions of the ODI. Their 
findings suggested that the original (version 1.0) and second version (Version 2.0) 
provided adequate to good construct validity but a third version described by Hudson-
Cook et al. (1989) was found to have inferior construct validity. The original Version 
1.0 was the ODI utilized in the clinical research of this thesis. 
High test-retest reliability coefficients have been reported for the ODI (Versions 1.0 
and 2.0) with Fairbank et al. (1980) reporting a value of r=0.99 over 24 hours, and 
Baker, Pynsent and Fairbank (1989, p. 174-186) finding a value of r=0.83 (Versions 
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1.0 and 2.0) for the same-day test-retest. Kopec et al. (1995) reported the absolute 
ICC=0.94.  
Validity is the ability of the questionnaire to measure what it is designed to measure 
(Huck, 2007; p. 75-76). Clinically therefore, it must accurately measure the persons 
disability and participation in day-to-day activities due to LBP. The effect size 
measures the practical significance associated with the strength between two 
variables (<0.2 = small effect size, 0.5 moderate, >0.8 large effect size). Childs and 
Piva (2005) reported the effect sizes ranging from 1.97 at 1 week to 2.53 at 4 weeks. 
Fritz and Irrgang (2001) found the the effect size in their study to be 1.12 while Müller 
et al. (2004) reported floor effects but no known ceiling effects on ODI (version 2.0). 
Fairbank and Pynsent (2000) revealed that the ODI (Version 1.0) correlated with the 
RMDQ (n=500, r=0.77) and Roland and Fairbank (2000) revealed ‗moderate validity‘ 
with VAS (p=0.62) for ODI (version 2.0) with an effect size of 0.8.  
A number of authors have recorded responsiveness of the ODI however there seems 
to be little overall consensus regarding the Minimal Clinically Important Difference 
(MCID) levels reported. Jaeschke et al., (1989) was the first to define the concept of 
MCID as ‗the smallest difference in score in the domain of interest which patients 
perceive as beneficial and which would mandate, in the absence of troublesome side 
effects and excessive cost, a change in patient‘s management‘. In their review, MCID 
represents the smallest difference in the score of an outcome measure that a patient 
perceives as important. (Jaeschke et al., 1989; Stratford et al.,1998; Finch et al., 
2002:271). 
Beurskens, de Vet and Köke (1996) were the first to report a MCID for ODI of 4-10 
points (NSLBP patients) findings that mirrored those of Resnik and Dobrykowski 
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(2005). Similar results, but a small band-width, were published by Fritz and Irrgang 
(2001) with a MCID of 4-6 points (acute LBP patients) and by Childs and Piva (2005) 
who‘s MCID=9. Davidson and Keating (2001) reported much higher levels with a MCID 
of 10.5-15 with Muller et al., (2004) reporting a MCID of 16 (version 2.0). More 
recently, Goertz et al., (2012), in their systematic review of PROM‘s in HVLAT 
treatment for LBP reported within-group MCID‘s of 6-10% with ranges in scores, for a 
manipulation only treatment group, in the order of 5-20%. Interestingly, for groups that 
received a combination of manipulation plus ―other therapies‖ the range was much 
higher (5-35.6%) indicating the need to consider utilising different levels of MCID‘s for 
complex/multiple treatments approaches.  
Dwokin et al.‘s, (2005) consensus based decision suggested a 30% reduction from 
baseline to define the MCID of self-reported back pain measures. Ostelo et al., (2008) 
proposed that the MCID level of improvement for the ODI should also correspond to a 
30% improvement (for example, a patient assessed at baseline with an ODI=20 points 
or 40% functional disability, would need to improve by 6 points to achieve a minimum 
improvement in function of 30%) however, these authors did not differentiate between 
single treatment and multiple treatment responses. 
Fritz et al., (2009) looked beyond MCID and argued that for conditions such as LBP 
that have a ‗favourable‘ short-term prognosis the minimum amount of change in a 
quality of life measure that is either detectable or important may not be sufficiently 
stringent to measure treatment ―success‖ within a simple/binary construct. Indeed, a 
threshold MCID for ODI of 6 may be too easily achieved to be useful for distinguishing 
effectiveness of treatment from the natural tendency towards improvement. Fritz et al., 
(2009) argued using a threshold criterion of at least 50% improvement on the ODI to 
define success and they validated this threshold on a clinical LBP population of 243 
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subject, finding this threshold to have high sensitivity (0.84; 95% CI: 0.79, 0.88) and 
specificity (0.89; 95% CI: 0.85, 0.93). Bearing all these considerations in mind, it was 
decided that for the clinical study, an ODI change score (from initial assessment to 
final discharge) of greater than 50% would be the target MCID.   
2.3.3. The Roland Morris Disability Questionnaire (RMDQ) 
The RMDQ (also known as the St Thomas‘ disability questionnaire) is another widely 
used patient-administered outcome measure of LBP and disability that was developed 
in 1983. It was originally derived from 24 of the 136 items Sickness Impact Profile 
(SIP), a generic health measure initially intended for a variety of chronic diseases, with 
the term ‗because of my back pain‘ added to each item to make it LBP-specific (Gilson 
et al., 1975 and Bergner et al., 1981). The 24 dichotomous items (questions) describe 
possible activity restrictions in the present tense caused by back pain and requiring a 
―yes‖ or ―no‖ response about activities of daily living. By summing the ―yes‖ answers (1 
point each), the range of scores are from 0 (no impairment/disability) to 24 (severe 
impairment/maximum disability). 
The RMDQ primarily measures pain intensity and physical disabilities. There are a 
number of adapted versions from short form versions (RM-12 and RM-18; Atlas et al., 
2003 and Stratford and Binkley, 1997) to a modified version that measures functional 
limitation over the last 4 weeks rather than just on the day administered (Underwood, 
Barnett and Vickers, 1999). Within the musculoskeletal literature, more than 300 
citations of the use of RMDQ were identified. A number of studies have established 
the scales‘ validity (Roland and Morris, 1983) with an internal consistency measure of 
0.87 reported by Stratford and Binkley (2000) establishing the scales‘ construct 
validity. Reliability has been widely reported with ICC‘s ranging from 0.79 (Stratford 
45 
 
and Binkley, 2000) to 0.96 (Underwood, Barnett and Vickers, 1999). Sensitivity was 
reported to be 72% with specificity/responsiveness 82% (Stratford et al., 1998). 
Beurskens, de Vet and Koke, (1996) recorded responsiveness at 5 weeks with ROC = 
0.93 advising that the RMDQ demonstrated best discrimination between improved and 
non-improved patients within their cohort study of NSLBP patients. Psychometrically, 
the RMDQ has been determined to be the most sensitive and appropriate for patients 
with ‗mild to moderate disability‘ while the ODI is most effective for ‗persistent severe 
disability‘ (Roland and Fairbank, 2000; and Davies and Nitz, 2009). 
Davidson and Keating (2002) compared 5 low back disability questionnaires for their 
reliability and responsiveness. In contrast to previously reported studies, these authors 
found the ICC to be markedly lower =0.53 (95%; CI=0.29-0.71). The MCID previously 
reported by Stratford et al.  (1996a and b) of 4-5 points was considered to be too low 
and the authors suggested (from their data) the MCID for the RMDQ should be set at 
8.6-9.5 points and concluded that the RMDQ should not be recommended for use as a 
measure of functional outcome in a general clinical population as it lacked sufficient 
reliability and scale width for clinical application. However, it is worthy of note that 
Davison and Keating (2002) only had very small sample sizes (n=16 and n=47) and it 
would only take a few patients with unusual variability in scores to skew the reliability 
data a fact that the authors refer to in a small number of subjects who demonstrated 
―considerable variability‖ in RMDQ scores despite reporting ‗no change‘ in their 
condition. Riddle and Stratford (2002) further opposed Davidson and Keatings‘ claim 
contending that the overwhelming majority of evidence supports the use of the RMDQ 
scale, a stance supported by Deyo, Battié and Beurskens (1998), Bombardier (2000), 
Kopec (2000) and Davies and Nitz (2009). Goertz et al.‘s, (2012) systematic review of 
PROM‘s in LBP patients receiving HVLAT summarised that the within-group MCID for 
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HVLAT treatments was found to be 2.0-3.5 (range 1.0-22.7) and for treatment 
involving HVLAT plus ―other therapies‖ the range was (2.5-18.4). Whilst they 
acknowledged the RMDQ is widely utilised, they also mirrored the findings of Roland 
and Fairbank (2000) and Davies and Nitz (2009) that its use, particularly in chronic 
LBP patients (with persistent disability) may result in inconsistencies in interpretation 
due to the large variability in the range scores highlighted by their review. 
Nonetheless, the original 24-Item RMDQ has received the most use and praise within 
the literature and has been described as providing satisfactory measurement 
properties for NSLBP patients and resulted in it being recommended by an 
international group of experts (Bombardier, 2000) for studies into NSLBP.  
2.3.3. The Narrative Pain Rating Scale (NPRS) 
Despite the fact that pain is often considered to be a measurable physiological event, it 
is inherently a subjective and personal experience that can range in intensity from 
slight to agonizing. Pain is often considered to be one of the primary reasons for 
patients to seek health care advice and for clinicians it is considered a significant 
outcome measure however, Khorsan et al., (2008) suggested that it should be 
considered a single component of multiple domains in clinical trials, a sentiment 
shared by Turk and Dworkin (2004). 
Pain rating scales provide a patient-centred, quick and simple way for patients to rate 
pain intensity and for therapists to observe temporal changes within and between 
treatment sessions. Typical scales use a written or verbal numeric (e.g., 0-10) or visual 
(image/100mm line) descriptors to quantify pain between the two extremes. All scales 
are anchored at each end with a qualifying statement, that is, ―0 = No Pain and 10 = 
the worst pain imaginable‖ and the patient is asked to select the number that best 
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represents their intensity of pain. Unlike the VAS, which takes time to complete and 
analyse but has unlimited possible responses along the line, the NPRS utilises whole 
numbers and takes seconds to ‗administer‘, is easily translated, inexpensive and 
capable of being administered over the telephone. Despite these clinical benefits, 
Flaherty (1996) contended that pain rating scales lack sensitivity and oversimplify the 
patients‘ experience of pain by converting pain into a single dimension (intensity).  
The validity of NPRS‘s were originally determined by Downie et al., (1971) and NPRS 
validity was further established by Bijur, Latimer and Gallagher (2003). Jensen and 
McFarland (1993) supported these findings and also found the scale to be reliable 
within subjects. Bolton and Wilkinson (1998) reviewed the scales use amongst 
chiropractic patients and found it to be clinically responsive and Spadoni et al., (2003) 
reported an estimate of minimal detectable change at the 90% confidence level 
(MDC90) to be approximately 3-points (27% change) for patients with musculoskeletal 
problems. More recently, Childs, Piva and Fritz (2005) developed this work by 
characterising the scales responsiveness within a LBP patient population. In their 
findings, Childs, Piva and Fritz (2005) declared their confidence that a 2-point (20%) 
change on the scale represents clinically meaningful change that exceeds the bounds 
of measurement error for LBP patients. Goertz et al., (2012) in their systematic review 
of PROM‘s for HVLAT in LBP trials reported a slightly higher level indicating that for 
patients receiving this treatment, the within-group MCID for manipulation was 2.5 
(range 1.0-2.5) they also compared manipulation NPRS MCID‘s to literature 
comparing manipulation plus ―other therapies‖ and documented a within-group MCID 
range to be higher (2.0-3.3) indicating that studies utilising more than just manipulation 
as the treatment modality would need to consider the higher MCID level in their 
analysis of response to treatment.  
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2.3.4. Minimum clinically important difference (MCID) and the Response-shift 
Phenomenon 
 
Controversy exists over what constitutes a ‗minimum clinically important difference‘ 
(MCID) in terms of PROM‘s. The various authors have not been able to agree even on 
the terminology, and some use the term Minimal Important Difference (MID) to 
represent the concept of ‗MCID‘ (Beaton 2003). Norman, Sloan and Wyrwich (2003) 
suggest that 0.5 value (50% change) may be considered a universal standard as it is 
consistently achieved when MCID is divided by standard deviation. However, the 
issues of measurement of change strongly indicate that the concept of meaningfulness 
is context-based (Bombardier, Hayden and Beaton 2001). What represents a MCID of 
an outcome measure can be affected by a number of factors such as whether change 
between or within individuals is measured, between groups or individuals, and what 
approach is used to measure change (Bombardier, Hayden and Beaton 2001, Beaton 
2003).  For instance, Stratford et al., (1998) found that the baseline RMDQ scores can 
have an effect on the magnitude of responsiveness statistic estimated for patients with 
low back pain (<6 weeks) i.e., higher baseline RMDQ scores necessitated that a 
greater amount of change was needed to be considered clinically important change 
(see table 3; Stratford et al., 1998). However, the results could be influenced by recall 
bias, and gender can also influence the patient‘s response to a self-report 




Table 3: Minimum Clinically Important Difference for Roland-Morris Disability Questionnaire 
Scores 
Adapted from Cairns (2002) 
 
Goertz et al., (2012) reported within- and between-group differences, for groups 
receiving manipulation and manipulation plus ―other therapies‖ that cast doubt on the 
consistency of PROM‘s and of MCID‘s with heterogenous populations.  
Ceiling and floor effects have also been observed in RMDQ and ODI outcome 
measures. When compared to ODI scores, a greater proportion of patients scores fall 
into the top half of the RMDQ score (Kopec et al., 1995). Stratford et al., (1996) found 
that the MCID for RMDQ ranged between 4-20 points in a 24 item scale. This indicates 
that RMDQ may not detect improvements in patients with scores less than 4 and 
deterioration in patients with scores greater than 20. Hence, it is recommended that 
ODI may be a better choice in populations with higher disability levels, while RMDQ 
may be more suitable for the general population where the majority may not have 
higher levels of disability (Bombardier 2000). Furthermore, Gatchel and Mayer (2010) 
suggest that the recommended 30% improvement in the ODI may not be a valid index 
and that a 50% improvement, relative to baseline, should be set to identify the MCID in 
future studies. Theodore (2010) also suggested that an appropriate anchor should not 
be a subjective assessment but rather an objective external criterion/marker. 
Glassman and Carreon (2010) contended that this is not currently possible and 
This item has been removed due to third party copyright. The unabridged version of the thesis may be 
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proposed that return to work and work retention are the only plausible external 
criterion for defining MCID although, the National Institutes of Health-funded PROMIS 
initiative (Gershon et al., 2010) is endeavouring to foster the creation of new measures 
of both pain and physical functioning. This is particularly relevant as Pransky et al., 
(2011) suggests that assessment of functional limitations in patients may have greater 
clinical value than assessing reports of pain intensity.   
Schwartz and Finkelstein (2009) have highlighted the fact that patient ―response-shift 
phenomena‖ can likely significantly affect the measurement properties of a standard 
PROM from pre-treatment to post-treatment and may account for inconsistencies in 
patient-reported outcomes after spinal treatments. Response shift bias refers to an 
error associated with PROM‘s which is a threat to the validity of the results (Brown 
and Burrows 1992: p.13). In simple terms, the changes after treatment intervention 
lead to a change in participant‘s perception of the initial level of functioning, called 
response-shift bias (Howard 1980: p.94). The concept of functional status is based 
on patient perceptions of their health status, and could be different for each 
individual, as some individuals make more demands on themselves than others 
(Beurskens, De Vet and Koke 1996).Thus, a change in individual‘s perceptions after 
treatment may have influenced their responses to post-treatment PROM‘s such as 
RMDQ and ODI. Scwartz and Finkelstein (2009) suggest that the duration of 
symptoms may be a factor in the phenomenon as it can influence the mechanism of 
coping as the patient adapts to their disability. These authors suggest that the affects 
of the response shift phenomenon may be more relevant when the completed 
treatment effect is partial rather than total (e.g. in LBP with associated leg pain 
where outcomes are less favourable) and may account for under-emphasis of the full 
measurement of treatment outcomes. They advise that consideration of this possible 
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source of bias will enhance the meaningfulness and interpretability of clinical 
research data and limit the obfuscation of differences between treatments (Schwartz 
and Finkelstein, 2009). 
2.3.5. Summary 
Health-related quality of life measures are important and widely utilised assessment 
tools for spinal treatments because of their established validity and reliability, 
however, it is recognised that some outcome scores (e.g. the NPRS) do not always 
translate into meaningful changes in patients lives and changes in patients 
perception of their condition, over time, and can result in interventions being 
universally rejected or to response-shift bias adding to the complexity of 
interpretation of change. Clearly, a more objective measure of patients‘ status (i.e. 
SC activity levels) at inception, and the extent and nature of change (percentage 
change in SC response), over time, that is not biased by subjective elements and 
diverse patient-coping mechanisms, could be a useful adjunct to patient assessment 
and to therapeutic management. 
MCID‘s have been recognised as important benchmarks for improvement in 
individual patients however, there is little consensus within the literature regarding 
appropriate targets for LBP patients. For patients undergoing physiotherapy 
interventions reported targets for the NPRS have been set at 2-3 points on an 11 
point scale (Childs, Piva and Fritz, 2005; Farrar et al., 2010 and Goertz et al., 2012); 
ODI has been suggested to be set at 10.5-15 points out of a possible total of 50 
(Davidson and Keating, 2002) or a percentage improvement in score of 50% or more 
(Fritz et al. 2009) with RMDQ set between 3-13 points (Cairns, 2002). More recently 
the emphasis has turned towards levels of Significant Clinical Benefit (SCB) rather 
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than the minimum change indicated by the MCID scores with change levels for 
NPRS quoted as 2.5 points (Spandoni et al., 2003, Stratford, 2001; Goertz et al. 
2012); 19 points for ODI (Davidson and Keating, 2002) and 8.7 for RMDQ (Ostelo et 
al., 2004) however, these are more reflective of a group mean rather than individual 
change scores which are considered to be more representative of clinical effect. 
Lastly, the reliability of SC measurements (utilising the Biopac data acquisition 
system) have not been reported. Furthermore, observational data on different 
populations (healthy normals and symptomatic patients) is lacking, particularly in the 
lumbar region. Finally, relationships between SCR‘s and PROM changes following a 
course of physiotherapeutic intervention are unknown thereby highlighting a 
knowledge gap in this area of research.  
 
2.4. The autonomic nervous system, neurophysiological measurements and pain 
processing 
The following sub-chapters review the anatomy of the autonomic nervous system 
(ANS and its divisions) and discuss how ANS responses are currently measured. It 
continues with an exploration of the mechanism of control of blood vessels and the 
sudomotor system with a focus on the sympathetic nervous system (SNS) and its 
cortical, spinal and peripheral connections. Finally, a review of the current concepts 
that underpin the theories of pain processing are discussed before the following 
section that explores the effects of manual therapies on SNS activity and SCR‘s. 
 
2.4.1. Anatomical Divisions of the Autonomic Nervous System 
The last two decades have provided some promising insight into the potential capacity of 
elements of the autonomic nervous system (ANS) to provide an objective measure of 
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physiological change occurring during complex therapeutic interventions. The following 
section aims to introduce the reader to the key elements of the ANS and how changes in 
this system can be captured and linked to current knowledge and concepts underpinning 
the mechanisms of action of manual therapies. 
 The ANS controls the internal environment of the body and supplies viscera, glands, 
smooth muscle and cardiac muscle. It is divided, topographically and anatomically, into 
two complementary parts – the sympathetic nervous system (SNS) and the 
parasympathetic nervous system (PNS). See figure 2 (overleaf). The ANS regulates the 
internal state of the body and acts, either catabolically (SNS – expending energy; 
increasing heart rate and shunting blood centrally from the periphery), or anabolically 
(PNS – conserving energy; slowing heart rate and absorbing nutrition) (Goldberg, 2010, 
p54-55). These two ‗systems‘ leave the central nervous system (CNS) at different sites 
and usually have opposing effects on the structures they supply through endings that are 
mainly adrenergic or cholinergic. Within the nervous system, both the somatic and 
autonomic nervous system function as one unit, with interaction between both systems. 
Notably, their functioning can be influenced by each other (Benarroch, 2006) with several 
areas of interaction between the somatic and ANS being purported in the periphery, DH of 
the spinal cord, brainstem, and forebrain (Zusman 2002). 
Like the somatic nervous system, the ANS has afferent, connector and efferent neurones. 
The afferent impulses originate in the visceral receptors to the CNS. The efferent 
pathways comprise of pre- and post-ganglionic neurones which form the ganglia which sit 




Taken from Williams et al., (1989; p.1154) 
Figure 2: A diagram of the efferent paths of the ANS. 
The parasympathetic pathways are represented by 
blue and the sympathetic by red lines; the interrupted 
red lines indicate postganglionic rami to the cranial 
and spinal nerves. 
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Topographically, the PNS and SNS‘s differ with respect to their connections to the 
central nervous system. Parasympathetic nerves emerge from the central nervous 
system in selected cranial (III, VII, IX and X) and sacral (S2 to S4) spinal nerves. 
Sympathetic axons emerge from the spinal cord in the T1 to L2 spinal nerves. 
Accordingly, parasympathetic nerves are described as having a craniosacral outflow 
and sympathetic nerves as having a thoracolumbar outflow. 
The SNS is the larger part of the ANS being widely distributed throughout the body. 
Its function is to prepare the body for an emergency and redistributed the blood to 
the core and muscles (brain and heart) and from the periphery (skin causing it to 
sweat) and the gastro-intestinal tract (arresting digestion) (Snell, 2010; p.397). The 
SNS consists of the efferent nerve fibre pathways (SNS outflow) from the spinal 
cord, two ganglionated sympathetic trunks, branches, plexuses and regional ganglia.  
Anatomically, unlike somatic motor pathways, which have no synapses once leaving 
the CNS, autonomic motor pathways show synapses within autonomic ganglia, 
which are aggregates of cell bodies outside the CNS. Thus, an autonomic pathway 
involves two neurons in series. Axons conveying information from the CNS to such 
ganglia are called preganglionic axons, and the neurons that form the ganglia and 
whose axons lead from them to the peripheral target organs are called 






Figure 3: The anatomical similarities and differences between the sympathetic and 
parasympathetic nervous systems 
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The anatomical difference between the sympathetic and parasympathetic nervous 
systems is that parasympathetic ganglia lie close to the target organ, while 
sympathetic ganglia lie some distance away. Consequently, postganglionic 
parasympathetic fibres may be short, and postganglionic sympathetic fibres are 
relatively longer. The different locations of ganglia should also be noted, i.e. in the 
sympathetic division, ganglia lie close to the spinal cord and consist of two chains 
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Central Nervous System Peripheral Nervous System 
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(Taken from Palastanga et al., 1994; p.871 with permission) 
 
In contrast, ganglia of the parasympathetic branch lie within or near to the visceral 
organ that they supply. The SNS, which is the larger division of the ANS, has a much 
more widespread distribution than the parasympathetic system as it innervates the 
sweat glands of the skin, the muscles of piloerection, and the muscular walls of many 
blood vessels. Since sweat gland activity is controlled soley by sympathetic nerve 
activity, this measurement has been considered as an ideal way to monitor the 
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autonomic nervous system. Fowles (1974 and 1986) and Venables and Christie (1980) 
first documented the use of SC (otherwise known as electrodermal activity/response – 
EDA/R; Galvanic skin response – GSR or skin potential response - SPR) as a means of 
quantifying and monitoring SNS activity levels and responses to stimuli. Cholinergic 
stimulation of cutaneous blood vessels in the epidermis, via fibres from the sympathetic 
nervous system, constitutes the major influence on the production of sweat by these 
eccrine glands. Thus,it is recognised that the measurement of sweat responses, to 
therapy, are a valid choice for direct measures of SNS and superior to measures of HR 
and BP that can be influenced by both the PNS and the SNS thereby making direct 
changes in SNS activity levels, in accordance to therapy, more complicated. Indeed, 
Bialosky et al., (2009) have presented a model which identifies several pathways within 
the peripheral and central nervous system that could explain the effects of manipulation. 
Within this model, it was suggested that the effects of manipulation either could 
influence or be influenced by the autonomic nervous system. During a state of central 
sensitization, there is a corresponding over-activity in the lateral gray matter and an 
expected increase in sympathetic activity will be present (Sato, 1979 and 1997). 
The cell bodies of preganglionic sympathetic neurons are located in the lateral horns 
of the grey matter in the T1 to L2 segments of the spinal cord. Their axons leave the 
spinal cord in the ventral roots of the spinal nerves at these same levels. After 
traversing the spinal nerve, preganglionic sympathetic neurons enter the ventral 
ramus of the spinal nerve, and just beyond the intervertebral foramen form the white 





Figure 5: The course of the preganglionic sympathetic axons. 
(Taken from Palastanga et al., 1994; p.873) 
 
On entering the sympathetic trunk, preganglionic sympathetic neurons terminate or 
assume an upward or downward course within the trunk. Preganglionic neurons from 
the WRC, derived from lower thoracic and lumbar WRC tend to pass downwards to 
lower lumbar and sacral levels within the trunk, before terminating. When they 
terminate, preganglionic sympathetic neurons do so by synapsing with the cell 
bodies of postganglionic sympathetic neurons located in the sympathetic ganglia. 
The axons of the postganglionic sympathetic neurons then leave the sympathetic 
trunk, or pass upward or downwards within it before leaving. 
Of interest in the present series of studies, unlike the WRC (which only exist 
between T1 and L2 levels), grey rami comminicantes (GRC) leave the sympathetic 
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trunk at all levels, so that every ventral ramus receives a GRC, and importantly for 
the segmental levels of L3 to S1 only GRC are evident. This is of significance when 
considering the lumbar plexus, as Williams and Warwick (1980) observed that, 
occasionally, an interruption of preganglionic fibres occurs in ganglia situated 
proximal to the sympathetic trunks; these are known as ‗intermediate ganglia‘ and 
are most numerous on the GRC in the cervical and, more importantly here, the 
lumbar regions. Harris and Wagnon (1988) described these cervical and lumbar 
regions as being non-sympathetic, and attribute this fact to their conflicting 
observations between the sympathetic thoracic region and non-sympathetic cervical 
and lower lumbar regions. 
Once they join the ventral ramus, some of the postganglionic sympathetic neurons 
assume a short recurrent course to enter the dorsal ramus of the spinal nerve, but 
the majority pass distally within the ventral ramus. The postganglionic neurons use 
the course of the dorsal rami and ventral rami to reach their destinations which are 
principally the blood vessels in the tissues supplied by these rami. These include the 
blood vessels in any of the muscles or joints supplied by the rami, and any blood 
vessels in the skin, in the case of those nerves with cutaneous branches. In addition, 
some postganglionic sympathetic neurons follow the course of cutaneous branches 
of the somatic nerves to reach sweat glands in the skin and muscles of piloerection. 
Table 4 summarises the key anatomical, physiological and pharmacological 
characteristics of the SNS and PNS and Table 5 details the effects that these 





Table 4: Comparison of the anatomical, physiological and pharmacological 
characteristics of the two divisions of the ANS. 
Adapted from Snell (2010, p406) 
Table 5: The effects of ANS on organs of the body & means of detecting response 
(see Glossary of terms for details of measurement definitions) 
Adapted from Snell (2010, p 407) 
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2.4.2. Control of Blood Vessels, the Sudomotor System and SNS Activity 
With few exceptions, there is no significant parasympathetic innervation of blood 
vessels. Indeed, a rich supply of sympathetic postganglionic nerve fibres regulate 
vasomotor and sudomotor activity making electrodermal measures of sweat activity 
a valid measure of stimulus response for the SNS.  
The efferent postganglionic fibres that pass in the GRC to the spinal nerve supply 
vasoconstrictor fibres to the blood vessels, secretomotor fibres to the sweat glands 
and motor fibres to the muscles of piloerection in the areas supplied by the 
corresponding spinal nerve. Thus most, if not all, peripheral branches derived from 
the spinal nerves contain postganglionic sympathetic fibres. However, considerable 
uncertainties exist regarding the sympathetic supply to the lower limb (Williams and 
Warwick, 1980).  
The pelvic section of the sympathetic trunk comprises four or five sacral ganglia and 
is continuous, proximally, with the lumbar plexus. As mentioned earlier, only GRC 
pass from the ganglia to the sacral and coccygeal spinal nerves, i.e. no WRC pass to 
this part of the sympathetic trunk. 
Vascular branches from the pelvic sympathetic plexus pass postganglionic fibres to 
the roots of the sacral plexus, particularly those forming the tibial nerve, to be 
conveyed to the popliteal artery and its branches in the leg and foot. The 
preganglionic fibres concerned with supplying the lower limb are derived from the 
lower three thoracic and upper two or three lumbar segments of the spinal cord, via 
the white rami which can pass either to the lumbar or, via synapses in the upper two 
or three sacral ganglia, where postganglionic axons pass to the tibial nerve and its 
subsequent connections to the lower leg. 
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Cutaneous fascicles of human peripheral nerves convey post-ganglionic sympathetic 
axons destined to the blood vessels, sweat glands and hairs. The fibres are involved 
in thermoregulation, so the skin and core temperatures determine the relative levels 
of sympathetic activity directed to each set of end-organs (Macefield and Wallin, 
1996). Spontaneous and elicited/evoked changes in skin conductance (SC) have 
been suggested as a measure of neurophysiologic arousal followed by activity in the 
SNS (Wallin, 1981 and Storm et al., 2000). Storm et al., (2000) concur that SC 
measurement changes may provide a valid and objective method for evaluating a 
persons‘ state of arousal and help detect covert changes that may ordinarily escape 
subjective evaluation or direct observation. Moreover, these variables have been 
used to evaluate the reaction to pain and CNS processing dysfunctions (Gutrecht, 
1994).  
Figure 6: The cerebral origins of the skin conductance response 
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The neuroanatomical substrates of neurophysiologic SC activity arousal in humans 
are not fully understood but it is assumed that it is linked to increased sympathetic 
activity (Tranel and Damasio, 1994). Tranel and Damasio (1994) found that the 
brain-stem reticular substance, hypothalamus, premotor cortex, amygdala, 
hippocampus and the sympathetic preganglions were all actively involved areas in 
increasing SNS activity (figure 6). Two different types of post-ganglionic sympathetic 
efferent nerve fibres in the skin have been described; noradrenaline synapses in 
smooth muscles in the vessels, and fibres with acetylcholine that innervate the sweat 
glands. SNS activation of palmar and plantar sweat glands, result in increased sweat 
production that is measurable with SC. The high density of sweat glands in these 
areas makes this means of measurement highly responsive (Storm et al., 2000). Lim 
et al., (2003) investigated the sudomotor nerve conduction velocities and central 
processing times (CPT) of SC responses in the hands and the feet of 30 healthy 
adults. Their results found that SC amplitudes were greater in the fingers compared 
to the toes (onset times to electrical stimulation; 1.6 seconds and 2.38 seconds 
respectively) and they determined that this was due to the higher density (24-30%) of 
sweat glands in the hands compared to the toes and the fact that the neural outflow 
volley to the feet has greater dispersal due to increased distance travelled. Central 
processing times (CPT) for fingers and toes were calculated to be between 141 and 
194 ms respectively. Lim et al., (2003) concluded that the comparability of the 
finger/toe CPT‘s were that the SC responses in the lower limb had been 
compensated by faster neural conduction along the small myelinated autonomic 
efferent fibres in the spinal cord between T6 and L2. These findings were contrary to 
those of Bach et al., (2010) who found no difference in the test variance between 
hands and feet and their standard response times but agreed that response times 
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were 1.3 seconds and that response times in excess of 10 seconds represented 
CNS processing prior to response. Overall, both Bach et al., (2010) and Lim et al., 
(2003) recommended that SCR‘s are a potential tool for ANS assessment within 
clinical practice and are stable for detection of SNS changes secondary to evoked 
stimulation. Furthermore, Hengedus et al., (2011), advised that although the 
evidence is limited in the use of SCR‘s in patient populations, and particularly in the 
lumbar region, future studies should now be focused on responses of patients to 
interventions and correlates to functional limitation and symptom intensity changes.   
Electrophysiological experiments have shown that, under normal conditions, human 
peripheral nociceptive fibres, Aδ axons (Elam and Macefield, 2004) and C axons 
(Elam et al., 1999), are not directly activated by SNS activity, findings that are 
supported by the pharmacological studies by Zahn et al., (2004) and clinical 
research investigating SNS arousal in chronic regional pain syndrome (CRPS) 
patients (Baron et al., 2002). It is therefore widely accepted that the SNS does not 
activate nociceptors in the sensory nervous system under normal conditions 
however, there remains a lack of clarity regarding the behaviour and the role of the 
SNS in symptomatic/patient populations. 
 
2.4.3. Central Connections of the Autonomic Nervous System (ANS) 
The last two decades have seen the advancement of functional brain imaging with 
concomitant developments in the knowledge of cerebral brain processing. Despite 
this there remains a lack of clarity in understanding of brain activity in relation to the 
regulation of pain-related physiological responses.  
Beyond the peripheral nociceptor and dorsal horn, nociceptive information ascends 
to the thalamus in the contra-lateral spinothalamic tract (STT) and to the medulla and 
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brainstem via the spino-reticular and spino-mesencephalic tracts. Dostrovsky and 
Craig (2006, p. 187-203) identified that these tracts serve different purposes related 
to both their lamina origin in the dorsal horn and their final central destination. Tracey 
and Mantyh (2007) advised that these spinal projections to the brainstem are 
important for integrating nociceptive information with autonomic processes and for 
the conveyance of nociceptive information to the forebrain after brainstem 
processing thereby influencing the interpretation of pain experiences and perception. 
Although the thalamus plays a central role as a critical relay site for nociceptive 
information, its connections spinally and supra-spinally are still debated in terms of 
processing in humans particularly chronic pain, however in 1981, LeBars et al., 
described experiments on rats and identified that distal noxious thermal conditioning 
stimulation was able to induce strong inhibition of A-alpha and C-fibre responses 
which were diminished by the injection of naloxone. These finding were further 
developed in 1990 by DeBroucker et al., who revealed, in a case controlled series of 
3 human participants, that noxious, but non-painful, stimulation was able to trigger 
the distant/diffuse noxious inhibitory control (DNIC) system in patients with thalamic 
lesions which, these authors considered, excluded the possibility that masking of 
pain, by a second, distal, painful focus could be soley due to attentional processes, 
furthermore, they concluded that lemniscal and spino-thalalmic pathways could not 
be involved in triggering DNIC systems thereby indicating that the brainstem and the 
spino-reticular tracts must represent key neuronal links. This is a construct that has, 
more recently, been supported within a review conducted by Yarnitsky (2010) who 
renamed the process previously known as DNIC as Conditioned Pain Modulation 
(CPM) and found that in patients with chronic pain syndromes (e.g. fibromyalgia, 
tension-type headache, idiopathic pain syndrome and irritable bowel syndrome) 
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there was evidence that pain inhibited pain, particularly with respect to the 
inducement of distal pain to inhibit proximal pain. These findings support the 
developing concept that a central neuroplastic mechanism exists, particularly in 
chronic pain states. Indeed, Apkarian et al., (2004), utilising magnetic resonance 
imaging (MRI) scanning on chronic LBP patients, found that this group of patients 
had 5-11% less neocortical gray matter volume than healthy control subjects and 
that the reduction in gray matter volume was correlated to the chronicity/duration of 
their pain symptoms. Apkarian et al., (2004) suggested that the observed thalamic 
and prefrontal cortex atrophy may be an adaptive change to the hyper-toxicity of 
neuro-transmitters leading to long-term neural plasticity. They also suggested there 
may be an initial hyper-perfusion of these regions in the first 3-12 months of LBP but 
as the pain continues, hypo-perfusion occurs causing the resultant atrophy at the 24-
36 month period and that this may be the reason why patients become less 
responsive to therapeutic interventions as their LBP becomes chronic and is 
reflected in the transition from thalamic processing (in acute pain) to thalamo-cortical 
processing in the chronic stages (Moseley, 2007). Ruscheweyh et al., (2011) 
countered these findings in a study performed on patients with chronic pain, controls 
and past-pain patients. Whilst these authors agree that there was evidence of gray 
matter degeneration similar to the findings of Apkarian et al., (2004), Ruscheweyh et 
al., (2011) found no correlation between the extent/volume of degeneration and the 
duration of symptoms, furthermore, they also revealed that these degenerative 
changes were reversible after 10-12 months cessation of pain. Tracey and Mantyh 
(2007) suggested that severe chronic pain could be considered a neurodegenerative 
disorder that particularly affects the prefrontal cortex with consequential negative 
effects on the descending inhibitory system which, if unarrested may contribute to 
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the chronic pain state supporting Hurwitz‘s (2011) commentary that more focus 
should be placed on the early resolution of pain in the acute pain state to prevent 
chronicity in LBP. 
Piché, Arsenault and Rainville (2010) investigated the cerebral correlates of pain-
ratings, motor responses and skin conductance evoked by noxious electrical 
stimulation utilising data acquisition by the Biopac system (SC & EMG in the lower 
limbs) and functional-MRI (fMRI) brain imaging equipment of 11 healthy volunteers. 
In their covariance analysis they revealed that brain regions activated during pain 
were also involved in sensorimotor and SNS physiological regulatory responses (see 
table 6 below for a summary of the regions identified) which support the research 
conclusions of Rhudy, MacCabe and Williams (2007) that noxious stimuli evoke a 
robust SC response that is driven (rather than precipitated by) low-level neural 
processes but is sensitive to the psychological context.  
Table 6. A summary of the responses of brain activity regions during pain, motor 
system & SNS activity, primary associated response and clinical interpretation. 
 Brain activity regions Clinical Interpretation 






Suggests an important 
contribution of higher-order 
brain processes to individual 
differences in pain sensitivity. 
 
Subjective emotional & 
cognitive correlates with 
decision-making, reward- 
prediction, expectation and 
actualisation 
Motor evoked activity ACC 
OFC 
Corresponds with the role of 
these areas in goal-oriented 
cognitive/ behavioural 
processes 




Negative correlation between 
SNS reactivity and brain 
activity. 
Key: ACC = Anterior Cingulate Cortex; PHG = Parahippocampal Gyrus; mPFC = Medial Prefrontal Cortex;  
        OFC = Orbitofrontal Cortex; PAG = Periaqueductal Grey/Midbrain MCC = Midcingulate Cortex. 
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Tracey et al., (2002) specifically monitored PAG activity in their experiment 
assessing the influence of attention and distraction on pain perception. They found 
significant increases in activity within the PAG in subjects who were distracted 
compared to when they paid attention to their pain, with concomitant changes in pain 
ratings that suggested a varying capacity to engage the descending inhibitory 
system. Wagner et al., (2004) extended these observations to consider the influence 
of expectations on brain region activity. They found that there was stronger prefrontal 
cortex activation during anticipation of pain and that this correlated with greater 
placebo-induced pain relief and increased PAG activation particularly during 
anticipation of an ‗event‘ and that this was related to activity in the dorso-lateral pre-
frontal cortex. Furthermore, responses in Primates have revealed that OFC and PFC 
activity levels are correlated to reward prediction, reward expectation and reward 
actualisation/ detection and that these are linked to motivation and goal-directed 
behavioural processing and decision-making (Rolls and Grabenhorst, 2008). These 
results support the concept that prefrontal mechanisms can trigger dopamine and 
opioid release within the brainstem during expectancy and can thereby influence the 
descending pain modulation system with subsequent modulation of pain perception 
and processing (Leknes and Tracy, 2008). Lidstone, de la Fuente-Fernandez and 
Stoessle (2005) revealed that the placebo response is partly mediated by the 
activation of reward-circuitry and that meso-corticolimbic dopamine release plays a 
central role and is highly linked to expectancy. They found that expectation of a 
clinical improvement was a form of expectancy of reward resulting in striatal 
dopamine release and placebo analgesia via the endogenous opioid systems. 
Placebo activated cortical areas that are known to respond to reward expectation 
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include the OFC, dorso-lateral PFC and the ACG (Schultz, Dayan and Montague, 
1997; Mayberg et al., 2002 and Petrovic et al., 2002).  
Contrary to the above findings, Piché, Arsenault and Rainville (2010) found that their 
subjects displayed individual differences in pain perception, motor reactivity and SNS 
activity which reflected individual differences in brain activity (e.g. subjects that 
displayed high ANS reactivity were inversely active – less active – in the PAG region 
of the brain). They also identified an inverse relationship between motor responses 
and SNS activity and subjects who had less OFC activity had higher ANS activity. 
From this, Piché and colleagues were able to identify brain sub-systems (particularly 
within OFC processing for pain) that suggest that psychological factors related to 
pain may inversely influence ANS and motor reactivities and that negative emotional 
states that result in activation of the ACC (Devinsky, Morrell and Vogt, 1995; Vogt, 
2005), amygdala and the PAG (Devinsky, Morrell and Vogt, 1995) may exert 
ongoing regulatory feedback through the descending pathways affecting spinal 
nociceptive processes. In contrast, the body of works by Critchley and colleagues 
(Critchley et al., 2000 Critchley, 2005) found that in acute pain states, the activity in 
the Insula/inferior frontal gyrus covaried with SC amplitudes and reflected the 
ongoing regulation of SNS responses associated with pain arousal. 
In conclusion, research supports the use of SC responses as a measure of 
SNS/ANS reactivity to stimulation and that there are fMRI links to brain activity and 
SC responses particularly in acute pain states, the picture is more cloudy as acute 
pain states become more chronic/affective whereby individual differences in pain 
sensitivity reflect the variability in the supra-spinal elaboration of afferent information 
and the neuro-plasticity and adaptive changes that are occurring in the thalamo-
cortical and pre-frontal cortices of the brain.   
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2.4.4. Determinants of peripheral sympathetic nervous system activity 
Quantification of ANS responses have been performed by a variety of proxy 
measurements which are summarised in table 7. 








Peripheral Shoulder Simon, Vicenzino & Wright 1997 GHJ AP Gd III ↑ SC, ↓ ST 
Elbow Paungmali et al., 2003 MWM elbow jt ↑ SC, 
Vicenzino, Collins & Wright 2004 Neuro Mob ↑SC,PPT & PFGF  
Wrist & Hand    
Hip    
Knee    
Ankle & Foot    
Spinal Cervical Petersen, Vicenzino & Wright 1993 C5/6 PA Gd III ↑ SC 
Vicenzino et al. 1994 C5 Lat Glide ↑ SC, ↓ ST 
Vicenzino et al. 1995 C5 Lat Glide ↑ SC, ≈ ST 
Chiu & Wright 1996 C5 PA diff rates ↑ SC  ≈ ST 
Vicenzino, Collins & Wright 1996 Lat Glide C5 ↑ SC, no change ST 
Vicenzino et al., 1998 Lat Glide C5/6 ↑ SC, no change ST 
Sterling & Watson 2001 Uni-lat PA C5 ↑ SC,↓EMG,↓pain 
Moulson & Watson 2006 MWM Rotation ↑ SC ≈ ST 
Slater, Vicenzino & Wright 1994 Uni-lat PA T6 ↑ SC (bilateral) 
Thoracic Jowsey & Perry 2010  Rotatory Mob ↑ SC, no change ST  
Colloca et al., 2000 & 
Colloca et al., 2003 
Intra-operative 
manip 
↑ SC (Bilateral) 
Lumbar  Perry & Green 2008 Unilat PA L4/5 ↑ SC (Ipsilateral) 
Perry et al., 2011 EIL & Manip ↑ SC  
Moutzouri, Perry & Billis MWM L4 ↑ SC (bilateral) 
 
Skin conductance responses (SCR‘s) have been identified in the literature to be the 
more stable proxy measure of SNS activity in the limbs (as compared to skin 
temperature changes) and rely on the detection of a peak/maximum response or 
computing the mean response over an anticipated time window relative to baseline 
(Bach et al., 2010). SC responses can loosely be grouped into; spontaneous (Bach et 
al., 2010), anticipatory (Patterson et al., 2002) or evoked/reactive (Patterson et al., 
2002; Donaldson et al., 2003). Many authors have identified SC responses to a variety 
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of stimuli; heat pain (Bach et al., 2010; Logia et al., 2011); anger (Janssen et al., 2004); 
empathy (sambo et al., 2010); deep and superficial pain (Burton et al., 2008 and 2009), 
mechanical pain (Breimhorst et al., 2011), electrical pain (Macefield et al., 2002, 2003 
and 2010; Donaldson et al., 2003; Breimhorst et al., 2011) and psychological anxiety 
(Donaldson et al., 2003). Within the physiotherapy literature, maximum SCR‘s have 
been utilised to monitor the SNS response to a variety of treatment modalities, both 
peripherally and spinally. These are summarised in table 7. 
2.5. Pain perception and nociceptive processing 
The physiological basis of nociception, particularly the mechanisms of signalling and 
modulation of nociceptive stimuli is covered in this section. 
Pain is one of the main reasons that patients seek musculoskeletal out-patient 
physiotherapy intervention for LBP. Peripheral nociceptors are specialist neural tissues 
that are sensitive to noxious change occurring within their receptive field. Given the 
presence of ‗adequate stimulus‘ (potential or actual tissue damage, for example, with 
facet joint and associated ligamentous and capsular injury or disc degeneration) their 
thresholds are met and a signal is transmitted to the associated neurone. Torebjörk and 
Ochoa (1980) determined that there were two types of afferent nociceptor fibres; Aδ and 














Axon type Aδ C Aβ C-Tactile Afferents 
Myelination Yes No Yes No 
Fibre diameter  3 μm 0.5 μm 8 μm  
Conduction 
speed  
15 m/s 1 m/s 50 m/s 0.6 to 1.3 m/s
-1 






































signalling in lamina II of 
dorsal horn 
Adapted from Strong et al., (2002, p.15-16) and *Olausson et al., (2008 & 2010) 
 
Somatosensory nociceptors can be divided into 2 distinct types; mechanical nociceptors 
and polymodal nociceptors. Mechanical nociceptors have characteristically high 
thresholds and respond specifically and in a slowly-adapting way, to strong mechanical 
stimuli but not to heat, cold or chemical irritants. Their receptive fields are distinctive and 
their neural units myelinated with conduction speeds of 5-25 metres per second and 
densely distributed over the skin. Polymodal nociceptors also respond to strong 
mechanical stimuli, but unlike mechanical nociceptors are sensitive to noxious heat, 
strong skin cooling and to chemical irritants (Meyer et al., 1994. p.13-44). A mechanical 
stimulus may be generated; cutaneously, by stroking (massage) manoeuvres; 
arthrogenically, by joint mobilisations, mobilisations with movement techniques and 
manipulation (to name a few); myogenically by specific soft tissue techniques, exercise, 
muscle release techniques, massage and deep transverse friction manoeuvres; and 
74 
 
neurodynamic techniques (e.g., sliding and gliding techniques). Although a number of 
high quality articles have discussed the outcomes of these techniques on observable 
patient outcomes (e.g. range of movement and pain intensity levels) few have 
conducted research on the SNS responses to mechanical treatment techniques. 
Relating to the haptic sense, Olausson and colleagues (2008 and 2010) have 
recently published their findings regarding the existence of unmyelinated tactictile C-
fibre mechanoreceptive afferents that are responsive to stimulation from pleasant 
touch rather than noxious stimulation. Olausson and colleagues (2008 and 2010) 
claimed to have identified these nerve units in humans within non-glaborous, hairy 
skin that respond ―vigorously‖ to slow and light stroking usually performed with a soft 
object. Olausson et al., (2002) identified, through fMRI, that the signals generated by 
stimulation of C-tactile afferents project via lamina I & II of the spinothalamic tract to 
the posterior lobule of the insular cortex and to the posterior ventral medial nucleus 
but, unlike A-Beta fibres, not to the ventral posteror lateral nucleus of the thalamus 
and from there to the somatosensory areas 1 and 2 of the cortex. Morrison, Löken 
and Olausson (2010) suggest that C-tactile afferents have more in common 
anatomically with interoceptive and visceral systems – relevant to a broad set of 
bodily feelings like pain, itch and hunger – than to exteroceptive afferent systems 
processing tactile and nociceptive stimuli. Morrison, Löken and Olausson (2010) 
went on to claim that activation of C-tactile afferent brain projections is associated 
with somatic and multimodal responses which may reflect cortical processing of 
affective touch that they termed ―social touch‖ thereby supporting Craigs‘ (2008) 
proposal that the posterior and anterior insular regions integrate emotionally salient 
inputs between the limbic regions (ACC and OFC) with pluripotent effects on 
homeostatic regulation on motivational conditioning (reward-related) and social 
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conditioning. The role of C-tactile afferents in homeostatic function was further 
defined by Olausson et al., (2008) in an experiment involving subjects who 
specifically lacked A-beta afferents. They found that activation of C-tactile afferents 
on the forearm were able to produce (excitatory) sympathetic skin responses 
(detected in the palm of the hand) although it is worthy of note that this study only 
had 2 subjects and responses were not consistent between subjects. The findings of 
these authors are worthy of note given the social, professional context of the 
―therapeutic encounter‖ within which patients are consensually touched and receive 
motivational input and reward from the treatment episode (Bialosky et al., 2008).      
Within the classical framework of neural anatomy, it is accepted that as primary 
afferent fibres in peripheral nerves travel proximally, they group together to form 
spinal nerves with ventral and dorsal roots prior to entering the spinal cord and 
dividing into short ascending and descending branches that run longitudinally in the 
dorsolateral fasciculus Lissauer. Within several segments they leave the tract to 
synapse on neurones in the dorsal horn. The dorsal horn is the first site for 
integration and processing of incoming sensory information and is divided into 
different laminae with distinct functions and chemical profiles (Willis and Coggeshall, 








Figure 7: the terminations of afferent fibres in the dorsal horn. 
 
Taken from Bandler and Shipley (1994) 
 
Laminal I (the marginal Zone) is an important nociceptor relay site with high densities 
of projection neurones identified that function to process nociceptor information and 
in may be influenced by non-nociceptive mechanical stimulation generated by 
manual therapy interventions (Pickar, 2002; Dishman and Bulbulian, 2000 and 
Zusman, 2004 and 2010). There are nociceptive-specific neurons that are elicited 
solely by nociceptors, and wide dynamic range neurons (also in lamina V and, in the 
cervical and lumbar regions only, lamina VI), which respond to both nociceptive and 
mechanoreceptive input (Strong et al., 2002).  
Afferent fibres of all distal origins establish a matrix of connections with the dorsal 
horn neurons, exerting a homeostatic changing pattern of excitatory and inhibitory 
inputs that determine the firing of the dorsal horn projection neurons and of 
interneurons that mediate spinal reflex responses. In health these neurons are 
This item has been removed due to third party copyright. The unabridged version of the 
thesis may be viewed at the Lanchester Library, Coventry University.
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segregated however, Woolf, Shortland and Coggeshall (1992) identified that 
peripheral nerve injury can trigger sprouting of afferents into Lamina II with resultant 
adaptation of function and threshold levels of the afferent fibres to this lamina.   
Second-order neurones arise from different regions of the dorsal horn, cross the 
midline and ascend the spinal column to the brain stem and thalamus in the antero-
lateral column. They synapse in a number of brainstem nuclei (including the 
periaqueductal grey region/PAG) and in several thalamic nuclei. The PAG surrounds 
the cerebral aqueduct of the midbrain and can be divided, anatomically, into 4 distinct 
regions; medial, dorsal, dorso-lateral and ventro-lateral, each with a high degree of 
functional specificity (Henderson, Keay and Bandler, 1998). These columnar 
longitudinal projections from the PAG permit connections with all levels of the nervous 
system and plays an important role in integrating functions critical to survival (fight or 
flight) through its influence on the nociceptive, autonomic and motor systems 
(Behbehani, 1995 and Morgan et al., 1998). Functions controlled by the PAG include 
pain facilitation, analgesia as well as fear and anxiety (Behbehani, 1995). Pain 
modulation can be demonstrated from stimulation of various regions of the PAG 
however, stimulation of the dorsolateral and ventrolateral subregions produces 
different autonomic and motor system responses (Lovick, 1991 and Morgan, 1991). 
Fields and Basbaum (1994; p.243-257) reported that stimulation of the PAG or the 
nucleus raphe magnus inhibits spinothalamic tract cell transmission and has been 
proposed as a possible mechanism of action of manual and manipulative therapies 
(Zusman 1986, 2004 and 2010; Pickar 2002 and Bialosky et al. 2009). Olasson et al., 
(2008 and 2010) add that C-tactile afferent stimulation (light stroking or ―social touch‖), 
may also play a part in inhibiting noxious transmissions by providing a blockade in 
laminae I and II of the dorsal horn and that cortically, stimulation of these fibres are 
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processed interoceptively (by the posterior insular cortex) resulting in SNS, emotional 
and motivational changes rather than motor responses. 
Injury of any source results in marked up-regulation of nociceptive system function 
(Boal and Gillette, 2004) and, consequentially, enormous neuroplasticity and change 
in many aspects of central nervous system function (Woolf 1994 and 2011, Bakkum 
2007) . Up-regulation of nociceptive system function has effects on somatomotor and 
somatosympathetic function (Storm et al., 2000) and whilst this system is normally 
quiescent, regular strong, intense, potentially damaging stimuli triggers pain 
perception, a cascade of interactions between these systems and, ultimately, a 
hyperalgesic state that is characterized by a diminished threshold for noxious 
stimulation and, through the process of neuroplasticity, altered response thresholds 
for other forms of stimuli (Moseley et al., 2006 and Wand and O‘connell, 2008) . As 
indicated, along with somatosympathetic activity alterations, an emergent model was 
proposed by Sterling et al., (2001) who advocate, alongside sympathetic changes, 
pain also influences concurrent alterations on patterns of neuromuscular activation 
and control. Sterling et al., (2001) suggest that the presence of pain leads to 
inhibition or delayed activation of local (to the source of pain) deep muscles or 
muscle groups (e.g. Multifidus) that perform key synergistic functions thus limiting 
unwanted motion with resultant alterations in the patterns of motor activity and 
recruitment during functional activity. This concept is supported by the research of 
Hides, Richardson and Jull (1996) and Hodges and Richardson (1996) and while the 
changes in the control of these muscle may be initiated by pain and/or tissue injury, 
they are often sustained beyond the acute pain phase (Hides, Richardson and Jull, 
1996), and may contribute, unless arrested, to chronicity (Hides, Jull and 
Richardson, 2001 and Wand and O‘Connell, 2008). 
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Primary (peripheral) sensitization is characterised by nociceptive system activity with 
a concomitant up-regulatory response following tissue injury. This is a complex 
sensitization process whose different forms of sensitisation may develop depending 
on the nature of the injury or disease. Activation of nociceptors, sensitisation of 
currently responsive nociceptors, recruitment of mechanically insensitive or silent 
nociceptors, and phenotype conversion of non-nociceptive afferents, represent four 
major mechanisms whereby temporal and spatial summation of nociceptive afferent 
inputs to the central nervous system may occur following tissue injury (Johnson 
1997). Acting in concert, these mechanisms can contribute to substantial up-
regulation of peripheral nociceptive system function. Ultimately, this may be 
interpreted as pain at higher levels within the CNS leading to neuroplastic changes 
and central sensitization (Woolf, 1994 and 2011). Central sensitisation may be 
considered to be a possible link between the presence of pain, the sensory-motor 
system and the autonomic nervous system (Wand and O‘connell, 2008 and Bialosky 
et al., 2011) 
Central sensitization describes the changes occurring at a cellular level to support 
the process of neuronal plasticity that occurs in the nociceptive system neurones in 
the spinal cord and in the supraspinal centres because of excitation of nociceptive 
pathways (Woolf, 1994 and 2011). Central sensitization contributes to a number of 
aspects of neuroplasticity, including increased excitability of a wide dynamic range 
(WDR) cells (Woolf, 1989), increased receptor field size (Cook et al., 1987) and 
changes in somatic withdrawal reflexes (Woolf, 1984) and, more recently, wider 
appreciation of the role of changes occurring at cellular (Chacur et al., 2009) and at 
genetic levels (Chiang et al., 2010) with, ultimately, clinical manifestations occurring 
80 
 
secondary to neuroanatomical reorganisation in the dorsal horn neurons (Flor et al., 
1997 and Flor, 2003). 
Peripheral and central sensitization have been implicated in changes in autonomic 
function and research over the last two decades has begun to reveal that a link may 
exist between the experience of pain and alterations in sympathetic activity, and 
suggesting that sympathetic outflow may influence (or maintain) afferent activity in 
nociceptive neurons (Campbell et al., 1992 p.121-149; Koltzenburg, 1992 p.213-243; 
Janig and Koltzenburg 1992; Devor, 1995, Sato, 1997; Benarroch, 2001; Zusman, 
2002 and Lim et al., 2003). The potential role of the SNS and postganglionic 
noradrenergic neurons in complex regional pain syndromes remains controversial, 
and little consideration has been given to the role of these mechanisms in less 
severe musculoskeletal disorders, including LBP. However, alterations in SNS 
function have been recorded, and abnormalities of somatosympathetic reflex 
responses demonstrated in patients with frozen shoulder (Mani et al., 1989) and  
patients with tennis elbow (Smith et al., 1994 and Thomas et al., 1992) as well as 
neck pain (Sterling et al., 2001). 
More recently, functional brain imaging (fMRI) studies have provided evidence of the 
close association between areas of the nervous system responding to pain (e.g. the 
thalamus and the anterior cingulated, anterior insular, somatosensory and premotor 
cortices) and areas controlling autonomic and motor function and emotional state 
(Porro and Cavazzuti, 1996). Lovick (1991) and Chudler and Dong (1995) revealed 
that both the basal ganglia and the PAG region receive nociceptive inputs as well as 
coordinating important aspects of movement and motor control.  
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The afferent nociceptive pathways and central mechanisms of processing and 
modulation provide a complex means of indicating to an organism the potential for 
injury and are systems that can be countered by other associated networks. In 1969 
Reynolds published a seminal study investigating the descending pain inhibitory 
system (DPIS) and highlighting the importance of the PAG in the control of 
nociception. Reynolds (1969), Cannon and Liebeskind (1987) and Jones (1992), 
revealed that stimulation of discrete brain regions produced profound endogenous 
analgesia in animals. Furthermore, these authors identified two distinct forms of 
analgesia with associated behavioural, physiological and pharmacological correlates. 
Bandler and Shipley (1994) found that both the dorsolateral and ventrolateral 
columns appear to be important for modulating pain perception. Figure 8 provides an 
illustration of these pathways. 
The characteristics of each PAG region are summarised in Table 9 overleaf. 
Essentially, the dorsolateral column of the PAG region has characteristic analgesia 
associated with fight/flight behaviour, aversive reactions (Besson, Fardin and 
Oliveras, 1991; Fanselow, 1991, and Morgan, 1991) and sympathoexcitation (Lovick, 
1991 and Lovick and Li, 1989). Pharmacological studies indicate that dorsolateral 
PAG analgesia is non-opioid as it is not blocked by naloxone administration (Cannon 
et al., 1982) and does not exhibit tolerance (Morgan and Liebeskind, 1987), also its 
onset is generally rapid, within 20 minutes (Takeshige et al., 1992). Projections from 
the dorsolateral PAG utilize noradrenaline as a neurotransmitter and this 
noradrenergic system has a key role in mediating morphine analgesia in relation to 
mechanical nociceptive stimuli by inhibiting the release of substance P at spinal cord 
level (Kuraishi, 1990 and Kuraishi et al., 1983 and 1991). 
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Figure 8: The lateral and ventrolateral columns within the periaqueductal grey 
region.(Injection of excitatory amino acids within each of these columns elicits opposing response 
characteristics as indicated.) 
Taken from Bandler and Shipley (1994) 
 
Table 9: A comparison between the dorsolateral and the ventrolateral PAG and its 
characteristics. 














Not blocked Not blocked 
Stimulation tolerance 
 
Non exhibited Exhibited 
Onset time 
 
Rapid (3-20 mins) 20-40 minutes 




Mechanical Nociception Thermal nociception 
Primary Actions  At Spinal cord level  
Inhibits release of Substance P 
Inhibits release of somatostatin 
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The ventrolateral column of the PAG region has characteristic analgesia associated 
with immobility (Morgan, 1991) or ‗freezing‘ (Fanselow, 1991), recuperative 
behaviour and sympathoinhibition (Lovick, 1991). The analgesic effect is blocked by 
the administration of naloxone in the dorsal raphe nucleus (Cannon et al., 1982) and 
is tolerant to repeated stimulation (Morgan and Liebeskind, 1987) and described as 
an opioid form of analgesia, requiring a longer period of peripheral, thermal 
stimulation (Takeshige et al., 1992). Projections from the ventrolateral PAG, via the 
nucleus raphe magnus, use serotonin (5-hydroxytryptamine) as a neurotransmitter 
and is specific to morphine analgesia directed towards thermal nociceptive stimuli 
(Kuraishi et al., 1983) by inhibiting the release of somatostatin (Kuraishi, 1990). 
2.5.1. Summary 
Research over the last two decades has indicated that mechanisms exist to sensitize 
nociceptors, to recruit previously inactive nociceptors and to utilize afferent inputs via 
myelinated neurons to contribute to nociception. These mechanisms contribute to 
substantial spatial and temporal summation of nociceptive inputs. Central 
mechanisms are important in neuroplastic adaptations seen in continued pain states 
and there is a movement away from a peripheralist view of pain to a much more 
integrated understanding that recognises the highly diverse, interactive, emotive, 




2.6. The proposed mechanisms of action of spinal manual therapy 
Having reviewed the key components within the nociceptive processing system, this 
section reviews the literature supporting the proposed mechanical, physiological and 
neurophysiological mechanisms of action of spinal manual therapy and explores the 
use of skin conductance activity levels and maximum SC responses as outcome 
measures to analyze the effects of different physiotherapeutic approaches to 
musculoskeletal pain with a focus on the critical evaluation of previous literature on 
the neurophysiological effects of MT techniques. Details of the literature search 
strategy are provided in appendix II. 
2.6.1. Review of the literature on the origins, definitions and evidence of effects of 
spinal manipulative therapy (SMT) techniques 
 
Spinal Manipulative Therapy (SMT) is one of the oldest forms of healing art practised 
as far back as 2500 years ago (Hooper 2005:746). Hippocrates, the father of modern 
medicine, had utilised spinal manipulation for treating various conditions such as 
scoliosis , and even designed a table for manipulation which remained in use for 
more than 2000 years (Hooper 2005:746). In the early part of nineteenth century, 
spinal manipulation was largely viewed with suspicion due to increasing concern 
about its safety in patients with tuberculosis (Hooper 2005:746). In the present era, 
SMT is used widely by chiropractors, osteopaths and physiotherapists for relieving 
pain for various musculoskeletal disorders such as non-specific low back pain, 
mechanical neck pain, and certain types of headaches (Bronfort, Haas and Evans 
2005) and has become one of the most studied treatment options for LBP (Mierau 
2000:208). For example, there were only nine studies in the Ottenbacher and 
DiFabio (1985) review but the review by Van Tulder, Koes and Bouter (1997) had 25 
studies in it (Bronfort, Haas and Evans 2005:150). However, large scale surveys in 
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UK found that only 3-9% of physiotherapists use manipulation clinically, in contrast to 
59% use of joint mobilization (Foster et al., 1999, Jackson, 2001 and Gracey, 
McDonough and Baxter, 2002). This is, in part, due to the fact that the exact 
mechanisms through which SMT relieves pain have not been clearly established 
(Pickar, 2002) and the concerns about the safety of SMT (Ernst and Canter 2006) 
render it less ‗acceptable‘ (for clinical applicability/use) in the eyes of the scientific 
and clinical communities.  
In general, the recommendations for the management of acute LBP are similar 
among the clinical guidelines of various countries (Koes et al. 2001 and Pillastrini et 
al., 2011). Most, but not all, of the countries recommend spinal manipulation for the 
treatment of acute LBP patients without nerve root problems or serious spinal 
pathology.  However, the Dutch, Australian and Israeli guidelines do not recommend 
the use of spinal manipulation for acute LBP patients (Koes et al., 2001).  This 
discrepancy in the recommendation of clinical guidelines concerning the SMT for 
acute LBP patients among the different countries may be due to different 
interpretations of the available evidence, as recommendations are based not only on 
research evidence but also on consensus as well (Koes et al., 201, Pillastrini et al., 
2011). Despite a growing number of studies reporting on clinical effectiveness of 
SMT in patients with acute LBP, the uncertainty surrounding the precise 
mechanisms by which SMT relieves symptoms (pain and functional impairment) 
provides a background for academic and clinical debate within an acute LBP patient 
setting.  
There is a plethora of manual techniques such as joint mobilizations, passive joint 
stretching, and muscle energy techniques used under the umbrella term SMT 
(Hooper 2005:747). The complex issue of terminology in defining SMT was 
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considered by American Academy of Orthopaedic Manual Physical Therapists who 
defined SMT based on six characteristics, namely: Rate of force application, 
Location in range of available movement, Direction of force, Target of force, Relative 
structural movement and patient position (Mintken et al., 2008). Evans and Lucas 
(2010) in their reappraisal of manipulation, devised a model to identify specific 
‗action‘ features (of the practitioner) and specific ‗response‘ features (on the part of 
the recipient). This model is presented in Figure 9. 
Figure 9: The relationship of the features of manipulation, compared with other 
manual therapy interventions  
 
 However, for the purposes of this thesis SMT is used to denote a high-velocity low-
amplitude thrust (HVLAT) delivered to a joint (i.e., Lumbar segment facet joints) in a 
(Taken from Evans & Lucas, 2010)  
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specific direction (Bergmann, 2005:756). In other words, Spinal manipulation is 
defined as a ‗small-amplitude rapid [thrust] movement, not necessarily performed at 
the limit of a range of movement, which the patient cannot prevent taking place‘ 
(Maitland et al., 2005: xvi) and involving joint gapping in a starting position that 
involves a combination of 3 physiological movements that are in a coupled manner 
and designed to produce an audible ―pop‖/gapping of the joint surfaces. In this 
thesis, ―Spinal Manipulation‖, ―Spinal Manipulative Therapy‖ (SMT), ―Rotatory 
Lumbar Manipulation‖ and ―High-Velocity Low-Amplitude Thrust‖ (HVLAT) are used 
synonymously.  
SMT was originally, thought to have some local mechanical effects. For example, 
SMT helped release trapped synovial meniscoids in zygapophyseal joints of the 
spine, change the thixotrophic property of synovial fluid, help reduce a subluxed disc 
material and break joint adhesions (Greenman 2003:108). However, there is no 
evidence to support these assertions. 
SMT essentially delivers a mechanical input to the tissues of the spine (Pickar, 2002). 
SMT is often, but not always, associated with a cracking or popping sound called 
cavitation (Conway et al., 1993). In other words, cavitation is the ‗formation of 
gaseous bubbles within the synovial fluid of the joint, as a result of a distraction that 
causes a local reduction in pressure‘ (Potter, McCarthy and Oldham, 2005). Brodeur 
(1995) proposed that the sound associated with the cavitation is generated by elastic 
recoil of the synovial capsule as it is released from the capsule/synovial fluid interface 
and the review paper by Evans (2002) concluded that cavitation should not be an 
absolute requirement for the mechanical effects to occur but agreed that it may be a 
reliable indicator of successful joint gapping. Although Protopas and Cymet (2002) 
concluded from, their review paper, that the articular release is a physiological event 
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that may or may not be audible and that not all noise coming from a joint signifies an 
articular release, moreover, due to the paucity of evidence, they were unable to state 
whether or not cavitation occurred in the absence of an audiblt crack. Cramer et al. 
(2000) found MRI evidence to support the hypothesis that spinal manipulation 
(lumbar side-posture spinal manipulation) leads to joint gapping (1.2 mm) in spinal 
zygapophysial joint. However, authors acknowledged the small sample size (n= 16) 
of their study and recommended that a larger clinical trial needed to be carried out to 
further define these results. This cavitation is associated with 5-10 degrees increase 
in joint Range of Motion (ROM) (Sandoz, 1976). However, association does not 
mean causation; and it is debatable whether the increase in range of motion is the 
result of cavitation (Beffa and Mathews, 2004) indeed, there is now growing evidence 
indicating that the achievement of an audible ―crack‖ does not influence 
neurophysiological response (SNS activity changes) nor does it influence 
hypoalgesia (Sillevis and Cleland, 2011). The conventional belief asserts that when 
SMT is applied to a particular joint, cavitation occurs in that particular joint. In other 
words, anatomical location of cavitation is directly related to the selected technique. 
In contrast, Beffa and Mathews (2004) analysed the cavitation sounds from thirty 
asymptomatic adults obtained by applying SMT for two different regions of the body 
(Lumbar and Sacro-iliac joint). The results indicated that there was no correlation 
between the anatomical location of cavitation sounds and the adjustment technique 
selected. Some authors argued that the sound of cavitation is a sign that the 
procedure has been performed correctly and thus will have the desired therapeutic 
effect (Lewit 1978:466). However, the evidence is contrary to the established 
convention. Flynn, Childs and Fritz (2006) in a pragmatic study (n=70), found that 
there was no correlation between the presence of lumbar cavitation and improved 
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outcomes in terms of pain intensity, range of motion and functional disability levels 
(Oswestry Disability Score) in patients with non-radicular LBP. Similarly, a 
prospective cohort study (n=78) of patients with mechanical neck pain found that 
there was no correlation between the number of audible pops (i.e., cavitation) heard 
during thoracic SM and clinically meaningful improvement in pain, range of motion 
and disability, although Bereznick et al., (2008) did demonstrate (in a case-study, 
cohort design) that responses to a side posture lumbar manipulation (that produced 
and audible crack) did demonstrate a ―refractory period‖ of 40-95 minutes however, 
the study had only 3 asymptomatic subjects and lacked clinical application. In 
summary, there is some evidence to suggest that cavitation is required during SMT to 
achieve the required joint capsule and musculo-reflexogenic effects and that 
therapist's can accurately detect a cavitation. However, there is less certainty 
regarding the segmental level that underwent the cavitation particularly when based 
on the sound and that the sound of an audible release does not necessarily indicate 
that the appropriate reflexes were stimulated. Furthermore, there is a lack of research 
that explores whether or not cavitation is always audible, leading Bakker et al., (2004) 
to suggest that the therapeutic benefits reported with SMT and the audible release 
may not be physiological in nature but rather psychological with the joint ―crack‖ 
having a powerful placebo effect on both the patient and the practitioner.   
One of the theoretical rationales for the mechanisms underlying the effects of SMT is 
that the mechanical thrust leads to alteration in the sensory signal from paraspinal 
tissues resulting in the improvement of physiological function (Pickar, 2002).  Ianuzzi 
and Khalsa (2005) investigated this issue based on the hypothesis that SMT may 
alter the inflow of sensory information from mechanoreceptors in the facet joint 
capsules which may explain the neurophysiological effects of SMT. In the human 
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lumbar spine, the displacement rate produced due to physiological rotations gave 
rise to concomitant increases in the magnitude of facet joint capsule strain. But, 
unique patterns of facet joint capsule strains were also recorded in response to the 
high loading rates of simulated spinal mobilisations. Ianuzzi and Khalsa (2005) 
inferred that this unique mechanical input may have resulted in a novel pattern of 
mechanoreceptor firing and subsequently, a novel input to the central nervous 
system. The high variability, the small sample size and the use of cadaveric 
specimens limits the generalisability of the results of Ianuzzi and Khalsa (2005) 
study.  
A musculo-reflexogenic mechanism has also been proposed for the attenuation of 
pain following SMT. SMT elicits an inhibitory stretch reflex response generated from 
the capsules of the zygapophysial joints (Indahl et al., 1997). The distension of a 
porcine zygapophysial joint by injecting saline resulted in decreased motor unit 
action potentials of paraspinal muscles (Indahl et al., 1997). This phenomenon 
wherein SMT is followed by brief reflex relaxation of paraspinal muscles was 
investigated by Dishman and Bulbulian (2000). The effect of spinal manipulation and 
mobilization on the amplitude of tibial nerve H reflex from gastrocnemius muscle was 
recorded before and after the manual techniques in asymptomatic subjects. The 
authors concluded that manual techniques lead to short-term inhibitory effects on the 
motor system. However, the results did not discriminate between the effects of the 
manipulation and the mobilization techniques. Also, the experimental procedure 
involved changing the subject‘s position between mobilisation and the H-reflex 
measurements. This change in positions could have affected the results of the study, 
as it is known that H-reflex response is sensitive to movement (Meier-Ewert, 1973 
and Hayes and Sullivan, 1976). Hence, it is difficult to attribute the results to 
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manipulation alone although Suter, McMorland and Herzog (2005) attempted to 
rectify this potential dilemma by investigating the effect of SMT on H-reflex in healthy 
subjects without changing position finding no significant changes in H-reflex 
amplitude in their healthy subjects in response to Sacro-iliac manipulation. Thus, the 
authors inferred that the attenuation observed in H-reflex in healthy subjects is 
attributable to movement artefacts and not to the effect of manipulation. Interestingly, 
in the second part of this experimental study (Suter, McMorland and Herzog 2005), 
the authors found that the H-reflex amplitude was decreased in low back pain 
patients who received sacro-iliac manipulation, even when the patients were treated 
and tested in the same position. Thus, there is some evidence to support the view 
that SMT leads to motor neuron attenuation. More importantly, the clinical 
consequence of motor neuron attenuation has yet to be fully established (Dishman 
and Bulbulian 2000). Possibly, the inhibition of motor neuron excitability, following 
SMT, could disrupt the ‗pain-spasm-pain cycle‘ which might be present in low back 
pain patients. Although, it should be noted that this concept of ‗Pain-Spasm-Pain 
Cycle‘ is controversial and not clearly established (Roland 1986) and this transient 
inhibition of motor neuron excitability can possibly be due to the phenomenon of 
‗post-activation depression/inhibition‘ (Dishman, Cunningham and Burke, 2002). 
Herzog, Scheele and Conway (1999) investigated the segmental effect of SMT by 
applying SMT to cervical, thoracic, lumbar and sacro-iliac joint and measuring EMG 
readings of various limb and back muscles. The results indicated that different SMT 
to different regions elicited distinct EMG responses. Hence, the authors argued 
against the general effects of SMT. However, there was overlap of muscle 
responses when SMT was applied to different regions of the body. For example, 
cervical SMT affected thoracic muscles, thoracic SMT affected cervical and shoulder 
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muscle and lumbar SMT affected thoracic muscles. Thus, SMT does produce distinct 
responses when applied to each region of body but the responses do overlap and do 
not correspond to a particular segment as previously believed. In conclusion, the 
premise that segmental effects are based on the convergence of paraspinal tissues 
on motor neuron pool of cervical and lumbar region is not strongly supported by the 
evidence.  
2.6.2. The proposed neurophysiological mechanisms of action of spinal manipulative 
therapy 
Pickar (2002), Zusman (2004 and 2010) and George et al., (2003 and 2006) argued 
that explanations for the pain relieving/hypoalgesic outcomes observed after SMT 
cannot be entirely attributed to biomechanical effects occurring in the target tissues. 
Bialosky et al., (2008 and 2009) supported this opinion, stating that studies which 
support the biomechanical effects of manual therapy were merely based on 
quantification of movements within the joints (Gal et al., 1997 and Colloca et al., 
2006) and not on long term positional changes within the structures as advocated by 
Mulligan (2004) with the use of MWM techniques (Tullberg et al., 1998 and Hsieh et 
al., 2002).  Furthermore, Bialosky et al., (2009) highlight that the effects of 
manipulative therapy applied on a joint will not be limited to that joint alone, as the 
forces generated by the technique tend to dissipate over a larger area, affecting the 
surrounding muscles, nerves and fascia (Herzog, Kats and Symons, 2001 and Ross, 
Bereznick and McGill, 2004). Indeed, Kent et al., (2005) and Cleland et al., (2006) 
argued that the choice of technique does not seem to influence the outcome as 
much as identifying an individual likely to respond, and signs and symptom 
responses don‘t necessarily correlate to the region of application (Cleland et al., 
2005 and 2007) suggesting that mechanisms other than biomechanical alterations 
are associated with the changes observed in patients (and asymptomatic individuals) 
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following administration of treatment interventions. The current literature therefore 
supports, in part, a neurophysiological mechanism as one of the underlying process 
for the outcomes observed with SMT (Pickar 2002, George et al., 2006, Moseley, 
2007, Bialosky et al., 2009 and Zusman 2004 and 2010). It is also recognized that 
motivation, emotion, genetic factors and expectation also contiribute to the overall 
response (Bialosky et al., 2008).   
On application of SMT, joint mechanoreceptors and muscle proprioceptors are 
stimulated and bombard the spinal (dorsal horn) and supra-spinal centers (peri-
aqueductal region/PAG in the midbrain) with afferent sensory input (Pickar and 
Wheeler, 2001; Pickar, 2002, Wilson 2001 and Zusman, 2004). Evidence of the 
influence of SMT on these centers was provided by Malisza et al., (2003), who 
performed knee joint mobilizations, following capsaicin injection in rats, 
demonstrating decreases in the activation of areas pertaining to pain generation in 
the brain and the dorsal horn (DH) of spinal cord. Peripherally, musculoskeletal injury 
induces an inflammatory response which induces the body‘s natural healing 
processes, reduces the thresholds of nociceptive receptors and influences pain 
processing which can be influenced with observed effects on blood and serum 
cytokines levels. Indeed, a number of researchers have explored these peripheral 
mechanisms of pain modulation notably Teodorczyk-Injeyan, Injeyan and Ruegg 
(2006) who found, in asymptomatic individuals, that spinal manipulation was able to 
reduce levels of inflammatory cytokines but not those of Substance P and, more 
recently, Teodorczk-Injeyan et al., (2010) found that SMT can influence interleukin-2 
–regulated responses in LBP patients. Interleukin-2 is a key immunoregulatory 
hormone which has been found to be immunosuppressed in LBP patients, the 
authors suggest that the systemic consequences of SMT may encompass a 
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―priming‖ effect on the immune system (via stimulation of systemic somatoautonomic 
reflexes) with resultant restoration of interleukin-2 levels in the blood. Degenhardt et 
al., (2007) revealed changes of blood levels of b-endorphin, anandamide, N-
palmitoylethanolamide, serotonin and endogenous cannabinoids following SMT and 
Padayachy et al., (2010) found that SMT had an immediate effect on serum cortisol 
levels in patients with mechanical LBP. Recent insights have demonstrated a central 
role for dopaminergic neurotransmission in modulating pain perception and natural 
analgesia in supraspinal regions including the key pain processing regions of the 
brain, notably, the basal ganglia, insula, thalamus and peri-aquaductal gray regions 
(Wood, 2008 and Gabriela et al., 2011). Dopamine‘s primary role involves pleasure 
and motivation and increases in levels of dopamine are correlated to ―risk-taking‖, 
insomnia, exercise and ‗reward‘. Skinner et al., (2011) found that painful stimuli 
classified as ―physically or emotionally distressing‖ resulted in increased dopamine 
release and brain activity that were correlated with anti-nociception. Clearly this is an 
area of research that requires consideration when constructing management 
strategies in patients with sleep deprivation and high levels of anxiety. This, and the 
immune and hormonal influences of SMT, are in the very embryonic stages of 
investigation and not within the scope of this thesis however, it is noted that ANS 
stimulation has wide-reaching, systemic effects beyond those reported immediately 
after instigation.  
There is growing evidence to suggest that SMT may exert an effect on the spinal 
cord, and in particular the dorsal horn (DH). Boal and Gillette (2004) looked at a LBP 
population and reported (both in vivo and in vitro) evidence identifying long-term 
potentiation in DH nociceptive neurons and concomitant DH and central nervous 
system neuroplastic changes occurring following the onset of LBP. They went on to 
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reveal that these LBP patients, who underwent SMT, incurred neuroplastic changes 
in their DH and the authors suggested that HVLAT provides ―an intense 
somatosensory afferent barrage‖ to the nervous system that facilitates the activity of 
the small mechanosensitive afferents (Aδ fibers) and suppressing central and spinal 
hyperexcitability generated by C-fibre stimulation. Pickar and Wheeler (2001) agreed 
with this premise by proposing that joint based therapies ―bombard the central 
nervous system with sensory input from muscle and proprioceptors‖. Bakkum (2007), 
undertaking research on rats, also found that the presence of a hypomobile lumbar 
spinal segment caused activity dependent neuroplasticity in the dorsal horn with 
resultant mal-adaptive central changes. Malisza et al., (2003), also experimenting on 
rats, quantified observed DH responses by fMRI during light touch, noting a trend 
towards a decrease in DH activation following ‗therapy‘. Other authors have 
associated the effects of MT with hypoalgesia (Vicenzino et al., 2001; Mohammadian 
et al., 2004; George et al., 2006), muscle activity changes (Herzog et al., 1999 and 
Sterling et al., 2001) and spinal reflex excitability changes (Bulbulian et al., 2002; 
Dishman and Burke, 2003) which Bialosky et al., (2009) speculated may indirectly 
implicate a spinal cord mediated effect. Bialosky et al‘s., (2009) proposed pathway 
(spinal and supra-spinal) model is reproduced in figure 10 overleaf. 
Supraspinally, as indicated in an earlier sub-chapter, there are a number of 
structures implicated as being instrumental in the pain experience. Specifically, 
structures such as the anterior cingular cortex (ACC), amygdale, rostral ventromedial 
medulla (RVM) and the periaqueductal gray (PAG) regions (Vogt et al., 1996; 
Derbyshire et al., 1997; Peyron et al., 2000; Moulton et al., 2005; Guo et al., 2006; 
Bee and Dickenson, 2007; Oshiro et al., 2007; Staud et al., 2007). Bialosky et al., 
(2009) also classified placebo and psychological responses to MT within the 
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supraspinal mechanism of action arguing that such factors are related to the 
descending pain inhibitory system (DPIS) with associated changes in the opioid 
system (Sauro and Greenberg, 2005), in dopamine production (Fuente-Fernandez et 
al., 2006), and in the central nervous system (Petrovic et al., 2002; Wager et al., 
2004; Matre et al., 2006) although these observations were not in studies exploring 




Figure 10: Bialosky et al‘s (2009) proposed pathway of spinal & supra spinal mediated 
effects of manual therapy.                                   (Bold arrows indicate suggested mechanisms)  
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2.6.3. Skin conductance as a measure of sympathetic nervous system activity 
Skin conductance (also known as: galvanic skin response - GSR; Electrodermal 
activity - EDA; sweat response; skin resistance - SR) has been described as a 
measurement of spontaneous alterations in the electrical potential or electrical 
resistance of the glaborous areas of the skin on the toes and feet (Balconi 2010: 
p.36, Bryant and Oliver, 2009: p.194). An increase in the SNS activity leads to 
release of noradrenaline (which activates synapses in smooth muscles in the 
vessels) leading to vasoconstriction, and fibres with acetylcholine that innervate the 
sweat glands (Venables and Christie 1973; Storm et al., 2000) and has been utilised 
in SMT research for the last 25 years. 
The earliest recorded investigations into the SNS effects of MT were fraught with 
methodological issues concerning poor experimental variable control and low sample 
sizes (e.g.. Harris and Wagnon, 1987; Ellestad et al., 1988). In 1993, Petersen et al., 
identified the need for methodologically superior studies into the role of the SNS in 
the manual and manipulative therapies and published a repeated measures, double-
blind, placebo-controlled trial on 16 asymptomatic, physiotherapeutically naïve males 
who received a cervical mobilisation whilst having the skin temperature changes 
(ST) and SCR recorded in their upper limbs. Their results revealed a 50-60% 
increase, from baseline levels, in SC for the treatment group compared to a 30% 
increase for the placebo condition. Petersen et al., (1993) suggested that the manual 
contact aspect of SMT had a substantial (30%) placebo effect, nevertheless, they 
suggested that it was the movement/oscillatory component that maximised the 
neurophysiological effect (50-60%). These researchers did not report any attempt to 
establish the measurement error of their equipment (not Biopac) nor did they attempt 
to validate their placebo technique therefore it is difficult to ascertain the true effect of 
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the SMT technique above that of the equipments measurement variability, a 
common problem within most of the published reports in the 1990‘s and addressed, 
in this thesis in the reliability study of chapter 3. 
Chiu and Wright (1996) sought to establish the maximal neurophysiological effects of 
two different rates of application of a commonly used SMT technique performed in 
the cervical spine. The authors compared the effects of a fast (2Hz) and slow (0.5Hz) 
rate of cervical SMT on SC in the upper limbs of asymptomatic participants utilizing a 
repeated measures design. The researchers defined SMT performed at the rate of 
2Hz as 2 oscillations per second, and 0.5Hz as 1 oscillation per 2 seconds and 
recruited 16 healthy, male volunteers (age: 18-25 years), which made generalizing 
the findings of this study difficult to a general population. Furthermore, no power 
calculation was performed to justify the sample size. Treatment conditions (2Hz, 
0.5Hz and control) were order-randomized over 3 consecutive days however, the 
process of randomization and allocation was not stated. Both the treatments involved 
application of 1 minute x 3 sets of grade III, postero-anterior mobilizations performed 
centrally on C5 vertebrae, at different rates. To blind the researcher and participants, 
the recording equipment was situated in an adjacent room and whilst this reduces 
the possibility of assessor bias, it was, however, unclear if an independent assessor 
was employed to measure the outcomes. It was also unclear if participants had 
knowledge about the purpose of study, or about the treatment interventions applied. 
The results of recorded SCR‘s determined a significant difference between SMT 
(2Hz) and SMT (0.5Hz) (p=0.0022), and between SMT (2Hz) and control conditions 
(p =0.0008), during treatment, favouring mobilizations performed at 2Hz.  
Additionally, the SMT (2Hz) condition demonstrated a sympathoexcitatory response, 
with a magnitude of effect of 50-60% from baseline SC values, reflecting those of 
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Petersen et al., (1993). SNS changes in the 0.5 Hz technique demonstrated an 
increase of 15-20% with an increase in the order of 14-18% for the control condition. 
The outcomes of Chiu and Wrights‘ (1996) investigation established that 
mobilizations performed at a faster oscillation rate produced an increase in 
sympathetic activity, over mobilizations of slower oscillation rate, suggesting that the 
movement component of SMT may be an important factor to gain maximum 
neurophysiological output. However, in the absence of a placebo condition, the 
effects of factors other than SMT (such as psychological factors) on SC output could 
not be determined. Non-significant ST changes were recorded and because no 
placebo condition was instigated and the study was conducted on a small sample 
population of asymptomatic health volunteers, interpretation to a patient group is 
limited. 
The results of the work of Chiu and Wright (1996) are in direct contrast to the study 
by Willett, Hebron and Krouwel (2010) who also investigated the immediate effects 
of different rates of SMT (2Hz, 1Hz and 0Hz) performed on the lumbar spine. Their 
measures of hypoalgesia included PPT but not SNS, utilizing a repeated measures 
design. Recruiting 30 healthy volunteers (age: 18-57 years), participants were 
randomized by an electronic randomizer into conditions involving different rates of 
lumbar mobilization, which were carried out on 3 separate occasions. However, it 
was unclear about the duration of time gap given between the three conditions which 
may have generated carry-over effects. The treatment technique engaged 1 minute x 
3 sets of grade III, large amplitude, postero-anterior mobilizations applied centrally 
on the L5 vertebrae. PPT measures were recorded using a pressure algometer, at 4 
different sites: paraspinal muscles adjacent to L5 vertebrae; signature zone of L2 
dermatome; signature zone of L5 dermatome; 1st dorsal interossei. However, it was 
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unclear if an independent researcher was employed to record PPT measurements. 
The results did not demonstrate any significant difference in PPT measures between 
the different rates of lumbar SMT (p=0.26), indicating that alterations in the rates of 
SMT did not influence the amount of hypoalgesia produced. However, within each of 
the individual rates of SMT technique, a difference between before and after 
treatment was noticed for PPT values, at all 4 measurement sites. These results may 
be due to methodological issues with population bias (the participants were not naïve 
to the treatment conditions) with a resultant type II error (failure to reject the null 
hypothesis when, in fact, the alternate hypothesis is supported), or simply because 
of the difference between cervical and lumbar regional responses to SMT. Use of 
SNS measures may have provided the link needed for further extrapolation of 
findings. 
In a similar study by these authors, Krouwel, Hebron and Willett (2010) conducted an 
investigation to compare the effects of large, small and quasi-static amplitudes 
(depth) of lumbar SMT on hypoalgesic outcomes of PPT, utilizing a repeated 
measures design. Similar to the researchers‘ previous study, this study also recruited 
30 healthy volunteers (mean age: 26.43 years) again, without performing a power 
calculation. Participants were randomized into conditions involving different 
amplitudes/depths of lumbar mobilization, which was carried out on 3 separate 
occasions, this time, with a gap of 48 hours between each. All treatments were 
conducted at a rate/frequency of 1.5 Hz. PPT measures were recorded, again using 
a pressure algometer, but at 4 different sites: paraspinal muscles, adjacent to L3; 
region above patella; 5th metatarsal; mid deltoid. However, similar to researcher‘s 
previous study, it was unclear if an independent researcher was employed to record 
PPT measurements and not all participants were physiotherapeutically naïve 
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therefore unblinded. The results did not reveal any significant difference in PPT 
measures between the different amplitudes of lumbar SMT (p=0.864), indicating that 
alterations in amplitudes of SMT did not influence the amount of hypoalgesia 
produced however, it was unclear if the SMT‘s were into or out of the point of joint 
resistance and, to date, the clinical significance of changes in PPT‘s within a 
symptomatic patient population have yet to be established. This was in contrast to 
Maitland et al., (2001) who claimed that mobilizations with larger amplitude were 
superior to smaller amplitudes at reducing pain levels in patients. The researchers 
therefore suggested that the difference between SMT amplitudes might be larger if 
the study were to be conducted on a symptomatic, segmentally hypomobile 
population.  
Vicenzino et al., (1994) investigated sudomotor changes in their repeated measures, 
double blind, placebo-controlled trial again using (n=34) normal, asymptomatic, 
naïve subjects. Uniquely, these researchers utilised a peripheral/dermatomal region 
(C6) to detect sudomotor changes from a unilaterally conducted treatment technique 
(C5/6 left lateral glide) and finding that SC was significantly different in the treatment 
group (up to 33% increase compared to placebo (7%) and control (4%) groups). 
Notably, Vicenzino et al., (1994) performed measurements bilaterally and discovered 
a general SNS response rather than a response that was specific to an intended 
unilateral target area. They concluded that this represented a complex supra-spinal 
reflex rather than the result of the traditionally conceptualised simple spinal reflex 
and in doing so provided the groundwork for almost two decades of investigation into 
the effects of SMT on neurophysiological responses, with the resultant call, by a 
number of authors (George et al., 2007, Moseley et al., 2007, Bialosky et al., 2009 
and Hengedus et al., 2011 to name a few) for a paradigm shift in how health 
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professional assess and manage patients with pain and functional impairment 
following musculoskeletal injury. 
Slater et al., (1994) revealed opposing results to those of Vicenzino et al., (1994). 
Slater et al., (1994) found that a unilaterally applied T6 postero-anterior accessory 
mobilisation to the costovertebral joint (Maitland et al., 2005; p311) combined with a 
sympathetic slump (Butler, 1991; p.142) produced a 300% change in SC values for 
the treatment condition (a 50% increase above placebo), which was greater in the 
right upper limb compared to the left. This study by Slater et al., (1994) was not 
without its flaws in that although the authors used a placebo treatment, it was 
considered that the results obtained from placebo and experimental conditions might 
have simply been a response to orthostatic adjustment. Furthermore, they also failed 
to establish the stability of their SNS measurement within and between participants. 
The results of Slater et al., (1994) appeared to be in conflict with those of Vicenzino 
et al., (1994), in that their results supported the argument that SNS activity changes 
are not simply a generalised response, but can be biased to an anatomical region, a 
finding that was supported by Perry and Green (2008) who conducted a ―high 
quality‖ (Hengedus et al., 2011) randomized control trial investigating the outcomes 
of an unilaterally applied oscillatory lumbar mobilization technique on SCR in the 
lower limbs, utilizing an independent group design. The investigation recruited 45 
healthy participants, based on a power calculation from data obtained from the study 
by Vicenzino et al., (1995). Whilst the inclusion of all male, and aged matched 
population, made the group homogenous and negated the effects that the female 
hormone (progesterone) may have on sweat levels, it was difficult to generalize the 
findings of this study to a larger, clinical population. Nonetheless, the investigation 
followed stringent methodological criteria. The participants were randomized using a 
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concealed third party allocation into groups: SMT, placebo and control. Participants 
were blinded to their allocation to groups. Also, the post trial questionnaire confirmed 
that participants could not distinguish between treatment and placebo interventions 
(p=0.388), however, they could comprehend when they received the control 
intervention. The researcher and the subjects were blinded to the outcomes by 
utilising an independent assessor, unaware of the treatment allocation and screening 
the equipment from the treatment area. The SMT intervention, a unilateral grade III 
oscillatory mobilization (at a rate of 2Hz), was applied to the Left L4/5 zygapophyseal 
joint (3x1 minute applications over a 5 minute period). The results indicated a 
statistically significant side specific difference in SCR in the SMT group 
(sympathoexcitory SCR of 13.47%) that was greater to the placebo (-1.93%) and 
control (-0.87%) groups, for the treatment period (p<0.005), adding to the developing 
construct that SMT in the lumbar spine may have both a spinal (dorsal horn) and a 
supraspinal (dPAG) influence. This experiment was performed in a laboratory 
controlled environment on asymptomatic participants and although Biopac 
equipment was used and the researcher established their own reliability (in pre-trial 
pilot studies) at performing the grade and the rate of the technique, the equipments‘ 
measurement variability/stability was not assessed.  
These studies did not attempt to demonstrate any analgesic effect of the technique 
however, the work of Vicenzino et al., (1995 and 1998b) and Sterling et al., (2001) 
provide some support for the theory that SMT produces mechanical hypoalgesia. 
Vicenzino et al., (1995) demonstrated that a left lateral glide to the cervical spine 
produces a significant increase in SC values (>150% compared to baseline) and in 
pressure pain thresholds (PPT) in the order of 123% above baseline for normal 
subjects (125% and 107% for SC and PPT respectively for placebo condition).  
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George et al., (2006) suggested that pain relief after SMT could be due a number of 
possible mechanisms involving spinal and descending inhibitory pathways. In an 
experimental study, asymptomatic subjects (n=40) were randomised to ride a 
stationary bike, perform lumbar extension exercises or receive spinal manipulation. 
The subjects underwent thermal pain sensitivity testing pre and post-treatment. 
George et al., (2006) found evidence to support the view that local dorsal horn 
mediated inhibition of C-fibre input was a potential hypoalgesic mechanism for SMT 
in healthy subjects and corroborate the view that SMT may have both segmental 
effects as well as global ones. Thus, SMT may invoke the pain gate mechanism at 
the spinal cord level resulting in hypoalgesia.   
Most authors and clinicians now recognise that pain relief, due to SMT, involves a 
number of complex interactions including spinal and central neural pathways, 
endocrine responses with contributory elements from motivational, reward and 
expectation factors. Song et al., (2006) found that (activator-assisted) SMT delivered 
to male rats lead to reduction in pain and hyperalgesia caused due to intervertebral 
foramen inflammation. In a study by Skyba et al., (2003), SMT led to a significant 
decrease in experimentally induced pain in rats, even after the administration of 
naloxone (blocks opioid receptors) and bicuculline (blocks GABA receptors). From 
this result, the authors inferred that pain relief results from descending inhibitory 
mechanisms mediated through serotonin, dopamine and noradrenaline. However, 
these results were based on animal models which limits the generalisability of these 
studies to human (and patient) populations. Mohammadian et al., (2004) investigated 
the hypoalgesic effects of SMT in experimentally induced pain and inflammation in 
asymptomatic, healthy subjects. The authors found that administration of SMT lead 
to a significant reduction in experimentally induced allodynia and hyperalgesia. The 
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authors inferred that pain relief was due to a centrally-mediated mechanism as there 
was no appreciable increase in local blood flow. However, the authors did not 
explain the exact mechanism through which the conceptualised central-inhibition 
could have occurred.  
Unfortunately, much of the published research exploring the effects of manipulative 
therapy on the SNS has focused upon outcome measures occurring within the upper 
quadrant, on asymptomatic healthy volunteers and on animals. Few studies have 
explored the responses of SMT on symptomatic individuals, and, none have been 
performed on symptomatic patients with low back pain. The following discussion 
looks at the limited literature on patient populations. 
Vicenzino et al., (1998), in a repeated measures design study, performed 30 
seconds x 3 sets of cervical SMT (grade III oscillatory, lateral glide) technique on 
C5/6, on patients with contra-lateral side lateral epicondylalgia. Along with 
statistically significant changes for SC and PPT measures for the treatment condition 
(different from placebo and control groups), the study also reported that an increase 
in SC was strongly correlated with an increase in PPT outcomes supporting the 
theory that SMT induced hypoalgesia, distal to the location of treatment, was due to 
an increase in the SNS activity and not local elbow myogenic changes.  
The concurrent effects of cervical SMT on pain, sympathetic nervous system and 
motor activity were investigated by Sterling, Jull and Wright (2001). The study 
recruited 31 symptomatic participants (mean age: 35.77 years; SD: 14.92 years) with 
a history of chronic (>3months) lower cervical pain. The inclusion criteria were 
reinforced by involving a physiotherapist to diagnose if symptoms of cervical pain 
originated from the C5/6 segment. However, no power calculation was evident. A 
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repeated measures design was implemented, involving three conditions: SMT, 
placebo and control. Although, the participants were randomized, by drawing lots, to 
determine the order of the conditions received, on the 3 separate days, the method 
of allocation was not mentioned. The SMT technique involved 3 sets of 1 minute 
grade III postero-anterior mobilizations applied unilaterally to the symptomatic 
articular pillar of C5/6. However, the frequency at which mobilizations were 
performed was not defined. Various outcome measures were employed:  Pain levels 
were evaluated using pressure pain threshold (PPT), thermal pain threshold (TPT), 
and a visual analogue scale (VAS), before and after the intervention; SCR‘s and ST 
changes were continuously recorded throughout the treatment technique to measure 
the sympathetic nervous system response; Motor activity was measured, by asking 
patients to perform a cranio-cervical flexion test before and after treatment, while 
EMG was recorded from superficial neck muscles. An independent assessor was 
employed to measure the outcomes, in order to blind the researcher to the results. 
Although, being a repeated measures design, the post trial questionnaire revealed 
that merely 3 out of 30 participants could identify the treatment accurately, indicating 
that participants were blinded effectively. The results showed a significant difference 
between SMT and placebo, and between SMT and control for the values of SCR‘s, 
towards the SMT group (p<0.05), during the treatment. SMT demonstrated a 
sympathoexcitatory response of SCR‘s, with a magnitude of effect of 16%. 
Unfortunately, SCR‘s were not recorded post treatment. As a result, the longitudinal 
effects of cervical SMT could not be analyzed. In contrast, no changes between 
groups were observed for ST change values. The PPT measures revealed a 
significant difference between SMT and placebo, and between SMT and control, 
demonstrating a hypoalgesic effect post treatment, on the side specific to treatment. 
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The magnitude of effect for changes in pain threshold (PPT) post treatment was 
22.5%. Similar outcomes were observed with EMG results for superficial neck 
muscles, during a cranio-cervical flexion test, performed after the treatment. A 
significant difference was noticed, for EMG values, between SMT and placebo, and 
between SMT and control. In contrast, the VAS measures of pain intensity, post 
treatment, did not exhibit any significant differences between SMT and placebo. The 
overall results supported that SMT-induced hypoalgesia was due to an increase in 
the sympathetic nervous system activity.  
There exists a counter-view that the effect of SMT is through placebo analgesia. 
Bialosky et al., (2008) investigated the effect of participant-expectation in the relief of 
pain associated with SMT. In this study, a symptomatic patient population was 
selected and participants (n=60) were randomly assigned to receive positive, 
negative or neutral expectation instructions regarding the effects of SMT on pain 
perception. All patients underwent quantitative testing before and after SMT. The 
results indicated that a significant correlation was present in pain perception of 
patients who had received a negative instruction and significant hyperalgesia. 
Bailosky et al., (2008) concluded that patient expectation (of a negative response) 
does influence pain perception (accentuates) but that positive expectations do not. 
Again, an important consideration, within a typical complex therapeutic encounter, 
between therapist and patient within a clinical setting. 
In conclusion, there is some evidence to suggest that SMT has mechanical, 
musculo-reflexogenic, neurophysiologic and placebo effects. However, the overall 
strength of evidence supporting SMT is weak and few studies have been conducted 
on a symptomatic patient population with none on patients with LBP. 
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2.6.4. Review of the literature on the evidence of neurophysiological effects of the 
Mulligan ‗mobilisation with movement‘ (MWM) technique 
 
The Mulligan concept, initially established by Brian Mulligan in the 1970's (Exelby 
1995), has become an essential component of spinal MT involving the simultaneous 
application of an accessory joint glide and an active physiological movement to 
restore normal motion within a joint, therefore termed Mobilizations With Movement 
(MWM) (Mulligan Concept, 2011). An accessory glide is described as a translation or 
sliding movement performed by application of an external force on a joint (Maitland 
2001: 221). Whereas, a physiological movement of a joint is identified as normal 
movement of a body segment in any given direction (Petty and Moore 2001: 46). The 
MWM technique, when applied on the spine, is also called Sustained Natural 
Apophyseal Glide (SNAG) since it engages a sustained accessory glide to the 
vertebral joint, in combination with an active physiological spinal movement, 
performed by the patient (Exelby 2001; Mulligan 2004: 44). A large survey conducted 
by Konstantinou et al., (2002), which had a response rate of over 2300 
questionnaires, revealed that more than one in three chartered physiotherapists in 
Britain utilized SNAGs as part of their intervention for patients with LBP being a 
popular treatment of choice as it produced instant pain relief followed by an increase 
in spinal range of motion (Wilson 2001; Exelby 2002). Moreover, MWM‘s can allow 
for the treatment to be performed in weight bearing positions (Mulligan 2004: 44), 
and into the direction of symptom reproduction (Exelby 2002), making it feasible to 
instantaneously monitor outcomes. The effectiveness of Mulligan techniques has 
been linked to conflicting hypotheses (Hing 2009). Initially, it was believed that 
SNAG‘s corrected minor positional faults or mal-tracking problems in zygopophyseal 
joints (Mulligan 2004: 17; Exelby 1995). This biomechanical effect was thought to 
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restore the previously reduced accessory glides in joints, resulting in relief of 
symptoms (Exelby 2002). However, Hearn and Rivett (2002) dispute that since 
SNAGs were performed in an upright position, compressive forces acting on the 
joints due to gravity or due to stabilization provided by the surrounding musculature, 
increased the resistance in joints, and decreasing the amount of accessory glides 
possible. Recent research has therefore postulated the possibility of a 
neurophysiological mechanism, to be the basis of effectiveness of Mulligan SNAGs 
(Moulson and Watson 2006; Moutzouri, Perry and Billis 2012), similar to various 
SMT techniques. Furthermore, Vicenzino, Paungmali and Teys (2007) speculated 
that the almost instantaneous effects of SNAGs were unlikely to be because of 
activation of the descending pain inhibitory system (DPIS), and were more likely to 
be as a result of biomechanical effects. Krouwel, Hebron and Willet (2010) argued 
that this theory was based on subjective and physiological reasoning, and was not 
supported with any evidence. Nonetheless, on analysis of the studies on the 
neurophysiological effects of SNAG‘s by Moulson and Watson (2006), it is evident 
that although the technique demonstrated a sympathoexcitatory effect, there was no 
significant difference between treatment and placebo conditions during the 
intervention. However, the number of repetitions of SNAGs performed was fewer 
than that advocated by Mulligan (Hing, Bigelow and Bremner 2007) with Moulson 
and Watson (2006) suggesting that if a higher dosage of SNAGs had been applied, a 
larger difference between the SNAGs and placebo groups may have been observed. 
In general, the dosage of Mulligan techniques has been ill defined in the literature, 
and in particular, the number of repetitions performed has varied between different 
research articles (Hing, Bigelow and Bremner 2007). According to Vicenzino and 
Cleland (2007), in clinical practice, Mulligan techniques are most commonly 
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prescribed in sets of 6 to 10 repetitions although, there has been no published 
research that has investigated the optimal dosage of Mulligan techniques required to 
be performed in treatment sessions. A Rao and Perry (2011) attempted to answer 
this research question and, utilising 90 asymptomatic, healthy participants in a 
randomised controlled trial, revealed that although both 6 and 10 repetitions of a 
flexion SNAG centrally applied to L4 spinous process did produce statistically 
significant sympathoexcitatory responses (compared to the control group), the skin 
conductance responses for the 10 repetition participants were significantly greater 
than the 6 repetitions group (mean SCR change for 10 reps 20.5% and for 6 reps 
14.5%,  p<0.005) suggesting that 10 repetitions of the MWM had a greater 
magnitude of effect on SNS activity outcomes compared to the 6 repetition choice.    
Thus, the understanding of the neurophysiological mechanism as a source of the 
perceived effectiveness of Mulligan techniques remains inadequate. Moreover, the 
majority of the research on the Mulligan concept has been limited to peripheral 
MWMs with studies on the neurophysiological effects of MWM‘s on lumbar spine 
very rare indeed. The following discussion aims to review the current literature on the 
effects of MWM‘s on the SNS.  
 
Moulson and Watson (2006) evaluated the effects of cervical SNAGs on SC and ST 
measures in both upper limbs, adopting a repeated measures design. The study 
included 16 asymptomatic participants (age: 18-37 years). However, there was no 
power calculation performed to justify this selection which might have lead to a type 
II error in the analysis and inferences of the results (Pinnock, Lin and Smith, 2002: 
922). While, the order of participants receiving each of SNAGs, placebo and control 
conditions was randomized, the authors failed to mention the process of 
randomization or allocation. SNAGs were applied for 3 repetitions x 1 set on the 
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C5/6 intervertebral joint, while participants performed simultaneous right cervical 
rotation. The number of repetitions of SNAGs implemented (3 repetitions) was less 
than recommended by Mulligan (2004) and Vicenzino and Cleland (2007). Other 
areas of bias in the study were that the participants dictated the speed and 
distance/range of cervical right rotation, resulting in a potential lack of control of this 
extraneous variable. Additionally, it was not evident if data that was provided (of the 
SCR‘s and ST recordings) were converted to percentage changes from baseline for 
during and after treatment periods. As a result, the validity of direct comparison of 
the measurements to other studies is questionable. The results of the post 
intervention questionnaire revealed that 13 out of 16 participants were aware of 
SNAG‘s being the actual treatment, due to the nature of repeated measures design 
which may have influenced the results.  The results revealed that Mulligan SNAG‘s 
demonstrated a sympathoexcitatory response, with a statistically significant increase 
during treatment (p<0.0005) and after treatment (p=0.001), in comparison with the 
control condition. However, there was no significant difference detected in SCR‘s 
during the treatment period, between SNAG‘s and placebo conditions (p=0.176), 
although there was a trend towards an increase in SCR‘s favouring the SNAG‘s 
condition. It was also observed that none of the ST change measures reached 
statistical significance between conditions. 
Moutzouri, Perry and Billis (2012) studied the effects of lumbar SNAG‘s on SCR‘s in 
the feet of 45 asymptomatic participants (age: 18-46 years), utilizing a randomized, 
independent group design. Similar to Moulson and Watson (2006), there was no 
power calculation performed which may have lead to a type II error in the 
interpretation of the results (Pinnock, Lin and Smith, 2002: 922). SNAG‘s were 
applied for 6 repetitions x 3 sets on the L4/5 lumbar segment, while participants 
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performed simultaneous lumbar flexion. In addition to the treatment SNAG, a control 
(no movement or hands-on procedure) and a placebo condition were utilised with the 
placebo intervention just requiring participants to perform forward flexion for 6 
repetitions x 3 sets without the glide component, which could be speculated to be the 
physiological component of SNAGs technique, as described by Mulligan (1999). 
Lumbar flexion from a seated position involved movement of multiple spinal (e.g. 
thoracic, cervical) and peripheral (e.g. hips, shoulder) joints, unlike in Moulson and 
Watson‘s (2006) study, where cervical right rotation could be principally isolated to 
the cervical spine. Blinding of the subjects was validated by a post-treatment 
questionnaire and results demonstrated a significant sympathoexcitatory response to 
the SNAG treatment during the treatment period compared to control for both the left 
(p=0.004) and right (p=0.044) lower limbs. However, there was no significant 
difference between SNAG‘s and placebo conditions for left (p=0.87) and right 
(p=0.84) lower limbs, although there was a trend towards an increase in SCR‘s 
favouring the SNAG condition. This was similar to the results of Moulson and 
Watson (2006), suggesting that SNAG‘s may not utilize dPAG mediated analgesia to 
produce its effects. However, this could be due to the fact that fewer repetitions of 
the technique were performed. This hypothesis might be supported by the small-
scale study by Konstantinou et al., (2007) who, using lumbar MWM‘s as a treatment 
and a static resting position as placebo, found that although there was a statistically 
significant improvement in lumbar range of flexion in the MWM group (p= 0.005) 
there was no difference between the groups (nor any reduction in intensity) with 
respect to pain (p=0.800) although it is worthy of note that the true increase in range 
of flexion was less than 4° highlighting the importance of considering if statistical 
significance equates to clinical significance. Indeed, Moutzouri, Perry and Billis 
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(2012) found no difference between their asymptomatic SNAG and placebo groups 
in lumbar flexion range of motion, suggesting that the proposed biomechanical 
changes are not translated to asymptomatic volunteers with no functional 
impairments. Furthermore, Konstantinou et al., (2007) and Moutzouri, Perry and 
Billis (2012) did not use patient populations nor PPT measures of effect to allow 
comparison of hypoalgesia and SNS activity responses to treatment. 
Experimental studies investigating the effects of MWM‘s have been conducted on 
patient populations with lateral epicondylalgia. Paungmali et al., (2003) conducted a 
repeated measures, placebo controlled study on 24 patients with chronic lateral 
epicondylalgia (mean age 48.5 years) in order to evaluate whether MWM‘s at the 
elbow produced concurrent hypoalgesia and sympathoexcitation. These authors 
were the first to publish the reliability of their measures of SNS (equipment utilised 
was a AT64 Skin Conductance Monitor) reporting stable measures (across the pre-
treatment period) with a very high ICC (0.88) and a small Standard Error of 
Measurement (0.011 micro-siemens). The MWM treatment resulted in an initial 
hypoalgesic effect and concurrent sympathoexcitation with improvements in pain 
resulting in increased pain-free grip force and pressure pain thresholds. The authors 
suggested that the MWM treatment technique exerted neurophysiological effects 
similar to that reported for some spinal manipulations. A year later, Paugmali et al., 
(2004) published an article reporting the effects of the same lateral glide MWM 
technique (to 18 patients with lateral epicondylalgia) and measuring changes in pain-
free grip strength, PPT, TPT and range of movement at the elbow with an upper limb 
neural provocation test, with radial nerve bias (ULNPT 2b), after administration of 
naloxone, saline or control substance by injection. The authors reported that none of 
the 3 injections achieved statistical significance, suggesting that the initial 
115 
 
hypoalgesic effect observed following the MWM was not antagonized by naloxone, 
implicating a non-opioid mediated hypoalgesic mechanism of action following the 
MWM technique.   
 
2.6.5. Summary 
Skin conductance responses (SCR‘s) have been utilized by various researchers to 
measure the responses, within the sympathetic nervous system, of SMT (Chiu and 
Wright 1996; Vicenzino et al., 1998; Sterling, Jull and Wright 2001; Moulson and Watson 
2006; Moutzouri, Perry and Billis, 2012; Perry and Green, 2008; Jowsey and Perry, 2010; 
Perry et al., 2011, Rao and Perry, 2011). In addition to skin conductance, some research 
studies also employed skin temperature (ST) changes measurements for the same 
purpose (Chiu and Wright 1996; Sterling, Jull and Wright 2001; Moulson and Watson 
2006; Jowsey and Perry 2010). Although, Moulson and Watson (2006) suggest that ST 
changes were superior in comparison to SCR‘s in terms of its validity and sensitivity to 
record sympathetic nervous system activity, they failed to fully justify their reasoning for 
this assertion and most published studies (including their own study) have not 
established statistically significant response effects with ST measurement. In their recent 
systematic review of the neurophysiological effects of SMT, Hengedus et al., (2011) 
support the lack of evidence to support the use of ST changes over SCR‘s as a measure 
of SNS activity. As a result, this thesis utilized skin conductance activity levels and 






2.7. Conclusion of the literature review and scope of the thesis  
Epidemiologically, LBP is recognised as a global problem with potentially serious 
personal, societal, service and economic ramifications that have lead to the development 
of Guidelines for the assessment and management of the condition. However, it is also 
recognised that the application of guideline-endorsed practice, by the primary target 
population, can take time to embed especially in the absence of empirical primary 
research in diverse, heterogenous patient populations. Nonetheless, risk factors for the 
development of chronicity in LBP patients have been established (e.g. age, work and 
educational status) and factors indicating patients who could be at risk of a poor outcome 
identified (e.g.. high levels of functional disability and pain intensity, the duration of 
symptoms, presence of leg pain, age, stress levels and poor socioeconomic status). The 
classification of patient sub-groups, that are identifiable as being responsive to therapy, 
remains controversial, with clinical prediction rules and tools to identify ―at risk‖ patients 
(STarT-Back Tool, Hill et al., 2008 and 20010) being developed but lacking full validation. 
Conversely, the development and utilisation of patient reported outcome measures (ODI, 
RMDQ and the NPRS) are increasingly accepted as being useful adjuncts to clinical 
assessment of patient status at inception, and as a means of determining the extent of 
―benefit‖ from treatment at discharge. Whilst some PROM‘s are considered to be reliable 
and valid within the construct of LBP populations they are not yet universally applied by 
clinicians and are open to interpretation bias. For this reason, there remains a distinct 
lack of consensus, within the practice-guideline documents, as to the best tool for the 
patient and the clinical context within which they present. This fact is confounded by a 
discernible lack of objectivity in PROM‘s with a number of critiques claiming that they fail 
to capture the patients‘ true experience of LBP and are open to mis-interpretation due to 
the summative nature of comparisons made. However, the last 2 decades has seen the 
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development of objective measures, including neurophysiological tools to measure 
changes in patients‘ sympathetic activity although the development of this area of 
research has lacked preliminary establishment of the tools (Biopac) reliability 
(measurement variability, repeatability and stability). Furthermore, there is a paucity of 
research available that provides normative data from asymptomatic (normal) populations 
or research that has translated normative findings into patient populations.  
Thus, the key research questions and knowledge gaps that form the basis of this thesis 
include:- 
Chapter 3 - What is the reliability (retest correlations, measurement stability and 
variability –SEM  and SRD) of the Biopac data acquisition system for 
SC measurement collection in a non-laboratory environment?  
Chapter 4 -  What are the effects of a lumbar rotatory manipulation technique or a 
repeated McKenzie EIL exercise of SCR‘s in normal healthy 
volunteers?  
Chapter 5 - What are the SC activity levels of patients presenting for a course of 
guideline endorsed physiotherapy management for acute or sub-
acute LBP?  
Chapter 5 - How do SCR‘s to guideline endorsed physiotherapy treatments 
correlate with currently utilised PROM‘s of pain intensity (NPRS) and 
functional disability (ODI and RMDQ) at inception and at discharge 
from treatment?  
Chapter 5 - What is the feasibility (to inform future clinical RCT studies) of using 
Biopac to identify any trends in SCR‘s to treatment thereby 
suggesting a critical value (cut-off point) to indicate patients, at 




Overall, the researcher has sought to establish the reliability and measurement error 
of the Biopac measurement system (chapter 3), to generate pre-clinical SC data on 
the effects of 2 specific (guideline endorsed) treatments for LBP. Furthermore, this 
data set facilitated the estimation of an appropriate sample size calculation for the 
final clinical study and for future research in the (natural) clinical environment. The 
third study comprised of clinical SC observations conducted on the target, patient 
population with LBP symptoms. Analysis of the data generated from this arm of the 
study was used to determine normative, patient values (for Biopac SC readings) 
which were then analysed correlatively, with currently utilised clinical PROM‘s. Lastly, 
trend analysis provided information (to inform future research and RCT development) 
suggesting the feasibility of Biopac as potential tool for use, in future patient-therapy 
studies.  
Figure 11 overleaf illustrates the trail of evidence and the research gaps (in light pink) 
that informs the next three chapters (green blocks) and the key areas of research 























Figure 11: Flow chart indicating the key research gaps and research areas of this thesis 
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3. Pilot Study to Detemine The Reliability of Biopac Measurements 
 
3.1. Introduction.  
The last two of decades have seen an increasing interest in the measurement of 
sympathetic nervous system (SNS) changes in the detection of response to manual 
therapies. Notably, changes in skin conductance (SC) have been the most 
commonly utilised measure and are recognised as being superior to ST, HR and BP 
recordings. Conceptual theories incorporating the detection of neurophysiological 
responses (SNS) in the periphery are now emerging and are at the forefront of 
research into the effects of manual and manipulative therapies. Physiological 
recordings of SC activity levels and of changes (percentage change) in skin 
conductance responses (SCR‘s) are commonly measured using a Biopac GSR100B 
Electro-dermal Activity Amplifier (MP35; Biopac Systems Inc; Santa Barbara, CA) 
with silver/silver chloride electrodes applied to the digits of the hands or feet. 
Paungmali et al., (2003) using, National Instruments software card (6504 Bridge 
Point Parkway, Austin, Texas) to collect skin conductance readings on an 
Autogenics AT64 monitor (620 Wheat Lane, Wood Dale, Indiana), found SC 
measures to be stable, reporting acceptable levels of reliability with a high ICC (0.88) 
and a small SEM (0.011 μsiemens), however, these reliability measures were 
undertaken in a controlled laboratory environment and not in a busy environmentally 
variable non-laboratory setting that would typify the traditional clinic or hospital 
treatment area. Thus, Paungmali et al.‘s, (2003) findings cannot be considered 
transferrable to the Biopac equipment nor to a clinical environment. Therefore a 
reliability study of Biopac SC measures, within a ―natural‖ environmentally variable 
(with regards to noise, environmental temperature and activity levels) setting was 
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conducted to determine the reliability, measurement stability and variability of the 
Biopac equipment within a non-laboratory setting thus ensuring accurate 
interpretation of SCR change scores for the clinical study. 
 
3.2. Aims and Objectives. 
The overarching aim of this pre-clinical pilot study was to assess the test-retest 
reliability (reproducibility) of the Biopac baseline (pre-treatment) measurements of 
SC in a normal, asymptomatic population. To achieve this, a number of objectives 
were set:- 
i. to determine the retest correlation coefficient (ICC, 2,1 model) to facilitate 
comparison with Paungmali et al‘s. (2003) findings 
ii. to assess random or systematic changes in the mean SC measurement 
between two applications (mean differences; SEM; confidence intervals; and 
Bland and Altman Plots with Limits of Agreement) 
iii. to quantify measurement variability between applications (SEM, SEM%; 
SRD) in order to determine (for future studies) the minimum effect size for the 
assessment of treatment response. 
Test-retest reliability is an assessment of the stability of a measure over time 
(Rousson, Gasser and Seifert, 2002; Lexell and Downham, 2005). It determines 
whether the measure is able to produce reliable results or whether it is significantly 
influenced by the situation or the state of the subject over time (Rousson, Gasser 
and Seifert, 2002). Assessing the reliability and sensitivity of a measurement may 
involve a number of different statistical techniques. These may include evaluating the 
relationship between two sets of measurement; evaluating the difference between 
repeated sets of measurements; determining the level of agreement between 
measures (Bland and Altmand, 1986), or assessing the level of inherent variability 
between repeated measurements. In this study, a combination of these statistical 
122 
 
methods rather than a single statistical test was chosen as it has been generally 
agreed within the literature, that a set of statistical methods rather than a single 
statistical test is required for assessing reliability and sensitivity (Lexell and 
Downham, 2005; Ageberg, Flenhagen and Ljung, 2007). 
Without test-retest reliability or reproducibility, it would not be possible to assess the 
degree to which a measure is sensitive enough to detect a change in participants‘ 
responses as a result of targeted interventions (Beckerman et al., 2001). 
Responsiveness or sensitivity to change has been defined as the ability of a scale or 
measurement to detect clinically relevant changes over time (Guyatt, Walter and 
Norman, 1987). Guyatt and colleagues describe responsiveness in relation to typical 
variation within-subjects, between repeated test measurements (Guyatt, Walter and 
Norman, 1987), therefore reproducibility has a direct influence on the 
responsiveness of a measure. To determine the direct influence of any intervention, 
it is thus necessary to be aware of these variations and the amount of measurement 
error contained within the Biopac instrument itself.    
3.3. Design.  
This investigation was a prospective cohort study utilising a repeated measures 
design. 
3.4. Methods.  
3.4.1. Participants. 
The study recruited a convenience sample of 12 healthy, asymptomatic, non-
smoking volunteers from the student and staff population at Coventry University (6 
women and 6 men, aged 19-53 years; mean 37.4 years, SD = 7.45) by placing an 
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advertisement on the notice board in the Faculty of Health and Life Sciences Charles 
Ward Building for a two week period.  All volunteers that responded to the 
advertisement were telephone interviewed (n=19) to ascertain their appropriateness 
for the study and of the 16 individuals that met the inclusion criteria, 12 could attend 
on the two individual days of the study. An information leaflet was provided for those 
that agreed to attend for their consideration prior to commencement of their data 
collection (appendix III). Three days prior to the day of data collection all 12 of the 
participants  were consented and assessed (by means of a standard physiotherapy 
subjective and physical examination) to ensure that they met the criteria for the study 
(see table 10 overleaf). A mixed gender group was utilised, to ensure that 
extrapolation of the results to the target research population was not inhibited. 
Ethical approval was obtained from the Coventry University research ethics 
committee (appendix IV). Once the researcher and the participant were satisfied of 
their eligibility, the participant was asked to sign the consent form and informed of 
their right to withdraw at any time (Polit and Hungler, 1995). In accordance with good 
ethical practice, a cooling-off period of 72 hours was provided between the 
participant signing the consent form and their first data collection appointment. On 
each of the two days of data collection an abbreviated screening (re-) assessment 
was performed to ensure that no changes in their status had occurred and that they 




Table 10: Inclusion and exclusion criteria 
Inclusion Criteria Exclusion Criteria 
 
Male or female gender 
 
Age between 18 and 55 years 
 











History of musculoskeletal symptoms within 
the last 6 month 
 
Existence of concurrent medical disorders or 
psychiatric illnesses that may affect 
neurophysiological readings (e.g. Diabetes, 
anxiety disorders, Multiple Sclerosis, 
rheumatoid arthritis) 
 
Previous history of lumbar spine surgery or 




Skin disorders at the site of electrode 
placement (e.g. athletes foot, psoriasis, 
eczema, verruca) 
 
Previous history of trauma with resultant 
persistent dysthesia (abnormality of 
sensation which would affect 
neurophysiological readings) 
 
Alcohol dependency and smokers (that 
could affect neurophysiological readings) 
 
Those participants not willing or able to 
consent to inclusion 
 
 
3.4.2.  Equipment 
Physiological recording of SC was measured by a BioPac GSR100B Electro-dermal 
Activity Amplifier (MP35; BioPac Systems Inc; Santa Barbara, CA), employing a 
constant voltage technique, sampled absolute direct current SC at the rate of 200 
samples per second, and recorded through a BioPac AcqKnowledge computer 
software package running on an IBM compatible computer with Microsoft Windows 
installation (Figure 12). The Biopac software programme was installed, under license, 
on the investigators password protected laptop which was kept in a locked cabinet in a 




Figure 12: The Biopac computer set up           Figure 13: Electrodes and equipment  
 
A low frequency filter was set at 0.2Hz and a high frequency filter at 500Hz in order 
to limit any extraneous signal interference (e.g. other electrical devices in close 
proximity as might occur within a hospital/clinical environment). SC readings were 
recorded using silver/silver chloride electrodes (Figure 13 above) from the plantar 
aspect of the second and third toes of both feet simultaneously (12mm electrode gel 
contact area), using Biopac Systems Gel medium (as recommended by Biopac 
Systems manufacturer). The selection of electrode placement was determined by 
consideration of the spinal region most commonly producing symptoms (L4-S1 
segments). The L4-5/S1 segments have a cutaneous branch, the medial plantar 
nerve, which supplies the plantar aspect of the toes under study (Williams et al., 
1989).  
To facilitate measurement consistency and thereby enhance the reliability of the study, 
the same diurnal appointment time was repeated for the second attendance of the 
participant. Reliability was further enhanced by using the same researcher to apply the 
electrodes and take the recordings. The subjects did not receive any feedback 
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regarding the outcomes of the recordings, ensuring blinding on the part of the 
participant. 
3.4.3.Procedure: 
All participants were asked to refrain from exercising, eating or drinking any caffeine 
products 3 hours prior to the measurements (on both days). 
Participants lay quietly on a plinth, in a standardised position (supine with their arms by 
their sides and their legs supported at the knees by a single pillow).  The participants lay 
with the lower half of the body unclothed to underwear/shorts. The skin on the toes of 
each foot was prepared by cleansing of the conductance electrode sites with isopropyl 
alcohol to remove any unwanted skin residue that might affect the measurements 
(Petersen et al., 1993; Chiu and Wright 1996 and Perry and Green 2008). The Biopac 
SC electrodes were then applied to the second and third toes of each foot (Figure 14 
overleaf). During the recording period the participants were requested to lay still, try not 
to deep breathe, cough, sneeze, interfere with the electrodes or fall asleep. All 
participants were compliant with these instructions. The procedure was repeated on a 
second occasion (one week between recordings as was considered standard clinical 
practice for patients undertaking a programme of physiotherapy) so that each 
participant provided two sets of data for analysis. The diurnal timings of the two 
measurements were replicated to prevent any external bias between the two 













Following the protocol employed by Perry and Green (2008), the participants had an 
initial 10-minute stabilisation period, used to allow the subject‘s body to acclimatise 
to the environment. Following this period, recordings of SC were considered settled 
and stable and a 2-minute period of data acquisition was recorded for statistical 
comparison. At the end of the data acquisition period the recordings were terminated 
and the electrodes removed. The internal validity of the data acquisition process was 
enhanced by blinding both the participants and the researcher to the data being 
recorded (the data acquisition equipment was placed in a position whereby neither 
could observe the recordings and were therefore unable to influence the nature of 
the recordings throughout the procedure). Furthermore, the researcher did not 
analyse any of the data until the final participants‘ second data recording session 
was completed. 
 
3.4.4. Statistical Data Analyses: 
Analysis of the SC data obtained involved calculation of the ―Integral Measurement‖  
(µmho‘s) for the final two minutes of the 12 minute data collection period for each 
participant on each attendance (for details of the integral measurements gained from 
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Biopac software analysis program please refer to appendix V). The Statistical Package 
for Social Scientists (SPSS v.14) software package was used to calculate the intra-
class correlation coefficient (ICC 2,1) and the MedCalc statistical software package 
was used to calculate the Bland and Altman Limits of Agreement. 
 
To assess the test-retest reliability of the Biopac measures of SC as robustly as 
possible, the following statistical methods were used:- 
 
i) Retest correlation co-efficient 
Assessment of agreement between of the two sets of test results was conducted using 
the intra-class correlation coefficient (ICC 2,1) and is defined as the between-subject 
variance divided by the between-subject variance plus the within-subject variance 
otherwise known as the ―relative reliability‖. The Pearson‘s product moment correlation 
co-efficient was not chosen as this test is traditionally used to assess the strength and 
linear association between two different variables/measures rather than assessment of 
the agreement between two (or more) sets of the same measurement (Bland and 
Altman 1986 and 1995). Indeed, Shrout and Fleiss (1979; p.420-428) suggest that the 
ICC (and in particular ‗Model 2,1‘ whereby the measurement is carried out on each 
subject by the same rater) is the more appropriate statistic for measurement of 
agreement. Fleiss (1986; 2-31) recommends ICC values above 0.75 for excellent 
reliability and values between 0.4 – 0.75 for fair to good reliability, with values below 
0.4 suggestive of poor reliability. However, an ICC only produces a value between 0 
and 1 which can be difficult to interpret clinically (Ageberg, Flenhagen and Ljung, 
2007) and according to Lexell and Downham (2005) would not be a suitable 
standalone measure of an instruments‘ retest reliability, in this case, the test-retest of 
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the 2 minutes of data recording following the stabilisation period on the two different 
attendances of the 12 participants. 
i) Assessment of changes in the mean 
To assess for any random or systematic change in the results between the two test 
situations (Lexell and Downham, 2005; Ageberg, Flenhagen and Ljung, 2007; Bland 
and Altman, 1986) the following indices were recorded: mean difference between the 
test occasions with the standard error of the mean difference and the 95% confidence 
intervals (95% CI) and the Bland & Altman plots of the 95% limits of agreement (LOA). 
These methods can estimate any systematic bias, e.g. if values on the reliability 
presentation were always greater than those on the initial presentation then the mean 
difference would always be positive and the reverse would be true if the b=values were 
smaller, suggesting a systematic shift in measurements between test occasions. If 
zero is included in the 95% CI, no significant systematic change in the mean is 
present. The Bland & Altman LOA graphs also allow visual assessment for other 
systematic biases and magnitude of the inherent variability within the Biopac measure.   
 
iii) Assessment of measurement variability 
To quantify the actual size of the variability between the two sets of measurements (or 
the ―within-subject variation‖, or ―typical variation‖ Lexell & Downham (2005), the 
following indices were used: Standard Error of Measurement (SEM) which calculated 
as the square root of within-subject variance which is the square root of total variance 
multiplied by 1- ICC); and SEM% which is the calculation of SEM divided by the mean 
and multiplied by 100. Any change following an intervention that is smaller than the 
typical variation would need to be interpreted with extreme caution. To evaluate if 
change scores represent important changes a reference range which takes account of 
measurement variability can be calculated; the Smallest Real Difference (SRD) which 
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is equal to 1.96 x SEM x √2; and 95% SRD which equals the mean difference between 
the two test occasions ± SRD. If the difference in score/measurement for a participant 
following in intervention is outside this reference range then it can be said to represent 
a ―real‖ change that is likely to be attributable to an intervention and not inherent 
variability. Therefore, the smaller the reference range, the more sensitive the measure 
is at detecting ―real change‖ (Lexell and Downham, 2005). 
 
3.5. Results. 
Results revealed an ICC=0.997 (2,1; two-way random effect model; Absolute 
Agreement Definition) that was statistically significant (p<0.0005) and a confidence 
interval (CI)  = 0.996-0.999, suggesting a strong correlation between test scores and 
representing excellent reliability (Fleiss 1986) that can be considered satisfactory for 
clinical measurement.  
 
Bland and Altman Limits of Agreement (1986) are illustrated in Figure 15 and 
confirmed that the bias between the two applications was small (1.4 μmho‘s) with the 
difference lying, in 95% of participants, between 11.1 to -8.2 (+/-21.8) µmho‘s. Zero is 
contained within the 95% CI indicating that the small degree of variability observed 




Figure 15: Bland Altman Plot illustrating the Limits of Agreement for the two 

















Calculations of the standard error of measurement (SEM) revealed that to be 95% 
sure that any SC results are not due to measurement variability a change in the 
order of +/- 0.1138 μmho‘s (SEM = SD√1-Cronbach‘s alpha; 2.0782√1-0.997) would 
need to be recorded which is translated into a percentage error value of 4.632%  
[ =  (SEM/mean) x 100]. The smallest real difference measurement was calculated to 
be 0.315 μmho‘s (1.96 x SEM x √2) and represents the minimum difference required 





3.6.  Discussion of Findings and Limitations of the study 
It was the aim of this pilot study to assess the test-retest reliability, measurement 
variability and calculate the smallest real difference statistic of the Biopac equipment 
measures of SC in an asymptomatic healthy population. This was necessary in order 
to establish the reliability of Biopacs‘ use for research on SNS (SC) responses within 
a natural (non-laboratory) environment, thereby providing validity for the use of 
Biopac SC measures in the pre-clinical and, latterly, the patient study as well as for 
future clinical research. To gain information regarding the degree of test-retest 
measurement agreement, as well as systematic or random change and variability of 
the Biopac equipment in a natural environment, different statistical techniques were 
employed as it has been suggested that no one standalone statistical measure 
should be deemed sufficient (Bland and Altman, 1986; Ageberg, Flenhagen and 
Ljung, 2007). 
The results showed that the Biopac equipment had acceptable random 
measurement error and test-retest reliability. There was evidence of minimum 
measurement variability between applications of the equipment (ICC=0.997; 
p=0.0005;  2:1 two-way random effect model; Absolute Agreement Definition) which 
is comparable with the findings of Paungmali et al. (2003) who had an ICC of 0.88 
for their SC data acquisition unit within a laboratory setting. Bland and Altman Limits 
of Agreement were conducted to detect any bias between applications and findings 
revealed only small bias between applications (1.4 µMho‘s) with the difference lying, 
in 95% of participants, between 11.1 to -8.2 (+/-21.8) µMho‘s. This indicates that 
although it was possible to observe a small degree of variability, this variability was 
not systematic. As no other published study has conducted this type of analysis, 
comparisons to laboratory settings was not possible. 
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Further analysis of the data calculated that the Standard Error of Measurement was 
0.1138 μmho‘s, with a percentage error value of 4.6326% and a Smallest Real 
Difference of 0.3154 μmho‘s. The SRD is the smallest measurement change that can 
be interpreted as a real difference, taking account of the fact that the measurement 
error makes the observed value of a measure differ from its true value (Beckerman 
et al., 2001). Although Paungmali et al., (2003) did calculate a SEM in the order of 
0.011 μmho‘s (a value lower than the current study), their measurements were taken 
in an environmentally controlled laboratory setting which was not transferrable to a 
clinical hospital setting therefore, this is the first study to provide data for use within a 
natural, clinical environment. Furthermore, the conversion of the SEM of 0.1138 
μMho‘s into percentage change in SCR permits application of the measure into SCR 
(percentage change) within future clinical studies.  
It was therefore considered that Biopac SC measurements in the lower limb were 
reliable for measurements of SNS response within a clinical/non-laboratory setting, 
with any measurement in excess of 0.3154 μmho‘s (>4.633% change from baseline 
to treatment period) being regarded as an SNS change that is independent of any 
measurement error or variability and ascribable to the intervention under 
investigation.  
The main limitation of the findings was that the study sample was a convenience 
sample, and the participants were healthy asymptomatic volunteers and therefore 
may not be representative of a symptomatic patient population. However, it was felt 
that the advantages of using asymptomatics outweighed the disadvantages as the 
recruitment of an asymptomatic population (see inclusion/exclusion criteria in Table 
10) permitted strict control of any potential confounding variables that might 
otherwise distort or bias the SC readings (e.g. The effects of medications used for 
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pain, spasm or anxiety and the effects of symptoms of musculoskeletal, 
cardiovascular or neurological conditions). 
To the authors knowledge this is the first study to conduct these normative values of 
SC activity levels with the Biopac data acquisition equipment within a natural, non-
laboratory environment and to publish the results for future studies (Perry et al., 
2011). These findings should help researchers determine whether a change in 
individuals‘ readings, are a true change rather than simply measurement error.  
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4. Magnitude of Effect of Physiotherapy Treatments 
 
4.1. Introduction 
Dagenais et al‘s., (2010) systematic review of LBP management supports the 
recommendations of Ernst and Canter (2006) and Bronfort et al., (2008) who call for 
primary research on manual and manipulative therapies to determine the 
effectiveness of the variety of options for the management of LBP. Until recently, 
determining the nature of neurophysiological responses occurring as a result of 
specific manual therapies has been a challenge due to the difficulty in accurately, 
quantitatively and non-invasively measuring the proposed effects on the key target 
tissues. Several researchers have explored the neurophysiological basis of specific 
MT techniques in the cervical spine (Sterling et al., 2001; Moulson and Watson, 
2006) and upper limbs (Vicenzino et al., 2001 and Paungmali et al. 2003), utilising 
the SNS (SCR) as a measure of neurophysiological response. However, there is 
only a limited research base studying the lumbar spine and lower limbs (Perry and 
Green, 2008, Tsirakis and Perry 2010; Moutzouri, Perry & Billis, 2012).  
The purpose of this pre-clinical study was to provide empirical evidence of the 
neurophysiological effects (as measured by recordings of sympathetic nervous 
system –SNS- activity) of two commonly advocated specific MT approaches to the 
management of LBP; repeated McKenzie Extension In Lying Exercise with 
overpressure (EIL) and a rotatory segmental manipulation (Manip) technique. Key 
objectives were to compare and contrast observed SNS responses within and 
between the groups and to discuss these findings with those of other previously 
conducted studies on other treatments for LBP (i.e. unilateral spinal mobilisations 
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and mobilisations with movement). Furthermore, the study aimed to contribute to the 
developing knowledge-base that provides evidence of SNS responses to specific 
treatments and thereby inform future clinical research and to enhance clinical 
decision making. 
The recent publication of guidelines for the management of LBP, recommended the 
use of MT and exercise for the condition (CSP, 2006; van Tulder et al., 2006; 
Savigny et al., 2009 and Chou et al., 2009). These guidelines are supported by a 
number of studies that demonstrated clear patient-reported benefits (Konstantinou et 
al., 2007; Goodsell et al., 2000; Bialosky et al., 2009). However, there continues to 
be debate within the literature regarding the magnitude and the clinical significance 
of observed treatment effects (Potter et al., 2005; Theodore, 2010) with a lack of data 
available regarding specific treatment effects.  
Specific sudomotor SNS changes (otherwise known as galvanic skin response, or 
electro-dermal activity – GSR and EDA – and hitherto referred to as skin 
conductance responses – SCR‘s) have been reported with lumbar and lower limb 
MT treatments on normal healthy populations. Perry and Green (2008) reported 
statistically significant SCR‘s changes in the order of 13.5% (p=0.005) on the side of 
treatment in their treatment group receiving unilateral grade III Postero-anterior 
mobilizations (at a rate of 2Hz). This was the first study to demonstrate a significant 
side specific effect compared to the untreated side, to placebo and control conditions 
(p=0.002).  Moutzouri, Perry & Billis (2012) explored the effects of a centrally applied 
mobilisation with movement (MWM sustained natural apophyseal glide - SNAG) 
performed on the L4 motion segment revealing a percentage increase in SCR‘s in 
the right and left lower limbs in order of 10.6% and 11.2% respectively. This 
response was double that of the placebo condition and statistically significant 
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compared to the control group (p=0.04 and p=0.0004 respectively). Tsirakis and 
Perry (2010) also investigated the effects of a unilaterally applied modified Spinal 
Mobilization with Leg Movement (SMWLM) technique (Mulligan, 2004:77) on SNS 
changes in the lower limbs. These authors revealed that the SMWLM technique 
resulted in a statistically significant increase in a percentage change in SCR‘s in the 
order of 30.6% (p= 0.049) within the treatment side.  
It is now recognised that MT can produce neurophysiological (SNS) effects, in 
humans, and that SNS responses to MT are linked to immediate hypoalgesia (Wright 
and Vicenzino, 1995; Vicenzino et al., 1995 and 2001; Paungmali et al., 2003; Solly, 
2004; Zusman, 2004; Bialosky et al., 2008 and 2009b) and sympathoexcitation 
(Paungmali et al., 2003 and Perry and Green, 2008). These SNS responses were 
found to be specific to mechanical nociception (Vicenzino 1995 and 1996; Sterling et 
al., 2001) and thermal nociception (Bialosky et al., 2008 and 2009). These findings 
have led to the concept that MT exerts its initial effects by activating specific 
pathways from the peri-acqueductal gray (PAG) region of the brain (Potter et al., 
2005; Lanotte et al., 2005; Bialosky et al., 2009) and also by the spinal cord and 
central pain modulatory circuits and inhibition of the dorsal horn (Price et al., 2002). 
These mechanisms can be influenced differently by different types of manual 
techniques including oscillatory (Chiu and Wright, 1996; Perry and Green, 2008; 
Jowsey and Perry 2010) and non-oscillatory techniques (Paungmali et al., 2003; 
Moulson and Watson, 2006; Tsirakis and Perry, 2010; Moutzouri, Perry and Billis, 
2012). However, prior to this study, no published articles have reported recordings of 





4.2. Aims and Objectives 
The aim of this pre-clinical study was to generate data on 2 commonly utilised 
lumbar treatment techniques and to compare the magnitude of SNS change (SCR) 
during and between the two treatments.  
Objectives:- 
The objectives of this pre-clinical study of the effects of different treatment on SNS 
responses were as follows: 
1) to observe the SCR‘s to a repeated McKenzie Extension In Lying (EIL) 
treatment technique 
2) to observe the SCR‘s to a rotatory grade V segmental (L4/5) lumbar 
manipulation technique (Manip) 
3) to calculate any differences in effect  between the two techniques 
4) to compare any effects between the uppermost/―opening‖ (or gapping – 
Evans, 2009) side and the underneath/―closing‖ (or impacting – Evans, 2009) 
side during the manipulative procedure. 
5) to generate SCR data to permit a power calculation for the clinical study on 
LBP patients and for future post-doctoral research.  
 
4.3. Null Hypotheses 
The following null hypotheses were tested within this pre-clinical study:- 
H01) There is no significant difference in SCR‘s as a result of performing 3 
sets of 10 McKenzie EIL exercises. 
H02) There is no significant difference in SCR‘s as a result of performing a 
rotatory grade V lumbar manipulation to the L4/5 segment. 
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H03)  There is no significant difference in SCR‘s between the McKenzie EIL 
exercise and the manipulation (grade V) technique. 
H04)  There is no difference in SCR;s between the uppermost/―opening‖ (or 
gapping – Evans, 2009) side and the underneath/―closing‖ (or 
impacting – Evans, 2009) side during the manipulative technique..  
 
4.4. Method 
The overarching methodological philosophy of this study was positivistic, that is, 
seeking falsification of the null hypothesis through the process of hypothetico-
deduction. A prospective, quasi-experimental, randomized, independent subjects 
design was selected to establish a cause-effect relationship. Quasi-experimental 
designs are appropriate to investigate differences in effect of two interventions (the 
manipulation [grade V] or McKenzie EIL technique) in the absence of a control group. 
The reasons for not recruiting a control group in this study were based upon the fact 
that previously published researchers (and this studies researcher) have conducted a 
number of other studies where control group data had been gathered. Subsequent 
comparisons of this data had revealed that all control groups had very similar findings 
regarding SCR‘s. The findings of studies where control group data have been 
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L4/5 uni-lateral PA mobilisation 
 
 















MWM Rotation to C6 
 
 
(Repeated Measures design) 















Unilateral Glide to C5/6 
 
 











(Where Blue boxes indicate lumbar spine data; Pink boxes represent asymptomatic participants and 
other treatment areas. N/A = Not Available) 
 
Unfortunately, not all published studies reported control group percentage change in 
the intervention period (Sterling et al., 2001; Vicenzino et al., 1998) however, in 
those studies that provide this data, a comparison of the results (of the 255 control 
condition participants) are very similar demonstrating a small amount of variance, 
both within and between studies, with a combined-data range of -1.01 to 0.83% 
indicating stability in control readings in the ‗intervention period‘ thereby countering 
the need to recruit a control group for the current study as it was reasoned that the 
results would not be dissimilar. Furthermore, the percentage change recorded in the 
control conditions in the above studies is below the bounds identified by the previous 
reliability study of this thesis (Chapter 3), that identified the SRD value as 4.632%. 
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4.3.1. Power calculation for sample population 
A previous study (Perry and Green, 2008) recorded SCR‘s in the lower limbs in control, 
placebo and lumbar spine treatment situations. Using the n-Query advisor software and 
based upon a pooled standard deviation estimate from placebo and control groups of 
9.4%, it was calculated that 50 participants (25 per group) would enable a SCR 
difference of 7.5% in percentage change from baseline to be detected at the 5% 
significance level with 80% power. This effect size was selected as has been utilised in 
a previous paper looking at SNS treatment responses in the lumbar mobilisations (Perry 
and Green, 2008) and was greater than the SRD established in the pilot study (4.6%). 
 
4.3.2. Participants  
The study recruited a convenience sample of 52 healthy, physiotherapeutically naïve, 
asymptomatic, non-smoking volunteers from the student and staff population at 
Coventry University (demographic characteristics are detailed in table 12). Of those 
recruited, 2 were unable to attend on the day of data collection and were therefore 
omitted from the final data analysis. 








Gender         (n) 
                  Male 






37.7 (8.28) 36.9 (8.27) 
Height (cms) 
Mean (SD) 
176.4 (11.12) 175.8 (10.98) 
Weight (Kgs) 
Mean (SD) 
70.36 (10.14) 71.10 (11.03) 
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Recruitment was achieved by visiting the lectures and seminars (where the target 
population were in attendance), handing out information sheets with the researchers 
contact details, and inviting students and staff to consider participation in a one-off 
data acquisition procedure whereby they would undergo one treatment commonly 
used in the management of lower back symptoms. Participants that contacted the 
investigator were interviewed for their suitability for the study (by phone) and, if 
considered suitable, invited to attend for a brief assessment and for consenting to 
the study (see consort diagram, figure 16 for details of the recruitment process). All 
volunteers satisfied the criteria set out in previous studies (Moulson and Watson, 
2006; Perry and Green, 2008) and documented in table 10 of the previous chapters 
reliability study. The only difference in the exclusion criteria being that they had no 
contra-indications to manual therapy treatments as detailed by Maitland et al. (2005). 
An asymptomatic population was again selected for this pre-clinical study as it was 
unknown if any responses could be detected in a normal healthy population and it 
was necessary to limit the potential confounding effects that prescription 
medications, pain and the existence of co-morbidities might have on the primary 
outcome measure (SCR). Furthermore, it is recognised that, ethically, it is good 
clinical practice to establish normative values in an asymptomatic population prior to 
conducting clinical research on patient populations (DoH Research Governance 
Framework, 2005). 
Prior to acceptance into the study, participants were assessed by the researching 
therapist (JP) means of a standard physiotherapy subjective and physical 
examination to ensure that they had no contra-indications to either treatment 
procedure. A mixed gender group was utilised, to ensure that extrapolation of the 
results to the target patient population was not inhibited.    
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Figure 16: Consort diagram illustrating the recruitment and randomisation of participants 
 
All volunteers received written information (appendix VI) indicating that they would 
be given a commonly administered manual therapy treatment technique for ‗back 
trouble‘. Participants were advised that the nature of the treatment would be painless 
and that they may or may not hear a ―click‖ in their back and that this is normal and 
they should not be concerned but should they wish to discontinue the treatment at 
any point they would be allowed to do so without prejudice or coercement. They all 
indicated that they understood the information provided and gave informed consent 
prior to the experiment (appendix VI). They were not advised about the specific 
nature of the measurements being taken (that is, SNS responses), just that the 
measures were non-invasive, painless and were recording any sweat changes in 





































LBP n= 2  
 b) UTA n=2 
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The fifty participants attended, on one occasion, in order to undergo one of the two 
experimental conditions (the manipulation or the McKenzie EIL technique – see 
below). The researcher was responsible for conducting the treatments as the final 
clinical study would involve the researcher providing the treatments to the follow-on 
clinical/patient population and was considered to be a suitable strategy to reduce any 
bias that might occur as a result of different therapists utilising different treatment 
approaches. At the time of the study, the researcher performing the treatments was a 
senior physiotherapist with 16 years of musculoskeletal clinical experience, she had a 
Masters degree in Manipulative Therapy (Coventry University, 2001), was a full 
member of the Musculoskeletal Association of Chartered Physiotherapists (MACP) 
and had previously held the position of Clinical Team Lead in a musculoskeletal out-
patients department of a Leicester city accident and emergency hospital (Band 8a). 
Currently, the researcher works as an academic within the Faculty of Health and Life 
Sciences at Coventry University as a senior lecturer in musculoskeletal physiotherapy 
research, lecturing on both the undergraduate and post-graduate programmes and 
specialising in spinal musculoskeletal and manual therapy. 
Internal validity of the study was enhanced with the incorporation of a number of 
strategies, namely; by using the same therapist to conduct all treatments thereby 
minimising variability in the technique, by blinding both the participants and the 
researcher to the data being acquired during the treatment procedure, and by the 
utilisation of random allocation of participants to one of the two treatments by using 
random numbers tables generated by the nQuery software programme. For the 
participants receiving the manipulation technique, further randomisation of the side 
of treatment (right or left) was conducted by also employing a random numbers table 
generated by the nQuery software programme. 
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Ethical approval for the study was granted from the Coventry University Ethics 
Committee (appendix IV).  
4.3.3. The choice of segmental level for treatment application 
 
The two treatments selected for this study were the rotatory grade V lumbar 
manipulation technique and the repeated McKenzie EIL exercise which are detailed 
below. Both techniques were performed by the Researcher and localised to the L4/5 
segmental level in order to maximise the focus of the effect. The L4/5 segment was 
selected as it has been reported to be the most common site of symptoms within the 
lumbar region (Louis, 1981; Butler, 1991 and Grieve, 1994) and reflected the 
researcher‘s clinical experience of patients attending for physiotherapeutic 
management of LBP. In most instances, the area of symptom provocation is the 
lower lumbar segmental region (L4/5 and L5/S1 levels) and is frequently 
accompanied by referred symptoms into the lower limb and foot. This observation is 
supported by Nathan (1968) who dissected 390 adult cadaveric lumbar sympathetic 
trunks and discovered that osteophytic encroachments resulted in macroscopic 
changes in the sympathetic trunks of 78.4% of his subjects. The highest incidence 
was seen at the L4/5 intervertebral joint and it is speculated (Grieve, 1994) that 
symptoms of sympathetic trunk compression may be expected to appear in the lower 
limbs and/or pelvic viscera. 
 
Based on the cadaveric studies of neuraxial motion by Louis (1981), the concept of 
neural ‗tension points‘ was introduced (Butler, 1991). Butler (1991) has observed  
three such tension points within the central nervous system, at the C6, T6 and L4 
levels. With specific reference to the L4 segment, he argues that the dura mater is 
firmly attached to the posterior longitudinal ligament, and consequently tethers the 
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system, limiting movement of the emerging peripheral nerves, therefore generating a 
vulnerable site within the nervous system at this level. It is this phenomenon and its 
potential effects on both neural and vascular biomechanics, which he suggests may 
be, in part, responsible for his clinical observations. 
 
It was therefore, a combination of both personal clinical observation, and the 
anatomical considerations of cadaveric and clinical studies that led to the decision to 
focus this element of research on the L4/5 segment.  
 
4.3.4. Treatment Modalities 
 
i) The Repeated McKenzie EIL exercise technique: - A localised centrally applied 
postero-anterior mobilisation technique was statically applied to the spinous process 
of the L5 segment (with over-pressure) whilst the subject actively performed 3 sets of 
10 repetitions of a lumbar extension manoeuvre in prone lying (see figure 17 
overleaf) according to the protocol described by McKenzie (2003). There was a one 
minute rest between each of the three sets (of 10 repetitions). The EIL treatment 




















ii) Rotatory Manipulation Technique: - Following the localisation and isolation of 
the L4/5 mid-range position (between lumbar flexion and extension) with a passive 
physiological intervertebral movement (PPIVM) technique (Maitland, 2005), a 
localised segmental rotation technique (high-velocity low amplitude grade V 
manipulation) was performed to the L4/5 segment (that involved joint gapping in a 
starting position that included a combination of 3 physiological movements that were 
in a coupled manner and designed to produce an audible ―pop‖/gapping of the joint 
surfaces). Random allocation procedures determined whether the participant 
received this in either right or left side-lying (computer generated random allocation 
of left or right side) and the treatment technique was performed according to the 
detailed protocol described in Maitland et al., (2005), by Herzog (2000) and provided 
in video CD format within the book by Gibbons and Tehan (2000; see a snap-shot of 
the technique in figure 18 below). In accordance to the procedure detailed by 
Gibbons and Tehan (2000), and including the PPIVM technique to isolate the L4/5 
This item has been removed for data protection reasons. 
The unabridged version of the thesis may be viewed at 
the Lanchester Library, Coventry University.
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segment, the treatment took 2 minutes to complete (the last 50 seconds was the 
HVLAT manipulation technique). 
 












4.3.5. Sympathetic Nervous System outcome measures (data collection) 
 
Physiological recording of SC was continuously measured, without interruption, 
throughout the entire experimental period (pre-treatment, peri-treatment and post-
treatment) by a Biopac GSR100B Electro-dermal Activity Amplifier (MP35; Biopac 
Systems Inc; Santa Barbara, CA), employing a constant voltage technique and 
sampling the absolute, direct current SC at the rate of 200 samples per second using 
silver/silver chloride electrodes in exactly the same way as detailed in the pilot study. 
  
Prior to data collection the temperature and humidity of the room were noted in 
accordance with the protocol set out by Petersen et al., (1993) and Chiu and Wright 
(1996). The skin was prepared in accordance with the standard protocol for Biopac 
This item has been removed for data protection reasons. The 




measurement (Petersen et al., 1993; Chiu and Wright, 1996 and Perry and Green, 
2008) and replicated the set-up procedure detailed in the previous chapter. The SC 
electrodes were applied, as before, to the second and third toes of each foot as 
advised by Perry & Green (2008). During the entire experimental procedure 
participants lay in a comfortable position upon an adjustable treatment plinth. As 
before, participants were instructed, prior to the commencement of data recording, 
not to sleep, deep breathe, cough or sneeze, talk, fidget with the sensors, or move 
unless otherwise instructed to do so by the investigator. Following previously 
documented protocols (Chiu and Wright, 1996; Perry and Green, 2008), the 
participants lay quietly for the initial 10 minute period, used to stabilise the SC 
measures. SC values were continuously recorded throughout the course of the 
experimental period (pre-treatment, peri-treatment and post-treatment), including the 
10 minute final rest period. The whole procedure lasted no more than 24-26 minutes 
(manip or EIL technique respectively). After all the data was collected and saved, 
analysis of the output consisted of calculating the ―integral‖ readings for the three 
data capture points (baseline, intervention and final rest periods). The ‗baseline 
period‘ consisted of the 2 minutes following the 10 minute stabilisation period. The 
‗intervention period‘ readings were taken as the initial 2 minutes of the treatment 
period (where either the McKenzie EIL or the Manipulation technique was 
performed). Following completion of the treatment and during the 10 minutes of rest 
(in the original starting position) the last 2 minutes of the rest period were used and 
documented as the ‗final rest period‘. Thus, each participant generated 3 readings 
each representing a 2-minute period in the baseline (illustrated in Figure 19 overleaf 




Figure 19: Schematic representation of the timing protocol employed for each participant 







                 Stabilisation Period              Baseline  Intervention                       Final Rest Period 
                                                                     Period       Period                                        
 
Time Period (In Minutes) 
 
By turning the laptop screen away from the treatment area neither the participant nor 
the principal Investigator was able to receive any feedback regarding SNS activity 
(see figure 11 in the pilot study), thus ensuring the blinding of the participant and the 
researcher to the effects of treatment. 
4.3.6. Data analysis of skin conductance resoponse (SCR) 
Analysis of the SC analysis and the SCR data obtained involved calculation of the 
―Integral Measurement‖ (µMho‘s) for baseline, intervention and final rest periods. 
Intervention and final rest period values were then converted into percentage change 
(PC) from baseline using the formula below and further detailed in a previous paper 
(Perry and Green, 2008). 
 (% change) SCR =  (y-x) x 100 
                                                                  x          1 
 
Where:-  y = new SC reading, x = original SC reading 
 
The Statistical Package for Social Scientists (SPSS v.15) software was used to 
calculate descriptive (mean, SD, mean differences, maximum, and minimum values) 
and inferential statistics (paired and unpaired t-tests) to test the 4 null hypotheses.  
2 Mins            2 Mins            2 Mins           




4.4.1. Environmental conditions 
Room temperature was recorded at the beginning and end of each subject‘s 
experimental session as per published guidelines (Uematsu et al., 1988) with relative 
constancy within each session demonstrated (mean 24.7 C, SD 0.275, range 24.2–
25.3 C) with a maximum within subject experimental room temperature variation 
being no more than 0.3 C (mean 0.2 C, SD 0.1 C, range 0.0-0.3 C). 
 
4.4.2. Skin Conductance Analysis 
Demographic characteristic of the participants are displayed in table 13 below. Both 
groups were similar in age and the gender distribution. 
Table 13: Demographic characteristics of the two treatment groups (Age and Gender) 
 Manipulation Group 
(n=25) 
McKenzie EIL ex Group 
(n=25) 



















Descriptive statistics for the primary outcome measures (SC analysis and SCR‘s) for 
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Figure 20: Boxplot of changes in SC (μmho‘s) between the baseline, intervention and final 








There was increased SC activity levels (sympatho-excitation) from baseline to 
intervention periods for both treatments (McKenzie EIL = 35.5μmho‘s, 36% change 
from baseline; manipulation group = 74.6 μmho‘s, 76% change from baseline). Both 
these results were considerably greater than the SEM (0.1138), percentage error 
(4.632%) and the SRD (0.315) values (of the previous chapter) indicating that the 
results were not due to measurement error/ variability. Differences between the 
intervention and the final-rest periods revealed that for the McKenzie EIL technique 
there was a return of SC activity levels after cessation of the intervention (2.7% 
change from baseline). The manipulation group also had a return in activity towards 
baseline although the activity remained higher than that of the McKenzie EIL 
treatment (12.9% change).  
Descriptively, differences in the magnitude of effect between the two groups 
indicated that the manipulation technique resulted in higher SCR‘s (76.35%) 
compared to the EIL exercise (35.74%). Indeed, the difference between the 
manipulation technique and the EIL exercise was more than twice (in favour of the 
manipulation technique) with the treatment SCR‘s, in the final rest period, remaining 
higher for the manipulation technique (12.94%) than for the EIL exercise (2.72). 
Regarding the existence of any side-specific SCR‘s within the manipulation group 
only, data is provided in table 15 and figure 21 (overleaf) and suggested that there 
was little difference between the uppermost (opening) side (79.65%) and the 
underneath (closing) side (73.06%) during the intervention periods. This was also the 
case in the final rest periods (15.57% and 10.30% respectively) although the opening 




Table 15: Comparisons between the percentage change (PC) in SC between the 
















Opening Side 74.57 79.65 84.90 
Closing Side 75.77 73.06 65.38 
Final Rest 
Period 
Opening Side 9.83 15.57 37.98 
Closing Side 11.07 10.30 23.27 
 
Figure 21: Boxplot comparing the manipulation group treatment sides                                   
(where  * indicates an extreme case) 
To test the null hypotheses, inferential statistical analyses were conducted. For H01 








the baseline, intervention and the final-rest periods revealing that there was a 
statistically significant difference in the McKenzie EIL group between the baseline 
and the intervention period (p=0.0005), between the intervention and the final-rest 
period (p=0.0005) but not between the baseline and the final-rest period (p=0.173). 
therefore null hypothesis 1 was rejected as there was evidence to suggest that there 
was a statistically significant difference in SCR during the intervention period but that 
SCR was not maintained into the final rest period. 
Inferential testing of H02 (with the manipulation group) revealed a statistically 
significant differences in SCR‘s between the baseline and the intervention period 
(p=0.0005), between the intervention and the final-rest period (p=0.0005) and 
between the baseline and the final-rest period (p=0.001). Therefore null hypothesis 2 
was rejected as there was evidence to support a statistically significant difference in 
SCR‘s during the intervention period that was maintained into the final rest period.  
To test H03, an unpaired/independent t-test was performed between the two groups 
during the intervention periods and between the final-rest periods to test for any 
difference in magnitude of SCR‘s and differences in the longevity of the SCR‘s 
between the two techniques. During the intervention period there was a statistically 
significant difference between the two groups with the manipulation technique having 
a greater effect in the order of 40.61% (p=0.001) clearly exceeding the SEM, 
percentage error and SRD measurements. During the final-rest period there was 
also a significant difference between the groups with the manipulation group having 
a 10.22% greater response overall (p=0.048).  
Testing of H04 within the manipulation group revealed that there was no statistically 
significant difference between the sides during (p=0.76) or following (p=0.557) 
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treatment. Therefore, null hypothesis 4 was not rejected as there was no statistically 
significant evidence of a difference in SCR‘s between the opening and the closing 
sides during or following the manipulation. 
Details of the power calculation for the clinical study are provided in the following 
chapter. 
 
4.5. Discussion and limitations of the findings 
This is the first study to objectively measure the magnitude of effect (on the SNS) of 
two commonly used treatment techniques to the lumbar spine. Both techniques 
produced statistically significant changes in SNS activity in the lower limbs (that were 
greater than the SRD) with the manipulative technique producing twice the size of 
effect as the McKenzie EIL technique (74.6 μmho‘s or 76.3% increase in activity from 
baseline p= 0.0005 for manipulation; 35.5 μmho‘s or 35.7% increase, p=0.0005 for 
the McKenzie EIL exercise group). Only the manipulation technique had a lasting 
effect that was carried into the final rest period (12.9% increase from baseline 
p=0.012 manipulation group; 2.7% increase, p=0.173 for McKenzie EIL group). 
These findings suggest that although both techniques are capable of causing 
statistically significant changes in SNS activity, the manipulation technique was able 
to cause twice the magnitude of response (when compared to McKenzie EIL) and 
has an effect that continues into the final rest period. The lasting effects of 
manipulation were also recorded by Haas et al., (2003) who reported effects (on 
patient-reported pain and joint stiffness) lasting up to 5 hours post-manipulation in 




The changes in SNS activity following the two treatments in the current study are 
comparable to other studies effect with a unilateral PA mobilisation to the lumbar 
spine resulting in a 13.3% increase in activity (Perry and Green, 2008), a centrally 
applied MWM to L4 resulting in a 10.2-11.6% increase in activity (Moutzouri, Perry 
and Billis (2012) and a SMWLM resulting in a 30.6% increase in SNS activity in the 
treated leg (Tsirakis and Perry, 2010). In terms of the observed efficacy of SCR‘s in 
asymptomatic participants, it would appear that manipulation achieves the greatest 
increase in SCR (76%), followed by McKenzie EIL exercises (36%), SMWLM 
technique (30%), unilateral facet joint mobilisation (13%) and MWM into lumbar 
flexion (10-11%). Certainly, future research now has a quantifiable platform from 
which to launch a raft of further enquiry with respect to these, and indeed, other 
treatments. However, this data may not be transferrable to a patient population with 
LBP and further research exploring the neurophysiological status and SCR‘s to 
treatments is warranted to verify the findings for clinical application. 
 
A possible explanation for the findings of this study may be the differences in the 
physical nature of the treatment. Although both treatments involved physical contact 
between the therapist and the participants lumbar region, the manipulative technique 
was a passive procedure (on the part of the participant) with the position of the heart 
remaining relatively static rather than the McKenzie EIL technique whereby the 
participant actively moves the torso thus causing relative vertical movement of the 
heart. Slater et al., (1995) considered this a possible explanation for the findings of 
their study, arguing that orthostatic changes may be responsible for changes in SNS 
activity. If this were the case in the present study then the McKenzie EIL technique 
would be most likely to cause BP changes and a greater SNS change due to the 
effort exerted, by the participant, and the changes in the head-body relationship 
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during treatment compared to the manipulation technique.  Another explanation may 
be the differences in the length of time each of the two techniques was performed 
(McKenzie EIL = 3 repetitions of 10 McKenzie EIL exercises with a one minute rest 
between repetitions versus one manipulation lasting approximately 50 seconds). If 
this difference were to be a governing factor in the magnitude of effect of the 
techniques then it would make intuitive sense that the more protracted, and 
participant active, technique (McKenzie EIL) would have the greatest magnitude of 
effect however this was not the case implying that it was not necessarily the time 
taken to complete the treatment that was the governing factor here. Finally, one 
other element that may have resulted in the differences in response, between 
treatments, may have been the extent of physical contact between the therapist and 
the participant. The manipulative technique requires the therapist to have a greater 
degree of close physical contact with the participant (arms, thighs and trunk) in order 
to achieve the required body-part leverage necessary to achieve a successful, 
localised thrust manoeuvre, whereas the EIL technique requires only localised 
segmental hand contact, at the 5th lumbar spinous process, during the technique. It 
is possible that this component of touch may have been an important element. 
Although no previous studies have reported the effects of touch on SCR‘s and SC 
activity levels, Olausson et al., (2008 and 2010) reported that light stroking touch 
stimulated C-tactile mechanoreceptors which were linked to cortical processing 
systems and to SNS excitability. Sefton et al., (2011) reported reductions in α-
motorneurone pool excitability and EMG amplitudes with an increase in cervical 
spine range of motion following a neck massage in 16 chronic neck pain patients. 
Although Sefton et al.‘s, 2011 study was a randomised cross-over placebo-controlled 
trial, the use of a repeated measures design and a limited sample size may indicate 
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that the results should be interpreted with caution. Furthermore, it may be argued 
that the haptic sense received during manipulation is dissimilar to the light stroking 
touch found, by Olausson et al., (2008), to induce SNS excitation.  
Many authors allude to the immediacy of effect of manipulative responses with the 
mechanism of action being ascribed to modulation of dorsal horn excitability (Boal 
and Gillette, 2004; Bialosky et al., 2009). Bialosky and his team conducted research 
on both normal healthy volunteers (Bialosky et al., 2008) and patients with 
symptomatic LBP (Bialosky et al., 2009) revealing that the lumbar manipulative 
technique produced significantly greater hypoalgesia than McKenzie EIL or 
stationary bicycling. Bialosky et al., (2008 & 2009) hypothesized that manipulative 
techniques inhibit pain at the dorsal horn of the spinal cord through alterations of 
neuroplastic changes consistent with central sensitization (Boal and Gillette 2004). 
They suggest that manipulation may provide a novel stimulus that acts as a counter-
irritant to C fibre-mediated pain. Wright and Vicenzino (1995), Vicenzino et al., (1996 
& 1998) and Sterling et al., (2001) observed that spinal MT‘s were also associated 
with SC changes and hypoalgesia in symptomatic participants (Kuraishi et al., 1983; 
Vicenzino et al., 1998; Sterling et al., 2001) leading to the concept that the dPAG 
region of the mid-brain may have a role in facilitating the descending pain inhibitory 
system and therefore an associated reduction in perceived pain. If this concept is 
extrapolated to the current study then it is plausible to expect a greater response to 
the manipulative technique rather than the McKenzie EIL technique although it is 
noted that the participants of the current study were asymptomatic and pain-free and 
therefore it was deemed necessary to repeat the study on a symptomatic LBP 
population in order to determine any anti-nociceptive effects. Although it is worthy of 
note that Bialosky et al., (2008 and 2009) found no differences, between a 
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normal/experimental population and a symptomatic/patient population, in the degree 
of hypoalgesia following lumbar spinal manipulation indicating that results on  
healthy normals may reflect patient responses.  
Further sub-group analysis of the manipulation group revealed that the SNS 
response was not a side-specific phenomenon, that is, that there was no significant 
difference in the magnitude of the effect between the uppermost/opening and the 
underneath/closing side (p= 0.76). From a clinical perspective, most therapists 
reason that placing the symptomatic side uppermost will theoretically ‗open‘ or ‗gap‘ 
the dysfunctional intervertebral foramen with the rotatory manipulative technique and 
hypothetically ‗release‘ impinged structures and augment healing through restoration 
of movement (through joint cavitation) and improved local motor control of the 
dysfunctional segment (Bialosky et al., 2009 and Herzog, 2010). Contrary to the 
findings of Perry and Green (2008), who observed a side-specific response to a 
unilaterally applied technique, the manipulative technique in the current study was 
not side-specific, that is, the rotatory manipulation technique was tensioning both 
facet joints of the selected segment rather than having a specific effect on the 
uppermost facet joint therefore accounting for the bilateral effect noted. An 
alternative explanation might be that the effect was not at a spinal segmental level, 
but was at a central/cortical level (Bialosky et al., 2009). The findings of Lovick 
(1991), Wright (1995), Zusman (2004) and Bialosky et al., (2009) might support a 
more global, central response to a segmentally applied technique. The findings of 
the current study suggest that the manipulation technique may be conducted on 
either side and still generate the same SNS response, although the author 
acknowledges that these results should be interpreted with caution until a larger 
(n=25 in this study which is small) or a patient population have been sampled and 
161 
 
the variability (spread/SD) within the data reduced.  Furthermore, the author 
acknowledges the argument that the use of t-tests in these analyses may have 
resulted in the risk of a type I error (rejection of the null hypothesis when in fact the 
null hypothesis is true), however, reanalysis, using an ANOVA statistical approach, 
confirmed the original results.  
 
At the time of conducting, and reporting (Perry et al., 2011) these preliminary pre-
clinical findings, it was not known how these responses might translate to a 
symptomatic population and were considered a limitation to this study. Indeed, it is 
proposed that future research be conducted on a symptomatic patient population to 
investigate how spinal treatments might influence SNS activity levels and whether 
there is any correlation in SNS findings and patient-reported levels of pain/symptoms 
and functional disability (through validated questionnaires). O‘Leary et al., (2007) 
conducted a study on patients with neck pain revealing that specific upper cervical 
spine (for C2/3 dysfunction) exercises resulted in immediate hypoalgesia but 
changes in peripheral SNS activity (C6/7 distribution) were negligible. Whilst the 
authors agree that different physiotherapeutic treatments may result in different 
physiological effects with different endogenous pain control mechanisms it is worthy 
of note that electrode placement may have been a factor in O‘Leary et al‘s., study. 
 
In conclusion, this pre-clinical study demonstrated that both the McKenzie EIL 
exercise and the rotator manipulation techniques can affect an immediate and 
statistically significant change in SNS activity (sympathoexcitation) and that the 
magnitude of activity for the manipulation technique was double that of the McKenzie 
EIL procedure. Also, only the manipulation technique had a prolonged effect on SNS 
activity levels into the final rest period. The study also revealed that there was no 
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side specific effect with the manipulation treatment. Putting together the results of 
the reliability study of chapter 3 and the current study, it would appear that both the 
manipulation technique and the McKenzie EIL exercise are viable treatment options 
(along with MWM and facet joint oscillatory mobilisation techniques – Moutzouri, 
Perry and Billis, 2012 and Perry and Green, 2008) for the lumbar spine as indicated 
by SCR‘s over and above those that can be explained by measurement variability 
(SRD) and these results complement those of other researchers indicating that both 
mobilisation techniques (Perry and Green, 2008) and MWM‘s (Moutzouri, Perry and 
Billis, 2012) performed to the lumbar spine can result in skin conductance responses 




5. Clinical Study 
5.1.Title 
“A Longitudinal, Pragmatic, Observational Study Of The 
Sympathetic Nervous System Responses to Guideline-Endorsed 
Physiotherapy on Acute & Sub-Acute LBP Patients” 
 
A pragmatic, longitudinal observational study designed to explore the responses (as 
recorded by Biopac SC activity levels and SCR‘s) of LBP patients (of 12 weeks 
duration) to guideline-endorsed physiotherapy treatment and to determine the 
correlation of SCR‘s to currently utilised, clinically applied, PROM‘s with a 
preliminary evaluation of the utility of the Biopac system at predicting (at inception to 
a course of treatment) patients functional outcome at discharge. 
5.2. Summary of the background to the study 
Despite a decade of published guidance supporting the use of physiotherapy in the 
rehabilitation of LBP patients, there continues to be a paucity of empirical knowledge 
to support evidence-informed clinical decisions, guide patient choice and advise 
policy makers. Questions exist about; the presenting neurophysiological status of 
patients attending clinics with LBP and the changes that occur, within and between, 
treatments that use guideline-endorsed physiotherapeutic strategies; about the 
comparability of findings between patients and asymptomatic healthy volunteers 
from previously published studies; and the presence and strength of any correlations 
between patients‘ neurophysiological responses to treatment and currently utilised 
patient-reported measures of clinical change/improvement (pain intensity [NPRS] 
and functional disability [ODI and/or RMDQ]). Furthermore, there is currently no data 
available to clinicians regarding the nature of any trends in the neurophysiological 
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SCR‘s recorded during guideline-endorsed physiotherapy management. Lastly, there 
is a no information currently available that has explored the feasibility of using the 
Biopac system (SCR‘s) for determining, in the initial assessment, the predictive 
capacity for a positive outcome (currently recognised as being an improvement in 
ODI score of >50%), at discharge.  
5.3. Introduction: 
A number of studies and clinical Guidelines have endorsed the use of physiotherapy 
in the management of acute and sub-acute LBP. It is widely recognised that 
systematic reviews of LBP management (CSP Guidelines 2006; Ernst and Canter, 
2006; Murphy, van Teijlingen and Gobbi, 2006; Haldeman and Dagenais, 2008; 
Bronfort et al., 2008) emphasise the need for studies that investigate the effects of 
the various treatment options recommended with LBP patient populations rather than 
normal healthy volunteers. These are important considerations for the treating 
clinician, for patients and for health care policy makers. Despite both clinical 
research and anecdotal evidence supporting patient-reported benefits of 
physiotherapy treatment (van Tulder, Koes and Boulter, 1997; Foster et al., 1999; 
Sparkes, 2005), the biological/ neurophysiological mechanisms underlying the 
effects of treatment modalities, particularly within patient populations, remain 
unknown and there are currently no published studies, using LBP patient 
populations, exploring the neurophysiological responses to guideline-endorsed 
physiotherapy management. Although this does not negate the clinical effects of 
physiotherapy, it hinders acceptance by the wider scientific and Health Care 
communities and impedes the development of rational strategies for improving the 
delivery and the accuracy of provision of therapy and has implications for effective 
resource management. It is recognised (Pengel et al., 2003) that most patients‘ 
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symptoms improve within the first month from inception however up to 84% have 
continued pain and recurrent episodes requiring further intervention, usually in the 
form of manual or exercise therapies, which has become a key feature of the 
guidelines for the management of LBP. In the Clinical Standards Advisory Group 
(1994) guidelines, manipulation was recommended where symptoms lasted for more 
than a few days and for patients who needed additional help with pain relief or who 
were failing to return to normal activities.  These proposals have some support from 
the CSP guidelines (2006 pt 2) and the NICE guidelines (2009) and a number of 
studies (Hadler, Curtis and Gillings, 1987; Goodsell, Lee and Latimer, 2000; UK 
BEAM, 2004 and Konstantinou et al., 2007) who have demonstrated clear patient-
reported benefits from manual and manipulative techniques. Despite this, there is 
debate within the literature regarding the magnitude and the clinical significance of 
observed treatment effects (Potter et al., 2005). Nonetheless, currently the outcomes 
reported in clinical studies are indirect, subjective measures of patient-reported 
benefits and are worthy of further substantiation with empirical, neurophysiological 
data comparisons.  
Although the clinician can currently assess the responses and effects of the treatment/s 
that they have prescribed utilising PROM‘s of functionality and pain intensities, to date, 
there is no means of determining (or measuring) the physiological effects of the array of 
therapies (especially the MT‘s) that they have at their disposal, nor can they accurately, 
quantitatively and non-invasively measure the proposed effects on the key target 
tissues. Currently used PROM‘s are considered valuable and valid measures, at 
discharge, of comparing the extent of changes that the patients report in their functional 
capacity and their pain experience, however they provide no predictive capacity, at 
inception, to the patients‘ outcome at discharge.  
166 
 
Several researchers (Petersen, Vicenzino and Wright, 1993; Vicenzino, Collins and 
Wright, 1994 & 1996; Slater and Wright, 1995; Vicenzino et al., 1995; Wright and 
Vicenzino, 1995; Chiu and Wright, 1996; Vicenzino et al., 1998 & 2001; Sterling, Jull 
and Wright, 2001; Paungmali et al., 2003; Moulson and Watson, 2006 and Jowsey and 
Perry, 2010) have explored the neurophysiological basis of specific physiotherapeutic 
techniques in the cervico-thoracic spine and upper limbs, utilising the sympathetic 
nervous system (SNS) as a measure of neurophysiological response. However, there is 
only a small number of published studies investigating the lumbar spine and lower limbs 
(Perry and Green, 2008; Perry et al., 2010 and Moutzouri, Perry and Billis, 2012), 
indeed, studies involving symptomatic patient populations are very limited, with small 
sample sizes (Slater and Wright, 1995; Vicenzino, Collins and Wright, 1996; Sterling, 
Jull and Wright, 2001; Vicenzino et al., 2001; Paungmali et al., 2003) and only report on 
symptoms in the cervico-thoracic spine and upper limbs and not in the lumbar spine and 
lower limbs. Specific SNS changes have been reported with cervical spine and with 
upper limb MT‘s, namely; sudomotor function (Petersen, Vicenzino and Wright, 1993; 
Vicenzino, Collins and Wright, 1994; Chiu and Wright, 1996; Sterling, Jull and Wright, 
2001) cutaneous vasomotor changes (Petersen, Vicenzino and Wright, 1993) and 
cardiac and respiratory functions (Vicenzino et al., 1998). These results provide 
reinforcement of the concept that the administration of spinal techniques can result in a 
SNS and an associated analgesic response and is worthy of extrapolation within a LBP 
patient population. Further re-enforcement for neurophysiological change measures 
within LBP patient research came from the review, by Wand and O‘Connell (2008) who 
challenged the concept of the existence of clinical sub-groups of LBP patient 
populations and proposed a model that purported that persistent back pain may be a 
problem of cortical reorganisation and degeneration. Whilst Wand and O‘Connell‘s 
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(2008) model was based on evidence within the literature that consisted of chronic, 
persistent LBP rather than acute and sub-acute LBP patients, the authors do 
acknowledge that sensitization of the nociceptive system and enhanced synaptic 
efficiency of nociceptive networks is not unique to chronic pain groups (>12 weeks 
duration), indeed, they recognise that the proposed changes in the periphery, the spinal 
cord (Thompson 2005; p. 379-397 and Apkarian and Scholz 2006) and the brain (Flor 
2003) may start within the initial few weeks of symptom onset (Giesecke et al., 2004). 
Furthermore, Wand and O‘Connell (2008) challenged researchers to develop clinical 
strategies that are targeted at normalising neurological processing, however, they do 
not suggest how these neurophysiological (and cortical) changes and responses might 
be pragmatically measured within clinical settings.   
 
Although early indicators demonstrate the validity and stability of neurophysiological 
measurements (SNS and in particular SC activity changes and SCR‘s) of the responses 
observed with specific treatments, no work has recruited a LBP patient population or 
attempted to correlate observed SCR‘s to other validated patient-reported measures of 
pain - NPRS (Childs, Piva & Fritz, 2005) and function - Roland-Morris Disability 
Questionnaire-RMDQ and the Oswestry Disability Index-ODI  (Roland and Fairbank, 
2000; Schiphorst Preuper et al., 2007).  These PROM‘s are recognised as being helpful 
as general indicators of improvements in symptoms and function (see chapter 2.3), but 
lack the objectivity that neurophysiological measurements may provide. 
 
5.4. Aims, objectives and hypotheses 
5.4.1. Aims of the study 
The aim of this clinical study was to observe and record the currently unknown 
neurophysiological status (SNS) of patients presenting for physiotherapy with acute and 
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sub-acute LBP (of up to 12 weeks duration) and observe any SNS changes (through SC 
activity response recordings) occurring as a result of receiving guideline-endorsed 
physiotherapy treatment (a complex healthcare intervention) at three data capture 
points during their entire programme of care (at inception, at mid-point and at 
discharge). Furthermore, the study aimed to compare within- and between-treatment 
skin conductance activity levels and skin conductance responses (SCR) with currently 
used (within the University Hospitals of Leicester NHS Trust) PROM‘s of pain intensity 
(NPRS) and functional impairment (ODI and RMDQ) and to attempt to evaluate the 
utility of Biopac readings of SCRs as a possible predictor, at inception, of patients‘ 
outcome at discharge (50% improvement in ODI score from inception to discharge – 
Flynn et al., 2002 and Childs et al., 2004) 
5.4.2. Objectives 
The objectives of the clinical study were as follows: 
 
i) To observe and analyse levels of neurophysiological activity and changes 
occurring during and after physiotherapy treatment within patients with 
LBP.  
ii) To understand the relationships between maximum SCR‘s to treatment 
and currently used PROM‘s that measure changes in pain intensity 
(NPRS) and functional disability (ODI and RMDQ).  
iii) To evaluate the utility of SCR‘s as a predictive tool, at inception, as an 
indicator of patient-reported functional outcome at discharge.    
 
5.4.3. Research Questions and Hypotheses for the Clinical Study 
In order to evaluate the utility of the Biopac SNS activity data acquisition system as a 
quantitative measure of neuro-physiological response to physiotherapy treatment of 
acute and sub-acute LBP patients, it was necessary to record SC levels of activity within 
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and throughout the entire treatment programme. In order to manage the vast amount of 
data generated 3 key data capture points were identified (inception, mid-point and at 
discharge) for comparison. Details of the measurements taken are provided in the 
following chapters. 
Research Question One 
―What are the SC activity levels of patients presenting for guideline-endorsed 
physiotherapy management of acute or sub-acute LBP, and do these SC activity levels 
change within and between episodes of treatment at inception, mid-point and at 
discharge?‖ 
 Null Hypothesis One (H0-1a) 
“There will be no differences in SC activity levels in (acute & sub-acute) LBP 
patients within individual physiotherapy treatment sessions.”  
 Null Hypothesis One (H0-1b) 
“There will be no differences in SC activity levels in (acute & sub-acute) LBP 
patients between individual physiotherapy treatment sessions.” 
 
Research Question Two 
―How do maximum SCR‘s to treatment correlate with other currently utilized, patient-
reported indicators of pain intensity and of functional disability at the commencement 
and the termination of the programme of care?‖  
 Null Hypothesis Two (H0-2) 
 
 “There will be no correlation between SCR‟s (during treatment) and reported 
levels of pain intensity (NPRS) and functional disability (ODI) at (and 
between) inception and discharge.” 
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Research Question 3 
―Is it possible to utilize Biopac SC measurements to identify any trends in SCR‘s to 
elements of treatment and as a potential indicator, at inception, of outcome of 
patients function at discharge?‖ 
 Null Hypothesis 3 (H0-3) 
 
“There will be no relationship between SCR‟s following guideline endorsed 
physiotherapy treatment at inception and a positive ODI change score greater 
than 50% at discharge” 
 
5.5. Methodology, Patient Recruitment and Ethical considerations and clearance 
5.5.1. Methodological Approach and the Research Design 
Altman (1991; p.75) acknowledges that research design is arguably the most 
important aspect of the statistical contribution to medicine. Using Altmans (1991; 
p75-99) classifications of research designs the most appropriate approach to 
answering the research objectives within a clinical population was to utilise a 
prospective, longitudinal, observational design. Altman (1991;p.75-76) advises that 
observational studies require the researcher to collect data on the attributes or 
measurements of interest, but does not directly influence or manipulate 
events/variables. This can often be the requirements of clinical studies that seek to 
observe, within a natural (hospital) environment, the influence of a ‗factor‘ (in this 
case guideline-endorsed physiotherapy treatment) upon a vulnerable (patient) 
population where ethical approval for otherwise ―untraditional‖ management 
strategies would be difficult to secure, in particular, interventions that might deny 
patients the full scope of therapeutic care in the absence of unequivocal evidence to 
support one approach above another . The attributes of interest in this arm of the 
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Thesis were SCR‘s to treatment, reports, from the patient, of their pain intensity 
(NPRS) and reports of their functional limitations (ODI and RMDQ) at inception, at 
mid-point and at discharge from the programme of care. The duration of LBP 
symptoms (in weeks), although not the primary or secondary variable of interest, was 
considered a covarible for the final analysis as it is recognised as an important factor 
that can potentially influence outcome at discharge. The primary SNS measurements 
being observed were the SC activity levels and the maximum SCR‘s (% change) that 
occurred within and between treatment episodes and within (SC activity levels & 
SCR‘s) and between (SCR‘s) individuals. The prospective and longitudinal 
components of the study were the extent of changes that occurred, over time, in 
NPRS, ODI, RMDQ and SNS measurements at the three data collection points 
(inception, mid-point and at discharge).    
Observational studies are best used to study factors (or exposures) which cannot be 
controlled by the researchers. In the current study, it would not be possible to 
randomize individuals to have or not to have LBP. Nevertheless, as stated by Gray-
Donals and Kramer (1988; cited by Altman, 1991;p.91), ‗the goal of an observational 
study should be to arrive at the same conclusions that would have been obtained by 
an experimental trial‘. As this was a prospective longitudinal study looking at 
changes that occurred over the course of a programme of physiotherapy treatments, 
a cohort study of a group of LBP patients was recruited. Altman (1991;p.96) 
explained that the benefits of prospective studies are that because of the nature and 
quality of the data recording undertaken, control can be carefully achieved thus 
ensuring internal (and also external) validity. However, it is acknowledged that 
prospective, longitudinal cohort studies are not without limitations. The most 
common (to cohort and other studies) is the selection of participants for the study. 
172 
 
This is particularly so for follow-up studies performed within a clinical setting where 
finding and recruiting participants who meet the strict inclusion and exclusion criteria 
(controlled for in order to minimise extraneous variables and strengthen the studies 
internal validity) can be a lengthy and time-consuming process. In order to minimise 
this component, it was decided that a Hospital (with an Emergency Department and 
a number of Out-Patient Consultant-led Musculoskeletal clinics) local to the 
researcher with a large number of acute and sub-acute referrals would provide the 
required sample population. Additionally, and pragmatically, a hospital where the 
researcher had previously worked (for 7 years) within the clinical setting and was 
familiar with the nature of the referrals, the referring practitioners, the department 
and the IT procedures and the administrative and clinical staff would provide a 
smoother transition into the practical research environment.  
Altman (1991; p.97-98) also advised that another difficulty specifically encountered in 
cohort studies is that some participants will fail to attend for follow-up for the length 
of the study (i.e. they move to other areas or lose interest in gaining treatment). The 
longer the study, the more participants are likely to be lost to follow-up thereby 
weakening any analysis and inferences that may be made thus resulting in bias. In 
order to minimise the effects of loss to follow-up a full and detailed explanation of the 
study (and its requirements) was provided to each potential participant in addition to 
ensuring that timings of treatment follow-ups were discussed and negotiated with the 
patient encouraging engagement in their own recovery goals and treatment plans. 
Treatment programmes were designed to be completed within a 6 week period thus 
limiting the potential influence of external events (e.g. changes in job) or habits (e.g. 
taking up a new hobby/sport) and limiting the effects of natural regression to the 
mean, a potential factor that might influence lengthier studies performed within an 
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acute or sub-acute population. By not using a postal questionnaires but ensuring 
completion of questionnaires (PROM‘s - ODI and RMDQ) on attendance, the issues 
of non-response/return was eliminated. Finally, the conduction of a power calculation 
to determine the optimum population sample size (including loss to follow-up) was 
conducted to limit bias, ensure ethical practice (by not over- or under-recruiting 
patients) and strengthen the internal validity of the study.   
5.5.2. Power Calculation to determine the optimum Sample Size 
As this was both an observational and a feasibility study of a surrogate objective 
marker (skin conductance response - SCR) for change in symptoms reported by 
patients complaining of a multidimensional disease (NSLBP), a power calculation 
was not strictly necessary. However, to meet the requirements of the Ethics 
Committee, a sample size was calculated using data gathered from the preliminary 
study (Chapter 3, Table 14  and Perry and Green 2010) in order to strengthen the 
internal validity of the clinical study and ensure that ethically speaking no patients 
had to receive research procedures (measures of SCR‘s) that they were not 
ordinarily required to do so.  
The number of participants required to calculate a statistically significant difference 
(p<0.05) at 80% power with an effect size of 0.38 (35% mean percentage change in 
SCR as a meaningful SCR difference from baseline for the treatment condition; 
standard deviation 92%) was 57 patient participants (Sim and Wright, 2005). 
Anticipating a drop−out rate of 20% (12-13 patients) it was determined that 70 
patient‘s would be required to account for possible loss to follow-up (Kirby, Gebski 




5.5.3. Ethical Approval Process 
This clinical study formed the final part of a PhD at Coventry University and was 
therefore peer reviewed by the Faculty (of Health & Life Sciences) Ethics Committee, 
the Coventry University Ethics Committee (Registry & Applied Research Dept), the 
NHS Research Ethics Committee (NREC) and the University Hospitals of Leicester 
(UHL NHS Trust) Research and Development Office (details of the submissions and 
approval letters are provided in appendix VII). The programme of study was 
supervised by a Director of Studies (Ann Green) and a Professorial Team based at 
both Coventry University (Professor Sally Singh) and within UHL NHS Trust 
(Professor Paul Watson). The Musculoskeletal Manager at the University Hospitals 
of Leicester NHS Trust (Mr Barry Savage) also reviewed the protocol and gave 
signed permission for the study to be completed within the Unit and on patients 
referred to the service for physiotherapy treatment of LBP.  
5.5.4. Patient recruitment 
 
A purposive, convenience sample was recruited for this study. All patients referred 
for treatment of LBP (as a primary complaint) to the Physiotherapy Department at 
the University Hospitals of Leicester NHS Trust (Leicester Royal Infirmary Site) that 
met the inclusion criteria for the research were considered for participation into the 




Table16: Inclusion and exclusion criteria 
Inclusion Criteria Exclusion Criteria 
 
Patients with an acute presentation of non-
specific LBP ≤ 12 weeks duration 
 
Male and female gender 
 
Age between 18 and 55 years 
 
Possesses an adequate understanding of spoken 
English 
 
Verbal Pain Rating Score of ≥ 2/10 
 
ODI baseline score of ≥ 14% 
 
RMDQ Baseline score of ≥ 4/21 
 
Mechanical provocation of symptoms/pain: 
postures, movement and activities 
 
Sick-listed for more than 12 weeks 
 
Chronic exacerbation of LBP  
 
Existence of concurrent medical disorders or 
psychiatric illnesses that may affect 
neurophysiological readings (e.g. Diabetes, 
anxiety disorders, Multiple Sclerosis, rheumatoid 
arthritis) 
 
Patients with previous lumbar spine surgery or 




Skin disorders at the site of electrode placement 
(e.g. athletes foot, psoriasis,  
eczema, verruca) 
 
Previous history of trauma with resultant 
persistent dysthesia (chronic abnormality of 
sensation which would affect neurophysiological 
readings) 
 
Alcohol dependency and smokers(that could 
affect neurophysiological readings) 
 
Those with precautions and contra−indications to 
physiotherapy treatment  (including exercise 
classes) 
 




Initially, the Therapist (that is, the researcher JP) reviewed all the paper/electronic 
referrals to the department and excluded all unsuitable participants according to the 
information provided by the referrer. All potential participants (n=159) were then 
contacted by the bookings clerk (by telephone) and permission to be contacted by 
the Therapist obtained. If the participant refused (or was uncontactable by 
telephone) at this stage they were given an appointment (in the usual way or, in the 
absence of a contactable number, by postal appointment) with another therapist 
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within the department. If the patient granted permission to be contacted by the 
Therapist (JP) then the Therapist (JP) contacted the participant (n=84) and, subject 
to the criteria being met for inclusion, the Therapist assessed the participants 
willingness to take part in the study, explained the nature of the study and provided 
an appointment for assessment and for the patient to sign the informed consent 
documentation (n=70). In addition to a verbal explanation of the study, participants 
were also sent an information leaflet (see appendix VIII) explaining the nature of the 
study with a written confirmation of their appointment details. This allowed the 
participant adequate time for consideration of the information provided and a cooling 
off period of at least 48 hours prior to assessment and recruitment. The formal face-
to-face recruitment, question and answer session and consent signing session took 
place in a private clinical room within the physiotherapy department. All clinical 
assessments, treatments and data collection procedures were undertaken within the 
clinical treatment area and always within the same cubicle with the same set up for 
each session in order to minimise any environmental variance between sessions. 
5.5.5. History and physical examination  
Patient recruitment, assessment and treatment took place between July 2009 and 
May 2011. For all participants, the initial ―consenting interview‖ allowed them to 
receive appropriate information to questions that they had about the study and its 
implications and also gave the participant the opportunity to discuss any elements of 
the study not clear from the information sheet in the invitation pack sent out with the 
appointment. The initial ―consenting-interview‖ and subjective assessment interview 
also allowed the researcher and the patient to determined their suitability for the 
study and if both were in agreement to continue, the participants were asked to sign 
the carbonated informed consent form (see appendix VIII) for the study (n=60), the 
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consent form was carbonated so that the top copy could be retained by the 
participant, a copy could be placed in the patients medical notes and a copy placed 
within the On-Site research file. Also at this time, a letter was sent to the referring 
clinician to advise them of their patients‘ inclusion into the study (appendix IX).  
At the initial assessment the patients completed a standard physiotherapy examination 
(maximum 45 minutes). The usual subjective assessment was completed (i.e. 
demographic information including, age and gender; social details and occupation 
(including working status; sick leave, restricted duties/phased return, normal work duties, 
does not work). All responses were documented as well as past-medical and drug 
histories. The patients‘ report of the duration and onset of the symptoms, the location, 
behaviour and nature of the symptoms were also recorded. Self-reported measures of 
pain/symptoms and functional limitations and SMART (specific, measurable, achievable, 
realistic and timed) goals were discussed and recorded. Finally, pain intensity (NPRS) 
and the two functional PROMS (ODI and RMDQ) were completed. This was performed 
prior to commencement of the physical examination (in accordance to the Trusts policy). 
Physical examination (see appendix X for a summary of patient findings) measures 
included lumbar active range of motion (Waddell et al., 1992), lumbopelvic assessment 
(Freburger and Riddle, 2001), neurological examination (of conductance [reflexes, 
myotomes and dermatomes +/- the Babinski test] and dynamics [straight leg raise test or 
femoral nerve neurodynamic test +/- the slump test]  – Shacklock, 2005) and palpation of 
lumbar segmental motion (Maitland et al., 2005 and Petty 2011). 
All participants included in the study were assessed to have a mechanical, nociceptive 
(+/- peripherally evoked neurogenic symptoms) presentation with restriction of one or 
more lumbopelvic movements and one or more hypomobile lumbar segments on 
palpation. On completion of the interview and physical examination, commencement of 
178 
 
the non-invasive recordings of their SC activity levels was undertaken. These were 
performed whilst the patient relaxed in a comfortable position on the treatment plinth 
(maximum 10 minutes). Physiological recordings of SC were continuously measured, 
without interruption, throughout the entire treatment period (up to 45 minutes depending 
on the nature of the program of treatment provided) by a Biopac GSR100B Electro-
dermal Activity Amplifier (MP35; Biopac Systems Inc; Santa Barbara, CA), employing a 
constant voltage technique and sampling the absolute, direct current SC at the rate of 
200 samples per second. Participants were informed (prior to attending their 
appointments) that they were required to avoid certain behaviours such as consuming 
stimulants (e.g. drinks with caffeine and nicotine products – Thomas, 2002), to avoid 
heavy exercise for about four hours prior to the appointment (Koltyn, 2000) and alcohol 
(Vicenzino et al., 1995) and to not eat within the hour of attending for treatment (Chiu and 
Wright, 1996). These factors are known to influence SNS measurements if not adhered 
to therefore participant compliance with these prohibitions was monitored by way of a 
series of screening questions prior to each session. All participants were adherent to the 
protocol. In accordance with the previous two studies, care was taken not to allow the 
patients to fall asleep, cough, sneeze, deep breath, or talk during baseline measurement 
recording.  
All examinations were conducted by the Therapist (JP) who also discussed the 
findings and treatment options with the participant. All treatments were prescribed in 
accordance with the guideline-endorsed recommendations and administered by the 
Therapist. The participants‘ right to withdraw at any stage was observed throughout 
their treatments.   
All patient data was anonymised and only minimal data kept on record (ID number, 
age, gender, symptom type, onset, behaviour and distribution, NPRS, ODI and 
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RMDQ Scores and dates of attendance). This data was kept in a study file that was 
locked and kept secure within the Hospital Department. All electronic (SNS) data 
recorded from the Biopac equipment was anonymised and stored in an encrypted 
computer file stored in the same locked cabinet. 
5.5.6. Patient information and consenting procedures and details of the treating therapist. 
Informed consent of the participant was ensured in a number of ways; by provision of 
an information sheet (appendix VIII) explaining the nature of the study, any potential 
risks, benefits and burdens to taking part as well as their role within the study at least 
48  hours prior to initial assessment as well as  written consent (see appendix VIII); 
by reviewing the nature and purpose of the study at the initial assessment and 
allowing the participant the opportunity to ask questions about the study and their 
role within it; by reminding the participants that they may withdraw from the study at 
any time and without prejudice to ongoing physiotherapy treatment.  
The Therapist is an experienced musculoskeletal physiotherapist (24 years) and a 
member of the Chartered Society of Physiotherapy (CSP), the Health Care 
Professions Council (HCPC) and the Musculoskeletal Association of Chartered 
Physiotherapists (MACP). For pragmatic reasons, the Therapist recruited, 
consented, assessed and treated the participants. In order to limit bias that might 
occur in the recruitment, assessment and treatment process it was decided that a 
single therapist be used rather than multiple therapists. Furthermore, because there 
was only one Biopac system available, it was not possible to undertake 
multiple/simultaneous treatments nor was it practicable to train the staff to set up the 
equipment and record readings on the password protected laptop that had the 
Biopac analysis software installed. Additionally, the nature of electronic appointment 
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times and booking system within the department did not permit the clinical staff to 
extend assessment and treatment times by the additional 20 minutes required to 
collect the baseline and final rest period SC activity levels so, for pragmatic reasons, 
the Therapist booked and conducted all data collection requirements. An additional 
advantage with this approach is that it was also possible to provide treatment times 
that better suited the patients and have appointment times, each week, that were at 
the same diurnal times thereby limiting measurement variations and enhancing 
patient compliance and reducing drop-out rates. Whilst all data collection was 
performed by the Therapist, the Therapist remained blind to the responses occurring 
during data collection. The data analysis was only conducted after all participants 
had finished the study thereby minimising any bias to the analysis procedure and 
ensuring ethical practice was adhered to. Additionally, the Therapist had also 
undertaken two nationally recognised GCP (Good Clinical Practice) courses at the 
Leicester General Hospital and had received GCP certification for training in ethical 
consent taking for researchers (see Appendix XI – Good Clinical Practice 
Certificates) and was considered to have a good understanding of the ethical 
principles underpinning informed consent within a patient population. This study did 
not involve vulnerable subjects and excluded participants who were unable to 
represent their own interests and therefore the study did not pose a risk to this 
population. 
5.5.7. Potential risks, burdens and benefits to patients 
No serious ethical issues were anticipated or encountered as a result of this study as 
patient‘s treatment and management choices did not differ to 'normal' treatment as a 
result of taking part in the study. The only burden to the patient was the additional 
10-15 minutes required (to their treatment time) in order to gather the required 
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neurophysiological data for the study. The neurophysiological measurements taken 
did not cause any change in symptoms nor was there any risk of it causing 
psychological distress to participants as the electrodes comprised of non-invasive 
surface sensors that were secured with a Velcro strap to the glabrous (hairless) skin 
over the second and third toes of each foot. Participants did not experience any 
discomfort from any of the measurement procedures nor the treatments undertaken, 
except for very minimal discomfort as a result of some of the manual treatments 
employed (e.g. exercise or joint mobilisations). Testing would have been terminated 
immediately upon the participants request or if they had expressed any undue 
discomfort, fatigue or if any abnormal responses to the treatment/s had occurred. 
This did not happen and all data was recorded according to the protocol described. 
Participants who consented to take part in the study did not benefit directly from 
inclusion in the study but they understood that their inclusion could enhance clinical 
understanding of the place of physiotherapy treatment in the management of low 
back pain and participants also had the opportunity to learn about the effects of their 
treatment programme on their functional, neurophysiological and pain status at the 
end of the study.  
Figure 22 illustrates the recruitment processes undertaken by the administrative staff 





Referral received in Physio Out-Patients 
Department at LRI. 
Initial screening of inclusion/exclusion criteria 
available on referral card. Participant considered 
potentially suitable at this stage? (n=159) 
Yes (n=93) No (n=66) 
Patient contacted by bookings 
clerk and permission to be 
contacted by CI requested 
Consent granted to be 
contacted by CI (n=84) 
Consent denied (n=9) 
 
CI advises potential 
participant of nature of study 
& determines willingness to 
attend for initial assessment. 
Patient contacted 
by bookings clerk 
in the usual 
manner & a routine 
appointment for 
assessment made 
with a Dept Physio 
Patient attends for 






Willing to consider 
participating and to attend 
for assessment with CI 
(n=70) 
Participant attends for 
initial assessment with CI 
Suitable & 
Consenting (n=60) 
Unsuitable or not 
consenting (n=10) 




Dept Therapist Baseline measures taken & 
routine treatment provided 
n=60 
Routine treatment completed 
& final measures taken 
(n=59, 1 drop-out) Discharged from Department 
with summary of treatment 
outcome to referring clinician 





















5.6. Assessment and Treatment Protocols 
5.6.1. Initial assessment (inception) 
Following the initial assessment and consenting procedures, and in accordance with 
current departmental policies, patients had the opportunity to discuss the findings of their 
assessment and the proposed, guideline-endorsed treatment options, which, although 
tailored to the patients specific requirements, consisted of techniques to address the 
primary and secondary physical dysfunctions found on the assessment. The choice of 
technique, and its application, was determined according to the severity, irritability and 
the nature (SIN) of the presentation. Regarding the nature of the condition, a structural 
(patho-anatomical) hypothesis was generated to assist the reasoning for treatment 
selection (i.e. arthrogenic/facet joint; discogenic; neurogenic; myogenic and combinations 
thereof). A summary of the primary complaints of the patients attending for initial 
assessment is provided in Table 17 below. 
Table 17: Summary of patient examination findings: primary & secondary complaints  
Primary Physical Complaint Total Number of 
Patients 




Localised lumbar facet joint dysfunction 31 35 
Discogenic dysfunction 24 33 
Neurodynamic dysfunction 5 26 
Limited internal Hip ROM > 35°  0 5 
Functional Core Instability/Muscle 
Weakness 
0 48 
Global/Aeorobic weakness 0 6 
Total 60 153 
 
Treatments were prescribed according to the assessed primary complaint and consisted 
of combinations of techniques designed to improve the mobility of hypomobile segments 
(including joint mobilisation techniques – accessory and physiological; the rotatory 
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manipulation technique [as per chapter 5]; a MWM technique and/or the repeated 
McKenzie EIL technique [seen earlier] or soft-tissue techniques [including trigger-point 
release, Swedish Massage or neurodynamic techniques – sliding or gliding techniques]), 
local and/or global exercise techniques to strengthen core musculature and enhance 
aerobic fitness (NICE, 2009). In addition to specific manual and exercise techniques, 
advice and education regarding the nature of LBP, and on pacing of activities, of return to 
work and to hobbies were also provided. 
Treatment began on their initial attendance. SC electrodes were attached to the toes in 
accordance to the protocol, outlined in the previous chapters, and left in place throughout 
the entire treatment time and for the 10 minutes post-treatment rest period. An attempt 
was made to schedule each subsequent visit at similar times of the day as the initial 
assessment in order to control the influence of any diurnal variation on the SCR. On each 
visit, patients had their NPRS, SC activity levels and SCR‘s recorded whilst undergoing 
the physiotherapy treatments as per the assessment findings and by the guideline-
endorsed treatment recommendations with appropriate modifications to the programme 
made in accordance to the progression of their condition (follow-up sessions took no 
more than 40 minutes). It was considered important that treatments were guideline-
endorsed and tailored to the presenting needs of the patient on each of their visits 
utilising manual therapy techniques (see below) over electrotherapy techniques as the 
NICE (2009) and CSP (2006) guidelines for the treatment of LBP, in this patient sub-
group, do not endorse electrotherapy modalities (e.g. Interferential therapy- IFT, 
Transcutaneous Electrical Nerve Stimulation - TENS, Ultrasound - US etc).  
The manual techniques employed consisted of segmental facet joint mobilisations (Perry 
and Green, 2008), the lumbar rotatory (HVLAT) manipulative technique (chapter 5 and 
Perry et al, 2011), the repeated McKenzie EIL technique (Chapter 5 and Perry et al., 
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2011), the MWM flexion/extension technique (3 sets of 10 repetitions, Moutzouri, Perry 
and Billis, 2012) and Swedish massage and trigger-point release (for 15 minutes) to the 
thoraco-lumbar region. Treatments were all performed by the Therapist and given in 
accordance to the decisions made on the day between the therapist and the patient. Not 
all treatments were required and classifications of the treatments offered are provided in 
table 18 below, with their intended purpose and desired outcome suggested. 
 Table 18: Classifications of the manual therapy (MT) techniques used on patients. 
 
MT technique  Definition  Desired Outcomes 
 
Joint biased 
 i) Manipulation 
 
 
 ii) Mobilization 
 
Passive movement of a joint beyond the normal 
range of motion 
 
Passive movement of a joint within its normal 
range of motion 
 
Improved range of motion 
  




Soft tissue biased 
 i) Swedish 
massage 
 
ii) Deep tissue   
     massage 
 
 iii)Trigger point  
 
Stroking and kneading of the skin and 
underlying soft tissue  
 
Deep stroking and pressure across the muscles 
and soft tissue 
 
Deep pressure to areas of local tenderness 
Improve circulation 
Decrease muscle spasm 
Relaxation 
Re-align soft tissue 
Break adhesions 
Increase range of motion 
Release muscle spasm 
Remove cellular exudates 
Nerve biased 
 i) Neural 
dynamics 
 
Passive, combined movement of the spine and 
extremities, within their normal range of motion, 
in ways to elongate or tension specific nerves. 
 
Improve range of motion 
Decrease pain 
Combined Joint & 
Soft Tissue 
i)  MWM (NAGS &  
    SNAGS) 
ii) McKenzie EIL (with   
    overpressure) 
 
 
Glide techniques to the spine, performed whilst 
the patient actively moves 
Sustained passive movement of a segment 
whilst the patient uses arms to achieve lumbar 
extension.   
 
 
Improved range of motion 
Improved motor control of 
movement 
Decrease pain 
Restore disc alignment 
Adapted from Bialosky et al. (2009) to provide a classification of the MT techniques utilised in the clinical study along 
with specific examples of each.  
 
 
In essence, patients presenting with a hypomobile segment/s received the 
manipulative, MWM and/or McKenzie EIL techniques as a primary management 
strategy, massage and/or myofascial trigger point release techniques were provided, 
as needed, for management of any soft-tissue/myogenic symptoms either in 
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combination with the above techniques or not. As indicated above, all patients 
received standard, guideline-endorsed advice and education to keep active and 
return to work in addition to a standardised exercise program to strengthen the core, 
maintain spinal and lower limb range and flexibility and to improve cardiovascular 
fitness.   
For the MWM treatment, the technique described by Mulligan (2004, p.44) was used 
(see figure 24 below). A Mulligan belt was placed on the anterior waist of the patient, 
below the anterior superior iliac spines (Mulligan 2004: 44) with the belt hanging 
open on the posterior aspect. When necessary, a towel was inserted between the 
belt and the patients‘ waist to avoid any undue pressure caused by the technique.  











In order to conduct the treatment the therapist stood posterior to the patient and put 
on the Mulligan belt below her own waist, applying a tension. Meanwhile, the patient 
was requested to remain stationary. The belt was useful in providing a counterforce 
This item has been removed for data protection reasons. The unabridged version of the 
thesis may be viewed at the Lanchester Library, Coventry University.
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for the application of the technique, and stabilising the patients position during the 
active lumbar flexion movement. Finally, the MWM (Sustained Natural Apophyseal 
Glide – SNAG – technique) was applied for 3 sets of 10 repetitions. 
 
SNAGs involved the application of a sustained accessory glide on the lumbar spine, 
along with the patient performing lumbar flexion (Exelby 2001; Mulligan 2004: 44). 
The direction of flexion was selected, as restriction of flexion range of movement was 
a common presentation in patients with LBP, in clinical practice (Sullivan, Shoaf and 
Riddle, 2000) and was also the case with the patients within this study (with any 
extension deficit being addressed by the McKenzie EIL technique). Considering 
individual variances, patients were requested to utilise their full, available, pain-free 
lumbar flexion range while performing forward flexion. The glide was applied with 
either the thumb pads of both hands, or the ulnar border of the therapists right hand 
while the left hand was placed on the treatment table for support (Mulligan 2004: 44). 
The researcher stood posteriorly in a long‐standing stride, close to the treatment 
table. The glide was applied centrally at the lowest point of the (superior) spinous 
process of the segment that was assessed to be hypomobile (Mulligan, 2004; p.15), 
and was not released until the desired number of repetitions of the SNAG (10 
repetitions) had been performed. A central technique was employed since 
Konstantinou et al. (2002) reported that centrally applied SNAG‘s were most 
commonly utilized in clinical practice. The amount of force applied with the active 
movement was that determined, by the therapist, to be required to overcome joint 
resistance but remain pain free. Wilson (2001) recommends that application of force 





5.6.2. Mid-point and discharge assessment and treatment 
During the subjective element of each/all reassessment/s, repeat ODI and RMDQ 
questionnaires were completed by the patient as well as an evaluation and 
documentation of the patients presenting NPRS status. After completion of the 
programme of treatment (i.e. following discharge from therapy) a retrospective 
calculation of the mid-point of the programme of care was established. For example, 
if the patient attended for 5 treatments, then the median treatment episode (number 
3) was identified as the mid-point data capture point. In cases where the mid-point 
fell between sessions (i.e. total number of treatments = 6) then the mean treatment 
episode way selected (i.e. 3rd treatment episode). As with the initial treatment 
episode, patients completed the questionnaires prior to commencement of SC data 
collection and their subsequent treatment session. The ‗half-way‘ point  data was 
completed by 59 participants (one drop-out was incurred due to geographical 
relocation with their work). By conducting this mid-way assessment it was hoped that 
a comprehensive picture of the changes in SC activity levels and SCR‘s would be 
gained.   
As with the protocol employed in all the previous treatment episodes (and according 
to Departmental policy), the patients final attendance for treatment (n=59) consisted 
of reassessment of clinical findings (e.g. lumbar ROM, neural conductivity and 
neurodynamic measurements, segmental mobility assessment and hip ROM), 
documentation of current pain intensities (NPRS) and functional disability levels (ODI 
& RMDQ). These were conducted prior to the recordings of SC activity levels and 
SCR‘s. Details of the participants scores at discharge are provided in appendix X 
with data summarising the SC activity levels (at baseline, during treatment and in the 
final rest periods) and SCR‘s detailed for each participant, in appendix XII. Most 
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programmes of treatment took between 3-5 treatments (maximum number 8) and 
were in accordance with the normal Trust protocol. Patients were discharged once 
their reported intensity of pain was intermittent and ≤1 on NPRS, they had 
restoration of full, pain-free range of lumbar motion or it was discontinued at the 
patients request as they had achieved their own personal goals (e.g. return to work).  
For all patients in the study, their referring physician was advised of their patients‘ 
completion of the study and the outcome of treatment at discharge. 
5.7. Data collection and analysis procedures 
Of the 60 patients recruited at inception, 59 completed the study (see consort 
diagram, figure 25) and their data was analysed using the SPSS (Statictical Package 
for Social Scientists version 17) and latterly the PASW (Predictive Analysis Soft 
Ware) statistical package (version 20). Additionally, MedCalc (version 11.6.1.0 
medcalc software company, Belgium) was used for the ROC Curve analyses. 
 
The indicator of SNS response that was used in this study, as in the previous study 
and those of other researchers (Vicenzino et al., 1998; Paungmali et al., 2003; Perry 
and Green, 2008, Perry et al., 2010), was the integral value (see appendix V) of the 
skin conductance (SC) measures. This is calculated, at source within the Biopac 
software, and was the primary outcome measure in the study. Skin conductance is 
classified as continuous data at ratio level and is measured in microMho‘s (μMho or 
μ℧). For each of the episodes of care that participants attended, three SC activity 
level measurements were collected from the continuous SC readings obtained; 
Baseline, During Treatment and Final Rest periods. For the baseline measurement, 
the final 1 minute of the 10 minute pre-treatment rest period was observed and 
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recorded. For the ―During Treatment‖ period, the maximum response was located 
(both visually and by employing the time-to maximum [t-max] feature on the Biopac 
screen) and a 1 minute period of time, that captured the maximum response, was 
also recorded (as well as documenting, retrospectively) the nature of the treatment 
being undertaken at that point in time (additional data analysis methods utilised in the 
patient & asymptomatic group comparisons are detailed in Appendix XIII). For the 
―Final Rest ― period, the last 1 minute of their 10 minute post-treatment rest period 
was recorded. A typical data chart from the Biopac unit is displayed in Figure 24 
overleaf displaying data gathered from a participant during the initial episode of 
treatment (at inception). 
 
Readings were obtained, simultaneously, from both the right and the left limbs for all 
3 periods within each of the treatment episodes at each data capture point (inception, 
mid-point and discharge). For each data capture point within (baseline, during 
treatment and final rest period) and between (inception, mid-point and discharge) 
each episode of treatment, the results from both limbs were pooled using the 
following calculation:- 
 
Pooled SC Activity Level =  Left leg SC Activity level + Right leg SC Activity level 






Figure 24: Schemata of Biopac Data recording from a participant indicating the 1 
minute data capture points within a single episode of care (baseline, during treatment and 
final rest periods – in pink). 




This raw data was defined ―SC Activity level‖. In some instances it was necessary to 
normalise the baseline for between-participant comparisons. In this case the 
calculation depicted in chapter 4 (sub chapter 4.3.6. page 150) was utilised to 
determine the percentage change of SC activity levels between two time periods. 
This data was termed the skin conductance response (SCR) and was expressed as 
a percentage (%) i.e. the percentage change in SC activity from one point in time 
(e.g. Baseline) to the new point in time (e.g. during treatment). Therefore the 
maximum effect indicator could be expressed as either the SC activity level or as 
SCR (% change) depending upon whether the focus of the question was within- or 
between-participant or event. 
Segment 1, 10:11:31 eil, 10:18:05 10:26:38 10:31:25 





































































Of the secondary outcome measures (ODI, RMDQ and NPRS), ODI is a 0-100% 
scale with an absolute zero value and was therefore considered (and has previously, 
be considered in published articles) to be of ratio level therefore permitting a 
parametric analytical approach (presuming that all assumptions, for parametric 
testing, are met). RMDQ is measured on a 0-24 item scale and, for the requirements 
of statistical analysis, was considered (and has previously been treated in published 
papers as), ordinal level data and therefore subject to non-parametric statistical 
analytical approaches. Regarding the NPRS, the decision was made to consider this 
0-10 scale as ordinal level data. Whilst some authors consider pain to be of 
interval/ratio level data, it was decided that this would only be true for within-
participant comparisons but not between-participant comparisons (one patients‘ pain 
may not necessarily equate to, or with, another individual). Also the narrow breadth 
of the measure meant that detailed comparative analyses may lead to type I 
(erroneous rejection of the null hypothesis) or Type II errors (erroneous failure to 
reject the null hypothesis) (Chou and Pong cited in Lu and Fang, 2003;p.446). In 
order to permit comparison for (some) correlation analyses ODI and NPRS change 
scores (e.g. change in score for ODI or NPRS from baseline to discharge) were 
converted into percentage change from the original value utilising the calculation 
detailed above for SCR. This also permitted comparisons of data to other published 
papers that have documented change scores for these measures (e.g. Childs et al, 
2004). 
Descriptive analysis of all data (including age, gender, symptom duration and 
number of treatments to discharge) was conducted using calculations of frequency, 
central tendency (number, sum, mean or median difference, with data on minimum, 
maximum and range), standard deviation, standardised error and confidence 
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intervals and displayed using tables and charts (simple and clustered box-plots, line 
graphs of means and simple or matrix scatter graphs) to highlight any differences, 
relationships or trends in observations. Prior to inferential testing of hypotheses 1a, 
1b and 2, data distributions were checked for normality (Skewness & Kurtosis) 
furthermore, all statistical analyses were independently checked and verified by Dr 
Tim Sparkes (statistician in the Mathematics and Statistics Department at Coventry 
University). 
In order to test the null hypotheses, inferential statistical analyses, exploring the 
differences and the distribution of variables were performed and included: 
(independent and paired) 2-way ANOVA; Pearsons Correlation (SCR and ODI data) 
or Spearman rank correlation co-efficient (RMDQ where used and NPRS data) with 
predictive values being calculated with ROC curves (receiver operator characteristics 
curves) and direct logistic regression analyses with the final models including 
significant variables. Where necessary, detailed considerations and justifications for 
specific tests have been included within the results sections for clarity. All p values 





5.8. Results of the clinical study. 
This section details the descriptive and inferential statistical analyses performed on the 
clinical data collected on patients referred to the University Hospitals of Leicester NHS 
Trust (UHL NHS Trust) from local Primary Care Trusts (PCT‘s) and Hospital 
Consultants. The primary outcome variables included Skin Conductance (SC) activity 
levels and SC responses (SCR‘s - %). The secondary OM‘s included the Narrative 
Pain Rating Scale (NPRS), the Oswestry Disability Index (ODI) and the Roland Morris 
Disability Questionnaire (RMDQ).  
 
5.8.1. Summary of preliminary comparisons of patient and normal participants 
 
Prior to the main analysis of the patient data, a between-group comparison was 
conducted to determine the homogeneity of a random selection (using a random 
numbers table generated by n-query software package) from a sample of the 
patient/clinical participants (n=50) to a previously published (Perry et al., 2011) 
‗normal‘ asymptomatic (experimental) population (n=50, detailed in the previous 
chapter). This was conducted in order to determine if the baseline data from the two 
populations were homogenous thereby endorsing the validity of the planned statistical 
analysis conducted on the findings of the patient population. Details of the sampling 
procedures and the analyses are provided in appendix XIII. Results indicated 
homogeneity of baseline findings between the normal healthy participants and the 
symptomatic patient population. Further analysis, conducted to investigate any 
differences in SCRs between the patient and the asymptomatic groups revealed that 
the patient groups responded with significantly greater magnitude of effect (over two-
fold) to both treatments (manipulation technique SCR‘s > 200%, McKenzie EIL 
exercises SCR‘s >104%) than the asymptomatic population (manipulation SCR‘s 
>76%, McKenzie EIL exercises SCR‘s >35%) and, similar to the pre-clinical findings 
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on the asymptomatic population (chapter 4, Perry et al,., 2011) that the manipulation 
treatment provided the greatest magnitude of response (almost two-fold) when 
compared to the McKenzie intervention; where ―group‖ (patients versus normal‘s) was 
the factor, F=9.618, p=0.003 and where the treatment intervention (manipulation 
versus EIL) was the factor, F=12.410, p=0.001. These results indicated that although 
there was comparative homogeneity of the groups (at baseline) with comparable, 
sympathoexcitatory responses (and magnitudes of response within each group) to the 
two treatments, the patient group had significantly greater overall responses to 
therapeutic interventions than the asymptomatic groups.  
 
5.8.2. Main Analysis of Patient data 
The following, main, analyses featured the observations taken, with the Biopac 
system, of SC activity levels (raw data at baseline, during treatment and in the final 
rest periods) and maximum treatment responses (SCRs – percentage change values) 
for the patient group only. The first analysis details the Biopac readings obtained, 
longitudinally, detailing within- and between- session analyses, at the three key data 
capture points (inception, mid-point and at discharge)  and identifying the patients‘ SC 
activity levels at baseline, during treatment and in the final rest periods.  
 
Further analysis of the results of the Biopac system, with a LBP patient population, 
examined any correlations between SCR‘s and the secondary outcome measures, 
namely, the standardized patient-reported outcome measures (NPRS, ODI and RMDQ).  
The final analysis, explored and analysed the emergent trends in the data and 
evaluated the feasibility of using the Biopac system (SCR‘s), at initial assessment, as 




5.8.3. Characteristics of the patient group at initial appointment (inception) 
 
5.8.3.1. Demographic and anthropometric data analysis  
 
The Consort Diagram (figure 25) details the recruitment of participants into the 
patient study. Of the 84 patients who were telephone-contacted, 70 agreed to attend 
for initial assessment. Of the 70 who attended the department for interview to 
consider the study, 60 consented to take part or met the inclusion criteria and were 
eligible for entry into the study. These 60 consented participants went on to receive 
the standard physiotherapy assessment (detailed earlier). Of the 60 who entered the 
study, 59 completed all elements of the study and formed the basis of the completed 
analysis (one drop-out was recorded who moved geographical locations, during their 
treatment, due to work).  
 
Figure 25: A Consort Diagram Illustrating the recruitment of patients 
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a) Diabetic = 1 
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g) Red Flags requiring 
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elsewhere = 2 
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wish to take 





Table 19 details the demographic characteristics of the patient group with Table 20 
provide a summary of the key examination findings (details for each individual 
participant [age, gender, Quebec Task Force Classification, work status, ODI, 
RMDQ, NPRS scores and primary physical findings] are provided in Appendix X). 
Appendix XII provides details of the SC readings for baseline, treatment and final rest 
periods for the three data capture points (inception, mid-point and discharge). Sixty 
patients were assessed at inception with 59 patients completing their course of 
treatment and providing data (at mid-point and discharge) for all within- and between-
session analyses. Table 19 summarises the key findings at inception. The mean age 
was 39 years with 25 males and 35 females. The mean symptom duration at 
assessment was 7 weeks. For the primary outcome measure of maximum SCR the 
mean change of 219.4% was recorded. For the secondary outcome measures, 
functional disability and pain intensity levels mean ODI‘s were 43%, with RMDQ‘s 
being 12 (out of a possible score of 24; median= 11) with pain intensity means 
(NRPS) recorded as 7.5 (out of 10; median = 8). Lastly, 25/60 (42%) were unable to 
work due to their symptoms with 77% (46/60) having symptoms radiating into the 
lower limb. Lumbar flexion ROM was restricted for 87% of the participants with 58% 
presenting with limitation of lumbar extension and 70% with restricted side flexion. 
Despite 43% of participants having limitation in neurodynamic mobility tests, only 8% 
had positive neurological (conduction) findings. All patients had one or more 





Table 19: Summary of the key patient OM data at inception 
 
n= 60 Mean (SD) Minimum Maximum Standard 
error 
Age (yrs)  
 
39.75 (8.32) 21 54 1.07 
Symptom Duration (Weeks) 
 
7.03 (3.62) 1 12 0.47 











42.93 (17.82) 16 86 2.30 
RMDQ 
 
12.68 (4.70) 4 22 0.64 
Pain 
Intensity 
NPRS 7.50 (1.36) 3 10 0.17 
 
 
Table 20: A summary of the key clinical findings at inception 
 




















n 35 25 14 22 19 5 52 35 42 9 26 
% 58 42 23 37 32 8 87 58 70 15 43 
 
5.8.3.2. Research question 1 (H0-1a &b) Observed SC Readings within and between 
treatment sessions 
 
Table 21 summarizes the SC activity levels recorded within the treatment episodes 
(baseline, during treatment and in the final rest period) and between each of the three 




Table 21: Illustrating the characteristics and the SC activity levels (In μmho‘s) and 
percentage change (PC) from baseline levels within and between treatments  
SC activity levels (in μmho’s) 


















34.1 47.9 49.2 
15 to 156 13 to 224 15 to 199 
73 to 91 85 to 110 87 to 113 
Treatment Period   










85.0 83.2 66.4 
106 to 437 55 to 397 30 to 316 
208 to 253 195 to 238 154 to 178 
Final Rest Period    










54.9 78.3 70.4 
34 to 259 41 to 389 28 to 297 
125 to 154 142 to 182 125 to 162 
 
Descriptive analyses (of H01) included means, standard deviations, range and 
confidence interval analyses. Findings revealed that within each of the episodes of 
treatment (baseline, during treatment and final rest) there was a change in SC activity 
levels with an observable increase in levels (sympathoexcitation) in the ―during 
treatment‖ period (from the ―baseline‖ period) that was maintained (but not fully 
sustained) into the final rest period. This was the case at each of the three data 
capture points; inception, mid-point and discharge. Furthermore, whilst baseline SC 
activity levels across the three data capture points increased (from inception to mid-
point and to discharge), this was not the case for the ‗during treatment‘ SC activity 
levels whose responses, although still sympathoexcitatory, diminished as the 
programme of therapy progressed to discharge (also indicated with comparisons 
between the SCR data). The final rest period SC activity levels were observed to 
remain relatively consistent from inception to mid-point and on to discharge. These 
trends are illustrated in figure 26 and later in Figure 27. 
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Figure 26: Boxplot illustrating the change in SC levels (in Micro Mho‘s) at the three data 
capture points (Inception, Mid-Point and Discharge) within each episode of treatment 
(Baseline, Treatment and  Final Rest Periods).(where * indicates an extreme case). 
 
A summary of the inferential statistical analyses of null hypotheses 1 a and b (H01 a 
and b) are presented in tables 22 and 23 respectively.  
Table 22: Two-way Uni-variate ANOVA of SC activity levels (Baseline, Treatment and 




(Factors:- Participant & 
Treatment time period) 





F value  
 
p value 
Inception 150.8  
(CI 144 to 158) 
59 3.162 <0.0005 
Midpoint 158.9 
(CI 154 to 164) 
58 10.978 <0.0005 
Discharge 138.6 
(CI 134 to 143) 
58 9.740 <0.0005 




























For H01a (no differences in SC activity levels within individual treatment sessions and 
between participants) a uni-variate 2-way ANOVA (general linear model) was used with 
the SC activity levels (in micro-mho‘s) as the dependent variable and the two factors 
being; the participant and the treatment time period (baseline, treatment and final rest 
periods). This analysis indicated that within each individual participant there were 
statistically significant differences in SC activity levels between the different phases of the 
treatment episode (baseline, treatment and final rest period) and that these differences 
were significant at each data capture point (inception, mid-point and at discharge). 
Furthermore, post hoc analysis using Tukeys HSD (honestly significant difference) 
revealed that the differences were significant (p < 0.0005) between all three treatment 
periods (see appendix XIV for further details) indicating that between baseline and final 
rest, treatment and final rest, and baseline and final rest periods there was a significant 
change in SC activity levels at each of the data capture points throughout the programme 
of care. Consequently, Null hypothesis H01a was rejected as there is evidence to 
suggest that a difference in SC activity levels exists within individual physiotherapy 
treatment sessions in an acute and sub-acute LBP population.  
To test null hypothesis H01b (no difference in SC activity levels between data capture 
points – inception, mid-point and discharge – within the baseline, treatment and final 
rest periods), a uni-variate 2-way ANOVA (general linear model) was used with the SC 
activity levels (at baseline, during treatment and in the final rest period) as the 
dependent variable and the two factors being; the participant and the data capture point 
(inception, mid-point and discharge). A summary of the findings are presented in figure 





Figure 27: Line graph charting the SC activity levels (means) within each treatment 
session at the three different data capture points (inception, mid-point and discharge) 
(with Error Bars: 95% CI‘s). 
 
Table 23: Two-way Uni-variate ANOVA of SC activity levels between participants and the 
three data capture points (inception, mid-point and discharge) at the three treatment time 
periods (Baseline, Treatment and Final Periods)  
 
2-way ANOVA 
(Factors:- Participant & 
Data Capture Point) 






F value  
 
p value 
Baseline Periods (mean) 93  
(CI 89 to 97) 
2 7.503 0.001 * 
Treatment Periods (mean) 207 
(CI 198 to 216) 
2  14.722 <0.0005 * 
Final Rest periods (mean) 148 
(CI 141 to 155) 
2 3.980 0.021 * 
(where * indicates a statistically significant) 
 
  
SCLA at Inception 
SCLA at Mid-Point 
SCLA at Discharge 
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Table 24: Post Hoc analysis using Tukeys HSD analysis  
 






Baseline 0.005 * 0.001 * 0.915 
Treatment Period 0.430 <0.0005 * <0.0005 
Final Rest Period 0.022 * 0.857 0.085 
(where * indicates a statistical significance) 
 
The results of this analysis indicate that between each data capture point there was a 
statistically significant difference in SC activity levels through the different phases of the 
treatment session (baseline, treatment and final rest period) and between participants. 
The post-hoc analyses (using Tukeys HSD – table 24) highlight that between each of the 
baseline periods there was a rise in SC activity levels from inception to mid-point (18% 
increase) but this rise, although maintained, did not increase, to the point of statistical 
significance, from mid-point to discharge (a further increase of only 4% i.e. the SC activity 
level was maintained from treatment to final rest periods). For the ‗during treatment 
periods‘ the most significant change occurred in the latter part of the programme of 
therapy (mid-point to discharge) where the SC activity levels diminished (25% reduction 
by discharge on top of the 6% reduction from inception to mid-point) that is also 
highlighted by the reduction in the magnitude of SCR‘s from baseline to during 
treatment). Within the final rest phases, the most significant change (decreased SC 
activity level) occurred in the earlier treatment sessions (inception to mid-point) and 
beyond that the activity levels stabilized with no statistically significant activity level 
changes.   
Overall, interpretation of these results would indicate that patients receiving 
physiotherapy management, for an acute and sub-acute LBP population, can be 
observed to have lower levels of SC activity at the commencement of therapy and that 
these levels increase as they progress, through the programme of care, to discharge. 
Furthermore, patients have higher magnitudes of SC level change to treatment at the 
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inception of their programme of care. But, as the programme of care continues towards 
discharge, SC activity levels diminish. Final rest period SC activity levels initially rise but 
soon stabilize. Consequently, Null hypothesis H01b was rejected as evidence exists to 
suggest that there is a difference in SC activity levels in LBP patients between data 
capture points as they progress through their programme of therapy. 
 
5.8.3.3. Research question 2 - Comparisons between skin conductance responses 
(SCR‘s) and patient-reported outcome measures (H0-2) 
 
In order to determine if maximum neurophysiological responses (SCR‘s) to treatment 
are associated with other currently utilized, patient-reported indicators of pain 
intensity or functional disability, correlative analyses were conducted to test the null 
hypothesis (H0-2) “There will be no correlation between SCR‟s (during treatment) 
and reported levels of pain intensity (NPRS) or functional disability (ODI or RMDQ) 
from inception to discharge”. The correlation coefficient  r  measures the degree of 
‗straight-line‘ (linear) association between variables thereby providing a value from  
-1.0 to +1.0 (Altman, 1991; p.278).The validity of correlation coefficient calculations 
(and their associated hypothesis tests) requires that the variables display a ‗normal 
distribution‘ which, according to Altman (1991), is best checked by examining 
means, standard deviations and ranges (Altman, 1991;p.123-124) and, visually, with 
a scatter diagram of the data (Altman 1991;p. 279). In the absence of a normal 
distribution, or, when categorical/ordinal level/ranked data (e.g. NPRS) is utilized 
then the non-parametric equivalent (Spearman‘s rho correlation) may be utilized.   
Table 25 summarises the key descriptive findings from the primary and all secondary 





Table 25: Summary statistics for the outcome measures at the three data capture points. 
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9 to 12 
* indicates that this value reached a statistically significant difference of p<0.0005 
NB. (#) = the SCR’s from previous to current subsections are slightly different as the previous analysis was to 1 
decimal point and this analysis to 2 decimal points 
 
Prior to the main correlational analysis it was necessary to explore the relationship 
between the two functional disability PROM‘s (ODI and RMDQ) because Altman (1991; 
p.282-283) advises that even when the assumptions for correlation are not violated, 
misuse of correlation (and the subsequent mis-interpretation of results) can occur when 
two methods are used to calculate the same quantity (Altman, 1991; p.284), in the case 
of this study, this would occur when including both ―functional disability‖ scales (ODI and 
RMDQ). A Spearmans rho correlation (for RMDQ, ordinal level data) was therefore 
performed prior to the main correlational analyses (see appendix XV - ODI and RMDQ 
analyses) and, as might be anticipated, this analysis revealed the existence of a strong 
positive, linear, statistically significant correlation between the ODI and the RMDQ 
disability scales (r=0.645; p=0.0005). Consequently, it was decided that the use of both 
scales in further analyses could potentially bias the results and their subsequent 
interpretation. Therefore, the decision was made to only report and utilise (for 
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comparison purposes) just the one scale in the final analyses. The ODI scale was 
selected by virtue of the fact that the ODI scoring system has the added quality of 
providing a predictive element to the success, at discharge, of outcome to treatment 
(Flynn et al., 2002 and Childs et al., 2004) although it was acknowledged that the 
RMDQ may be more sensitive to this acute/sub-acute population (Goertz et al., 2012). 
 
Main Correlation analyses 
In order to conduct a thorough analysis of any relationships between the primary and 
the two secondary OM‘s an analysis of relationships between SCR, ODI and NPRS 
was performed, for all three data capture points independently (inception, mid-point 
and at discharge) as Altman (1991; p.283-284) advises that repeated measures may 
provide ―spurious‖ correlations. Details of this set of preliminary analyses are provided 
in Appendix XVI with assessments of the assumptions of normality also included. 
 
Overall, findings indicated that throughout all data capture points (inception, mid-point 
and discharge) there were moderate (Cohen, 1988) positive correlations between the 
two secondary OM‘s of functional disability (ODI) and pain intensity (NPRS) (r=0.525; 
r=0.454; r=0.543 for inception, mid-point and discharge respectively) that reached the 
statistically significant level (p < 0.0005 for all points) indicating that levels of reported 
functional disability were consistently, moderately and positively correlated with 
reported pain levels (i.e., high levels of reported pain intensity correlated with high 
levels of reported functional disability). Regarding SCR and ODI there was a strong 
positive, statistically significant correlation at inception (r=0.821; p<0.0005) indicating 
that at inception, high SCR‘s to treatment are correlated to high levels of reported 
functional disability). Interestingly, this was not the case at mid-point (r= 0.139; 
p=0.293) or discharge (r= -0.106; p=0.426). This phenomenon was also observed for 
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SCR and NPRS (although the extent of the relationship was not as strong) where, at 
inception, there was a moderate positive statistically significant correlation (r=0.459; 
p<0.0005) suggesting that at the commencement of the programmme of treatment 
there was a relationship between high SCR‘s to treatment and to high levels of 
reported pain intensity. As with ODI and SCR, this correlation was not maintained (nor 
statistically significant) at mid-point (r= -0.163; p=0.217) or at discharge (r= -0.159; 
p=0.229) however, it was noted that the level of change in the NPRS OM, from mid-
point to discharge, was so small (0-1) that it was likely that the assumptions 
associated with this type of statistical analysis were at risk of being violated and, 
therefore, results should be interpreted with caution. 
 
Ultimately, preliminary trends in the data analysis of correlation would indicate that at 
inception, SCR has a stronger positive relationship to functional disability levels (ODI 
scores) than to levels of pain intensity (NRPS reports) but that this relationship does 
not appear to be consistent throughout the programme of care to discharge and may 
be a product of sampling violations (i.e. it was not a random sample).  
 
Correlations between levels of change in skin conductance responses (SCR‘s) from 
inception to discharge 
 
Having explored the strength and nature and the significance of correlations at the 
three different data capture points and found that there were trends in changes 
between the primary OM (SCR) and the secondary OM‘s (ODI and NPRS) 
particularly at inception, it was necessary to explore the nature and magnitude of 
changes occurring between the two definitive data capture points, from inception to 
discharge, in order to determine whether SCR‘s might be considered a feasible 
objective measure of neurophysiological status, in LBP patients, and a tangible 
measure of physiological change over time that might be reflective of functional 
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disability and pain intensity levels. The mid-point data capture point was not utilised 
in this analysis as prior studies exploring changes in the key PROM‘s at mid-point 
were not available for data comparison. Furthermore, it was acknowledged that 
unlike inception, the mid-point and discharge data capture points were not fixed 
points for each patient and therefore it may be considered to posses the potential for 
statistical bias. 
 
In order to compare changes between individuals, data for all OM‘s were converted 
into percentage change measures; for SC activity levels, these were the SCR‘s 
(‗baseline‘ to ‗during treatment‘ period from inception to discharge), for ODI and for 
NPRS these were the calculations of percentage change in scores from inception to 
discharge. Descriptive statistical analyses are detailed in table 26 with further 
analyses of skewness and kurtosis provided at the end of appendix XVI). 
 
Table 26: Descriptive statistics of percentage change measures for skin conductance 
response (SCR), narrative pain rating score (NPRS) and Oswestry disability index (ODI) 
from Inception to Discharge 
 
Percentage Change from 
Inception to Discharge 
Mean Std. Deviation N 
SCR (baseline to treatment) -123.3 110.14 59 
NPRS -96.0 6.81 59 
ODI -78.7 23.27 59 
 
The results indicate that descriptively there was a drop, from inception to discharge in all 
three OM‘s with SCR‘s reducing by 123% with corresponding reductions in pain intensity 
(NRPS) by 96% and reported functional disability (ODI score) by almost 79%. Therefore, 
descriptively speaking, it would appear that patients, at discharge, were reporting 
reductions in pain intensity and improvements in functional ability with corresponding 




Further, descriptive and inferential statistical analyses were conducted to identify the 
direction, strength and statistical significance of any relationships between the all OM 
variables. Scatterplots and both Pearson‘s Correlation coefficients (for SCR and ODI) 
and Spearman‘s rho correlation coefficients (for NPRS data comparisons) were utilised to 
investigate the relationships between percentage change measurements from inception 
to discharge for the three OM‘s (SCR, ODI and NPRS). The findings are summarised in 
the matrix scatter graph (figure 28) and in table 27 overleaf. 
 
Figure 28: A matrix scatter-plot illustrating the interaction between the three OM‘s 





Table 27: Inferential statistical analysis (using Pearson‘s Correlation and Spearman 
Rho Correlation Coefficients) of relationships between percentage change 
measurements from inception to discharge for the three OM‘s (SCR, ODI and NPRS) 





 * = Correlation is significant at the 0.05 level (2-tailed). 
 
As can be seen from Table 27 above, the results were similar for both Pearsons and 
Spearman‘s rho calculations with respect to comparisons of NPRS and the other OM‘s. 
The decision to utilise Spearman‘s rho correlations for NPRS was made in view of the 
‗rank‘ nature of this OM which is better suited to Spearman‘s rho investigations as the 
assumptions (Altman, 1991; p.285) for the use of this test are less stringent than those 
of the parametric equivalent (Pearsons Correlation).  
  
Results regarding the relationships between the primary OM (SCR) and the two 
secondary OM‘s (ODI & NRPS) revealed that there was a weak (r= 0.278; p =0.033), 
but statistically significant, positive correlation between changes in SCR‘s and ODI 
scores indicated that as functional disability mean changes diminished (from inception 
to discharge) so did the mean difference in the maximum SCR to the treatment. There 
was, also a weak positive correlation between mean differences in SCR and median 
differences in NPRS (Spearman‘s rho) from inception to discharge, however, this weak 
positive relationship did not reach a statistically significant level (r= 0.229; p =0.080). 
Not unsurprisingly, there was a moderate, statistically significant correlation 
 SCR ODI NPRS 
SCR Pearson Correlation 1 0.278
*
 0.141 
Sig. (2-tailed) - 0.033 0.286 
N 59 59 59 





Sig. (2-tailed) 0.033 - <0.0005 
N 59 59 59 
NPRS Spearman‘s rho Correlation 0.229 0.509
*
 1 
Sig. (2-tailed) 0.080 <0.0005 - 




(Spearman‘s rho) in the differences between the two secondary OM‘s of ODI and NRPS 
(r= 0.509; p <0.0005) indicating that as functional disability levels diminished so did pain 
intensity. A similar comparison was performed for the RMDQ scale and details provided 
in appendix XVI with the assessments of normatility for this data. 
 
Regarding null hypothesis two (H0-2) - “There will be no correlation between SCR‟s 
(during treatment) and reported levels of pain intensity (NPRS) or functional disability 
(ODI) at, or between, inception and discharge”, the null hypothesis was rejected as there 
was evidence, at inception, of a moderate-strong relationship between SCR‘s and 
functional disability (ODI scores) and a moderate relationship between SCR and pain 
intensity levels (NPRS), and that by discharge, percentage changes in SCR (reductions in 
SC responses) were correlated to improvements in reported function (ODI) (from inception 
to discharge). However, it was not possible to demonstrate a statistically significant 
relationship between changes in SCR and pain intensity improvements from inception to 
discharge. Interpretation of the results of these analyses should be considered with 
caution due to the non-random sampling of the patients and the potential for spurious 
correlational effects involving repeated measures over time (Altman, 1991; p. 282-283). 
 
5.8.3.4. Research Question 3 
 
Identification of trends in SCR to treatment 
 
In order to evaluate the utility of Biopac SC measurements (during treatment) as a 
potential indicator, at inception, of final, functional outcomes at discharge, the maximum 
SCR‘s to treatments were identified by visual inspection using markers that indicated 
treatment-type that were documented following the completion of each treatment 
episode and by reference to patient treatment notes. Furthermore, trend analyses, of 
the nature of the treatment being undertaken at the time of the maximum SCR reading, 
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were examined. The findings are summarised below and in appendices XXIII and XIX. 
For the 60 participants initially taking part in the study at inception, 59 attended at mid-
point and again at discharge thereby providing 60 + (2 x 59) = 178 potential data 
collection points for recordings of the maximum SCR to treatment. Of these, 176 were 
identified as being recorded in three key treatment areas; 1) Rotatory lumbar 
manipulation (HVLAT), 2) Repeated McKenzie Extension in Lying exercises and, 3) 
mobilisations with movement with just 2 treatments being classified as ―other‖ (specific 
soft tissue techniques). Details of the SCR data on the three key treatment types 
identified at the three data capture points (inception, mid-point and discharge) are 
summarised in table 28 and illustrated in figure 29. 
Table 28: Details of the key treatments providing maximum SCR‘s for trend analysis  
 

















Inception        n 
   mean SCR (%) 
                      SD 
31(52%) 14 (23%) 15 (25%) 60 - - 
266.7 172.3 165.4 219.4* 3.316 0.043 
192.9 80.7 52.0 153.1 - - 
Mean ODI % (SD) 47.65 (20.37) 39.64 (16.57) 36.27 (9.32) 47.65 (17.82) 2.492 0.092 
 Mean NPRS (SD) 7.55 (1.41) 7.29 (1.64) 7.60 (0.99) 7.50 (1.36) 0.228 0.797 
Mid-point        n 
      mean  SCR (%) 
                      SD 
32 (56%) 6 (10%) 19 (33%) 57 - - 
181.6 128.0 139.3 161.9 0.465 0.708 
198.2 72.1 75.3 156.7 - - 
Mean ODI % (SD) 15.62 (6.71) 19.33 (6.77) 14.00 (5.45) 15.59 (6.34) 1.308 0.281 
 Mean NPRS (SD) 2.78 (1.39) 2.33 (1.86)  2.84 (1.54) 2.73 (1.45) 0.336 0.799 
Discharge        n 
             SCR (%) 
                      SD 
40 (68%) 4 (7%) 15 (25%) 59 - - 
72.1 83.7 155.1 94.0* 4.720 0.013 
39.6 23.3 166.0 95.1 - - 
Mean ODI % (SD) 6.80 (7.06) 17.0 (1.16) 8.13 (10.34) 7.83 (8.12) 3.091 0.053 
 Mean NPRS (SD) 0.25 (0.44) 0.75 (0.50) 0.20 (0.41) 0.27 (0.45) 2.658 0.079 
(significant differences between treatment types at the p<0.05 level indicated by a *  and 
highlighted in red) 
 
Overall, the rotatory lumbar manipulative technique (HVLAT) was the most frequently 
recorded maximum SCR of all the techniques peformed (n=103, 58%) at all 3 data 
capture points, followed by MWM‘s (n=49; 28%) and McKenzie EIL exercises (n=24; 
14%). Regarding the magnitude of response at inception and mid-point, the lumbar 
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manipulative technique resulted in the highest sympathoexcitatory response (266.7% 
and 181% response respectively) however, by discharge the patients SCR‘s to this 
technique had diminished (by 114.6% inception to discharge) with the largest 
magnitude of response, at discharge, being recorded with the MWM technique 
(155.1%) despite the fact that manipulation was still the most utilised procedure at 
discharge. This observation can also be seen in figure 29. 
Figure 29: Box-plot illustrating the max SCR‘s of the key treatment techniques at the 






































(where * indicates an extreme value) 
 
 
Normality of secondary OM‘s for between-treatment (type) ODI (p=0.092) and NPRS 
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(p=0.797) measures at inception was established (table 28 above) prior to inferential 
statistical comparison (using one-way ANOVA - i.e. no difference between ODI and 
NPRS between treatments at all 3 data capture points). Results suggested that the 
difference in the recorded maximum SCR‘s at inception (and also at discharge) may be 
due to the nature of the treatments undertaken (inception; p =0.043 for spinal 
manipulation and at discharge; p=0.013 for MWM‘s). However, it is emphasised that 
these results are only a preliminary trend analysis and that findings should be 
interpreted with caution as violations to the assumptions of these tests must be 
acknowledged (non-random selection, the potential for underpowered sample sizes and 
lack of homogeneity in the numbers of participants in the different treatment types and 
small deviations in skewness and kurtosis – appendix XVI) and hypothesis testing is 
inappropriate as a true ‗cause-effect‘ relationship is not verifiable at this stage. 
 
Magnitude of SCR at inception as a predictor to a positive functional outcome 
(change in ODI of >50%) at discharge 
 
The correlation analyses of research question 2 provided information describing the 
nature, strength and significance of relationships between the primary and the 
secondary OM‘s however, this type of analysis is unable to predict the value of one 
(known) variable in an individual (e.g. functionality – an improvement in function at 
discharge as measured by a change in ODI score > 50%) when the value of only one 
variable (SCR to treatment at inception) is known (Altman, 1991; p.277). In order to 
explore the viability of using the Biopac System, within a clinical environment for future 
research into treatment effects, it was of interest to investigate the potential for the 
Biopac System to predict at inception (using SCR‘s to treatment), either a positive (> 
50% improvement in ODI) or a negative (< 50% improvement in ODI) functional 
outcome at discharge using a recognized PROM with a known, validated, measure of 
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change (Childs et al., 2004). To achieve this, determination of a ―cut-off‖ point is 
recommended (Altman, 1991; p.417-419) whereby ―successful‖ outcome (in this case 
―ODI discharge improvement >50%‖) can be predicted from the magnitude of maximum 
SCR to treatment at inception. Altman (1991; p418) recommends a graphical approach 
whereby sensitivity is plotted against 1-specificity for each cut-off. By joining up these 
points, the resultant curve (ROC curve – receiver operating characteristics curve) is 
generated and the best cut-off point can then be calculated (a value that maximizes the 
sum of the sensitivity and specificity). Medcalc software (version 12.3.0.0) was utilized 
to perform the analysis and the ROC curve displayed in figure 30 below. 




From this small sample of data, early indications suggested patients with a maximum 
SCR critical value >195% (cut-off point) at inception are most likely (z=3.564; 
SCR at Inception (in Micro mhos's)


















p=0.0004) to achieve a positive outcome at discharge (ODI change >50%), 
(sensitivity 52%, 95% CI= 37.4 to 66.3; specificity 100%, 95% CI= 66.4 to 100) 
although it is acknowledged that this type of analysis does not establish cause-effect 
and further study is required to verify and validate this preliminary finding and to 
determine any link between specific treatments and ultimate clinical outcome. Further 
details of the analysis are provided in Appendix XVII.  
 
Using the inception SCR 195% criterion as a cut-off threshold, comparative analyses 
of the study population identifies that 46% (n=27) of the patients (who had readings 
in excess of 195% SCR to treatment) achieved an ODI change score in excess of 
50% at discharge. The details of the differences between the participants achieving 
the 195% SCR cut-off threshold (and those below this limit) are summarised in table 
29. Overall, the characteristics of patients, who were most likely to get a positive 
outcome at discharge (according to the ODI change score of >50%) appear to have 
received their initial treatment at an earlier point in time following onset of symptoms 
(5.7 weeks compared to 8.1 weeks; p=0.011), had higher functional disability levels 
at inception (ODI 55% compared to 31.5%; p <0.0005: RMDQ scores 15.2 compared 
to 9.5; p <0.0005) and higher pain intensities (NPRS 8 compared to 7; p=0.004). 
Conversely they required fewer treatments (mean 4.1 compared to 6.4, p < 0.0005) 
and were more likely to achieve a significant clinical benefit (SCB) level in their 
RMDQ change scores (13.5 compared to 7.6; p < 0.0005) and reduction of pain 






Table 29: Comparisons of participants achieving and not achieving the 195% SCR 











(p value) Less than 195% More than 195% 
Number 59 32 27 - 
Age 39.7 39.5 40.0  0.798 
Gender (%Female) 59% 59% 59%  1.000 
Symptom Duration (wks) 7.0 8.1 5.7  0.011* 
Number of Treatments 5.4 6.4 4.1  <0.0005* 
ODI Baseline score  
Mean ODI score change Base to DC 
 
% achieving MCID ODI Change > 50% 
at DC 
42.4% 31.5% 55.3%  <0.0005* 
-78.7% -74% -85%   0.077 
85% 41% 44%  0.057A 
RMDQ Baseline score 
 
Mean RMDQ score change base to DC 
 
% patients achieving MCID > 8.7 at DC 
12.1 9.5 15.2  <0.0005* 
10.4 7.6 13.5  <0.0005* 
63% 24% 39%  0.003* 
NPRS Baseline Score 
 
Mean NPRS score change base to DC 
  
% patients achieving MCID > 2.5 at DC 
7.5 7.0 8.0  0.004* 
7.2 6.7 7.8  0.003* 
100% 100% 100% 1.000 












160.1 126.5 200.0  0.067 
94.0 67.2 125.7  <0.017* 
Key: SCR=Skin Conductance Response; wks=weeks; DC=Discharge; Sig=significance value;  
   * = statistically significant  
A = the assumption of ‗minimum expected frequency‘ value violated for the Chi Squared test 
 
These findings were supported by a preliminary regression analysis that assessed the 
predictive capacity of the new/unknown variable (SCR) against the previously known and 
validated outcome predictor (ODI improvement score > 50% at discharge – Flynn et al., 
2002 and Childs et al., 2004). According to the advice of Altman (1991; p.320-321 and 351-
358), direct logistic regression analysis was conducted and the results of this analysis are 
provided in Appendix XVIII indicating that SCR has the potential to be a stronger predictor 
of ODI improvement >50% (inception to discharge) greater than duration of symptoms and 
of age. However, it is acknowledged that these findings require validation within a larger 
sample population and should therefore be interpreted with caution.  
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5.8.4. Summary of the results. 
The preliminary comparative analyses involving the 2 populations of this research 
thesis (asymptomatic volunteers in chapter 4 and the group of patients with LBP) 
determined that SCR‘s in both populations were similar regarding their 
sympathoexcitatory nature as well as with respect to the differences in the 
magnitude of response between the two treatment techniques (the lumbar rotatory 
manipulation technique and the repeated McKenzie EIL exercise). However, 
regarding the extent of SCR‘s between the two populations, interesting differences 
revealed that the patients experienced SCR‘s that were more than twice that of the 
asymptomatic groups for both the rotatory manipulation technique and the repeated 
McKenzie EIL exercise.  
 
The LBP patient data analysis provided evidence to support that SC activity levels 
could be observed to change within-treatment sessions (with recordable 
sympathoexcitatory SCR‘s to guideline-endorsed treatment approaches) and 
between-treatment episodes with observed increases in SC activity levels and 
diminution of SCR‘s (to treatment) from inception to discharge. Further correlational 
analyses of SCR and PROM data (ODI and NPRS) suggested that correlations exist. 
Furthermore, correlations in the differences in SCR‘s, ODI and NPRS change 
scores, from inception to discharge indicated that SCR‘s were better correlated to 
measures of functional ability than to pain intensity reports. Lastly, preliminary trend 
analyses indicated that three key elements of the multi-faceted guideline-endorsed 
physiotherapy approach were observed to have maximum SCR‘s within treatment 
periods and at the different data capture points of therapy. Although numbers for 
analysis were acknowledged to be limited (making hypothesis testing inappropriate), 
the treatment elements that were identified included; lumbar manipulation, McKenzie 
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EIL exercise and MWM‘s. Lastly, the provision of guideline-endorsed physiotherapy, 
to acute and sub-acute LBP patients‘, was found to achieve positive clinical 
outcomes, at discharge, as measured by improvements in excess of the published 
minimally clinically important difference (MCID) and the significant clinical benefit 
(SCB) levels of validated PROM‘s. Furthermore, using the previously validated 
improvement threshold score in ODI (of > 50%), results indicated that it may be 
feasible to consider utilizing a SCR critical value of 195% (recorded at inception 
during treatment) as a possible predictor of a positive functional outcome at 
discharge as it is a stronger predictor (of outcome) than duration of symptoms and 
age (commonly recognized predictive factors), although future corroboration and 





















5.9. Discussion of Clinical Results, recommendations for future research and 
study limitations. 
 
The following section focuses on a discussion of the results from the LBP patient 
study, notably; the observed changes (within and between treatment episodes) in SC 
activity levels and SCR‘s during physiotherapy treatments for LBP, on correlations 
between SC measures and PROM‘s and, finally, it included an evaluation regarding 
the potential of SC measures as a predictor (at inception) for a positive functional 
outcome at discharge. Comparisons between the asymptomatic and the patient 
populations are presented in the final discussion.  
 
Unlike other clinically-based studies, in the current study there was a very low drop-
out rate of participants. Indeed, of the 70 who agreed to attend for initial interview to 
consider participation, 60 were eligible for the study (85%) and only 1 patient 
dropped-out after commencement of data collection and treatment (due to 
geographical relocation with work) representing a final drop-out rate of <2%. This is 
considered a strength of the study as intention to treat and imputation statistical 
analyses were not necessary which might have biased the following discussion.   
 
5.9.1. Comparisons between the current patient population and other published research 
 
Epidemiological and PROM (ODI, RMDQ and NPRS) comparisons between the current 
clinical studies patient population with other published research indicated that the 
patient group of the current study bore strong resemblances to the baselines of the 
populations of other, published studies. Studies reviewing the clinical course of acute 
LBP (Grotle et al., 2005) and those investigating the effects of physiotherapy and MT‘s 
on symptomatic populations of LBP patients were visually compared (Childs et al., 
2004; Konstantinou et al., 2007; Owens et al., 2007; Juni et al., 2009; Thomas et al. 
2009; Fritz et al., 2010; Brontford et al., 2011). Demographically, similarities were 
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observed in age (39.7yrs for the current study; Grotle et al., 2005 = 38.9; Konstantinou 
et al., 2007 = 38.3; Owens et al., 2007 = 40 and Fritz et al., 2010 = 37.2). Inception 
PROM comparisons identified similarities in the mean scores of the ODI, with the 
current study = 42.9 and Fritz, Delitto and Erhard (2003) = 42.8, Childs et al., (2004) = 
41.2, Thomas et al., (2009) = 39.5 and Fritz et al., (2010) recording a mean population 
score of = 41.7. Davidson and Keating (2005) classified scores within this banding as 
‗moderate disability‘. RMDQ scores for the current study were 12.7 with Grotle et al., 
(2005) recording scores of = 9.0, Konstantinou et al., (2007) = 11.4 and Juni et al., 
(2009) = 12.8. For NPRS, the mean for the current study was 7.5 with Grotle et al., 
(2005) = 6, Konstantinou et al., (2007) = 7 and Juni et al., (2009) = 6.8. 
 
Grotle et al., (2005) advised that the natural (untreated) clinical course of recovery, in 
acute LBP patients (0-20 days duration), is typified by an improvement in pain, at 12 
weeks, of 58%. In the current study the reported reduction in pain, at discharge, was 
96%. Whilst this time point may not be strictly analogous with Grotle et al.‘s (2005) it is 
worthy of note that the current studies population had a greater mean improvement, 
above Grotle el al.‘s scores, in the order of 42% which is almost double the 
improvement seen as a result of the natural (untreated) course of healing. Indeed, the 
overall improvement, at discharge in NPRS was more than 7 which is in excess of the 
published MCID (of 2.5). Regarding the functional disability scores, Grotle et al. (2005) 
advised that the natural (untreated) course of acute LBP would result in an 
improvement, in RMDQ scores, in the order of 68% (for the 3 months data collection 
point) whereas the current study reported an improvement in RMDQ scores, at 
discharge of 87%. Relating this to the MCID, the current study reported an average 
improvement of 10.36 which is greater than published standards of improvement that 
patients perceive as beneficial (RMDQ = 8.7). Grotle et al., (2005) did not report ODI 
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changes during the natural course of LBP resolution, however, other published 
researchers have reported change scores secondary to their intervention. ODI scores 
for the current study demonstrated significant improvements in functional ability 
throughout the programme of treatment (scores were reported as 42.9% at inception 
reducing to 15.6% at mid-point and then to 7.8% at discharge). These improvements 
are in excess to those reported by Fritz, Delitto and Erhard (2003) at their 4 week data 
capture point (21.4% for the SMT group) and at the 1 year follow-up (17.4%) indicating 
that the guideline-endorsed treatment option was, at least comparable, in ODI outcome, 
to Fritz, Delitto and Erhard‘s (2003) intervention and therefore may represent an 
appropriate choice of management. Regarding the MCID for ODI (19 points or 30-50% 
in published papers), the current study recorded a mean score improvement of 34.5 
points (78.7%) which is a difference that is in excess of those that are perceived, by 
patients, as representing beneficial improvement further supporting the treatment 
approaches utilized. Whilst these results (for all PROM‘s) do not imply causation, the 
use of guideline-endorsed physiotherapy management approaches (defined by the 
MRC in 2000 as a complex intervention) are certainly capable of achieving 
improvements in pain and in function beyond the levels, perceived by patients, as 
representing beneficial change.   
 
One issue with the use of MCID‘s and PROM‘s in evaluating patient responses to 
treatment was recognised, initially, by Hays and Woolley (2000) and, more recently, by 
Copay et al., (2007) who found that the baseline severity of symptoms can influence the 
ultimate outcome of the MCID and that the MCID will vary depending on the variability 
of the presentation in the population, for example, patients presenting with localised/ 
simple, non-radiating LBP will have different MCID findings than a patient with LBP with 
radiculopathy (Lauridsen et al., 2006). Another predicament with the use of PROM is 
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the reporting of summed average scores. Ringash et al. (2007) reported that the use of 
a summed average score for a population results in regression to a common mean that 
can dilute extreme or diverse changes that can occur and can result in clustering of 
responders ―average score‖ with the potential to weaken or, at worst, distort the nature 
(and strength) of the distribution of scores thereby causing mis-interpretation. 
 
Conversely, Taylor et al. (1999) argued that ODI changes in scores are able to infer 
meaning because of the tools well-defined and reported responsiveness.  Davidson and 
Keating (2002) suggested that condition-specific outcome measures are less 
responsive than their general health counterparts in that they lack other facets 
associated with disability (emotional, social, and psychological factors). Although Walsh 
et al. (2003) claimed that the use of condition-specific measures is acceptable in the 
general population but that supplementation with general health measures such as the 
Short Form 36 is advisable, especially in multidisciplinary management of LBP. For the 
current study, the use of inclusion and exclusion criteria, for participant selection, 
enhanced the homogeneity of the group (and therefore the internal validity), 
furthermore, the reported inception PROM‘s for the current population were comparable 
to other published studies in LBP populations. However, it is acknowledged that the use 
of patients with and without radicular symptoms may have increased the variability 
(diversity) in the PROM‘s reported, a factor that may have been disguised by the use of 
the summed population average score (Ringash et al., 2007). Future SC measurement 
studies should consider sub-grouping patients with and without radicular symptoms. 
 
Another issue with the use of PROM‘s is that they require patients‘ to understand the 
context of improvement and are asked to report on changes to a current state of health 
which requires the individual to make a retrospective judgment. The nature of this 
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practice has been identified as being subject to recall bias (Norman, Stratford and 
Regehr, 1997; Beaton, Boers and Wells, 2002; Guyatt et al., 2002) and has been 
documented as possibly producing the ‗response-shift phenomenon‘ (Schwartz and 
Finkelstein (2009). In the current study, the use of PROM‘s at each attendance may 
have limited the potential effects of recall bias and the response-shift phenomenon, 
however, a more immediate measure of change, as provided by recordings of SC, might 
be considered a less subjective, reflective or retrospective indication of change.   
 
5.9.2. Skin conductance values as a measure of within and between treatment change 
 
 
The results of research question 1 gathered SC information (activity levels and SCR‘s) 
on patients presenting with acute and sub-acute LBP (of up to 12 weeks duration) 
throughout a programme of guideline-endorsed physiotherapy. The study aimed to 
determine whether, SC levels changed within and between episodes of treatment at 
inception, through mid-point to discharge. Two components (null-hypotheses) were 
examined to explore this research question (within-treatment and between-treatment 
SC activity levels and SCR‘s). The key findings provided evidence to reject both null 
hypotheses in favour of the alternate hypotheses that both within- and between-
treatment differences in SC activity levels were observable. The results revealed a 
number of important areas for consideration. Firstly, that between data capture points 
the baseline (pre-treatment) SC activity levels increased as the course of treatments 
progressed with levels observed to increase from inception to mid-point (by 19.5%;   
16 µMho‘s), with a total increase, by discharge, of 22% (18 µMho‘s). These levels 
were in excess of those that may be attributed to measurement error (> than SRD of 
4.6%; 0.3154 µMho‘s, of chapter 3). These findings were supported by the Post-hoc 
analyses that indicated that the most significant change (increase) in this baseline 
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level occurred within the first few treatments (inception to mid-point 19.5%, p=0.005) 
but that the change from mid-point to discharge was not significant and did not rise 
above the SRD value. This pattern of SC activity level recordings was also reflected 
(to a lesser extent) in the final rest periods with an increase in SC activity between 
inception and mid-point of 8.6% (p= 0.022). 
 
Secondly, that during the ―treatment period‖ of each episode of care, SC activity levels 
were observed to increase (from baseline levels) indicating a sympathoexcitatory 
response to treatment (p<0.0005). This was particularly in the initial episode of care 
with SCR‘s of 219% however, it was also observed that the magnitude to this 
sympathoexcitatory response to MT stimulation diminished significantly (p<0.0005) 
from inception, through mid-point (SCR = 160%) to discharge (SCR‘s = 94%). Within 
the treatment episode, it was also noted that these excitatory, ―during treatment‖ 
responses were maintained into the final rest period (albeit to a lesser magnitude) at 
each data capture point indicating that the responses to treatment were not a 
temporary/transient/phasic phenomenon of the ―during treatment‖ period and that the 
effects of treatment may possess longevity, lasting beyond the point in time of 
application. Lastly, observations taken in the final rest period indicated that despite an 
initial increase in SC activity levels between data collection points (inception to mid-
point; p=0.022), overall, observations were relatively consistent throughout the 
programme of care (inception to discharge; p=0.857).   
 
Overall, the findings of the data from this element of the current thesis would support 
the concept that patients (with acute and sub-acute LBP) demonstrate SNS (SC) 
activity levels and SCR‘s suggesting that within- and between-treatment neurological 
(SNS) responses and adaptations occur within the stimulus-processing mechanisms of 
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the nervous system.  
 
Woolf (1994 and 2011) conceptualised that stimulation of peripheral nociceptive 
receptors (e.g. by injury and/or inflammation) results in substantial ‗up-regulation‘ of 
peripheral nociceptive function and sensitization of the dorsal horn (DH) with Storm et 
al. (2000) suggesting that this was reflected by altered states of SNS arousal.  Boal 
and Gillette (2004) further substantiated Woolfs‘ (1994) findings in their study reporting 
both in-vitro and in-vivo evidence that identified the development of long-term 
potentiation (enhancement of signal transmission) in nociceptive neurons specifically 
within the DH of patients with LBP. Boal and Gillette (2004) also discovered that the 
LBP patients in their study also developed concomitant neuroplastic changes in the 
DH and the central nervous system. This phenomenon is corroborated by Bakkum 
(2007) with the findings, in his laboratory-based research, revealing that the presence 
of experimentally induced hypomobile spinal segments, in rats, caused DH 
neuroplasticity with resultant mal-adaptive central changes. Bakkum et al., (2007) 
identified that his rats had increases in DH synaptic density, neuronal plasticity and 
synaptic hyperactivity that were related to the experimentally induced hypomobile 
segments, leading them to hypothesise that these changes occurred as a functional 
spinal physiological response to the diminished mechanical stimulation within the joint 
receptors.  
 
Considering these elements, within the context of the findings of the current study, it 
may be suggested that the LBP patients initially presented with inhibited baseline SNS 
(baseline SC at inception) activity levels which may represent the status of the DH 
(which would be sensitized and subject to neuroplastic changes [Woolf, 1994 and 
2011] , in the acute and sub-acute stages of the condition [Bakkum et al., 2007], due 
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to the long-term potentiation incurred by the ―up-regulated‖ state of nociceptor activity 
[Boal and Gillette, 2004] and the potential, reactive ―down-regulation‖/an 
altered/diminished arousal state of the SNS system [Storm et al., 2000]). 
Subsequently, the observed (high) sympathoexcitatory responses (during the 
treatment period) to the MT treatment-stimulus (SCR=219% above baseline levels at 
inception) may be a reflection of the heightened/adapted responses (to specific, 
segmental stimulation from the MT approaches employed) that could be anticipated 
within a sensitized and/or neuroplastically adapted DH, central and sympathetic 
nervous system. Furthermore, Woolfs‘ (1994 and 2011) concept is supported when 
considered in the light of the fact that the normal process of tissue healing (occurring 
naturally following an injury, e.g. LBP) is typified by restoration of peripheral nociceptor 
activation thresholds (―down-regulation‖) and the associated dorsal horn (DH) 
desensitization. Within the context of the findings of this thesis, the observed 
diminution of the ―heightened‖ magnitude of SCR to treatment, supports this ‗tissue 
healing model‘, that is, SCR to MT were initially high (SCR‘s 219% at inception) but as 
healing (―tissue repair‖) progressed and symptoms abated, SCR‘s diminished (160% 
at mid-point and 94% at discharge). Indeed, by discharge, SC activity levels were 
similar to those recorded in the normal healthy/asymptomatic participants (of chapter 
4), for example, looking specifically at the data trends of maximum SCR‘s to 
treatments (chapter 5, research question 3), in the case of the rotatory manipulation 
treatment, SCR‘s were initially high at inception (266%) but diminished by mid-point 
(182%) and further reduced by discharge (72%) achieving levels that were in 
accordance to the asymptomatic manipulation group of chapter 4 (SCR = 76%). These 
diminished magnitudes of response to treatment may have occurred either through the 
course of the conditions natural processes of healing (regression to the mean) or may 
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indicate the neurophysiological adaptive changes that were occurring with time. 
Alternatively, it may be speculated that the ―treatment‖ component (e.g. rotatory 
manipulation) could have been considered a ―novel‖ stimulus that would be expected 
to give a SNS response and that with repeated (mid-point and discharge) application, 
the patients either accommodated to or, through the process of cortical re-
organisation, the stimulus resulted in the observed reduction in the magnitude of 
responses. McCabe et al., (2005), Moseley and Gandevia (2005) and Mosely et al., 
(2006) demonstrated that strangeness, foreignness and peculiarity are features of 
movement stimulus when there is sensory-motor incongruence within the cortical 
processing regions of the brain. Fink et al., (1999) correlated such ―conflict‖ with 
increased activiation in the dorsolateral pre-frontal cortex, an area of the brain found to 
have altered activity and neurodegeneration in (chronic) LBP patients (Apkarian et al., 
2004). Clearly, the observational design of this study does not permit cause-effect 
relationships of this nature to be established, however, it is reasonable to suggest that 
SCR‘s may provide an alternative, empirical, method of quantifying the 
neurophysiological status and the changes occurring throughout a course of treatment. 
However, further (future) data collection and verification of these observations is 
warranted, within patient populations, to authenticate these suppositions.  
 
5.9.3. Comparisons between skin conductance measures and patient-reported OM‘s 
 
The second research question sought to verify whether or not SC readings correlated 
with commonly utilized clinical measures of patient status (PROM‘s) and changes in 
status as a result of therapeutic intervention. Results identified the nature and the 
strength of correlations between the primary OM of SCR‘s (percentage change in SC 
activity level reading from baseline to during treatment) with the secondary PROM‘s of 
functional disability and pain intensity. To the authors‘ knowledge, no other published 
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study has explored any correlations between SC measurements and currently used 
PROM‘s within a LBP patient population.  
 
Prior to the main analyses, preliminary data comparison of correlations between (just) 
the 2 functional disability measures, at inception, revealed a ―medium to large‖ positive 
correlation (according to the guidelines provided by Cohen, 1988. p.79-83) (r=0.645; p < 
0.0005). This finding compared well to other reported comparisons of ODI and RMDQ 
within LBP patient populations (at inception). Fairbank and Pynsent (2000) and 
Davidson and Keating (2002) both reported correlation co-efficients for the two scores in 
the order of r=0.77. Accordingly, for further correlative analysis, it was decided that only 
1 functional PROM (the ODI) would be used thereby ensuring that any potential 
interpretation bias was minimised (Altman, 1991; 282-284). Furthermore, the ODI was 
the functional PROM of choice as change scores of > 50% have been recognized as 
representing acceptable and validated levels of improvement in LBP populations with 
‗moderate‘ disability (40-60% on ODI) and has been used, in other studies, to establish 
criterion validity of other outcome responses to SMT (Fairbank and Pynsent, 2000; 
Roland and Fairbank, 2000; Childs et al., 2004 and Goertz et al., 2012) and therefore 
suitable for comparative analysis (Childs et al., 2004 and Davidson and Keating, 2005). 
The other secondary measure (NPRS) was also found to have a statistically significant 
medium positive correlation with ODI scores (r=0.525; p<0.0005) and compared well to 
other published reports of correlations between ODI and pain intensities (Roland and 
Fairbank, 2000 ODI and VAS r=0.62).  
 
Correlations for the primary OM (SCR) and the secondary PROM‘s (NPRS and ODI) 
at inception indicated there were strong positive and statistically significant 
relationships between SCR‘s (during treatment), levels of reported functional disability 
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(SCR and ODI; r=0.821, p<0.0005) and to reported pain intensity (SCR and NPRS; 
r=0.459, p<0.0005) with patients reporting high levels of functional disability and/or 
pain intensities being more likely to have SCR‘s to treatment that were of greater 
magnitude than patient‘s reporting lower levels of functional disability and or pain 
intensities. This might imply that SCR‘s may provide further insight into the patients 
―experience‖ of LBP (at inception) and provides some support for Woolf‘s (1994 and 
2011) concept (discussed above) that acute injury (in this case LBP) can result in 
neural adaptations and resultant modifications to nociceptor and sudomotor activity 
(function).    
 
Further analyses of the SCR and PROM data were performed in accordance with 
Altmans‘ (1991; p.284) recommendations with repeated measures designs. For this 
analysis, a single correlation, of the mean (SCR and ODI) or median (NPRS) 
differences was conducted for changes in measures (SCR, ODI and NPRS) taken 
from inception to discharge. Following on from the previous analyses (at inception), 
functionally, patients with higher reductions (from inception to discharge) in their 
magnitude of the SCR‘s (during treatment) were positively, although weakly, correlated 
(r= 0.278; p =0.033) with reductions in ODI score by discharge (i.e. patients with 
reductions in SCR‘s had similar reductions in reported disability). Furthermore, 
patients reporting reductions in NPRS by discharge had moderate to strong 
correlations between reduced pain intensity reports and reduced functional disability. 
However, in comparison, SCR‘s and NPRS correlates were only weakly positively 
correlated and, moreover, this relationship did not reach statistical significance (r= 
0.229; p =0.080). Indicating that SCR‘s changes (from inception to discharge) are 
better correlated to function than to pain but that function and pain are moderately, 
positively and significantly correlated (r=0.509, p<0.0005). At this point it is worth 
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acknowledging that the correlational change scores (for ODI and NPRS) indicated that 
a large number of the participants had highly favourable improvements in their 
reported function and reductions in pain intensities, this may have resulted in 
‗clustering‘ of OM change scores at one end (the ―improved‖ end) of the spectrum 
which could result in skewed analyses and mis-interpretation of inferences 
(Fitzmaurice, Laird and Ware, 2004) because of this, a log transformed analysis of the 
data was conducted but results were unchanged from those presented. Nonetheless, 
the results of the correlational analyses should be interpreted with caution in light of 
the spread/diverse nature of the inception data, the inherent clustering of change 
scores (high levels of functional ability and pain intensity improvements) and the 
limited sample size.    
 
Roland and Fairbank (2000) and Davies and Nitz (2009) found that psychometrically, 
ODI was most effective for persistent severe disability and therefore may not truly 
capture the functional problems of an acute and sub-acute population despite its 
widespread utilization in other acute populations (Childs et al., 2004; Flynn, Childs and 
Fritz, 2006 and Thomas et al., 2009 and Fritz et al., 2010). The ODI, although a highly 
validated and reliable tool has been found, by Müller and colleagues (2004), to posses 
floor effects and Bombardier (2000) recommends that ODI is a better choice for 
populations with higher disability levels whilst RMDQ is more suitable for populations 
with lower levels of pain intensity and physical disability although independent analysis 
of SCR and RMDQ change scores (inception to discharge) indicated no correlation 
between measures at all (appendix XVII, r= 0.028, p=0.834) which may be a reflection 
of the RMDQ‘s ordinal scale of measurement or that SCR and RMDQ are measuring 
two different entities. Davison and Keating (2005) considered that the ODI was able to 
represent different levels of disability in sub-groups of patients (with scores of 0-20% = 
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no disability; 20-40% = minimal disability; 40-60% = moderate disability; 60-80% = 
severe disability and 80-100% = ―Crippled‖). The population in the current study had 
ODI scores ranging from 18-86% which covers all of the available sub-group ranges 
and thereby might influence the results of the analyses, by limiting the strength of the 
relationships observed. Indeed, a number of researchers have excluded participants 
whose scores were less than 30% on the ODI scale at inception (Flynn, Childs and 
Fritz, 2006 and Thomson et al., 2009), and this might be a consideration (to enhance 
homogeneity) for future studies utilizing patient populations  and SCR values. 
Additionally, minimal values for inclusion criteria for the other PROM‘s have also been 
documented, with participant RMDQ scores of less than 4-6 being excluded (Hurley et 
al., 2004 and Owens et al., 2007 respectively) and NPRS values of less than 4-5 being 
proscribed in other studies (Schneider et al., 2010 and Santilli et al., 2006 respectively). 
Whilst in the current study RMDQ ranges were from 4-21, it was also noted that 
patients‘ NPRS‘s ranged from 3-10 which, like the ODI may be considered to be quite 
wide-ranging and although inclusive/representative of the diverse presentations of 
symptom intensity within an acute and sub-acute group with LBP, it may also have 
influenced the strength of any correlations between the OM‘s, indicating that this might 
be an area for further, future research.  
 
Ultimately, SCR‘s, pain intensity and functional disability are only 3 ways of exploring 
the phenomenon of LBP and may not truly ―capture‖ the full and diverse (qualitative) 
nature of the experience, indeed, Turk and Dworkin (2004) and Khorsan et al., (2008) 
warn against the uni-dimensionality of OM‘s and particularly the NPRS‘s by 
emphasizing that they should only be considered along-side other functional, 
emotional and physiological components (i.e. functional disability measures, ROM 
and, for this study, SCR‘s). Overall, it would appear that SCR‘s following the 
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administration of guideline-endorsed lumbar physiotherapy treatment, correlate better 
with function rather than pain intensity, but that function correlates strongly to pain 
suggesting that rather than SCR being a substitute for functional disability measures or 
pain intensity changes, it could represent an additional or alternative (objective/ 
empirical) adjunct to the currently utilized, subjective measures employed within 
clinical (as well as, research) practice.   
 
As alluded to above, these findings support the concept that normal (not maladaptive) 
neuroplastic changes (occurring secondary to nociceptive stimulation and DH 
hypersensitivity) result in CNS processing of pain and symptoms in the early stages of 
symptom onset and that these ‗processes‘ may be detected through changes that occur 
in the sudomotor system (functional disability levels reported with high ODI scores) and 
in pain reports (NPRS) and, now, the responses of the sympathetic nervous system to 
stimulation (maximum SCR‘s during treatment administration). Additionally, the results 
provide preliminary support for the concept that manual therapy treatments may result 
in SCR‘s that  could represent a non-invasive, proxy-indicator of central 
neurophysiological status, supporting the findings of Vicenzino et al., (2001), Frey Law 
et al., (2008) and Bialosky et al., (2008 and 2011) who found that pain sensitivity 
decreases directly in response to manual therapy.  
 
5.9.4. Trend analyses and evaluation of Biopac SC measures as a predictor (at 
inception) of a positive functional outcome at discharge. 
  
The final observations in this clinical study (research question 3) sought to explore any 
trends in the nature of the responses observed and to evaluate the feasibility of 
utilizing the Biopac system as an indicator (at inception) of patients that might be 
predicted as good responders to treatment by discharge.  
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Identification of trends in maximum SCR‘s to treatment indicated that of the 178 
SCR‘s recorded over the 3 data capture points, 103 were identified as responses 
occurring during a rotatory manipulation, 49 during a lumbar MWM manoeuvre and 
24 as a result of repeated McKenzie EIL exercise (2 treatments were identified as 
soft tissue techniques and because of the low numbers were not included in the 
analyses). Of these identified treatments, manipulation achieved the greatest SCR at 
inception and mid-point, but the magnitude of the SCR‘s tailed-off by discharge 
(266%, 182% and 72% respectively). The repeated McKenzie EIL exercise had 
responses, over time, that also indicated a diminishing response (172%, 128% and 
84% respectively) with the MWM technique being the most consistent responder, 
over time, between the three data capture points (165%, 139 % and 155% 
respectively). Whilst these are only identified trends, it is worthy of note that SCR‘s 
can be recorded and, indeed, may differ in the magnitude of the responses observed 
and may relate to the type of treatment being received. Future studies may find these 
observations of use in informing the development of appropriately designed and 
powered patient studies investigating (and quantifying) the magnitude of SCR‘s and 
establishing the efficacy of different treatments of LBP. That said, it is important to 
note that the SCR‘s used in this trend analysis were independent recordings of 
maximum treatment responses in the three data capture points and, therefore, do not 
represent repeated measures of within-patient manipulation, EIL or MWM recordings 
over time. Furthermore, the SCR values represented the overall maximum response 
achieved within the entire treatment episode, within each data capture points data 
recording period. Therefore, it is of note that the influence of other components of 
treatment, that also occurred within the treatment episode, are not known thereby 
preventing any causal links between observed responses and the specifics of the 
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treatments provided. Therefore, further randomized controlled trials are 
recommended to verify and to validate any cause-effect relationships between the 
specific treatments identified, in this study (and those of normal, asymptomatic 
volunteers).  
 
The predictive utility of the Biopac system SCR measures was evaluated by 
comparing a known clinical predictor (ODI percentage change score >50%), to the 
new primary OM of maximum SCR to treatment (Altman, 1991; p.277). Using a ROC 
curve analysis, early indications suggested that patients with a maximum SCR critical 
value >195% (sensitivity = 52, specificity = 100) at inception were most likely to 
achieve a positive functional outcome at discharge (z=3.564; p=0.0004). 
Interpretation of these findings would indicate that whilst the ability of the SCR cut-off 
value of less than 195% is excellent (specificity = 100) at indentifying patients who 
will have a poor discharge outcome with treatment (not achieve the MCID ODI 
threshold of 50% improvement), it was less able (sensitivity = 52) to identify patients 
(SCR >195%) who would ultimately report a good functional outcome to treatment 
(ODI >50%), indicating that a proportion of patients, despite having SCR‘s below the 
195% threshold (implying a less favorable ODI change score at discharge), managed 
to achieve the MCID improvement threshold of >50% improvement. This may 
indicate a number of possibilities; that the SCR threshold value of >195% has only 
limited predictive capacity (by accurately identifying those patients less likely to 
respond positively to manual therapies); that the ODI functional status indicator and 
change score MCID>50% has limited transferability as an indicator of 
neurophysiological responses to MT treatments over time; or that more data is 
required to verify these findings within LBP sub-populations. Clearly, further research 




The last analysis conducted in evaluating the predictive capacity of SCR 
measurements utilised direct logistic regression analyses (Altman, 1991; p.320-358). 
Results indicated that regardless of the 195% SCR threshold, SCR measures were a 
strong predictor of good outcome, at discharge, more so than currently recognized 
predictors of outcome, that is, the duration of symptoms and the patients‘ age. Indeed, 
putting all the predictive findings together, it was possible to identify trends, within the 
patient population that suggested that patients that met the critical value (of >195% 
SCR) at inception were characteristically those that had commenced treatment within 
the first 6 weeks of onset of symptoms (the most acute patients), that presented with 
higher levels of functional disability (ODI 55% for those with SCR‘s >195% compared 
to 31.5% for those not meeting the threshold; p <0.0005: RMDQ scores 15.2 
compared to 9.5; p <0.0005) and higher pain intensities (NPRS 8 compared to 7; 
p=0.004). Interestingly, those patients who achieved this 195% SCR threshold were 
also observed to require fewer treatments (mean 4.1 compared to 6.4, p < 0.0005) and 
were also more likely to achieve the MCID level (>8.7) in their RMDQ change scores 
(13.5 compared to 7.6; p < 0.0005) and reported greater reductions of pain intensity 
(NPRS reduction of 7.8 compared to 6.7; p=0.003). Consequently, it may be implied 
that the SCR threshold value may provide an independent indicator of improvement 
beyond levels of pain intensity, functional disability, duration of symptoms and age and 
certainly worthy of further, experimental investigation in future studies. 
 
Whilst the critical value/ ―cut-off‖ threshold of 195% lacks validation at this point, it is of 
interest that the patients not meeting the threshold represented the more sub-acute (> 
6 weeks duration of symptoms) patients who, by virtue of the protracted length of their 
symptoms may have undergone the ‗maladaptive‘ neuroplastic changes in the dorsal 
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horn and CNS, as described by Woolf (1994 and 2011), and which might be 
considered to require more than just the mechanical stimulus of SMT to facilitate the 
magnitude of change -in SCR- (as seen in more acute patients and in the early 
treatment sessions) and in the central processing system and activation of the DPIS. 
Indeed, it is not known if the benefits ultimately gained from these patients longer 
treatment programs (>6 treatments) and protracted interaction with the therapist 
provided a greater cognitive (frontal cortex) component to their outcome that may 
indicate a more ‗cerebral‘ element to the therapeutic interaction (Bialosky et al., 2011). 
Obviously it is beyond the scope of this study to determine this but certainly an area of 
research that is developing rapidly in the literature and an arm of future studies that 
might be interesting to explore further, particularly within a more chronic LBP sub-
population.   
 
5.9.5. The strengths and the limitations of the clinical study: 
 
The following discussion identifies the strategies utilized to enhance the rigor of the 
clinical study and some of the limitations of the chosen approach. 
 
The studies strengths and elements enhancing the rigor of the investigation. 
Key elements employed to enhance the rigor of the study included; 1) the performance 
of a pre-clinical study to provide data for the power calculation to determine the sample 
size for the clinical study (thereby ensuring ethical practice by not over-recruiting or 
underpowering the study and thereby minimizing the risk of type I and type II errors), 2) 
the utilization of pre-determined, strict inclusion and exclusion criteria (thereby reducing 
the influences of extraneous variables - that are characteristics of heterogeneous 
populations - on data analysis), 3) by providing clear information and interview 
opportunities for participants to discuss the additional requirements (temporal and 
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procedural) of taking part in the study which enhanced the rigor of the study by limiting 
the drop-out rate (n=1), 4) screening of the participants (prior to each data collection 
opportunity) to ensure adherence to the requirements of the study (e.g. refraining from 
consumption of alcohol, caffeine products, exercise etc for 4 hours prior to data 
collection), 5) providing similar appointment times for all treatment sessions thereby 
limiting the effects that diurnal variation may have upon the data recordings, 6) by 
utilising a standardized (and previously pilot-tested for reliability) set-up for SC data 
collection (and analysis), 7) using the same therapist to perform all treatments (for the 
pre-clinical and the clinical studies) in a standardized, predetermined manner (i.e. 
treatments were performed identically and in accordance with the procedures described 
in the text of the thesis chapters), 8) by performing the study in a ―natural setting‖ and 
undertaking guideline-endorsed physiotherapy practices, rather than single treatment 
modalities within a laboratory setting, thereby enhancing the external validity of the 
study to clinicians treating patients within Hospital environments and ensuring that all 
patients received clinically reasoned, evidence-informed treatment procedures thus 
ensuring that the requirements of the conditions detailed within the ethics committees 
approval documents were maintained (Coventry University, NREC and the local R&D 
office), 9) utilizing recognized, reliable and validated (within LBP populations) PROM‘s 
as secondary outcome measures, 10) by ensuring that the data collection times, within 
the assessment and re-assessment episodes of care, for the primary OM (SC) and the 
secondary PROM‘s (ODI, RMDQ and NPRS) were conducted independently (ie 
questionnaires were not completed whilst SC data was being gathered) ensured that 
the requirements (of OM independence in repeated measures designs) for data analysis 
were adhered to, 11) by taking PROM measures prior to the beginning of each 
treatment and then, retrospectively, identifying the mid-point of treatment for each 
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individual, thereby standardising this point for all patients and permitting an additional 
arm of analysis for trend identification,  12) by determining that statistical data extraction 
and subsequent analyses were only commenced after all treatments had been 
completed (for all patients), thereby minimizing any influence that  either assessor (and 
analyser) bias might have, furthermore, all data analyses were independently checked 
and verified by a statistician, employed within the Coventry University Mathematics and 
statistics department (Dr Tim Sparks). 
 
The studies limitations and proposed considerations for future research. 
The results of the present study should be considered in light of several limitations. 
Firstly, it is recognised that because of the design of this inquiry, a pragmatic 
observational study, it was not possible to assign a true cause-effect relationship to the 
data observations and trends made within this patient population, thereby limiting any 
inferences that can be made from the statistical analyses conducted. Nevertheless, it is 
also acknowledged that this is also the first study, of its kind, to record SC measures 
within a LBP patient population, thereby providing clinical data that might inform future 
randomised clinical trials (RCT).  For the current clinical study, however, weaknesses in 
the observational nature of the design meant that, no randomisation of patients was 
performed, no control group was allocated and the independent variables were not 
‗manipulated‘, thereby limiting the interpretation of the statistical analyses used 
(particularly with the parametric statistical tests). Future studies are proposed that utilise 
elements of variable (independent) manipulation, randomisation (allocation) and control 
that would permit inference of cause-effect following statistical analysis. 
 
Secondly, the use of a non-probabilistic convenience sample of acute and sub-acute 
LBP patients could limit the external validity of the study to the broader LBP population, 
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especially with respect to the more chronic sub-population of LBP patients. As indicated 
earlier, the use of patients with simple LBP in addition to those with radicular LBP 
symptoms may have weakened the homogeneity of the group leading to interpretational 
bias. Thus, future studies with sub-group delineation are recommended to enhance 
inference. 
 
Thirdly, although the therapist and patient were both blind to the SNS (SC) measures 
being recorded during all treatments (due to the fact that this was a pragmatic study), 
the therapist conducting the treatment was also the therapist performing the research 
which may have the potential to create bias. According to Schutz et al. (1995) the lack 
of blinding can lead to an exaggerated estimation of treatment effect in the order of 17% 
(although it is worthy of note that the reported SCR effect sizes within this study were in 
excess of this amount and all exceed the published MCID‘s for the PROM‘s) and all 
statistical analyses were independently checked and verified by a statistician (Dr Tim 
Sparks, Department of Mathematics and Statistics, Coventry University). 
 
Fourthly, no attempt was made to influence the order of the treatments delivered to the 
patients. Although the types of treatment were specifically detailed and consistently 
performed between patients (by the same therapist, thereby strengthening the internal 
validity) and are recognised as being ‗guideline-endorsed‘ approaches to LBP 
management, the order of the prescribed treatments may have influenced the SCR‘s 
obtained. Counter-balancing (Newell and Burnard, 2011: p. 172) may have alleviated the 
effects of potential confounding extraneous variable, however, due to the pragmatic nature 
of the study this was deemed unrealistic as it would not have reflected current clinical 
practice. Another solution might have been to have conducted a re-analysis of any order 
effects on the data however, because of the limited number of participants it was decided 
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that a more conservative analysis of the data was more realistic although it is 
acknowledged as being a potential limitation to the interpretation of the analyses 
presented.  
 
Fifthly, it is recognised that as a pragmatic study, the numbers of treatments given to 
the patients were not standardized, although the author attempted to limit the bias that 
this would create by pre-determining the criteria for the points at which patients were 
discharged (e.g. achievement of the NPRS levels, restored lumbar motion and return to 
work) and by ensuring that all PROM‘s were taken at each attendance with identification 
of the mid-point conducted, retrospectively, in order to limit bias in the data analysis. 
Despite this, it is acknowledged that the point of discharge may have been different for 
each patient because the reasons for discontinuing care were left to the discretion of the 
individual patient and the therapist. There were a variety of reasons for why care was 
discontinued; most were related to clinical improvement, but three of the patients 
programmes of care were protracted by scheduling difficulties with their return to work. 
Because the main aims of the study were to observe SC recordings under routine 
clinical circumstances, the length of time the patient spent within the clinic was 
extended (due to the requirements of stabilising the recordings prior to treatment and 
recording post-treatment responses) and discharge timing lacked strict control. This 
approach could have potentially caused the Hawthorne effect and influenced the 
outcome measures obtained. Recommendations for future studies would be to identify 
and control clear, pre-determined data capture points within a set time period. Based on 
the recommendations of the NICE (2009) guidelines, a 12 week treatment programme 
would suffice, however, considering the experience of the current study, and its acute 






Sixthly, companion psychometric questionnaires (e.g. The Hospital Anxiety 
Questionnaire, Fear Avoidance and Behaviour Questionnaire or the Short-Form 36 
health questionnaire) to determine which specific factors were elevated were not 
included. Whilst this was not standard practice in the Hospital setting utilised it may be 
important to examine such information for future research and for research on a more 
chronic patient population, as has been recommended by Walsh and colleagues (2003).  
 
Seventhly, although strict inclusion and exclusion criteria were adhered to, specific 
levels of pain intensity (NPRS) and of functional disability (ODI and RMDQ) were not 
included, which may have subtly influenced the homogeneity of the group for statistical 
analysis? Whilst it was intended to have a group that was the most representative of 
acute and sub-acute patients receiving treatment within the clinical setting, it might be of 
value, in future studies, to exclude patients with pain less than 5/10 (NPRS), an ODI 
score at inception less than 30% or RMDQ scores of less than 5/24. 
 
Although the feasibility of a the use of SCR measures to detect patients most likely to 
benefit from early, targeted treatments could not be verified in the context of the present 
study, the potential for the predictive capacity of this tool is worthy of further 
investigation. Current patterns of care indicate that most patients experiencing an 
episode of LBP initially enter the health care system through a primary care setting 
(Deyo and Phillips, 1996), and many patients are referred from a primary care setting to 
physiotherapists (Freburger, Carey and Holmes, 2005a). Referral from a primary care 
setting to physiotherapists adds to the costs of care but may also improve outcomes 
(Nordeman et al., 2006 and Pinnington, Miller and Stanley, 2004). Data on current 
practice patterns suggest that the decision to refer a patient with LBP to a 
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physiotherapist is highly variable across and within geographic regions and is markedly 
influenced by factors other than the consideration of modifiable prognostic factors 
(Freburger, Carey and Holmes, 2005b) and, as Childs, Flynn and Wainner, (2012) 
acknowledge, most referring clinicians are still reluctant to refer to physiotherapy before 
four weeks from onset of symptoms, despite the evidence that adherence to 
recommendations results in fewer clinic visits, reduced long-term health care utilisation 
and greater improvements in disability limitation and pain reduction (Fritz, Cleland and 
Brenan, 2007). Furthermore, practitioner and practice engagement and enforcement of 
the clinical guidelines for the management of LBP is not universal nor is it consistently 
applied although it is recognised, by practitioners, as being essential to ensure the 
appropriateness of therapeutic input at the optimum point in the patients‘ symptom 
episode which has the potential to substantially affect the quality of life, functional 
disability and the cost-effectiveness of care provided to patients with LBP. 
 
5.10. Conclusion to the clinical study 
To the authors‘ knowledge, this is the first study to evaluate the effects of physiotherapy 
treatment on SC activity levels and SCR‘s within an acute and sub-acute LBP patient 
population within a clinical environment.  The results indicated that patients may have 
SC activity levels and SC responses (to treatment) that may reflect the existence of an 
altered/adapted, plastic state of DH sensitisation in response to tissue injury and 
resultant up-regulation of nociceptor, DH and CNS activity and concomitant down-
regulation of the SNS. Over time, SC recordings may be able to monitor these 
neurophysiological adaptations/changes with identifiable reductions in SCR‘s to 
treatment as the programme of therapy progressed towards discharge. 
SCR and PROM correlates indicated that SCR‘s were more strongly correlated with 
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functional disability PROM‘s than with pain intensity although there was evidence to 
support strong correlations between function and pain. Observations indicated that 
SCRs to treatment diminished in magnitude, from inception to discharge, as functional 
ability improved and pain reduced. Furthermore, preliminary analyses of positive 
outcomes from therapy (as measured by an ODI improvement > 50%) indicated that 
maximum SCR‘s, during treatment, were stronger predictors of outcome than duration 
of symptoms and patient age, with patients who achieved the SCR critical value of 
>195% (with treatment at inception) most likely to require fewer treatments despite 
having higher initial levels of functional disability and higher intensities of pain at 
inception. Whilst the SCR critical value of 195% was able to identify poor responders to 
treatment, the predictive capacity of this 195% threshold level lacked specificity to 
predict those patients that would respond positively to treatment. 
 
Further research is highly recommended, within a number of areas, to verify and 
validate these unique observations and findings, and to determine whether SNS (SC) 
activity and response measurements are of value in clarifying and elucidating the 
magnitude and efficacy of treatments for LBP and adding to the body of knowledge that 
is developing within the areas of LBP classification, outcome prediction, and optimum 
prescription of guideline-endorsed physiotherapy that is considered to be a complex 




6. Final Discussion and Suggestions for Further Work 
 
The following discussion draws together all the previous chapters and having identified 
the knowledge-gaps from the literature review (chapter 2) places the findings of this 
research thesis (chapters 3, 4 and 5) into the current context of research within the area 
of the SNS and the effects of physiotherapy and manual therapies. The key findings of 
the thesis are reviewed within the current and evolving philosophy that underpins the 
―professional knowledge landscape‖ of physiotherapy and the manual therapies for the 
management of acute and sub-acute LBP. 
 
The concept of the neuro-musculoskeletal system as a dynamic continuum that is able 
to respond and adapt peripherally, spinally and supra-spinally to a variety of thermal, 
chemical, nociceptive, mechanical, physiological and cognitive stimuli is now well 
recognised within physiotherapy research. Nonetheless, the mechanisms by which 
clinicians (and researchers) are able to qualify and quantify the proposed mechanisms 
of action of the treatment programmes prescribed are still in the developmental 
phases. The use, clinically, of standardised and LBP specific PROM‘s is an 
acknowledged practice that assists the clinician in determining the status of a patient 
(in terms of pain intensity and functional disability) and the outcomes achieved 
following therapeutic intervention, furthermore, the identification of levels of MCID 
places the context of reported change measures within the bounds of acceptable 
patient-perceived benefits to therapy. Whilst these measures may be applauded for 
providing some insight into the experience of LBP and the role that therapy plays in 
affecting change, PROM‘s are recognised as suffering from a degree of subjectivity, 
floor and ceiling effects, recall-bias and the response-shift phenomenon causing some 
authors and critics to call for more objective and immediate indicators of change that is 
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not subject to patient, cognitive or psychological influence.  Measurement of SNS (SC) 
responses to therapy and the concept that SNS sympathoexcitation is related to 
hypoalgesia is a recognised phenomenon within the manual therapy research that is 
able to provide such immediate measurement of ―internal‖/physiological change 
however, most of the research into this area is in the upper quadrant and only a 
handful of studies have been conducted within patient populations. Whilst the Biopac 
Data Acquisition System is a widely used tool for measuring a variety of physiological 
responses, there has been no published research that has established the tools 
reliability, measurement variability and stability in taking SC measurements nor has 
the smallest real difference (SRD) statistic been calculated that facilitates 
interpretation of SC findings beyond measures that may be as a result of equipment or 
procedural/administration error. Furthermore, there was no available data of the 
equipments reliability within a non-laboratory, clinical environment (i.e. in an 
environment where heat, humidity and noise is not controlled), information that is 
essential for use within a clinical application with a patient population. 
  
The findings of chapter 3 indicated that the Biopac Data Acquisition System (for SC 
measures) had acceptable random measurement error and test-retest reliability for 
use in a non-laboratory situation. The research in this element of the thesis revealed 
that there was minimum measurement variability between applications of the 
equipment (ICC=0.997; p<0.0005) and that although it was possible to observe a small 
degree of variability, this variability was not systematic. Further analysis of the data 
found that any measurement in excess of the calculated smallest real difference (SRD) 
of 0.3154 μMho‘s (or 4.633%) could be regarded as an SNS (SC activity level) change 
that is independent of any measurement error or variability and could be considered to 
represent real change ascribable to the intervention under investigation. Whilst it is 
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acknowledged that these findings were the first to be published (Perry et al., 2011) on 
the Biopac System providing statistical levels of SRD for SC activity levels, it is also 
recognised that statistical measures of SRD do not necessarily translate into patient 
perceived measures of clinically important difference (MCID) indicating the need for 
further, patient-focused research in this field. 
 
In 2009, the publication of the NICE Guidelines for the management of LBP (in 
addition to the CSP, 2006 guidelines) recommended that LBP management and 
treatment strategies should include (amongst other recommendations) the use of 
manual and manipulative therapies, particularly in the acute and sub-acute stages of 
the condition. However, a knowledge gap was recognised, within the literature, 
indicating a lack of information regarding the SNS (SC) responses, observable in the 
lower limbs, as a result of lumbar spinal therapies. Indeed, prior to the research 
presented in this thesis there was only one paper providing insight into the SNS 
responses occurring with a lumbar treatment technique. Perry and Green (2008) 
identified that their population of naïve, normal, healthy males experienced 
sympathoexcitatory, side-specific responses to a uni-laterally applied postero-
anterior mobilisation technique to the L4/5 segment. More recently, Perry 
collaborated with other researchers in publishing a study identifying that a lumbar 
MWM technique was able to produce bilateral sympathoexcitation in the lower limbs, 
again in normal healthy volunteers (Moutzouri, Perry and Billis, 2012). However, 
there was still a knowledge-gap regarding the effects of other, commonly applied, 
NICE (2009) recommended, lumbar techniques, namely; lumbar rotatory 
manipulation and McKenzie‘s repeated EIL technique. Consequently, a pre-clinical 
study was designed and conducted (chapter 4) to determine normative SCR values 
as a result of these techniques. Findings revealed that both treatments had 
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statistically significant sympathoexcitatory responses (that were above the 
established SRD of 4.3%) and that the manipulation technique had a response (SCR 
76%) that was significantly greater (double the magnitude of response) than the 
McKenzie EIL technique (SCR 35%) and, unlike the Perry and Green (2008) article, 
that there was no significant side-specific difference in SCR (in the manipulation 
technique). Again, this study was the first to publish SC findings with lumbar 
treatment techniques (Perry et al., 2011). 
 
As identified above, one of the strengths of this body of work was the recruitment and 
recording of SC data, independently, from a patient and an asymptomatic/―normal‖ 
population of participants. Uniquely, therefore, this thesis provided an opportunity for 
comparison between data from an asymptomatic (chapter 4) and a symptomatic group 
(chapter 5) to determine whether there were any differences, or similarities in SCR‘s 
between the populations. Pre-clinical testing on asymptomatics is acknowledged as a 
valuable precursor for clinical testing (and ethically recognized as adhering to the 
protocol of Good Clinical Practice). Results from the analysis indicated that SCR‘s 
behaved similarly for both treatments in both groups. The observed sympatho-
excitatory responses (from baseline to during the treatment periods) both reached 
levels of statistical significance. Importantly, and uniquely to this study, the responses, 
in the patient groups were found to be significantly (statistically) greater (for both 
treatment techniques). Overall, the 25 participants retrospectively allocated into the 
manipulation technique group were recorded to have generated the greatest SCR with 
this selection of participants from the patient group having almost three times the 
magnitude of response than that observed in the asymptomatic group participants 
(SCR‘s 200% and 76% respectively) with the McKenzie‘s EIL exercise having a similar 
but reduced magnitude of response (SCR‘s 104% and 35% for patients and 
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asymptomatics respectively). To the authors knowledge these findings have not been 
reported in previously published papers despite patient populations being investigated 
(Vicenzino, Collins and Wright, 1996; Sterling et al., 2001, and Paungmali et al., 2003). 
Indeed, Schmid et al., (2008) conducted a systematic review of 15 papers that 
explored the evidence for a CNS component in the responses observed with passive 
mobilizations in the cervical spine. In their pooled data analysis Schmid at al., (2008) 
reported SCR responses (mean pooled differences between intervention and control 
measures) of 35.1% (+/- 16.5), however, these results did not distinguish between the 
data gathered from norms and from patients, indeed, of the studies meeting the quality 
criteria for the review, only 7 reported SCR findings, and of those, only 2 included 
patient populations that lacked normative comparisons (Vicenzino et al. 1998 and 
Sterling et al., 2001) thereby making any comparisons to the current study 
unconvincing. Nonetheless, the findings of the data from this element of the current 
thesis would support the concept that patients (with LBP) could be demonstrating SNS 
responses (SCR‘s) that indicate an adapted neurological pain processing mechanism. 
 
The findings of the pre-clinical study (chapter 4) were used to inform the sample size 
calculation for the final, clinical study (chapter 5) in this thesis. Further comparisons 
of the clinical, patient data and the data from the pre-clinical/normative study 
revealed that patients initially presented with SC activity levels (e.g. 90 µmho‘s in the 
manipulation responders) that were lower, in the early stages of LBP presentation, 
compared to their normal counterparts (119 µmho‘s), although these differences did 
not achieve a level of statistical significance (p=0.07) these findings might hint at the 
possibility that symptomatic LBP individuals present with SNS-inhibited activity levels 
and would be an observation worthy of further exploration in future studies. Looking 
at the patient populations‘ responses, over time, to treatment also revealed that 
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manipulation SCR‘s diminished from the heightened initial responses (i.e. 266% at 
inception to 182% at mid-point) to levels, at discharge, that corresponded to those 
observed in the asymptomatic population receiving the manipulation technique (i.e. 
72% for patients compared to 76% for asymptomatics). This could be considered to 
corroborate fit with the models proposed by Woolf (1994 and 2011), Boal and Gillette 
(2004) and Bakkum et al. (2007) that tissue injury and segmental lumbar 
hypomobility results in adapted nociceptor and mechanoreceptor DH, CNS and SNS 
synaptic activity.  
 
Thus, it is feasible, within the construct of the present studies findings, to consider 
that following the onset of injury, patients experiencing pain (LBP), particularly in the 
early stages, may present with enhanced/‖up-regulated‖ levels of DH neuronal 
excitability/sensitisation/potentiation (Woolf, 1994; Bakkum, 2007; Boal and Gillette, 
2004), that may not seemingly be evident in an asymptomatic population. 
Furthermore, these proposed ‗normal adaptive neuroplastic changes‘ to the DH and 
CNS (Boal and Gillette, 2004; Taylor and Murphy, 2010) have, through fMRI 
investigations, been specifically correlated to pain activated regions in the brain – 
Thalamus, Amagdala and Brainstem – (Piché, Arsenault and Rainville, 2010; and 
Nagai et al., 2004) and to the resultant triggering of the PAG, the DPIS and to the 
associated changes, systemically and peripherally, in SNS activity levels. The 
greater the magnitude of SCR‘s in the ‗acute‘ group (with symptom duration less 
than 6 weeks and associated high pain and functional disability levels) would support 
this construct but it would be worthwhile for future studies, to seek to verify this 





In his review paper, Woolf (2011) highlights‘ that whilst new research is emerging, 
regarding the discovery of genetic and environmental contributors to pain plasticity, 
treatments that produce analgesia by normalizing hyperexcitable central neural activity 
(ie SMT‘s) remain at the forefront in symptom management despite the relative paucity 
of strong evidence that observes these neuro-plastic changes within patient 
populations. Clearly, this is an area with a considerable knowledge-deficit, for future 
investigation within patient populations. 
 
Few published studies have been performed on patient populations and none, to the 
authors‘ knowledge, have looked at the lumbar spine and lower limbs. Other studies 
that have recruited patients have explored the thoracic and cervical regions but have 
reported effects of lesser magnitude (16%, Sterling et al., 2001) for treatments 
possibly reflecting regional differences in peripheral cutaneous innervation or central 
processing systems.  
 
Central to the premise that MT stimulates the SNS (and, through central processing 
systems, indirectly activates a descending pain inhibitory system [DPIS]), is the 
concept that MT stimulates local receptors which, in turn, are capable of directly or 
indirectly activating the PAG mechanisms (Zusman, 1986; Wright 1995). This study 
demonstrated that guideline-endorsed physiotherapy (and in particular MT), resulted in 
sympathoexcitation, suggesting activation of the dPAG (noradrenalin) and the DPIS 
(Lovick, 1991) that may also correspond to (either directly or indirectly) restoration of 
function with further correlations with reductions in pain intensity. The author readily 
acknowledges that it is not possible, from this study, to directly attribute a cause/effect 
relationship here and that other factors (such as the psychosocial and emotional 
constructs of pain processing) could play a significant part in the experience of 
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patients. Nonetheless, it is worthy of note that each patient in this study underwent a 
―therapeutic‖ experience by which they purported significant benefit regarding pain and 
symptom reduction and improvements in function (mean ODI score reduction of 79%) 
with 95% of patients having returned to work by discharge. Tracey et al. (2002) found 
that there was a distinct correlation between the level of engagement of the DPIS, pain 
reports and levels of ‗distraction‘ (including placebo and expectation) and Wagner et 
al. (2004) found that the PAG and dorso-lateral prefrontal cortex (emotions centre) can 
be selectively activated during anticipation of an ―event‖, triggering opioid release 
within the brain-stem thus modulating pain perception, it is possible that instigation of a 
MT technique might constitute just such an ―event‖ and be powerful enough to result in 
the cascade of central processing responses that may be responsible for clinically 
observed improvements. Future studies are recommended (which may incorporate 
Biopac EEG with SC) to explore this possible link. 
 
Historically, a number of authors (Wyke and Polacek, 1975; Yezierski, 1991) argue 
that local mechano-receptors, located within the musculoskeletal system in joints, 
capsule, ligaments, connective tissue and tendons may be responsible for local, spinal 
cord inhibitory reflex . Pickar (1995) demonstrated that manipulation of cat spinal joints 
stimulated receptors and afferent nerve fibres within the capsule and associated 
connective tissues of the spinal column. Furthermore, Wyke and Polacek (1975) and 
Katavich (1998) suggest that stimulation of large diameter, low threshold 
mechanoreceptors in articular and peri-articular structures by SMT may produce a 
local spinal cord inhibitory effect and that these effects represent predictions of the 
‗Gate Control‘ theory (Melzack and Wall, 1996). However, Zusman (1986) has 
challenged the ability of SMT to preferentially stimulate large diameter joint afferents at 
the expense of small diameter, high threshold afferents, arguing that the proposed 
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hypoalgesic effects of SMT include hysteresis, a decrease in joint afferent activity 
following sustained or repetitive passive movement. More recently, Bialosky et al., 
(2008) revealed that patient expectations of manipulative techniques directly 
influenced the magnitude of SNS responses, with other authors describing significant 
responses, to SMT, recording increased blood levels of inflammatory Cytokines but 
not of Substance P (Teodorczyk et al., 2006), of restoring levels of Inter-leukin-2 
(found to be depleted in LBP patients - Teodorczyk et al., 2010) in addition to 
increasing levels of b-endorphins and serotonin (Degenhardt et al., 2007). Additionally, 
Padayachy et al., (2010) found that serum cortisol levels were affected in LBP patients 
and that patients receiving SMT had increases in the levels of these hormones, a 
finding that Skinner et al., (2011) also identified with respect to levels of blood 
dopamine which have been found to be affected in subjects affected by pain, sleep 
deprivation and anxiety (Skinner et al., 2011). 
 
Ultimately, it is possible that the treatment techniques, used in this study, directly 
stimulated local sympathetic fibres especially as the ganglia have a close anatomical 
relationship with the vertebral motion segment (Slater, 2002) and therefore the 
observed SNS excitatory response may simply be a spinal reflex (Magoun, 1978). 
Sterling et al. (2001) reported changes in superficial muscle activity following SMT 
arguing that this may be a response to a locally induced muscle stretch and 
stimulation of mechanoreceptors with resultant activation of segmental myogenic 
spinal reflex mechanism, although a number of authors have reported direct causal 
links between SMT and reflex muscle inhibition (Indahl et al., 1997; Herzog et al.,1999 
and 2001; Dishman et al., 2000 and 2002; Colloca et al., 2006 and Zusman 2004). 
Indeed, it is feasible that the techniques in the current study may have been a SNS 
response to direct compression of the lumbar tissues overlying the painful segment. 
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Previous authors (Chiu and Wright, 1996 and Perry and Green 2008) have suggested 
that the parameters of the MT stimulus are important in determining the magnitude of the 
SNS activity. These authors theorised that the oscillatory aspect of the treatments they 
performed may have been responsible for the magnitude of the SNS change observed. 
Indeed, it has been argued that the lack of significant SCR‘s previously reported with the 
non-oscillatory SNAG performed in the study by Moulson and Watson (2006) further 
supported this argument although the more recent study by Moutzouri, Perry and Billis 
(2012) did find significant SCR‘s during their application of MWM‘s to the lumbar spine 
thus countering this argument or indicating that the lumbar spine may respond differently 
to the cervical region with regards to MWM techniques. However, Moutzouri, Perry and 
Billis‘s (2012) SCR‘s in the MWM group were not found to be significantly different to the 
placebo technique thereby questioning, further, this supposition. The results of the 
clinical study of this thesis, and the previous preliminary study on a normal population 
(Perry et al., 2011) neither support nor negate this theory as none of the treatments, that 
were identified as providing maximum SCR‘s, were oscillatory techniques. However, the 
magnitudes of response to the treatments in the currently reported studies were much 
greater than those found with oscillatory techniques (on normal/ asymptomatic 
populations) and therefore it may be argued that these results might counter this theory. 
The findings of the currently reported body of works endorse Bialosky et al.‘s (2009) 
model that considers both spinal cord and supra spinal mediated effects of manual 
therapy (see figure 31 overleaf) although, it is worthy of note that much of the evidential 
literature supporting Bialosky et al.s‘ (2009) model is based on animal experiments and 
laboratory-controlled experiments on asymptomatic healthy volunteers.  
 
With reference to the concepts within Bialosky et al.s‘ (2009) model (figure 31 overleaf), it 
is hoped that some of the findings of this thesis provide some additional information, 
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filling some of the knowledge gaps and areas lacking evidence of clinical (LBP) 
application that, until now, have only been established with laboratory studies on 
asymptomatic humans, animal studies and inferences from cervical spine studies. 
Analysis and consideration of the clinical data, from the current study, could provide a 
unique input (indicated by the bold red arrows) to the model by confirming the existence 
of a measurable effect (clinically, functionally and neurophysiologically) of treatment 
(SCR changes) that correlate to patient reported changes in pain intensity (NPRS) and 
functional disability (ODI and RMDQ scores). It is worthy of note that despite the 
publication of this and other models (e.g. George et al., 2006) and the general 
acceptance of these constructs within the profession, most of these models remain 
incomplete and purport a rather biomedical, approach to pain management, that is, that 
anatomical spinal structures are the source of pain and contribute to long-term 
potentiation of nociceptors. Indeed, whilst Wand and O‘Connell (2008) acknowledge the 
input that peripheral and spinal receptors have regarding clinical pain manifestations, 
they also challenge that therapies for LBP (and in particular chronic LBP) should be 
based around the ‗cortical dysfunctional model‘ presented in their review paper (figure 32 



























































































































































































This item has been removed due to third party copyright. The unabridged version of the thesis may be 
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Whilst the data generated by the current thesis does not include a chronic LBP 
population which is the focus of Wand and O‘Connell‘s (2008) review, nor does it 
provide any corroboration of the cortical dysfunctional elements that they purport, it is 
not inconceivable that the high pain intensities reported by the clinical population of the 
current thesis, coupled with the high functional disability levels reported could form part 
of the constructs within the chronic LBP model, that is; (refer to the coloured numbers in 
the following text corresponding with those in figure 32);          New episode of low back 
pain results in peripheral nociceptive input (high pain intensity reorts on NPRS);          
this leads to activation of the central pain neuromatrix with resultant          sensory-motor 
incongruence with back movements and functional activities (high functional disability 
levels in ODI & RMDQ scores)          and motor control changes, increased guarding 
and co-contraction;              where intra-/sub-cortical facilitation / decreased inhibition may 
represent the heightened SCR‘s to inception treatment. Clearly, more studies are 
required to explore these theories and to validate how SC activity levels and SCR‘s 
might contribute to this ‗cortical dysfunctional model‘ for chronic LBP populations. 
 
A preliminary evaluation was also conducted with the aim of estimating the predictive 
utility of the Biopac system SCR measures within a LBP population. Whilst it is 
acknowledged that this is not the same as calculating the MCID (a patient-perceived 
standard level of meaningful improvement), it was recognized that the data from this 
study could provide a unique opportunity to compare the new (SCR) data to a known 
patient-perceived and validated clinical predictor (ODI percentage change score >50%) 
of positive therapeutic outcome. Indeed, early indications from the analysis suggested 
that the critical value of 195% SCR (at inception) was excellent at identifying poor 
responders to MT treatment (specificity = 100) which could be useful, in the early stages 








approaches, the SCR 195% critical value was less able to detect good responders to 
treatment (sensitivity = 52) which could imply that the predictive capacity of SCR 
measures lack true application. Conversely, it was noteworthy that in the clinical study, 
a large number of the patient participants achieved MCID scores in excess of those 
reported, in other studies, as representing achievement of patient reported benefits from 
therapy. Indeed, the mean participant changes in PROM‘s demonstrated improvements, 
from inception to discharge, in function, on the ODI scale (an average improved score of 
34%, where reported MCID = 19%), on the RMDQ scale (average improvement of 11 
points, MCID = 8.7) and pain intensity NPRS (an average reduction of 7.2 points, with 
MCID = 2.5). Thus, it might be conceivable that this patient population responded to the 
guide-line endorsed therapeutic intervention in a manner that exceeded the 
expectations of PROM‘s within other similar clinical studies. This may have had 
implications for the correlation and for the predictive capacity analyses. Clearly, further 
studies are called for to verify and validate these findings. Finally, the last analysis, 
evaluating the predictive capacity of SCR measurements, indicated that regardless of 
the 195% SCR threshold, SCR measures were a strong predictor of good outcome, at 
discharge, more so than currently recognized predictors of outcome, that is, the duration 
of symptoms and the patients‘ age. Furthermore, good responders to therapy were 
characteristically those that had commenced treatment within the first 6 weeks of onset 
of symptoms (the most acute patients), that presented with higher levels of functional 
disability and higher pain intensities and were observed to require fewer treatments to 
achieve symptom abatement. Thus, despite its obvious limitations the SCR threshold 
value of 195% may provide an alternative and independent indicator of improvement 
beyond levels of pain intensity, functional disability, duration of symptoms and age and 




As discussed above, whilst the critical value/ ―cut-off‖ threshold of 195% lacks validation 
at this point, it is of interest that the patients not meeting the threshold represented the 
more sub-acute (> 6 weeks duration of symptoms) patients who, by virtue of the 
protracted length of their symptoms may have undergone the ‗maladaptive‘ neuroplastic 
changes in the dorsal horn and CNS, as described by Woolf (1994 and 2011), and 
which might be considered to require more than just the mechanical stimulus of SMT to 
facilitate the magnitude of change -in SCR- (as seen in more acute patients and in the 
early treatment sessions) and in the central processing system and activation of the 
DPIS. Indeed, it is not known if the benefits ultimately gained from these patients longer 
treatment programs (>6 treatments) and protracted interaction with the therapist 
provided a greater cognitive (frontal cortex) component to their outcome that may 
indicate a more ‗cerebral‘ element to the therapeutic interaction (Bialosky et al., 2011). 
Obviously it is beyond the scope of this study to determine this but certainly an area of 
research that is developing rapidly in the literature and an arm of future studies that 
might be interesting to explore further, particularly within a more chronic LBP sub-
population. Unfortunately, it was not within the scope of this research to validate this 
SCR cut-off threshold further, nonetheless, it is recommended that future clinical trials 
be conducted to legitimize this threshold parameter within stratified patient populations 
and to ascertain its validity at predicting overall outcome to manual, exercise and indeed 
cognitive therapies within different (primary and secondary) health care settings.  
 
Regarding the nature of the ―therapeutic‖ encounter that the patients in this study 
received, the Medical Research Council (MRC, 2000 and Craig, Dieppe and Macintyre, 
2008) might define the combined, pragmatic and clinically representative approach of 
advice/education, exercise and manual therapy techniques as a ―complex intervention‖. 
Within the context of researching the phenomenon of ―complex interventions‖, the 
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research within the current thesis may be considered to fall into phase II of the MRC‘s 
framework by providing, on the back of a broad theoretical understandings of MT 
interventions, an ‗exploratory‘ insight into a number of areas that could be used to 
inform definitive RCTs (phase III) and long-term implementation studies and clinical 
guidelines/recommendations (phase IV). How the current thesis fits into this framework 
is illustrated in figure 33 overleaf. Within the illustration, the 5 key findings of the thesis 
are depicted by the letters ABCDE where; A = the Biopac reliability study (chapter 3), B 
= the normative (pre-clinical) SC data for two commonly used lumbar treatment 
techniques, C = observational (clinical) SC data on Guideline-endorsed physiotherapy 
for acute and sub-acute LBP; and the comparative, preliminary, analysis of 
asymptomatics & patient populations, D = the correlative analysis of clinical PROM‘s 
and SC data, and E = the preliminary feasibility study of SCR‘s for predicting clinical 







Figure 33: A representation of the place of the thesis findings within the MRC framework for Complex 
Interventions (2000) the letters ABCDE refer to research questions addressed within the thesis, Bold 
blue lettering indicates areas for future research 
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The publication of the national guidelines (CSP, 2006 and NICE, 2009) for the 
management of LBP clearly recommend the use of manual and manipulative therapies, 
presenting moderate to strong evidence of its effectiveness, particularly in an acute 
patient population. Indeed, Sizer (2008), in his invited commentary on ‗spinal 
manipulative therapy for acute low back pain‘, argues that SMT should not be 
considered 2nd line treatment after GP care (advice on staying active and drug 
management) on the contrary, he cautions that SMT should be considered a non-
pharmaceutical 1st line care approach serving as a healthy alternative to the 
contemporary primary care practice model. However, Sizer (2008) does caution that 
biopsychosocial considerations should also be included when evaluating the influence 
of SMT treatment selection on outcomes, particularly with the more chronic patient 
populations. To the authors‘ knowledge, this study is the first to provide empirical, 
clinically relevant, evidence supporting the early use and the resultant positive 
outcomes of lumbar manual and manipulative treatments (in addition to advice, 
education and exercise) in an acute NSLBP population, supporting the published 
guidelines as well as clinicians anecdotal arguments for the integral use of MT 
treatment approaches within a comprehensive (guideline-recommended) patient care 
package. It would be of interest to consider a sub-group of chronic patients in future 
studies as it remains unknown what their SCR status, at inception, may be and how this 
might differ in terms of responses to treatment and to final outcome measurements, 
indeed, if the findings of the current study are extrapolated, beyond the 12 week 
symptom duration criteria, it may be anticipated that a more chronic LBP population 
would have a poorer SNS response to MT treatment approaches, and require more 
extensive treatment programs, including alternative, cognitive behavioural approaches 
to activate the central pain processing areas within the cortex and ultimately the DPIS 
(Oosterwijck et al., 2011).  Indeed, the work of a number of authors have demonstrated 
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that the presence of chronic pain, including back pain, is associated with decreased 
thalamic grey matter density (Apkarian et al., 2004 and Ruscheweyh et al., 2011) and 
that the provision of an appropriate ―stimulus‖ has the effect of ―rebooting the system‖ 
(Apkarian et al., 2005) and facilitating an adaptive change that aligns the patient back to 
normal parameters. Indeed, Apkarian et al. (2005) found that with the abolishment of 
pain there was observable (MRI and voxel-based analyses) restoration of regional grey 
matter densities in LBP patients (Ruscheweyh et al. 2011).  Moreover, Moseley (2008) 
advises that the presence of pain and the phenomenon of cortical reorganization are 
related and speculates that the effects of physiotherapy interventions/treatments on 
‗body and motor maps‘ requires the patient to carefully attend to and discriminate the 
location, quality and intensity of the therapeutic stimulus (i.e. an externally, mechanically 
and proprioceptively induced stimulant e.g. a manipulative procedure) facilitates 
normalization of the internal ‗maps‘.  
 
In contrast to this theory, Bialosky et al.‘s (2008) study revealed that normal 
(asymptomatic) subjects with negatively incited expectations, for SMT-induced 
hypoalgesia, experienced significant increases in pain perception following the 
procedure, suggesting the role of recipient expectation on the effects of SMT, and 
importantly, the role of the therapist in the competent assessment of patients‘ attitudes 
and the matching of patient choice and expectations to the optimum treatment approach. 
The elements of cortical reorganization, placebo and expectation formed a part of 
Moseley‘s (2007 and 2008) work and Bialosky et al.‘s 2009 ‗comprehensive model‘ are 
worthy of consideration however they are beyond the scope of this studies data analysis 
although their importance is acknowledged.   
 
Finally, the concept that neurophysiological (SC) activity levels and changes occurring in 
the lumbar region can be credibly and reliability monitored (with the Biopac system) and 
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potentially modulated with guideline-endorsed physiotherapy and MT treatment. This 
research provides observational evidence to support early active physiotherapeutic 
intervention that is seen to restore function and a pain-free status.  The findings of this 
study corroborate the advice provided in a number of key guideline texts that endorse the 
use of manual and manipulative techniques in the acute and sub-acute stages of 
symptom onset. Furthermore, whilst this programme of research is not definitive, it does 
provide clinicians, patients, GP‘s/referrers and managers supplementary evidence to 
support the early referral of LBP patients to appropriately qualified practitioners for 
consideration and application of guideline-recommended physiotherapy and MT 
treatment (CSP, 2006 part 2; Mercer et al., 2006; Fritz, Cleland and Brenan, 2007 and 






The processes of evidence informed practice and clinical research are inherently 
interwoven. This multi-level, integrated and often cyclic process starts with clinical 
observations and the generation of research questions. Through the conduct of 
research, the development and testing of theoretical concepts and the systematic 
collection and analysis of data, the findings may be disseminated back into the 
therapeutic encounter between the therapist and patient. In the execution of this 
mission and with the explicit, judicious and conscientious (Sackett et al., 1996) 
application of findings into clinical decision making, ultimately, it is hoped that patients, 
clinicians and managers achieve furtherment of knowledge and understanding. Thus, 
the administration of optimum, research-informed, clinically effective treatments that 
meet the patient‘s expectations, manage symptoms and provide appropriate education 
and advice in a timely manner.  
 
Contributions to Knowledge 
 
The aim of this series of studies was to contribute to the professional-knowledge 
surrounding the observable effects of physiotherapy (and particularly spinal manual 
and manipulative therapies) on patients presenting with LBP in a clinical environment. 
Chapter 2 identified the key knowledge-gaps in the LBP arena, recognising that 
although epidemiological risk factors, classification models, clinical prediction rules 
and OM‘s exist, none truly capture the diverse nature of the patient experience of LBP 
and none provide an objective marker for research comparisons. Furthermore, the 
current research in the area of SNS status and treatment responses to therapies was 
severely lacking in the lumbar region and lower limbs. Thus, the initial aim (chapter 3) 
was to establish the reliability and measurement stability of Biopac SC readings within 
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a natural (non-laboratory). This reliability study was paramount to the following 
chapters (4 and 5) of the thesis where knowledge-gaps in the effects of commonly 
used manual therapy treatments were investigated, initially in a pre-clinical, normal 
population and, latterly, and pragmatically, within an acute and sub-acute LBP patient 
population receiving guide-line endorsed physiotherapy treatment.    
The pre-clinical investigation (chapter 4) established normative values for SC 
responses to two, independently applied, specific MT techniques, applied to the 
lumbar region. Findings from this study revealed that both treatment techniques 
produced statistically significant sympathoexcitatory changes that were detectable in 
the lower limbs (and were greater than the SRD established in the reliability study). 
Moreover, the rotatory manipulative technique produced twice the size of SCR as the 
McKenzie EIL technique, and contrary to other research, was not side-specific, with 
only the manipulation technique having a lasting effect into the final rest period.   
The preliminary data comparisons of the pre-clinical asymptomatic participants with data 
extracted from observations from the patient participants challenged the assumption that 
normative and patient population studies were analogous. Results suggested that 
patients with acute or sub-acute LBP were significantly more (SC) responsive to 
treatment (at inception) than their normative counterparts. Whilst it was acknowledged 
that this may, in part be due to the ―composite‖ nature of the patient treatment 
experience, it was noted that future studies were necessary to enhance understanding 
within this remit.  
The main analyses of the patient observations suggested that initially, patients attended 
with inhibited baseline SNS levels of activity and these levels were observed to increase 
as they completed their programme of therapy. Additionally, SCR‘s were greatest at 
inception but as therapy progressed towards discharge, the magnitude of SCR to 
268 
 
treatment diminished to levels that corresponded to SCR‘s found in asymptomatic norms. 
Analyses of the existence of correlations between SCR and currently used PROMs, 
indicated that SCR‘s were positively and statistically correlated to functional disability 
more than to pain intensity. Due to the strength of the correlations it was hypothesised 
that SCR‘s might constitute an objective, alternative, and complementary measure of 
patient outcome within a clinical or research setting. Furthermore, a preliminary 
exploration of the utility of inception SCR measures at predicting functional outcomes at 
discharge (employing a validated ODI improvement score in excess of 50%) indicated 
that a (SCR) treatment response threshold of 195%, whilst excellent at identifying poor 
responders to MT treatment, was less accurate at identifying good responders, to manual 
and manipulative therapies. 
 
Clearly, the observational design of the clinical study was not able to infer any cause-
effect results, however, it does provide some interesting and new information that 
contributes, in phases one and two of the MRC‘s framework for ‗complex intervention‘ 
research that could inform future, definitive, phase 3 clinical randomised controlled trials 
into LBP management strategies.    
 
The findings of the clinical study indicated that patients have SCR‘s to treatment that are 
significantly greater than those seen in asymptomatic healthy volunteers, and that SCR‘s 
to treatment may reflect the DH sensitisation in the early stages of symptom onset 
indicated by higher treatment-SCR‘s that also correlate to higher levels of functional 
disability, to high levels of pain intensity and to short symptom duration. Patients with 
higher treatment SCR‘s treated in the early stages of symptoms required fewer 
treatments to achieve symptom and pain resolution and achieved positive functional 
outcomes so that by discharge treatment SCR‘s were significantly reduced, pain had 
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abated and there was a positive change in functional disability (as represented by an 
improvement score on ODI in excess of 50%).  
 
A key, but preliminary, suggestion from the findings of this study was that SCR‘s might be 
a non-invasive indicator of neuroplastic adaptations, DH and CNS processing that occur 
as a result of lumbar injury.    
 
It is believed that the findings of this study adds to the body of knowledge required to 
further understand the mechanisms of action of manual therapies, in particular 
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Study Outline
• Clinical element in a PhD programme of study
• Observational
• A pragmatic, non-experimental, prospective 
cohort design
• Neurophysiological responses 
(SC activity levels & SCR - % change)
• Acute & Sub-acute NSLBP (of up to 12 weeks duration)
• Guideline-endorsed Physiotherapy 
(CSP, 2006; NICE, 2009)
 
• Advice to stay active and return to work
• Self-management strategies




(CSP, 2006; NICE, 2009)
Guideline endorsed recommendations 
for the management of acute LBP
 
Background to the study - 1
• Patient-reported outcome measures widely utilised
• PROM‘s ―subjective‖ in nature 
• Currently utilised & validated with LBP:-
- Oswestry Disability Index (ODI, version 2.1)
- Roland Morris Disability Questionnaire (RMDQ)
- Narrative Pain Rating Scale (NPRS)
 
Background to the study - 2
• Strong conceptual links between SNS & pain processing
• SC is a quantifiable & reliable measure of response to 
manual therapies 
• Most studies with SNS conducted on asymptomatics
• Patient studies largely on the upper quadrant 
• None on patients with acute and sub-acute LBP
• Current knowledge gaps; normals & patients, PROM‘s & 
SCR‘s & patient treatment responses
Methods – 2 (SNS recordings)
Primary OM - recordings of SC & SCR’s:-
- Biopac Data Acquisition system (MP35)
- Non-invasive electrodes attached to  
2nd & 3rd toes both feet
- Continuous recording of SC activity





ALL Recordings for analysis taken: Inception & Discharge.
 
• Ethical approval obtained 
• The research design : observational, non-experimental, 
prospective, repeated measures cohort study
• A power calculation advised 57 patients needed (Perry et al, 2011) 
• 60 patients were recruited by convenience sampling
• 1 drop-out 
• n=59 
Methods - 1
Methods – 3 (SC recordings: inception & DC)
Segment 1 , 10 :11:31 e il, 10 :18:05 10:26:38 10:31:25 






























































Methods – 4 (Secondary OM‘s)
• ODI (version 2.1) (Fairbank et al, 1980 & 2000) 
- PROM of functional status/limitations
- 0 to 100% scale 
- high scores indicate high functional disability 
• NPRS (Childs et al, 2005)
- patient-reported measure of pain intensity
- 0 to 10 scale (11 points): 0 = ―no pain‖, 10 = ―the worst pain 
imaginable‖
- high scores indicate high pain intensity levels
 
RQ -1 
Do patients with acute & sub-acute LBP 
have the same SCR‘s as normal healthy 
volunteers? 
 
Results – 1 (normals V’s patient data)
Data analysis
• 2 independent groups
- 50 asymptomatics (Perry et al 2011)
- 50 patients (random selection)
• 2 independent treatments 
- 25 Rotatory L4/5 HVLAT Manipulation
- 25 Repeated (x10) EIL exercise
• Maximum SCR‘s compared for 2 treatments
• Homogeneity assured (age, gender, height & weight)
 
Results 1 
(Normals V’s Patient data)
- Both groups sympathoexcitatory
- regarding the 2 treatments :-
- within group differences in SCR‘s
(F=9.618; p=0.003)
- between group differences in SCR‘s 
(F=12.410; p=0.001)   & 
 
RQ -1 
Do patients with acute & sub-acute LBP 
have the same SCR‘s as normal healthy 
volunteers? 
• Both populations sympathoexcitatory
• SCR‘s for Manipulation greater than EIL exercise
Overall, patient‘s have a greater magnitude of response
RQ - 2 
What are the SCR‘s of patients to 
treatment over time? 
• Whilst baseline SC levels rose from 
inception to discharge
• Treatment responses declined (I to DC)
 
RQ - 2 
What are the SCR‘s of patients to 
treatment over time? 
 
RQ - 3 
How do SCR‘s to treatment compare with 
PROM‘s?
(what are the relationships between PROM‟s 






• Patients with acute or sub-acute NSLBP (<12/52)
• Findings at inception (population means):-
- ODI Inception = 42% (8% at DC = 78% improvement)
- NPRS Inception = 7.5 (0.27 at DC)
- SCR Inception = 219% (94% at DC = 123% reduction)
Results – 3 (patient data – OM correlations)
 
Results 3 - (Clinical data SCR & PROM correlations)
Inception
• ODI & NPRS moderately +vely 
correlated (r=0.525; p<0.0005)
• SCR & NPRS moderately +vely 
correlated (r=0.459; p<0.0005)
• SCR & ODI strongly +vely correlated 
(r=0.821; p<0.0005)
 
RQ - 3 
How do SCR‘s to treatment compare with 
PROM‘s?
(what are the relationships between PROM‟s 
and SCR‟s to treatment?)
• ODI & NPRS   - Moderately correlated
• NPRS & SCR  - Moderately correlated
• SCR & ODI      - Strongly correlated
• SCR better correlated to function than to 
pain intensity
 
RQ – 4 Trends 
Are there any observable trends in SCR 
according the to nature of the treatment 
that provides the max SC Response?
Is it feasible to utilise SCR‟s to treatment at inception as an 
empirical predictor of a positive functional outcome at 
discharge?
 
n=60 (SCR‘s at inception)
• Overall mean max SCR 219%
• 3 key treatments identified
- n=31 (52%) Manip (HVLAT) SCR 267%
- n=14 (23%) repeated EIL SCR 172%
- n=15 (25%) MWM SCR 165%
Results 4 – Observed trends
SCR at Inception (in Micro mhos's)















yResults 4a – (trends!) 
From this small sample of data:
• Possible trends identified using 
linear regression and ROC curve 
analyses
• SCR more powerful than age & symptom duration as a 
predictor for positive outcome at DC (ODI change score > 50% at 
discharge)
• Early indications suggest patients with a SCR critical value 
>195% at inception are most likely to achieve a positive 
outcome at DC (ODI change >50%) (Sensitivity 52; Specificity 100)
• Further study required to validate this……..
 
- n=31 (52%) Manip (HVLAT) SCR 267%
- n=14 (23%) repeated EIL SCR 172%
- n=15 (25%) MWM SCR 165%
ANOVA comparisons (& post hoc) analyses:
• No differences between treatments groups regarding ODI scores 
(p=0.082) & NPRS levels (p=0.797) 
• Differences between treatment regarding SCR’s (0.043) = 
manipulation treatment
Results 4 – Observed trends
Key Messages - 1
• SCR‘s in asymptomatics and patients comparable 
(sympathoexcitatory)
• However, patient SCR‘s are greater in magnitude than 
those in asymptomatic groups (x3 fold)
• Patients have inhibited SC activity levels at inception 
• By DC SCR‘s to treatment diminish
• SCR's, at inception, are strongly correlated with functional 
disability & moderately correlated with pain intensity





Key Messages - 2
• Preliminary observations indicate SCR‘s differ according to 
nature of treatment (lumbar rotatory manipulation > repeated EIL ex 
> MWM)
• Preliminary Regression & ROC curve analyses indicate 
SCR‘s (at inception) may have some feasibility in providing 
an early empirical indicator of functional outcomes at DC
• SCR‘s may be a useful tool for MT research in patient 
populations
 
Key Messages - 3
• Future studies (including suitably powered RCT‘s) 
are recommended for verification and validation of 
these preliminary findings and to establish the 
potential of any predictive capacity of SCRs in patient 
populations
Thank you for your attention…..
Thanks are extended to the patients and staff at the Leicester Royal Infirmary for their 
assistance in the completion of this study & to Coventry University for support in allowing time to 







Appendix II - Details of the literature search strategy 
 
The current research was based on a background of work performed by  
various researchers. This literature was searched using the EBSCO search 
engine within the library web-page. The following sources were selected: 
Academic Search Complete, AMED,CINHAL, Medline, PEDro, 
PsycINFO, Pubmed,SportsMed, SAGE Journals online and Science Direct   
databases.  
The keywords utilized included: 
manipulative therapy, manual therapy, physiotherapy, physical therapy,   
mobilization, manipulation, Mulligan, SNAG, NAG, MWM, 
mobilization with movement. There terms were changeably intermeshed with: 
sympathetic nervous system, autonomic nervous system, neurophysiological, 
manipulation induced analgesia, analgesia, descending pain inhibitory system, 
DPIS, skin conductance, SC, SCR, galvanic skin response, GSR, sweat 
response, skin temperature, Biopac, lumbar, low back, spine and spinal. 
 
In addition, a Zetoc alert was set up to search, on a weekly basis, for all 
articles with the following subject headings and authors: Manipulation, low 
back pain, sympathetic nervous system, Vicenzino (Author). 
Secondary searchers were also performed on key texts.  
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Appendix III - SUBJECT INFORMATION SHEET 
 
Title of Project: The reliability of the Biopac System Skin Conductance 
Measurements in a natural, non-laboratory setting with 
asymptomatic healthy volunteers.  
 
Principal Investigator: J. Perry MSc, MCSP, MMACP, mHPC, Grad Assoc 
Phys. PgCert Ed. Senior Lecturer (Physiotherapy) 
Coventry University. Tel 02476887890. 
 
Director of Studies: Mrs. A Green. Associate Head of Physiotherapy, 
Coventry University.  
 
Purpose of Study:   
You are invited to participate in this study that aims to determine the reliability of 
the Biopac System at measuring resting skin conductance (sweat levels) 
responses over two time periods. This data can then be used to determine if the 
Biopac is a reliable and stable measuring tool, outside of the laboratory setting, 
and for future use in hospitals to measure patients with back trouble.  
 
Procedures: 
If you are prepared to be involved in the study you will be required to attend the 
Charles Ward Building (room CWG01) on two separate occasions (and at the 
same time of day). The first visit will consist of a brief, 5 minute, interview to 
determine your suitability for inclusion to the project. This will comprise of a series 
of questions about your current and past health, any current medications and any 
conditions which might influence the results of the research (eg skin complaints). 
At this meeting, you will be invited to discuss any aspects of the study with the 
Principle Investigator. Following this, should you wish to be included in the study, 
you will be asked to sign a consent form before starting the measurements. Prior 
to your visits it is essential that you try not eat any food for 2 hours or have any 
drinks that contain caffeine (tea, coffee, coca cola etc) or refrain from alcohol for 
up to 24 hours prior to the study. This is important as food and certain drinks can 
affect the skins sweat responses. 
 
Experimental procedure: 
The experiment will take place in room CWG01. Your skins sweat response will be 
measured by asking you to lye still, on a treatment couch. You will be asked to 
remain completely silent throughout the procedure unless you have need to advise 
the researcher of any change in your condition which requires that you discontinue 
the test. Additionally, you will be asked not to cough or sneeze throughout the 
procedure. In order to measure your skin response it is necessary to place small 
disc/electrodes on the second and third toes of each of your feet. Once you are 
settled and comfortable, readings will begin. This should not take more than 15 
minutes and the researcher will inform you when the period of the test has ended.  
 
Risks, discomforts and benefits: 
It is not anticipated that you will experience any discomfort from any of the 
measurement procedures however, testing will be terminated immediately upon 
your request, if you experience any undue discomfort. The results obtained from 
xv 
 
the study will be very important in helping to determine the reliability of SC 




You will be allocated an identification number which will remain confidential to the 
principal investigator and the project director. All the data recorded, using only the 
assigned number for identification, will be stored on a password protected laptop 
computer that only the principal investigator and the project director can access. 
Consent forms will be stored in a locked cupboard. The results of the study will be 
reported but it will not be possible to identify individual subjects. Once the study 
has been completed, the data will be stored with the project director in a secure 
place for 7 years, after which time it will be destroyed.  
 
Request for more information: 
You are encouraged to discuss any concerns regarding the study with the 
Principal Investigator at any time, and to ask any questions you may have. 
 
Refusal or withdrawal: 
You may refuse to participate in the study and if you do consent to participate then 
you will be free to withdraw from the study at any time and without fear of 
prejudice. If you do decide to withdraw from the study then please contact the 
Principal Investigator at the earliest opportunity. In the event that you withdraw, all 
your data will be destroyed. 
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     CONSENT SHEET 
 
Title of Project:   
The reliability of the Biopac System Skin Conductance Measurements in a natural non-
laboratory setting with asymptomatic healthy volunteers.  
 
Principal Investigator:  
J. Perry MSc, MCSP, MMACP, mHPC, Grad Assoc Phys. PgCert Ed. Senior Lecturer 
(Physiotherapy) Coventry University. Tel: 02476887890. 
 
Project Supervisor:   
Mrs. A Green. Associate Head of Physiotherapy, Coventry University.  
Tel: 02476888883 
 
You are voluntarily making a decision whether or not to participate in this research study. 
Your signature certifies that you have had sufficient time to consider the information provided 
and that you have decided to participate, having read and understood the information 
provided and that you do not have any learning difficulty or medical condition that affects 
your ability to understand the information nor any decision regarding your participation. Your 
signature also certifies that you have received enough information about the study had the 
opportunity to discuss this study with the investigator and that all your questions have been 
answered to your satisfaction.  
 
I, (the undersigned)______________________________________________ 







consent to participate in this study and give my permission for any results from this study to 
be used in any report or research paper, on the understanding that confidentiality will be 
preserved. I understand that I may withdraw from the study at any time without prejudice. If 
so, I undertake to contact the Principal Investigator (Tel: 02476887890) at the earliest 
opportunity. 
 
Signature: ______________________________ Date: _________________ 
                                     Subject 
 
 I have explained the nature of the procedures involved in the study to which the  
 subject has consented to participate and have answered all questions. In my   
 judgement the subject is voluntarily and knowingly giving informed consent and  
 possesses the legal capacity to give informed consent to participate in this research  
 study. 
      
Principal Investigator: _________________________  Date: _____________ 
 
My signature as witness certifies that the subject signed this consent form in my presence as 










Appendix IV – An Explanation of the ‗Integral Measure‘ from Biopac Pro 3.7 
Software. 
 




Appendix VI - SUBJECT INFORMATION SHEET (Pre-clinical study) 
 
Title of Project: The effects of a physiotherapeutic treatment technique 
to the lower back on the immediate sweat response in 
the feet of normal healthy male volunteers. 
 
Principal Investigator: J. Perry MSc, MCSP, MMACP, mHPC, Grad Assoc 
Phys. PgCert Ed. Senior Lecturer (Physiotherapy) 
Coventry University. Tel 02476887890. 
 
Director of Studies: Mrs. A Green. Associate Head of Physiotherapy, 
Coventry University.  
 
Purpose of Study:   
Patients with back trouble often complain of pains and stiffness and seek 
physiotherapeutic advice and intervention to hasten recovery and relieve 
symptoms. Joint mobilisation (spinal manipulative therapy) techniques are popular 
techniques involved in the treatment of this condition. You are invited to participate 
in a study which aims to determine the effects of a physiotherapeutic technique 
applied to the lower back, currently used in clinical practice with patients with back 
trouble, by investigating the effects of this technique on changes in the skins sweat 
response in healthy subjects. 
 
Procedures: 
If you are prepared to be involved in the study you will be required to attend the 
Charles Ward Building (room CWG01) on one occasion. The visit will consist of a 
brief, 10 minute, interview to determine your suitability for inclusion to the project. 
This will comprise of a series of questions about your current and past health, any 
current medications and any conditions which might influence the results of the 
research (eg skin complaints). At this meeting, you will be invited to discuss any 
aspects of the study with the Principle Investigator. Following this, should you wish 
to be included in the study, you will be randomly allocated into one of two 
treatment groups. You  will receive either a rotation technique or a back arching 
technique whist skin electrodes record any changes in your sweat response. Prior 
to your visit it is essential that you try not eat any food for 2 hours or have any 
drinks that contain caffeine (tea, coffee, coca cola etc) or refrain from alcohol for 
up to 24 hours prior to the study.. This is important as food and certain drinks can 
affect the skins sweat responses. 
 
Experimental procedure: 
The experiment will take place in room CWG01. Your skins sweat response will be 
measured by asking you to lye still, on a treatment couch. You will be asked to 
remain completely silent throughout the procedure unless you have need to advise 
the researcher of any change in your condition which requires that you discontinue 
the test. Additionally, you will be asked not to cough or sneeze throughout the 
procedure. In order to measure your skin response it is necessary to place a small 
disc/electrode to the second and third toes of each of your feet. Once you are 
settled and comfortable, initial baseline measures will be taken (this takes 10 
minutes), then you will receive one of two treatments. This will last no longer than 
2 minutes. Following the treatment you will be asked to remain still for a further 5 
20 
 
minutes. During this period the researcher will remain in the room and will inform 
you when the period of the test has ended (total 17 minutes of recording time. The 
experiment will last no longer than 20 minutes.  
 
All measurements will be recorded by an associated, independent researcher. 
 
Completion of the experiment: 
Following the experimental procedure, you will be advised which treatment you 
received and the effects of that treatment on your sweat response. You will then 
be free to go. 
 
Risks, discomforts and benefits: 
It is not anticipated that you will experience any discomfort from any of the 
measurement procedures or the treatment technique, except perhaps for very 
minimal discomfort in the establishment of your joint‘s normal level of stiffness. 
The techniques are designed for treatment of patients with stiff and restricted joints 
and requires little active participation on the part of participant. It is therefore not 
physically demanding and so should not cause any undue tiredness. Testing will 
be terminated immediately upon your request, if you experience any undue 
discomfort of fatigue or if any abnormal responses to the technique occur. The 
results obtained from the study will be very important in helping to determine the 
effectiveness of this technique on the nervous system and will be used to 
determine choices for treatments on patients suffering with back trouble. 
 
Confidentiality: 
You will be allocated an identification number which will remain confidential to the 
principal investigator and the project director. All the data recorded, using only the 
assigned number for identification, will be stored on a password protected laptop 
computer that only the principal investigator and the project director can access. 
Consent forms will be stored in a locked cupboard. The results of the study will be 
reported but it will not be possible to identify individual subjects. Once the study 
has been completed, the data will be stored with the project director in a secure 
place for 7 years, after which time it will be destroyed.  
 
Request for more information: 
You are encouraged to discuss any concerns regarding the study with the 
Principal Investigator at any time, and to ask any questions you may have. 
 
Refusal or withdrawal: 
You may refuse to participate in the study and if you do consent to participate then 
you will be free to withdraw from the study at any time and without fear of 
prejudice. If you do decide to withdraw from the study then please contact the 
Principal Investigator at the earliest opportunity. In the event that you withdraw, all 






CONSENT SHEET (pre-clinical study) 
 
Title of Project:   
The effects of a physiotherapeutic treatment technique to the lower back on the immediate 
sweat response in the feet of normal healthy volunteers. 
 
Principal Investigator:  
J. Perry MSc, MCSP, MMACP, mHPC, Grad Assoc Phys. PgCert Ed. Senior Lecturer 
(Physiotherapy) Coventry University. Tel: 02476887890. 
 
Project Supervisor:   
Mrs. A Green. Associate Head of Physiotherapy, Coventry University.  
Tel: 02476888883 
 
You are voluntarily making a decision whether or not to participate in this research study. 
Your signature certifies that you have had sufficient time to consider the information provided 
and that you have decided to participate, having read and understood the information 
provided and that you do not have any learning difficulty or medical condition that affects 
your ability to understand the information nor any decision regarding your participation. Your 
signature also certifies that you have received enough information about the study had the 
opportunity to discuss this study with the investigator and that all your questions have been 
answered to your satisfaction.  
 
I, (the undersigned)______________________________________________ 







consent to participate in this study and give my permission for any results from this study to 
be used in any report or research paper, on the understanding that confidentiality will be 
preserved. I understand that I may withdraw from the study at any time without prejudice. If 
so, I undertake to contact the Principal Investigator (Tel: 02476887890) at the earliest 
opportunity. 
 
Signature: ______________________________ Date: _________________ 
                                     Subject 
 
 I have explained the nature of the procedures involved in the study to which the  
 subject has consented to participate and have answered all questions. In my   
 judgement the subject is voluntarily and knowingly giving informed consent and  
 possesses the legal capacity to give informed consent to participate in this research  
 study. 
      
 
Principal Investigator: _________________________  Date: _____________ 
 
My signature as witness certifies that the subject signed this consent form in my presence as 













Actual Value Criteria met 
Yes(√)/No(X) 
Age Over 18 years   
Medium height  5ft4  to 6ft 
(150 – 180 cms) 
  
Average weight  140 to 200 lbs 
( Kgs) 
  







No Previous PT 
or SMT 
  



















Nicotine Ingestion Non-Smoker   
Recent ingestion 
(within 2 hours) 
Caffine   
Food   
Recent ingestion  Alcohol   
Skin disorder affecting 
the sites of electrode 
placement 
clear   
 
 






























Appendix VIII                PARTICIPANT INFORMATION SHEET 
 
Title of Project:  The effects of a course of physiotherapy treatment for back pain on patients‘ levels of pain, 
on their return to normal activities and on their sweat levels (in both feet). 
 
Principal Researching Physiotherapist:  J.Perry MSc, mMACP, mCSP, mHPC, Grad Assoc Phys. 
PgCert.Ed Senior Lecturer in Physiotherapy, Coventry University, Faculty of Health & Life Sciences. Tel 024 
7688 7890                
 
Director of Studies:  Ann Green. Associate Head of Physiotherapy & Dietetics, Coventry University. Tel: 
024 7688 8883  
 
You are being invited to take part in a research study.  Before you decide it is important for you to 
understand why the research is being done and what it will involve.  Please take time to read the following 
information carefully. Talk to others about the study if you wish. This leaflet tells you the purpose of this 
study and what will happen to you if you take part and gives you more detailed information about the 
conduct of the study. Please do not hesitate to ask us if there is anything that is not clear or if you would like 
more information. Take time to decide whether or not you wish to take part. 
 
What is the purpose of Study?:   
You are invited to participate in a study which aims to determine the effects of physiotherapy techniques, 
currently used in clinical practice, on skin sweat values, on pain and on day-to-day activity. People with low 
back pain often complain of muscle and joint pain and stiffness and seek help from physiotherapists to 
relieve symptoms, hasten recovery and return to work. There are a number of treatment approaches used 
by physiotherapists that aim to restore function and reduce symptoms but little is known about their effects 
on the nervous system. By measuring the sweat levels in the feet, it is possible to measure the responses of 
the nervous system to the treatments given and to record any changes as recovery progresses. The 
purpose of this study is to record any nervous system changes at each treatment session and determine if 
these reflect and changes that you report in your symptoms. The study forms part of a Doctorate and is 
sponsored by Coventry University in partnership with the University Hospitals of Leicester NHS Trust. 
 
Why have I been chosen? 
All patients referred to the Leicester Royal Infirmary with lower back pain will be considered for the study. 
You may be asked to join the study if you have had your symptoms for less than 12 weeks, are between the 
ages of 18 and 55, you do not suffer with skin complaints affecting your feet, are a non-smoker and are 
willing to take part in the study which will involve you attending (and completing) a normal course of 
physiotherapy treatment. 
 
Do I have to take part? 
No. It is up to you to decide whether or not to take part.  If you do, you will be given this information sheet to 
keep and be asked to sign a consent form. You are still free to withdraw at any time and without giving a 
reason and without fear of prejudice.  A decision to withdraw at any time, or a decision not to take part, will 
not affect the standard of care you receive. It is customary for the Researcher to advise your referring 
clinician (eg. GP or consultant) of your decision to take part in the study unless you explicitly request that 
they are not notified. As in all cases, the physiotherapist will also write a discharge report at the end of your 
course of treatment to advise the Doctor of your progress. If you do decide to withdraw from the study then 
please contact the Principal Investigator/treating physiotherapist at the earliest opportunity. In the event that 
you decide not to continue with the study during your treatment program (but wish to continue having 
treatment), your case will be passed to another Physiotherapist who will continue your treatment. 
 
What will happen to me if I take part and what will I have to do? 
If you are prepared to be involved in the study you will be invited to attend the Physiotherapy Department at 
the Leicester Royal Infirmary NHS Trust for a normal/standard course of Physiotherapy treatment to your 
lower back (4-8 treatments – once or twice a week - tailored to your needs). The first visit, should you 
consent to join the program, will consist of an interview and physical assessment where you will be invited to 
discuss any aspects of the study with the Principle Investigator/Physiotherapist. Also on this occasion, 




 toes of 
your feet and asking you to lie still for 5-10 minutes. Treatment will be administered in accordance with usual 
care lasting 20-30 minutes. Further treatment sessions will then be booked in accordance to normal 
physiotherapy practice for the Trust. Treatments will be conducted as normal, the only difference to your 
sessions, from that of other patients not in the study, will be the addition of the recordings of your foot sweat 
levels. Because the readings are very sensitive to sweat changes, it is requested that prior to each visit you 
do not eat any food for 2 hours or have any drinks that contain caffeine (tea/coffee/Cola) or alcohol and that 
you refrain from heavy exercise prior to your treatment.  
 
Visit 1 Assessment and Initial Baseline Recordings: 
On the first visit a researcher will undertake a standard physiotherapy assessment of your back and evaluate 
your suitability for the investigation. This will comprise of a series of questions about your current and past 
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health, any current medications and any conditions that might influence the results of the research (eg skin 
complaints or prior illnesses). This will be followed by an examination of your spine and your presenting 
condition as well as the skin on your feet where the sensors will be placed. Next, recordings of your sweat 
levels will be made and you will be asked to lie absolutely still, in a comfortable position for 5-10 minutes. 
You will be asked to remain completely silent throughout the procedure unless you have need to advise the 
researcher of any change in your condition which requires that you discontinue the test. Additionally, you will 
be asked not to cough or sneeze throughout the recordings as this may disturb the readings. This visit 
should last no more than 1 hour. 
 
Visit 2 and Subsequent Treatment Sessions: 
On these visits your skin sweat level will again be recorded in the same way. You will then undertake normal 
physiotherapy treatment during which your skin sweat levels will be monitored. At the end of each treatment 
session a final measure will be taken during which time you will be asked to lay still for five minutes. During 
this period the researcher will remain in the room and will inform you when the period of the test has ended. 
This visit should last no longer than 45 minutes.  
 
Final Treatment: 
Following the completion of your course of treatment you will be interviewed and the outcome of treatment 
determined (ie pain levels, activity levels and return to work status). A final measure of your skin sweat 
levels will also be recorded. This session should last no more than 45 minutes. 
 
Risks, discomforts and benefits: 
It is anticipated that you will not experience any discomfort from any of the measurement procedures or the 
treatments undertaken, except perhaps for very minimal discomfort as a result of the treatments employed. 
The techniques used are designed for treatment of patients with stiff joints and many are passive techniques 
on the part of the patient and are therefore not physically demanding and so should not cause any undue 
tiredness. Testing will be terminated immediately upon your request, if you experience any undue discomfort 
of fatigue or if any abnormal responses to the technique occur. If you take part in the study you will learn 
about the place of this technique in the treatment of spine pain. The results obtained from the study will be 
very important in helping to determine the effectiveness of the techniques on the nervous system and will 
enhance our understanding of how physiotherapy to the lower back might accelerate healing. 
In the event that something does go wrong and you are harmed during the research study there are no 
special compensation arrangements.  If you are harmed and this is due to someone‘s negligence then you 
may have grounds for a legal action for compensation against The University Hospitals of Leicester NHS 
Trust, but you may have to pay your legal costs. The normal National Health Service complaints 
mechanisms will still be available to you (if appropriate). 
 
Will my taking part in the study be kept confidential?  
You will be allocated an identification number that will remain confidential to the Principal Investigator and 
the Director of Studies. All the data recorded, using only the assigned number for identification, will be stored 
on an encrypted, password-protected computer that is stored in a locked cabinet. Examination and 
Treatment records will be stored in a locked cupboard and managed according to the Trusts Data Protection 
Procedures. The results of the study will be reported but it will not be possible to identify individual 
participants. Once the study has been completed, the data will be stored in accordance with the Trusts Data 
Protection Policy and with Coventry Universities Data Protection Procedures.   
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any possible harm you might 
suffer will be addressed. In the first instance you are encouraged to discuss any concerns regarding the 
study with the Principal Investigator/treating physiotherapist (Miss Jo Perry 02476887890 or 0116 2585813). 
Should you have any further concerns you should contact the Director of Studies (Mrs Ann Green 
02476888803) or the Supervisors in the Trust (Professor Paul Watson 0116 2584613 or Professor Sally 
Singh). If you remain unhappy and wish to complain formally, you can do this through the NHS Complaints 
Procedure. Details can be obtained from the hospital. 
 
Reviewers of the Study: 
This study is sponsored by Coventry University and has been reviewed and approved by both the University 





Title of Project: 
The effects of a physiotherapy treatment to the lower back on sweat levels in both 
feet in patients with back pain. 
 
 
Study Number:  
 
Patient Identification Number for this study:  
 
 
Principal Investigator:  J.Perry MSc, mMACP, mCSP, mHPC, Grad Assoc Phys. PgCert.Ed Senior 
Lecturer in Physiotherapy, Coventry University, Faculty of Health & Life Sciences. Tel 024 7688 
7890                
 
Director of Studies:  Ann Green. Associate Head of Physiotherapy & Dietetics, Coventry University. 
Tel: 024 7688 8883  
 
 
Please initial box  
 
1. I confirm that I have read and understand the information sheet dated 17
th
 December 
2008 (version 1.) regarding the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily.  
 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time without giving any reason, without my medical care or legal rights being affected.  
 
 
3. I understand that relevant sections of my medical notes and data collected during the 
study, may be looked at by individuals from Leicester University, from regulatory 
authorities or from the NHS Trust, where it is relevant to my taking part in this research. I 
give permission for these individuals to have access to my records.  
 
 
4. I agree to my referring medical practitioner (ie GP) being informed of my participation in   
the study.  
 
 




_______________   ________________             _________________  
Name of Patient    Date     Signature  
 
 
_________________   ________________               ___________________  
Name of Person    Date      Signature  
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Appendix IX – Letter to Referring Clinician 







Dear (Clinician Name) 
 
Re- Patients Name; Address; NHS ID No; D.O.B. 
 
I write to advise that your patient has been invited to take part in a study observing 
the effects of routine physiotherapy treatment to the lower back on sweat levels in 
both feet. This is a non-invasive measure of sweat levels, before, during and after 
physiotherapy treatments and provides a proxy measure of neurophysiological 
activity which has been correlated to symptoms in neck pain and tennis elbow 
patients but not yet in a Low Back Pain population. Results of these 
neurophysiological measures will be compared to standard subjective measures of 
pain (Narrative Pain Rating Score) and disability (Oswestry Disability Index and 
Rolland Morris Disability Questionnaire).  
 
The study is being run as a collaboration between Coventry University (Faculty of 
Health & Life Sciences, Department of Physiotherapy) and The University Hospitals 
of Leicester NHS Trust at the Leicester Royal Infirmary. Please find enclosed a copy 
of the participant information sheet. If you have concerns about any part of the study 
then please do not hesitate to contact us to discuss the matter using the contact 
details at the end of this letter.  
At the end of the program of treatment we will write to advise you, in the usual 








Jo Perry (Chartered Physiotherapists)  MSc, mMACP, mCSP, mHPC, Grad Assoc Phys. 
PgCert.Ed. 







 Principal Investigator:  J.Perry MSc, mMACP, mCSP, mHPC, Grad Assoc Phys. PgCert.Ed Senior Lecturer in 
Physiotherapy, Coventry University, Faculty of Health & Life Sciences. Tel 024 7688 7890. Director of Studies:  Ann 






























Key Physical Findings at inception 

















1 F 49 1 a W W 10 2 8 0 40 1 √ √ √ - - - 
2 M 53 3 b I W 11 8 8 1 28 22 √ - √ - √ √ 
3 F 41 3 c W W 9 5 6 1 45 18 - - √ - - - 
4 F 38 1 b W W 10 1 3 0 24 5 √ - - - - - 
5 M 46 3 c W W 18 3 8 1 80 2 √ √ √ √ - √ 
6 F 44 2 c W W 18 3 7 0 48 20 √ √ √ - √ √ 
7 F 45 2 a I W 7 5 6 1 36 1 √ √ √ - - - 
8 M 26 2 c W W 6 2 8 0 38 0 √ - √ - - - 
9 F 37 2 c I I 10 1 6 0 28 4 √ √ √ √ - - 
10 M 33 3 c W W 4 0 6 0 44 6 √ - √ - - √ 
11 F 48 3 b W W 16 2 8 1 48 6 - - √ - - - 
12 F 36 1 b W W 8 1 7 0 38 1 √ - - - - - 
13 F 46 3 c I W 5 0 5 0 26 12 √ √ √ - - - 
14 M 21 1 b W W 14 0 7 0 36 18 √ - - √ - √ 
15 M 27 2 c W W 16 1 9 0 58 0 √ - √ - - - 
16 F 27 3 b W W 19 2 9 0 74 20 √ √ √ - - √ 
17 F 44 2 b I W 10 0 7 0 36 30 √ √ - - - - 
18 M 47 2 c I W 7 1 8 1 28 16 √ √ √ - - √ 
19 M 36 2 b W W 6 2 7 0 26 4 √ √ √ - - - 
20 M 48 2 a I W 12 0 8 0 40 0 √ √ √ - - √ 
21 F 49 2 b I I 10 2 8 1 38 4 √ - √ - - √ 
22 M 54 4 a I I 11 8 8 1 40 20 √ √ √ - - √ 
23 F 42 3 c I W 11 4 8 1 28 12 √ - √ - - - 
24 F 37 1 s I W 11 1 6 0 22 5 √ √ √ - - - 
25 M 44 4 a I W 16 1 10 0 64 4 - √ √ √ √ √ 
26 F 45 2 c W W 20 3 9 0 74 18 - √ √ - - - 
27 M 46 2 c W W 7 5 8 0 28 0 √ - - - - - 
28 F 30 2 c W W 9 1 8 0 36 0 √ √ √ - - - 
29 F 39 3 a I W 10 1 7 0 36 2 √ √ √ - - √ 
30 F 34 2 b W W 16 2 7 0 42 2 √ - - - - - 
31 F 47 3 c I W 14 2 8 1 32 0 √ - - - - - 
32 F 35 3 b W W 11 1 8 0 38 4 √ - - - - - 
33 F 48 3 b W W 12 0 8 0 33 0 √ - √ - - √ 
34 F 30 3 b I W 16 0 6 1 44 6 √ √ - - - √ 
35 M 32 3 a I W 16 1 4 0 16 14 √ √ √ √ - √ 
36 F 25 4 c W W 19 1 9 0 76 18 √ √ √ - - - 
37 F 43 1 b W W 12 0 8 0 38 0 √ - - - - - 
38 M 48 2 c I W 9 0 8 0 28 16 √ - √ - - √ 
39 M 24 3 b W W 6 2 6 1 24 2 √ - √ - - √ 
40 M 49 3 b I W 12 0 8 0 56 6 √ √ √ - - √ 
41 F 49 3 b W W 10 1 7 0 36 1 √ - - - - √ 
42 M 52 1 b W W 12 8 8 0 86 1 √ - √ - - √ 
43 F 43 1 b W W 12 5 7 1 48 22 - √ - - - - 
44 F 36 4 a I W 9 1 7 0 34 18 √ √ √ √ √ √ 
45 M 45 2 a W W 16 2 6 1 54 5 √ √ √ - - - 

























Key Physical Findings at inception 

















47 F 47 2 c W W 16 3 9 0 40 16 √ - - - - - 
48 M 29 1 b W W 10 1 8 1 18 10 √ √ √ - - - 
49 M 38 3 b I W 10 1 8 0 38 1 √ √ √ √ - √ 
50 M 33 1 c W W 14 0 8 0 44 2 - √ - - - - 
51 F 33 2 c W W 18 0 10 0 64 4 √ - - - - - 
52 F 44 2 b W W 12 0 9 0 34 1 √ - √ - - - 
53 F 29 2 b I W 10 1 8 0 36 5 √ √ √ - - √ 
54 M 30 1 b W W 14 0 8 0 34 2 √ √ √ - - - 
55 F 26 1 c W W 22 0 8 0 84 1 √ √ √ - - - 
56 F 41 1 a I W 22 0 9 0 76 2 - √ - √ - - 
57 M 44 2 a  W W 7 0 8 0 42 0 √ √ √ - - - 
58 M 50 4 b I W 8 3 4 1 16 2 √ √ √ - √ √ 
59 F 40 1 c W W 18 1 9 0 74 18 - √ - - - - 
60 M 41 2 b I ? 20 ? 8 ? 74 ? √ √ √ √- - √ 
 
Key 
QTF =  Quebec Task Force Classification  
  1 Pain without radiation 
  2 Pain with radiation to extremity (proximally) 
  3 Pain with radiation to extremity (distally) 
  4 Pain with radiation to extremity (with neurological signs - NC) 
  a < 7 days duration 
  b  7 days to 7 weeks duration 
  c > 7 weeks duration 
  W Working 
  I Idle (off work/sick) 
M =  Male 
F = Female 
NPRS = Narrative Pain Rating Scale 
ODI = Oswestry Disability Score 
DC = Discharge 
LspF = Lumbar spine Flexion range of movement 
LspE = Lumbar spine Extension range of movement 
LspLF = Lumbar spine Lateral Flexion range of movement 
HipIR = Hip Internal range of movement 
NC = Neural Conductivity Tests (myotomes, Dermatomes and Reflexes) 
ND = Neurodynamic tests (straight leg raise, passive knee flexion, slump) 
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1 36.6 114.5 45.1 1 33.2 75.8 43.5 2 14.7 30.3 27.7 2 
2 54.8 120.6 150.0 2 52.2 166.7 99.8 1 44.7 77.1 41.2 2 
3 91.6 230.5 106.7 1 98.4 230.5 194.4 1 100.0 159.8 156.1 4 
4 68.9 133.1 242.3 3 151.1 197.6 192.0 2 107.6 163.1 189.3 1 
5 84.2 437.4 87.0 1 76.7 204.4 165.5 1 94.9 180.6 173.2 1 
6 73.3 229.1 120.1 1 69.4 165.3 93.5 1 67.5 89.3 114.8 2 
7 56.3 123.7 166.7 2 78.2 173.1 129.6 2 70.3 113.3 245.9 1 
8 120.5 277.0 129.6 3 62.2 136.7 99.8 1 150.6 211.5 187.3 1 
9 129.0 279.2 242.3 3 156.4 259.7 165.1 3 107.6 163.1 189.3 1 
10 55.3 181.0 87.0 2 65.9 173.2 139.4 1 116.4 230.5 157.7 1 
11 79.3 279.2 75.5 1 76.7 201.7 165.5 1 94.9 180.6 104.9 1 
12 56.4 165.2 154.7 2 83.7 228.7 119.8 1 107.6 163.1 189.3 1 
13 69.5 135.3 150.8 3 77.3 325.9 131.9 2 67.5 119.3 114.8 2 
14 132.9 400.2 231.0 1 133.3 396.8 389.4 1 199.3 315.6 297.5 1 
15 77.4 259.7 155.8 2 53.7 220.0 131.5 2 90.9 232.3 121.4 1 
16 14.8 107.7 34.3 1 20.2 139.1 67.6 1 14.6 65.4 57.4 2 
17 110.6 285.6 179.8 3 72.6 174.6 112.6 1 87.5 187.9 98.7 1 
18 102.1 225.8 195.7 3 175.1 194.7 193.1 3 190.8 264.1 237.9 1 
19 120.5 236.3 129.6 1 118.6 360.2 186.4 1 151.6 210.6 177.3 1 
20 82.1 259.8 195.7 3 145.4 204.5 134.1 1 186.4 220.8 204.3 1 
21 36.6 105.6 45.5 2 23.2 55.3 41.3 1 14.7 30.3 27.7 2 
22 54.9 162.0 104.7 1 65.9 187.1 139.4 3 68.3 147.5 102.0 2 
23 92.7 219.2 104.2 1 70.5 142.5 111.0 1 101.0 187.8 173.1 4 
24 156.4 325.9 165.1 2 156.1 340.6 302.5 1 150.6 211.5 187.3 1 
25 50.6 396.8 68.2 1 60.4 105.8 79.7 1 70.8 154.2 109.0 1 
26 102.9 406.5 170.6 1 104.7 204.4 156.5 1 132.5 257.3 207.9 2 
27 58.0 139.1 168.3 1 83.1 157.8 130.9 1 44.7 77.1 41.2 1 
28 79.5 174.6 122.6 2 85.0 217.8 235.2 3 80.5 180.5 90.5 1 
29 127.5 277.2 242.3 3 129.2 282.7 209.4 1 107.6 263.1 189.3 1 
30 57.1 180.9 85.0 1 101.1 170.8 165.5 2 68.3 147.5 102.0 1 
31 111.6 279.2 149.1 2 95.6 201.6 174.2 4 94.9 180.6 104.9 1 
32 56.4 165.5 109.1 2 65.3 176.3 106.6 2 107.6 263.1 189.3 1 
33 77.3 235.3 131.9 3 63.2 128.9 80.0 2 80.5 213.7 147.3 2 
34 131.9 389.4 133.3 1 146.1 348.7 202.5 1 199.3 217.2 297.5 1 
35 141.7 282.7 258.9 1 145.4 204.5 174.1 3 90.9 132.3 121.4 1 
36 20.2 156.5 67.6 1 20.4 139.1 67.2 1 44.3 115.4 57.4 2 
37 72.7 220.0 112.6 1 96.2 214.4 162.4 2 113.5 263.1 64.0 1 
38 96.0 202.2 198.8 3 162.7 225.3 186.0 1 190.8 264.1 237.9 1 
39 120.5 235.1 129.6 1 156.1 340.6 302.5 2 107.6 114.9 189.3 1 
40 82.3 259.8 195.7 3 186.1 377.6 302.5 2 186.4 220.8 204.3 1 
41 36.6 110.5 45.0 2 38.3 80.5 53.7 1 32.3 60.3 27.7 2 
42 24.8 153.2 104.9 1 104.1 144.2 138.1 2 87.5 187.9 98.7 2 
43 90.8 240.6 103.8 1 94.4 201.5 112.9 1 102.0 177.8 175.1 1 
44 129.2 315.6 209.9 1 123.7 295.2 131.9 2 107.6 193.1 189.3 1 
45 60.2 191.1 124.0 1 96.8 192.9 142.3 1 70.8 154.2 109.0 1 
46 53.7 131.5 115.4 1 52.7 231.2 145.0 2 56.0 119.3 107.2 2 
47 55.8 190.8 168.3 2 90.2 293.9 148.3 3 70.3 113.3 245.9 1 
48 113.2 203.8 178.6 2 113.6 235.1 245.2 2 150.6 211.5 187.3 1 
49 128.9 279.2 242.3 2 156.1 340.6 302.5 2 107.6 130.5 189.3 1 
50 56.3 180.8 88.0 1 98.4 230.5 194.4 1 113.5 230.5 157.7 1 
51 69.6 269.1 114.4 1 69.2 153.2 113.4 1 44.7 77.1 41.2 1 



































52 100.5 265.7 147.3 3 95.6 201.6 174.2 2 80.5 113.7 119.0 2 
53 120.6 297.5 199.3 1 223.7 395.2 331.9 1 199.3 315.6 297.5 1 
54 90.9 230.5 121.4 1 67.5 241.7 104.7 1 90.9 132.3 114.8 1 
55 14.6 133.1 57.4 1 12.6 139.1 67.6 1 14.6 115.4 57.4 2 
56 124.0 437.4 144.5 1 90.7 183.9 124.3 2 68.3 139.4 76.4 1 
57 80.3 229.1 144.2 2 119.6 205.9 159.5 1 190.8 264.1 207.9 1 
58 82.7 163.7 145.7 1 63.2 128.9 80.0 2 107.6 163.1 64.0 1 
59 64.5 277.0 142.7 3 156.1 340.6 302.5 4 186.4 220.8 204.3 3 
60 63.4 279.2 131.8 3 - - - - - - - - 
 
Key to treatment Types:- 
 
1 = Spinal Manipulation 
2 = MWM 
3 = McKenzie EIL 
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Appendix XIII – Comparisons between the patient & the asymptomatic group  
 
Demographic, Anthropometric data and Experimental data extraction 
 
The data from participants recruited into the pre-clinical study (n=50) were 
compared with a random sample of the patient participants (data was taken from all 
3 data capture points where data was available for the treatments under 
investigation; the total number of manipulation events = 123, the total number of EIL 
events = 56 – it is of note that in some cases both treatments were conducted within 
the same treatment episode but only one treatment response was used for the 
analysis) from the clinical study (n=50). Concealed random selection was achieved 
by the constructing a random numbers table (in the nQuery software package) and 
selecting 50 patients (see tables below).  
Table: The allocation of patient participants from the data pool for manipulation 
(Manip) and EIL (McKenzie extension in lying exercise) treatment groups (where A = 















1 Manip A  26 EIL B 
2 EIL C  27 Manip C 
3 Manip C  28 Manip C 
4 EIL B  29 Manip A 
5 EIL B  30 EIL B 
6 Manip A  31 Manip A 
7 Manip C  32 EIL B 
8 EIL B  33 Manip A 
9 EIL B  34 EIL C 
10 Manip A  35 Manip A 
11 Manip A  36 EIL B 
12 EIL C  37 Manip A 
13 Manip C  38 EIL B 
14 Manip A  39 EIL B 
15 Manip A  40 Manip A 
16 EIL B  41 EIL B 
17 EIL B  42 EIL B 
18 EIL C  43 EIL C 
19 Manip A  44 Manip C 
20 EIL C  45 EIL B 
21 Manip A  46 EIL B 
22 EIL B  47 Manip A 
23 EIL C  48 EIL C 
24 Manip A  49 Manip C 
25 Manip C  50 Manip A 
 
Prior to allocating which data was extracted for which patient, each patient was 
identified as to which treatments had been performed on them (regardless of 
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whether it was a maximum effect recording or not), for the manipulation procedure 
123 events were identified within the 178 treatments episodes conducted. For the 
EIL technique, 56 events were recorded. Thirty two patients received both 
treatments within the same episode of care. Therefore, a data pool consisting of 
three groups was created for the randomization process (A = manipulation n=91; B 
= EIL = 24; C = manipulation and EIL = 32) and the data was extracted according to 
the treatment data required/allocated for that patient number. For both the clinical 
(patient) and the experimental (asymptomatic) groups, data was extracted that 
identified the independent participants as having a SCR to either the manipulation 
technique or the McKenzie EIL technique.  
 
Demographic comparisons (age and gender) were conducted between the two 
groups to detect any differences in age and gender between the groups. Results 
demonstrated that there was group homogeneity (ie that there was no statistically 
significant difference between the patient and the asymptomatic groups) regarding 
age (t-test: t= -0.890; p=0.376) and gender (Mann-Whitney U; z= -1.0; p= 0.317) 
where the level of significance was set at 95% (p <0.05). Analysis of recordings of 
the baseline levels of SC activity between the 2 treatments also revealed no 
statistically significant differences (level of significance set at 95%, p <0.05) 
between the patient and the asymptomatic groups (independent t-test; t=1.836; p 
=0.07). These results indicated that there was evidence to suggest that there were 
no significant differences (in age, gender and baseline SC levels) between the two 
groups and satisfied the requirements of equality of group variance permitting 
further inferential analysis. A summary of the findings are provided in the table and 































n= 25 25 25 25 
Mean SCR (%) 76.35 35.74 200.80 104.66 
SD 75.07 24.02 176.94 58.45 
95% CI 25 to 123 12 to 73 127 to 273 80 to 129 
SC activity  
at baseline 
119 85 90 76 
SC activity in final 
rest period 
129 88 140 118 
















Figure: A clustered boxplot illustrating the magnitude of effect (percentage change 
from baseline of SC activity) of two different treatment modalities (Spinal 
Manipulation & McKenzie EIL) between the Asymptomatic and Patient groups.  



















Red line indicates 0% 
change in SNS 





Descriptive analysis of the comparisons between the treatment responses of the 
two groups revealed that there was a greater response to both treatments for the 
patient group compared to the asymptomatic group (pooled analysis of the right and 
left limbs) in the order of more than double the magnitude of response (see table 
above) with the manipulation treatment having the greatest magnitude of response 
(almost twice that of the McKenzie EIL treatment) within both the patient and the 
asymptomatic groups. A univariate 2-way ANOVA (utilizing a General Linear Model) 
was used in order to test the null hypothesis that there would be no difference in 
SCR between the two treatments (manipulation and McKenzie‘s EIL) and between 
the two groups (patient and asymptomatic participants). The dependent variable 
was the maximum SCR during the treatment with the group (patient and 
asymptomatic participants) being the fixed factor and the intervention (manipulation 
and McKenzie) being the random factor. Results revealed that there was a 
statistically significant difference between both factors; Group F=9.618, p=0.003 and 
Intervention F=12.410, p=0.001 (level of significance set at 95%, p <0.05).  
 
Therefore, regarding the nature of the effect on SCR, both groups experienced a 
sympathetic-excitatory response to both treatments. Within and between the 
groups, there was a significant difference between the SCRs of the two treatments 
with the manipulation technique having the greatest magnitude of response which 
was notably highest within the patient participants. Consequently, it was possible to 
reject the null hypothesis as there is evidence to support the alternative hypothesis 
that there is a difference within the groups (baseline to treatment) and a difference 
between the groups regarding the magnitude of SCR between the two treatments 
although these results should be interpreted with caution as the variance within 
each of the groups for each of the treatments is high (SD‘s) which might lead to a 
type I error (rejection of the null hypothesis when it might actually be true). However, 
there is a degree of separation between the two groups regarding the 95% CI for 
the two treatments, that is; for the manipulation technique 95% CI‘s for 
asymptomatics and patients were 25 to123 and 127 to 273 micro Mho‘s respectively 
and for the EIL treatment 95% confidence intervals were 12 to 73 and 80 to 129 
micro Mho‘s for the manipulation and EIL treatments respectively, thus providing 
some support for the rejection of the null hypothesis.    
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Baseline 60 81.72 33.86 4.37 72.98 90.47 14.60 156.40 
Treatment 
Period 
60 231.23 84.51 10.91 209.40 253.06 105.60 437.40 
Final Rest 
Period 
60 139.53 54.48 7.03 125.46 153.60 34.30 258.90 
Total 180 150.83 86.72 6.46 138.07 163.58 14.60 437.40 
SCR at Mid-
Point 
Baseline 59 98.00 47.88 6.23 85.52 110.48 12.63 223.65 
Treatment 
Period 
59 216.73 83.22 10.83 195.03 238.41 55.30 396.80 
Final Rest 
Period 
59 161.99 78.34 10.20 141.58 182.41 41.31 389.40 
Total 177 158.91 86.18 6.48 146.12 171.69 12.63 396.80 
SCR at 
Discharge 
Baseline 59 100.04 49.18 6.40 87.23 112.86 14.55 199.30 
Treatment 
Period 
59 198.81 69.45 9.04 180.71 216.91 60.30 315.60 
Final Rest 
Period 
59 143.78 70.44 9.17 125.43 162.14 27.70 297.50 
Total 177 147.55 75.26 5.66 136.38 158.71 14.55 315.60 
 
Table illustrating the PAWS (SPSS version 17) output for the post-hoc (Tukey HSD) Multiple 
Comparisons analysis of SC activity levels when compared to data capture point (inception, mid-
point and discharge) and treatment period (baseline, treatment and final rest period) *. The mean 
difference is significant at the .05 level. 
 
Dependent 
Variable Data Capture Point Data Capture Point 
Mean 









SC at Inception Baseline Period Treatment Period -149.51
*
 11.18 >0.0005 -176 -123 
Final Rest Period -57.81
*
 11.18 >0.0005 -84 -31 
Treatment Period Baseline Period 149.51
*
 11.18 >0.0005 123 176 
Final Rest Period 91.70 11.18 >0.0005 65 118 
Final Rest Period Baseline Period 57.81
*
 11.18 >0.0005 31 84 
Treatment Period -91.70* 11.18 >0.0005 -118 -65 
SC at Mid Point Baseline Period Treatment Period -118.72
*
 13.17 >0.0005 -150 -88 
Final Rest Period -54.73
*
 13.17 >0.0005 -95 -33 
Treatment Period Baseline Period 118.72
*
 13.17 >0.0005 88 150 
Final Rest Period 54.73
*
 13.17 >0.0005 24 86 
Final Rest Period Baseline Period 63.99
*
 13.17 >0.0005 33 95 
Treatment Period -54.72
*
 13.17 >0.0005 -86 -24 
SC at Discharge Baseline Period Treatment Period -98.77
*
 11.74 >0.0005 -126 -71 
Final Rest Period -43.74
*
 11.74 =0.001 -71 -16 
Treatment Period Baseline Period 98.77
*
 11.74 >0.0005 71 126 
Final Rest Period 55.02
*
 11.74 >0.0005 27 83 
Final Rest Period Baseline Period 43.74
*
 11.74 =0.001 16 71 
Treatment Period -55.02
*
 11.74 >0.0005 -83 -27 
l 
 





 Mean Std. Deviation N 
ODI at Inception 42.93 17.821 60 
RMDQ at Inception 12.22 4.423 60 
 
 
Spearman's rho ODI at Inception RMDQ at 
Inception 
 












Sig. (2-tailed) . >0.0005 
n 60 60 












Sig. (2-tailed) >0.0005 . 
n 60 60 






 ODI at Inception RMDQ at 
Inception 
ODI at Inception 
Pearson Correlation 1 .719
**
 
Sig. (2-tailed)  .000 
N 60 60 




Sig. (2-tailed) .000  
N 60 60 





Appendix XVI - Preliminary analyses of correlations between OM‘s (SCR, ODI and 
NPRS at Inception, at Mid-point and at Discharge. 
 
In order to explore the relationships between the OM‘s at the 3 data capture points, 
3 Null hypotheses were generated:- 
H0a 
“At the initial treatment episode (Inception), there will be no relationship 
between SCR‟s (during the treatment period of the session) and levels 
of functional disability (ODI) and intensity of pain (NPRS) recorded at 
that time point.” 
H0b 
“At the mid-point of the treatment programme (Mid-Pointrge), there will 
be no relationship between SCR‟s (during the treatment period of the 
session) and levels of functional disability (ODI) and intensity of pain 
(NPRS) recorded at that time point.” 
 
H0c 
“At the end of treatment programme (Discharge), there will be no 
relationship between SCR‟s (during the treatment period of the 
session) and levels of functional disability (ODI) and intensity of pain 
(NPRS) recorded at that time point.” 
  
OM Correlations at the initial appointment 
Preliminary analysis of the relationships between OM‘s (SCR during treatment, 















Figure: A matrix scatterplot chart illustrating the relationships between the 
SCR, ODI and NPRS at inception (with the best fit line provided in red) 
 
The matrix scatterplot chart above illustrates the inter-relationships between 
the variables SCR, ODI and NPRS at inception. Individual scatterplots for 





















Individual scatter-plots for comparisons between the primary OM (SCR at 
inception during the treatment period) and ODI and NPRS at inception. 
 
a) SCR and ODI  

















b) SCR and NPRS 
















c) ODI and NPRS  





All relationships can be described as being positive in direction and the extent 
(rho value) and statistical significance (using Pearson Correlation Coefficient 
analyses) of the relationships are presented in table i. 
Table: Pearson Correlation Coefficient results for the OM at Inception 
 
 NPRS at 









Sig. (2-tailed)  <0.0005 <0.0005 
N 60 60 60 





Sig. (2-tailed) <0.0005  <0.0005 
N 60 60 60 







Sig. (2-tailed) <0.0005 <0.0005  
N 60 60 60 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
Analysis of the correlations revealed that both secondary OM‘s (ODI and NPRS) 
were positively and significantly correlated to SCRs. For ODI there was a strong 
(Cohen‘s guidelines, 1988) positive linear correlation (r=0.821; p>0.0005) 
indicating that at inception greater SCR‘s (during treatment) are positively 
associated with higher ODI scores (higher reported functional disability). Another 
finding of this analysis was that there was also a statistically significant, moderate 
positive correlation between SCR‘s and NPRS (r=0.458; p=0.0005) indicating that 
higher levels of reported pain levels at inception were positively associated with 
higher SCRs to treatment. Furthermore, there was also a moderate positive 
correlation between higher levels of patient-reported pain and greater functional 
disability (r=0.525; p<0.0005).  
OM Correlations at Mid-Point 
An identical analysis to that described above was conducted for the OM data 




Figure: A matrix scatterplot chart illustrating the relationships between the 
SCR, ODI and NPRS at Mid-Point (with the best fit line provided in red) 
 
The matrix scatterplot chart above illustrates the inter-relationships between 
the variables SCR, ODI and NPRS at mid-point. Individual scatterplots for 





















Individual scatter-plots for comparisons between the primary OM (SCR at 
inception during the treatment period) and ODI and NPRS at inception. 
 
a) SCR and ODI  

















b) SCR and NPRS 















c) ODI and NPRS  





At mid-point the only statistically significant relationship was between the two 
secondary OM‘s (ODI and NPRS) which was a positive correlation (r=0.454; 
p<0.0005). All other relationships were weakly negative and failed to reach 
the level of statistical significance (p<0.05). Results are illustrated in the table 
below. 
Table: Pearson Correlation Coefficient results for the OM at Mid-Point 
 
 NPRS at  
Mid-Point 





NPRS at Mid-Point Pearson Correlation 1 0.454
**
 -0.163 
Sig. (2-tailed)  <0.0005 0.217 
N 59 59 59 
ODI at Mid-Point Pearson Correlation 0.454
**
 1 -0.139 
Sig. (2-tailed) <0.0005  0.293 
N 59 59 59 
SCR during treatment at  
Mid-Point 
Pearson Correlation -0.163 0.139 1 
Sig. (2-tailed) =0.217 =0.293  
N 59 59 59 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
These results might indicate that at mid-point whilst ODI and NPRS are correlated 
with changes (reductions) in functional disability reductions corresponding to 
changes (reductions) in pain, these correlations did not hold true for SCR‘s to the 
treatments undertaken.   
 
OM Correlations at Discharge 
Preliminary analysis of the relationships between OM‘s (SCR during treatment, 













Figure: A matrix scatterplot chart illustrating the relationships between the 
SCR, ODI and NPRS at discharge (with the best fit line provided in red) 
 
The matrix scatterplot chart above illustrates the inter-relationships between 
the variables SCR, ODI and NPRS at discharge. Individual scatterplots for 





















Individual scatter-plots for comparisons between the primary OM (SCR at 
inception during the treatment period) and ODI and NPRS at discharge. 
 
a) SCR and ODI  

















b) SCR and NPRS 
















c) ODI and NPRS  





As with the mid-point results, the results at discharge revealed a moderate, 
positive relationships between ODI and NPRS (r=0.543; p<0.0005). All other 
relationships were weakly negative and failed to reach the level of statistical 
significance (p<0.05). Results are illustrated in the table below. 
 
Table: Pearson Correlation Coefficient results for the OM at Inception 
 
 NPRS at 
discharge 





NPRS at discharge Pearson Correlation 1 0.543
**
 -0.159 
Sig. (2-tailed)  <0.0005 0.229 
N 59 59 59 
ODI at discharge Pearson Correlation 0.543
**
 1 -0.106 
Sig. (2-tailed) <0.0005  0.426 
N 59 59 59 




 -0.106 1 
Sig. (2-tailed) 0.229 0.426  
N 59 59 59 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
Again, these results might indicate that at discharge whilst ODI and NPRS are 
correlated with changes (reductions) in functional disability reductions 
corresponding to changes (reductions) in pain, these correlations did not hold true 
for SCR‘s to the treatments undertaken however, it is worthy of note that the data 
for NPRS and ODI falls within such low parameters (0-1 and 0-30 respectively) 
that true comparisons are difficult to make. 
Duration of symptoms and SCR 
Further analysis, using duration of symptoms (at the time of inception) as a 
factor revealed a moderate negative correlation (according to Cohen‘s 
guidelines, 1988) between SCR during treatment and the duration of symptoms 
prior to initial treatment (r= - 0.411, p = 0.001) suggesting that SCR‘s diminished 
as time to initial appointment was lengthened (see figure 21 overleaf). 
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Furthermore, there was also a moderate negative correlation between 
symptom duration and ODI score (r= -0.391, p=0.002) and a weak negative 
correlation between symptom duration and NPRS however, this failed to 
reach the significance level (r= -0.165, p=0.206). These results suggest that at 
inception the levels of SCR and ODI scores may be a product of the length of 
symptoms duration, albeit of only moderate strength. Duration of syptoms is 
not a statistically significant correlative factor in reported pain levels.  
 
Consequently, Null Hypothesis H02 can be rejected as there is evidence to 
support a positive linear correlation between the primary OM (SCR) and the 
secondary patient-reported subjective measures of functional disability (ODI) and 
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of pain (NPRS). It is also noted that these results may be partially confounded by 
the duration of symptoms prior to commencement of treatment. 













SCR 59 -95.4 23.1 -54.6 23.35 0.785 0.311 1.276 0.613 
ODI 59 -100.0 -21.4 -78.7 23.27 0.995 0.311 -0.263 0.613 
NPRS 59 -10.0 -3.0 -7.2 1.52 0.813 0.311 0.782 0.613 
RMDQ 59 -100.0 -27.3 -83.5 20.57 1.711 0.311 2.093 0.613 
 














Appendix  XVII: Additional Correlative analysis of SCR and RMDQ changes from 
inception to discharge 
 
SCR and RMDQ score changes from inception to discharge were converted into 
percentage change scores to normalise the data for correlative analysis. 
Descriptively the change scores are illustrated in the table and the figure below:- 
 
Outcome measure n Inception Discharge min max Percentage change 
SCR 59 217.31% 160.13% -95.40 23.09 -54.57% (+/- 23.35) 
RMDQ 59 12.68 1.61 -100 -27.27 -83.50% (+/- 20.57) 
 
Figure plotting the percentage change readings of RMDQ scores and SCR‘s 
from inception to discharge. 
 
 
Correlative analyses, using the Spearman Rho correlation coefficient inferred 
that there was not a statistically significant correlation between the two OM‘s. 
See table below. 
 
 SCR RMDQ 
Spearman's rho 
SCR %change 
(Inception to DC) 
Correlation Coefficient 1.000 0.091 
Sig. (2-tailed) - 0.492 
n 59 59 
RMDQ Change 
(Inception to DC 
Correlation Coefficient 0.091 1.0 
Sig. (2-tailed) 0.492 - 




Appendix XVIII - ROC curve Data Analysis 
 
Variable SCR at Inception (% change in SC Activity from baseline to treatment periods) 
Classification variable ODI (those achieving > or < 50% change from inception to discharge) 
   
Sample size   59 
Positive group :  ODI > 50% = 1 50 
Negative group :  ODI < 50% = 0 9 
   
Disease prevalence (%) unknown 
   
Area under the ROC curve (AUC)  
   






 0.619 to 0.853 
z statistic 3.564 
Significance level P (Area=0.5) 0.0004 
a
 DeLong et al., 1988 
b
 Binomial exact 
   
Youden index 
   
Youden index J 0.5200 
Associated criterion >195.08 
   
 
 
SCR at Inception (in Micro mhos's)


















Criterion values and coordinates of the ROC curve 
   
Criterion Sensitivity 95% CI Specificity 95% CI +LR 95% CI -LR 95% CI 
≥80.04 100.0 92.9 - 100.0 0.00 0.0 - 33.6 1.00 1.0 - 1.0   
>80.04 100.0 92.9 - 100.0 11.11 0.3 - 48.2 1.12 0.9 - 1.4 0.00  
>95.1 94.0 83.5 - 98.7 11.11 0.3 - 48.2 1.06 0.8 - 1.3 0.54 0.06 - 4.6 
>96.1 94.0 83.5 - 98.7 22.22 2.8 - 60.0 1.21 0.8 - 1.7 0.27 0.05 - 1.4 
>119.62 78.0 64.0 - 88.5 22.22 2.8 - 60.0 1.00 0.7 - 1.5 0.99 0.3 - 3.7 
>120.07 78.0 64.0 - 88.5 44.44 13.7 - 78.8 1.40 0.8 - 2.6 0.49 0.2 - 1.2 
>129.88 74.0 59.7 - 85.4 44.44 13.7 - 78.8 1.33 0.7 - 2.4 0.59 0.2 - 1.4 
>139.83 74.0 59.7 - 85.4 66.67 29.9 - 92.5 2.22 0.9 - 5.7 0.39 0.2 - 0.8 
>146.72 68.0 53.3 - 80.5 66.67 29.9 - 92.5 2.04 0.8 - 5.2 0.48 0.3 - 0.9 
>150.18 68.-0 53.3 - 80.5 77.78 40.0 - 97.2 3.06 0.9 - 10.5 0.41 0.2 - 0.7 
>185.31 56.0 41.3 - 70.0 77.78 40.0 - 97.2 2.52 0.7 - 8.8 0.57 0.4 - 0.9 
>188.52 56.0 41.3 - 70.0 88.89 51.8 - 99.7 5.04 0.8 - 32.5 0.49 0.3 - 0.7 
>193.54 52.0 37.4 - 66.3 88.89 51.8 - 99.7 4.68 0.7 - 30.3 0.54 0.4 - 0.8 
>195.08 52.0 37.4 - 66.3 100.00 66.4 – 100   0.48 0.4 - 0.6 
>811.64 0.0 0.0 - 7.1 100.00 66.4 - 100   1.00 1.0 - 1.0 
   
 
 
The Biopac systems‘ ability to predict (using maximum SC treatment 
responses in the initial treatment episode) functional outcome at discharge, 
utilizing a known, validated predictor (an ODI change score equal to or greater 
than 50% from inception to discharge; Flynn et al., 2002 and Childs et al., 
2004) was unknown as prior to this investigation, no clinical data for this type 
of analysis was available. Therefore, a preliminary analysis was undertaken to 
explore the potential.  
 
Altman (1991; p.320-321and 351-358), advises that in order to conduct a 
regression analysis to assess the predictive capacity of an unknown variable 
(SCR) against a known outcome predictor (ODI improvement score > 50% at 
discharge), direct logistic regression analysis should be performed. 
Consequently, the ODI improvement score (0-100%) was transformed into a 
binary, categorical outcome (achieved or did not achieve ≥50% improvement). 
Out of the 59 patients who provided data at both inception and discharge, 50 
(84.7%) achieved, at discharge, an overall outcome in ODI change score in 
excess of 50% improvement. Furthermore, Altman (1991; p284-285) advises 
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that in cases where natural regression to the mean might be a covariant factor 
in the findings (eg. age and duration of symptoms prior to commencement of 
treatment), it is necessary to include these factors within the analysis, and 
therefore, the model included the main independent variable (SCR at 
inception) and two covariant factors; age and duration of symptoms.  
 
The full model, containing all predictors, was statistically significant, Chi 
Squared (3, n=59) = 25.19, p < 0.0005, indicating that the model was able to 
distinguish between respondents who reported an improvement > 50% in ODI 
function and those who did not achieve 50% improvement. The model as a 
whole explained between 34.7% (Cox & Snell R square) and 60.5% 
(Nagelkerke R squared) of the variance in ODI change scores and correctly 
classified 86.4% of cases. As shown in the table below all three of the 
independent variables made a unique significant contribution to the model (SCR 
at inception, symptom duration and age). The strongest predictor of reporting an 
improvement in ODI score >50% was the max treatment SCR at inception, 
recording an odd ratio of 1.029 (p = 0.042).  
Table  : Logistic regression predicting likelihood of achieving a 50% 
improvement in ODI score from inception to discharge 
 




Max SCR at Inception 
(%) 
.028 .014 4.141 1 .042 1.029 1.001 1.057 
 Age (years) -.216 .088 5.997 1 .014 .806 .678 .958 
Symptom Duration 
(weeks) 
-.591 .239 6.113 1 .013 .554 .346 .885 




Notes regarding Area under the ROC curve, with standard error and 95% 
Confidence Interval 
This value can be interpreted as follows (Zhou, Abuchowski & McClish, 2002):  
 the average value of sensitivity for all possible values of specificity;  
 the average value of specificity for all possible values of sensitivity;  
 the probability that a randomly selected individual from the positive group has 
a test result indicating greater suspicion than that for a randomly chosen 
individual from the negative group.  
When the variable under study cannot distinguish between the two groups, i.e. where 
there is no difference between the two distributions, the area will be equal to 0.5 (the 
ROC curve will coincide with the diagonal). When there is a perfect separation of the 
values of the two groups, i.e. there no overlapping of the distributions, the area under 
the ROC curve equals 1 (the ROC curve will reach the upper left corner of the plot).  
The 95% Confidence Interval is the interval in which the true (population) Area under 
the ROC curve lies with 95% confidence.  
The Significance level or P-value is the probability that the observed sample Area 
under the ROC curve is found when in fact, the true (population) Area under the ROC 
curve is 0.5 (null hypothesis: Area = 0.5). If P is small (P<0.05) then it can be 
concluded that the Area under the ROC curve is significantly different from 0.5 and 
that therefore there is evidence that the test does have an ability to distinguish 
between the two groups.  
 
Youden index 
The Youden index J (Youden, 1950) is defined as:  
J = max { sensitivityc + specificityc - 1 } where c ranges over all possible 
criterion values. 
 




The criterion value corresponding with the Youden index J is the optimal criterion 
value only when disease prevalence is 50%, equal weight is given to sensitivity and 
specificity, and costs of various decisions are ignored.  
The next section indicates the different selection criteria or cut-off values with their 
corresponding sensitivity and specificity of the test, and the positive (+LR) and 
negative likelihood ratio (-LR).  
When a test is used either for the purpose of screening or to exclude a diagnostic 
possibility, a cut-off value with a high sensitivity may be selected; and when a the test 
is used to confirm a disease, a higher specificity may be required. 
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approach. Biometrics 44:837-845.  
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Appendix XVIV – The Direct Logistic Regression Analysis of SCR‘s as a predictor   
 
The Biopac systems‘ ability to predict (using maximum SC treatment 
responses in the initial treatment episode) functional outcome at discharge, 
utilizing a known, validated predictor (an ODI change score equal to or greater 
than 50% from inception to discharge;Flynn et al., 2002 and Childs et al., 
2004) was unknown as prior to this investigation, no clinical data for this type 
of analysis was available. Therefore, a preliminary analysis was undertaken to 
explore the potential.  
 
Altman (1991; p.320-321and 351-358), advises that in order to conduct a 
regression analysis to assess the predictive capacity of an unknown variable 
(SCR) against a known outcome predictor (ODI improvement score > 50% at 
discharge), direct logistic regression analysis should be performed. 
Consequently, the ODI improvement score (0-100%) was transformed into a 
binary, categorical outcome (achieved or did not achieve ≥50% improvement). 
Out of the 59 patients who provided data at both inception and discharge, 50 
(84.7%) achieved, at discharge, an overall outcome in ODI change score in 
excess of 50% improvement. Furthermore, Altman (1991; p284-285) advises 
that in cases where natural regression to the mean might be a covariant factor 
in the findings (eg. age and duration of symptoms prior to commencement of 
treatment), it is necessary to include these factors within the analysis, and 
therefore, the model included the main independent variable (SCR at 
inception) and two covariant factors; age and duration of symptoms.  
 
The full model, containing all predictors, was statistically significant, Chi 
Squared (3, n=59) = 25.19, p < 0.0005, indicating that the model was able to 
distinguish between respondents who reported an improvement > 50% in ODI 
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function and those who did not achieve 50% improvement. The model as a 
whole explained between 34.7% (Cox & Snell R square) and 60.5% 
(Nagelkerke R squared) of the variance in ODI change scores and correctly 
classified 86.4% of cases. As shown in the table below, all three of the 
independent variables made a unique significant contribution to the model (SCR 
at inception, symptom duration and age). The strongest predictor of reporting an 
improvement in ODI score >50% was the max treatment SCR at inception, 
recording an odd ratio of 1.029 (p = 0.042).  
 
Table  : Logistic regression predicting likelihood of achieving a 50% 
improvement in ODI score from inception to discharge 
 




Max SCR at Inception 
(%) 
.028 .014 4.141 1 .042 1.029 1.001 1.057 
 Age (years) -.216 .088 5.997 1 .014 .806 .678 .958 
Symptom Duration 
(weeks) 
-.591 .239 6.113 1 .013 .554 .346 .885 
Constant 11.745 4.535 6.707 1 .010 126149.776   
 
 
 
